FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gadotti, AC
   Deus, MD
   Telles, JP
   Wind, R
   Goes, M
   Ossoski, RGC
   de Padua, AM
   de Noronha, L
   Moreno-Amaral, A
   Baena, CP
   Tuon, FF
AF Gadotti, Ana Carolina
   Deus, Marina de Castro
   Telles, Joao Paulo
   Wind, Rafael
   Goes, Marina
   Charello Ossoski, Roberta Garcia
   de Padua, Alessandra Michalski
   de Noronha, Lucia
   Moreno-Amaral, Andrea
   Baena, Cristina Pellegrino
   Tuon, Felipe Francisco
TI IFN-gamma is an independent risk factor associated with mortality in
   patients with moderate and severe COVID-19 infection
SO VIRUS RESEARCH
LA English
DT Article
DE COVID-19; Immune response; Interleukin; Cytokines
ID INHIBITION
AB Background: Innate and adaptive immune responses have been evaluated in infected patients with COVID-19. The severity of the disease has been supposed to be associated with some profile not reported with other bacterial and viral pneumonia. We proposed a study in patients with moderate to severe COVID-19 infection to evaluate the interleukin patterns and its role as prognosis factors.
   Methods: A prospective cohort with moderate and severe cases of COVID-19 infection from June to July 2020. Blood samples from patients were collected regularly to evaluate IFN-gamma, TNIF-alpha, IL-4, IL-6, and IL-10. Clinical, laboratory, radiological data, and outcomes were recorded. The outcome variable was in-hospital death, survival, mechanical ventilation, and admission at the intensive care unit. Data are presented in median and interquartile range [IQR].
   Results: We evaluated the Th1 and Th2 responses according to evolution, distinguishing possible predictive markers. The IFN-gamma median of 323 pg/mL [IQR 166-570] was found in patients who died and 208 pg/mL [IQR 155-392] in the survival group (p = 0.017). IFN-gamma was also higher in the early stages of the disease (394 pg/mL [IQR 229-575] against 162 pg/mL [IQR 117-259], p < 0.001). IL-4 that was increased in late-stage (182 pg/mL [IQR 162-199] against 131 pg/mL [IQR 124-152], p < 0.001) but not associated with mortality. Also, death was also related to male gender (relative risk = 1.5 [95 % confidence interval = 1.1-2.0]).
   Conclusion: Our results suggest that the activation of the host immune response between Th1 or Th2 in COVID-19 infection may be related to the final result between discharge or death. This implies an attempt to control cytokines, such as IFN-gamma, with combined therapies for clinical treatment.
C1 [Gadotti, Ana Carolina; Deus, Marina de Castro; Moreno-Amaral, Andrea] Pontificia Univ Catolica Parana, Lab Anemia & Immunol Res LabAIRe, Curitiba, Parana, Brazil.
   [Telles, Joao Paulo; Wind, Rafael; Goes, Marina] Hosp Univ Evangelico Mackenzie, Curitiba, Parana, Brazil.
   [Telles, Joao Paulo] Pontificia Univ Catolica Parana, Hosp Univ Cajuru, Curitiba, Parana, Brazil.
   [Charello Ossoski, Roberta Garcia; de Padua, Alessandra Michalski; Baena, Cristina Pellegrino] Pontificia Univ Catolica Parana, Sch Med, PUC PR, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Expt Pathol Lab, Curitiba, Parana, Brazil.
   [Tuon, Felipe Francisco] Pontificia Univ Catolica Parana, Lab Emerging Infect Dis, Curitiba, Parana, Brazil.
RP Tuon, FF (corresponding author), Pontificia Univ Catolica Parana, Lab Emerging Infect Dis, Curitiba, Parana, Brazil.
EM felipe.tuon@pucpr.br
CR Abate SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235653
   Arnaldez FI, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000930
   Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   De Biasi S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17292-4
   Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283
   FORTI RL, 1985, J CLIN MICROBIOL, V21, P689, DOI 10.1128/JCM.21.5.689-693.1985
   Gimenez E, 2020, J MED VIROL, DOI 10.1002/jmv.26213
   Gong J, 2020, CLIN INFECT DIS, V71, P833, DOI 10.1093/cid/ciaa443
   Han H, 2020, EMERG MICROBES INFEC, V9, P1123, DOI 10.1080/22221751.2020.1770129
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7
   Liang W La H, 2020, JAMA INT MED, DOI [10.1001/jamainternmed.2020.2033, DOI 10.1001/]
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   Luo Y., 2020, J CLIN IMMUNOL, DOI [10.1007/s10875-020-00821-00827., DOI 10.1007/S10875-020-00821-00827]
   Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451
   Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
   Robinson CM, 2010, J INNATE IMMUN, V2, P56, DOI 10.1159/000247156
   Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630
   Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017
   WHO, 2020, CLIN MAN SEV AC RESP
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wurtz O, 2004, INT IMMUNOL, V16, P501, DOI 10.1093/intimm/dxh050
   Xiong XL, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105953
   XU B, 2020, J INFECTION, V81, pE51, DOI 10.1016/j.jinf.2020.04.012
   Xu Dachun, 2020, medRxiv, DOI 10.1101/2020.04.30.20081257
   Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5
   Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6
   Zhang Haocheng, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa663
   Zhang XN, 2020, NATURE, V583, P437, DOI 10.1038/s41586-020-2355-0
NR 30
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD NOV
PY 2020
VL 289
AR 198171
DI 10.1016/j.virusres.2020.198171
PG 7
WC Virology
SC Virology
GA OE6FT
UT WOS:000580625200019
PM 32979474
OA Green Published
DA 2020-12-08
ER

PT J
AU de Paula, CBV
   de Azevedo, MLV
   Nagashima, S
   Martins, APC
   Malaquias, MAS
   Miggiolaro, AFRD
   Motta, JD
   Avelino, G
   do Carmo, LAP
   Carstens, LB
   de Noronha, L
AF Vaz de Paula, Caroline Busatta
   Viola de Azevedo, Marina Luise
   Nagashima, Seigo
   Camargo Martins, Ana Paula
   Scaranello Malaquias, Mineia Alessandra
   Ribeiro dos Santos Miggiolaro, Anna Flavia
   Motta Junior, Jarbas da Silva
   Avelino, Gibran
   Panini do Carmo, Leticia Arianne
   Carstens, Lucas Baena
   de Noronha, Lucia
TI IL-4/IL-13 remodeling pathway of COVID-19 lung injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CYTOKINE STORM
AB The COVID-19 fatality rate is high when compared to the H1N1pdm09 (pandemic Influenza A virus H1N1 subtype) rate, and although both cause an aggravated inflammatory response, the differences in the mechanisms of both pandemic pneumonias need clarification. Thus, our goal was to analyze tissue expression of interleukins 4, 13, (IL-4, IL-13), transforming growth factor-beta (TGF-beta), and the number of M2 macrophages (Sphingosine-1) in patients who died by COVID-19, comparing with cases of severe pneumopathy caused by H1N1pdm09, and a control group without lung injury. Six lung biopsy samples of patients who died of SARS-CoV-2 (COVID-19 group) were used and compared with ten lung samples of adults who died from a severe infection of H1N1pdm09 (H1N1 group) and eleven samples of patients who died from different causes without lung injury (CONTROL group). The expression of IL-4, IL-13, TGF-beta, and M2 macrophages score (Sphingosine-1) were identified through immunohistochemistry (IHC). Significantly higher IL-4 tissue expression and Sphingosine-1 in M2 macrophages were observed in the COVID-19 group compared to both the H1N1 and the CONTROL groups. A different mechanism of diffuse alveolar damage (DAD) in SARS-CoV-2 compared to H1N1pdm09 infections were observed. IL-4 expression and lung remodeling are phenomena observed in both SARS-CoV-2 and H1N1pdm09. However, SARS-CoV-2 seems to promote lung damage through different mechanisms, such as the scarce participation Th1/Th17 response and the higher participation of the Th2. Understanding and managing the aggravated and ineffective immune response elicited by SARS-CoV-2 merits further clarification to improve treatments propose.
C1 [Vaz de Paula, Caroline Busatta; Nagashima, Seigo; Scaranello Malaquias, Mineia Alessandra; Ribeiro dos Santos Miggiolaro, Anna Flavia; Motta Junior, Jarbas da Silva] Pontificia Univ Catolica Parana PUCPR, Postgrad Program Hlth Sci, Sch Med, Rua Imaculada Conceicao 1155, Curitiba, PR, Brazil.
   [Viola de Azevedo, Marina Luise; Camargo Martins, Ana Paula; de Noronha, Lucia] Pontificia Univ Catolica Parana PUCPR, Sch Med, Lab Expt Pathol, R Imaculada Conceicao 1155, Curitiba, PR, Brazil.
   [Avelino, Gibran] Pontificia Univ Catolica Parana PUCPR, Sch Med, Hosp Marcelino Champagnat, R Imaculada Conceicao 1155, Curitiba, PR, Brazil.
   [Panini do Carmo, Leticia Arianne; Carstens, Lucas Baena] Pontificia Univ Catolica Parana PUCPR, Sch Med, R Imaculada Conceicao 1155, Curitiba, PR, Brazil.
RP de Paula, CBV (corresponding author), Pontificia Univ Catolica Parana PUCPR, Postgrad Program Hlth Sci, Sch Med, Rua Imaculada Conceicao 1155, Curitiba, PR, Brazil.
EM carolbvaz@gmail.com
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [304356/2018-2]
FX LN is a researcher from CNPq (304356/2018-2).
CR Ackermann M, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00933-2019
   Akbari H, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118167
   Alhetheel Abdulkarim, 2020, Int Immunol, V32, P799, DOI 10.1093/intimm/dxaa047
   [Anonymous], 2010, CDC EST 2009 H1N1 IN
   Arriaga-Pizano L, 2015, ARCH MED RES, V46, P651, DOI 10.1016/j.arcmed.2015.12.003
   Barton LM, 2020, AM J CLIN PATHOL, V20, P1
   Bonafe M, 2020, CYTOKINE GROWTH F R, V53, P33, DOI 10.1016/j.cytogfr.2020.04.005
   Cunha LL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01748
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Du H, 2020, ALLERGY, DOI 10.1111/all.14452
   Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016
   Han H, 2020, EMERG MICROBES INFEC, V9, P1123, DOI 10.1080/22221751.2020.1770129
   Jin YF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040372
   Kalil AC, 2020, JAMA-J AM MED ASSOC, V323, P1897, DOI 10.1001/jama.2020.4742
   Lin L, 2020, CLIN IMMUNOL, V218, DOI 10.1016/j.clim.2020.108524
   Martinez-Ocana J, 2013, J CLIN VIROL, V58, P108, DOI 10.1016/j.jcv.2013.05.013
   McLeod JJA, 2015, CYTOKINE, V75, P57, DOI 10.1016/j.cyto.2015.05.019
   Meftahi GH, 2020, INFLAMM RES, V69, P825, DOI 10.1007/s00011-020-01372-8
   Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
   Menezes-Rodrigues FS, 2020, J THROMB HAEMOST, V18, P2073, DOI 10.1111/jth.14902
   Motta JD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.574862
   Passalacqua G, 2017, PULM PHARMACOL THER, V45, P95, DOI 10.1016/j.pupt.2017.05.007
   Patruno C, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13502
   Prompetchara E, 2020, ASIAN PAC J ALLERGY, V38, P1, DOI 10.12932/AP-200220-0772
   Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9
   Rokni M, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2107
   Sarzi-Puttini P, 2020, CLIN EXP RHEUMATOL, V38, P337
   Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
   SONG J, 2020, ALLERGY 0811, DOI DOI 10.1111/all.14517
   Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI 10.1056/NEJMra1608077
   Wang FQ, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106443
   Wong CK, 2010, EUR RESPIR J, V35, P883, DOI 10.1183/09031936.00088309
   Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zhang T, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, P496, DOI 10.3760/cma.j.cn112147-20200311-00312
   Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC
NR 36
TC 0
Z9 0
U1 0
U2 0
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 29
PY 2020
VL 10
IS 1
AR 18689
DI 10.1038/s41598-020-75659-5
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA OO9KN
UT WOS:000587692300086
PM 33122784
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Nagashima, S
   Mendes, MC
   Martins, APC
   Borges, NH
   Godoy, TM
   Miggiolaro, AFRD
   Deziderio, FD
   Machado-Souza, C
   de Noronha, L
AF Nagashima, Seigo
   Mendes, Monalisa Castilho
   Martins, Ana Paula Camargo
   Borges, Nicolas Henrique
   Godoy, Thiago Mateus
   Ribeiro dos Santos Miggiolaro, Anna Flavia
   Deziderio, Felipe da Silva
   Machado-Souza, Cleber
   de Noronha, Lucia
TI Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief
   Report
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Article
DE coronavirus; COVID-19; pandemics; pyroptosis; thrombosis
AB Objective: Alveolar-capillary endothelial cells can be activated by severe acute respiratory syndrome coronavirus 2 infection leading to cytokine release. This could trigger endothelial dysfunction, pyroptosis, and thrombosis, which are the vascular changes, commonly referred to as coronavirus disease 2019 (COVID-19) endotheliopathy. Thus, this study aimed to identify tissue biomarkers associated with endothelial activation/dysfunction and the pyroptosis pathway in the lung samples of patients with COVID-19 and to compare them to pandemic influenza A virus H1N1 subtype 2009 and control cases. Approach and Results: Postmortem lung samples (COVID-19 group =6 cases; H1N1 group =10 cases, and control group =11 cases) were analyzed using immunohistochemistry and the following monoclonal primary antibodies: anti-IL (interleukin)-6, anti-TNF (tumor necrosis factor)-alpha, anti-ICAM-1 (intercellular adhesion molecule 1), and anticaspase-1. From the result, IL-6, TNF-alpha, ICAM-1, and caspase-1 showed higher tissue expression in the COVID-19 group than in the H1N1 and control groups. Conclusions: Our results demonstrated endothelial dysfunction and suggested the participation of the pyroptosis pathway in the pulmonary samples. These conditions might lead to systemic thrombotic events that could impair the clinical staff's efforts to avoid fatal outcomes. One of the health professionals' goals should be to identify the high risk of thrombosis patients early to block endotheliopathy and its consequences.
C1 [Nagashima, Seigo; Ribeiro dos Santos Miggiolaro, Anna Flavia] Pontificia Univ Catolica Parana PUCPR, Sch Med, Postgrad Program Hlth Sci, Curitiba, Parana, Brazil.
   [Martins, Ana Paula Camargo; de Noronha, Lucia] Pontificia Univ Catolica Parana PUCPR, Sch Med, Lab Expt Pathol, Curitiba, Parana, Brazil.
   [Mendes, Monalisa Castilho] Inst Pesquisa Pele Pequeno Principe IPPPP, Fac Pequeno Principe FPP, Postgrad Biotechnol Appl Hlth Children & Adolesce, Curitiba, Parana, Brazil.
   [Borges, Nicolas Henrique; Godoy, Thiago Mateus] Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, Parana, Brazil.
   [Machado-Souza, Cleber] Inst Pesquisa Pele Pequeno Principe IPPPP, Fac Pequeno Principe FPP, Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Lab Patol Expt, Rua Imaculada Conceicao 1155, Curitiba, Parana, Brazil.
EM noronha@gmail.com
RI ; noronha, lucia/F-6339-2015
OI Castilho Mendes, Monalisa/0000-0003-2232-8720; Godoy, Thiago
   Mateus/0000-0002-1461-7656; Borges, Nicolas
   Henrique/0000-0003-2529-3869; noronha, lucia/0000-0003-0310-7164
FU Faculdades Pequeno Principe; Universidade Federal do Parana; Pontificia
   Universidade Catolica do Parana
FX We are grateful to the Faculdades Pequeno Principe, Universidade Federal
   do Parana, and Pontificia Universidade Catolica do Parana for their
   support.
CR Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432
   Henry BM, 2020, CLIN CHIM ACTA, V507, P167, DOI 10.1016/j.cca.2020.04.027
   Woywodt A, 2002, NEPHROL DIAL TRANSPL, V17, P1728, DOI 10.1093/ndt/17.10.1728
   Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223
   Yang M, 2020, SSRN ELECT J
NR 5
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1079-5642
EI 1524-4636
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD OCT
PY 2020
VL 40
IS 10
BP 2404
EP 2407
DI 10.1161/ATVBAHA.120.314860
PG 4
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA NY4ZL
UT WOS:000576399500010
PM 32762443
OA Green Published
DA 2020-12-08
ER

PT J
AU Motta, JD
   Miggiolaro, AFRD
   Nagashima, S
   de Paula, CBV
   Baena, CP
   Scharfstein, J
   de Noronha, L
AF Motta Junior, Jarbas da Silva
   Ribeiro dos Santos Miggiolaro, Anna Flavia
   Nagashima, Seigo
   Vaz de Paula, Caroline Busatta
   Baena, Cristina Pellegrino
   Scharfstein, Julio
   de Noronha, Lucia
TI Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway
   That May Link Interstitial Edema to Immunothrombosis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE SARS-CoV-2; COVID 19; mast cells (MC); cell-mediated immunity; immune
   responses; interleukin-4 (IL-4)
ID ACTIVATION; SYSTEM; ACE2
AB It is currently believed that innate immunity is unable to prevent the spread of SARS-CoV-2 from the upper airways to the alveoli of high-risk groups of patients. SARS-CoV-2 replication in ACE-2-expressing pneumocytes can drive the diffuse alveolar injury through the cytokine storm and immunothrombosis by upregulating the transcription of chemokine/cytokines, unlike several other respiratory viruses. Here we report histopathology data obtained in post-mortem lung biopsies of COVID-19, showing the increased density of perivascular and septal mast cells (MCs) and IL-4-expressing cells (n= 6), in contrast to the numbers found in pandemic H1N1-induced pneumonia (n= 10) or Control specimens (n= 10). Noteworthy, COVID-19 lung biopsies showed a higher density of CD117(+)cells, suggesting that c-kit positive MCs progenitors were recruited earlier to the alveolar septa. These findings suggest that MC proliferation/differentiation in the alveolar septa might be harnessed by the shift toward IL-4 expression in the inflamed alveolar septa. Future studies may clarify whether the fibrin-dependent generation of the hyaline membrane, processes that require the diffusion of procoagulative plasma factors into the alveolar lumen and the endothelial dysfunction, are preceded by MC-driven formation of interstitial edema in the alveolar septa.
C1 [Motta Junior, Jarbas da Silva; Ribeiro dos Santos Miggiolaro, Anna Flavia; Nagashima, Seigo; Vaz de Paula, Caroline Busatta; Baena, Cristina Pellegrino; de Noronha, Lucia] Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, Parana, Brazil.
   [Motta Junior, Jarbas da Silva; Ribeiro dos Santos Miggiolaro, Anna Flavia; Baena, Cristina Pellegrino] Hosp Marcelino Champagnat, Curitiba, Parana, Brazil.
   [Scharfstein, Julio] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Baena, CP (corresponding author), Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, Parana, Brazil.; Baena, CP (corresponding author), Hosp Marcelino Champagnat, Curitiba, Parana, Brazil.
EM cristina.baena@pucpr.br
FU CAPES COVID 19 scholarshipCAPES; FAPERJ/PronexCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/210.899/2016, CNE E-26/202.911/2017 CNPQ/Uni 432841/2016-4]
FX AM was a recipient from a CAPES COVID 19 scholarship, LN was a
   researcher from CNPq, and JS was a recipient of FAPERJ/Pronex
   E-26/210.899/2016; CNE E-26/202.911/2017 CNPQ/Uni 432841/2016-4.
CR Bawazeer MA, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172760
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Carvelli J, 2020, NATURE, DOI 10.1038/s41586-020-2600-6
   Fox S.E., 2020, PULMONARY CARDIAC PA, DOI [10.1101/2020.04.06.20050575, 10.1101/2020.04.06.20050575., DOI 10.1101/2020.04.06.20050575]
   Guilarte M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00846
   Henry BM, 2020, CLIN CHIM ACTA, V507, P167, DOI 10.1016/j.cca.2020.04.027
   Kritas SK, 2020, J BIOL REG HOMEOS AG, V34, P9, DOI 10.23812/20-Editorial-Kritas
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825
   Marshall JS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174241
   Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823
   Nascimento CR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00840
   Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008
   Patel AB, 2017, J PHARMACOL EXP THER, V361, P462, DOI 10.1124/jpet.117.240564
   Ponomaryov T, 2017, CIRC RES, V121, P941, DOI 10.1161/CIRCRESAHA.117.311185
   Sala-Cunill A, 2015, J ALLERGY CLIN IMMUN, V135, P1031, DOI 10.1016/j.jaci.2014.07.057
   Scharfstein J, 2018, CURR OPIN HEMATOL, V25, P347, DOI 10.1097/MOH.0000000000000444
   Skaria T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156002
   Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016
   Theoharides TC, 2020, BIOFACTORS, V46, P306, DOI 10.1002/biof.1633
   van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555
   Wang H Q, 2020, Zhonghua Yu Fang Yi Xue Za Zhi, V54, P713, DOI 10.3760/cma.j.cn112150-20200403-00508
   Wang J, 2014, EMBO MOL MED, V6, P952, DOI 10.15252/emmm.201303811
   Weng Z, 2015, J ALLERGY CLIN IMMUN, V135, P1044, DOI 10.1016/j.jaci.2014.10.032
   Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117
   Zhao XF, 2020, EPMA J, V11, P139, DOI 10.1007/s13167-020-00208-z
   Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146
NR 28
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 18
PY 2020
VL 11
AR 574862
DI 10.3389/fimmu.2020.574862
PG 6
WC Immunology
SC Immunology
GA NY5XH
UT WOS:000576461500001
PM 33042157
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Gewehr, DM
   Salgueiro, GR
   de Noronha, L
   Kubrusly, FB
   Kubrusly, LF
   Coltro, GA
   Preto, PC
   Bertoldi, AD
   Vieira, HI
AF Gewehr, Douglas Mesadri
   Salgueiro, Gabriela Rodrigues
   de Noronha, Lucia
   Kubrusly, Fernando Bermudez
   Kubrusly, Luiz Fernando
   Coltro, Gabriel Antonio
   Preto, Paola Cardoso
   Bertoldi, Andressa de Souza
   Vieira, Heloisa Iacomo
TI Plexiform Lesions in an Experimental Model of Monocrotalin-Induced
   Pulmonary Arterial Hypertension
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA English
DT Article
DE Monocrotaline; Vascular Remodeling; Neointimal; Pulmonary hypertension;
   Right Ventricular Hypertrophy
ID ANIMAL-MODEL; PATHOLOGY; PROLIFERATION; REVERSIBILITY; DYSFUNCTION; RATS
AB Background: The monocrotaline (MCT)-induced pulmonary arterial hypertension model is one of the most reproduced today, presenting as a limitation the absence of plexiform lesions, typical manifestations of the severe disease in humans.
   Objective: To evaluate the severity of MCT-induced pulmonary arteriopathy by pathological findings of lung and heart tissue samples, clinical course and 37-day survival.
   Methods: Fifty male Wistar rats were divided into one of the four groups - control (CG) (n = 10) and three intervention (MCT) groups. The MCT groups received intraperitoneal injection (60 mg/kg) of MCT and remained exposed to the substance for 15 days (G15, n = 10), 30 days (G30, n = 10) and 37 days (G37, n = 20). At the end of each period, the animals were sacrificed, and pulmonary and cardiac tissues were collected for anatomopathological and morphometric analysis. The Kruskal-Wallis test was used, considering a level of significance of 5%.
   Results: In the lungs of MCT animals, lesions related to pulmonary arteriopathy were found, including muscularization of the arterioles, hypertrophy of the middle layer and concentric neointimal lesions. Complex lesions were observed in MCT groups, described as plexiform and plexiform-like lesions. Right ventricular hypertrophy was evidenced by increased thickness and diameter of the cardiomyocytes and a significant increase in the right ventricular wall thickness (p <0.0000).
   Conclusion: The MCT model was able to generate moderate-severe pulmonary arteriopathy associated with secondary right ventricular hypertrophy. The 37-day survival rate was 50%. To our knowledge, this study was the first to note the presence of complex vascular lesions, similar to those observed in patients with severe pulmonary arterial hypertension, in an isolated MCT model.
C1 [Gewehr, Douglas Mesadri; Salgueiro, Gabriela Rodrigues; Kubrusly, Luiz Fernando; Coltro, Gabriel Antonio] Fac Evangelica Mackenzie Parana FEMPAR, Curitiba, Parana, Brazil.
   [Gewehr, Douglas Mesadri; Salgueiro, Gabriela Rodrigues; Kubrusly, Fernando Bermudez; Kubrusly, Luiz Fernando; Coltro, Gabriel Antonio; Bertoldi, Andressa de Souza] Inst Denton Cooley Pesquisa Ciencia & Tecnol IDC, Curitiba, Parana, Brazil.
   [de Noronha, Lucia; Preto, Paola Cardoso] Pontificia Univ Catholica Parana, Dept Med, Curitiba, Parana, Brazil.
   [Kubrusly, Fernando Bermudez; Kubrusly, Luiz Fernando] Inst Coracao Curitiba InCor Curitiba, Curitiba, Parana, Brazil.
   [Bertoldi, Andressa de Souza] Ctr Estudos & Pesquisa Emergencias Med & Terapia, Curitiba, Parana, Brazil.
   [Vieira, Heloisa Iacomo] Hosp Univ Evangelico Mackenzie HUEM, Curitiba, Parana, Brazil.
RP Gewehr, DM (corresponding author), Inst Denton Cooley Pesquisa Ciencia & Tecnol, Alameda Dr Carlos de Carvalho 2370, BR-80730201 Curitiba, Parana, Brazil.
EM douglasgewehr@gmail.com
RI Gewehr, Douglas/ABF-9938-2020
OI Gewehr, Douglas/0000-0001-9393-2445
FU Programa Institucional de Iniciacao Cientifica da Faculdade Evangelica
   Mackenzie do Parana
FX This study was partially funded by Programa Institucional de Iniciacao
   Cientifica da Faculdade Evangelica Mackenzie do Parana.
CR Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681
   Cabrini FPH, 2009, THESIS
   Campian ME, 2006, N-S ARCH PHARMACOL, V373, P391, DOI 10.1007/s00210-006-0087-9
   Coste F, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0533-x
   Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Gomez-Arroyo JG, 2012, AM J PHYSIOL-LUNG C, V302, pL363, DOI 10.1152/ajplung.00212.2011
   Guimaraes JI, 2005, ARQ BRAS CARDIOL S1, V84, P1
   HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533
   Hessel MHM, 2006, AM J PHYSIOL-HEART C, V291, pH2424, DOI 10.1152/ajpheart.00369.2006
   Hill NS, 2017, CHEST, V152, P1106, DOI 10.1016/j.chest.2017.10.007
   KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176
   LALICH JJ, 1962, J ATHEROSCLER RES, V2, P482, DOI 10.1016/S0368-1319(62)80020-9
   LALICH JJ, 1961, LAB INVEST, V10, P744
   Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005
   Martins P., 2010, THESIS
   Mathew R, 1995, CARDIOVASC RES, V30, P739, DOI 10.1016/0008-6363(95)00108-5
   Meyrick B, 2001, CLIN CHEST MED, V22, P393, DOI 10.1016/S0272-5231(05)70279-3
   Montani D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-97
   MOOI WJ, 2006, CURR DIAGN PATHOL, V12, P429, DOI DOI 10.1016/j.cdip.2006.07.003
   Morimatsu Y, 2012, J VASC RES, V49, P33, DOI 10.1159/000329594
   Nishimura T, 2002, AM J RESP CRIT CARE, V166, P1403, DOI 10.1164/rccm.200203-268OC
   Nogueira-Ferreira R, 2015, PULM PHARMACOL THER, V35, P8, DOI 10.1016/j.pupt.2015.09.007
   Pacagnelli FL, 2016, ARQ BRAS CARDIOL, V107, P33, DOI 10.5935/abc.20160083
   Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706
   Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033
   Polonio IB, 2012, J BRAS PNEUMOL, V38, P452, DOI 10.1590/S1806-37132012000400007
   Ruiter G, 2013, EUR RESPIR J, V42, P553, DOI 10.1183/09031936.00012313
   Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC
   Schultze AE, 1998, J TOXICOL ENV HEAL B, V1, P271, DOI 10.1080/10937409809524557
   Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC
   Taylor DW, 1997, TOXICOL APPL PHARM, V143, P196, DOI 10.1006/taap.1996.8083
   Thenappan T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5492
   Tuder RM, 2009, SEMIN RESP CRIT CARE, V30, P376, DOI 10.1055/s-0029-1233307
   Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010
   WAGENVOORT CA, 1984, J THORAC CARDIOV SUR, V87, P876
   Wagenvoort CA, 1977, PATHOLOGY PULMONARY
   White RJ, 2007, AM J PHYSIOL-LUNG C, V293, pL583, DOI 10.1152/ajplung.00321.2006
   WILSON DW, 1992, CRIT REV TOXICOL, V22, P307, DOI 10.3109/10408449209146311
   Xiao R, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004865
NR 39
TC 1
Z9 1
U1 0
U2 0
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI RIO DE JANEIRO
PA AVENIDA MARECHAL CAMARA 160-330 CENTRO, RIO DE JANEIRO, RJ 20 020-907,
   BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD SEP
PY 2020
VL 115
IS 3
BP 480
EP 489
DI 10.36660/abc.20190306
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA NZ6FU
UT WOS:000577202500010
PM 33027370
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Azevedo, MLV
   Malaquias, MAS
   de Paula, CBV
   de Souza, CM
   Costa, VH
   Raboni, SM
   Halila, R
   Rosendo, G
   Gozzo, P
   do Carmo, LAP
   Neto, PC
   Nagashima, S
   de Noronha, L
AF Viola Azevedo, Marina Luise
   Scaranello Malaquias, Mineia Alessandra
   Vaz de Paula, Caroline Busatta
   de Souza, Cleber Machado
   Costa Junior, Victor Horacio
   Raboni, Sonia Mara
   Halila, Renata
   Rosendo, Giuliana
   Gozzo, Priscilla
   Panini do Carmo, Leticia Arianne
   Cezar Neto, Plinio
   Nagashima, Seigo
   de Noronha, Lucia
TI The role of IL-17A/IL-17RA and lung injuries in children with lethal
   non-pandemic acute viral pneumonia
SO IMMUNOBIOLOGY
LA English
DT Article
DE Virus; Target therapy; Cytokines; Monoclonal antibodies; Mortality;
   Childhood; Immunohistochemistry
ID INFLUENZA-VIRUS; RHEUMATOID-ARTHRITIS; RESPIRATORY VIRUSES; NECROPSY
   SAMPLES; HOST-DEFENSE; INFECTION; IL-17; ADENOVIRUS; CELLS;
   QUANTIFICATION
AB This study aimed to evaluate IL-17A (interleukin 17A) and IL-17RA (IL-17A receptor) in a pediatric population that died with non-pandemic acute viral pneumonia compared to the non-viral pneumonia group. Necropsy lung samples (n = 193) from children that died after severe acute infection pneumonia were selected and processed for viral antigen detection by immunohistochemistry. After this, they were separated into two groups: virus-positive (n = 68) and virus-negative lung samples (n = 125). Immunohistochemistry was performed to assess the presence of IL-17A and IL-17RA in the lung tissue. The virus-positive group showed stronger immunolabeling for IL-17A and IL-17RA (p = 0.020 and p < 0.001, respectively). The result of this study may suggest that IL-17A and IL-17RA plays an essential role in the maintenance of viral infection and lung injuries. These aspects may increase the severity of the inflammatory response leading to lethal lung injuries in these patients. Children with community-acquired non-pandemic pneumonia that requiring hospitalization could benefit from using IL-17RA/IL-17A monoclonal antibodies to block their injurious effects.
C1 [Viola Azevedo, Marina Luise; Scaranello Malaquias, Mineia Alessandra; Vaz de Paula, Caroline Busatta; de Souza, Cleber Machado; Costa Junior, Victor Horacio; Halila, Renata; Rosendo, Giuliana; Gozzo, Priscilla; Panini do Carmo, Leticia Arianne; Cezar Neto, Plinio; Nagashima, Seigo; de Noronha, Lucia] Pontifical Catholic Univ Parana PUCPR, Sch Med, Lab Expt Pathol, R Imaculada Conceicao 1155, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Fed Univ Parana UFPR, Dept Med Pathol, R Padre Camargo 280, Curitiba, Parana, Brazil.
   [Raboni, Sonia Mara] Fed Univ Parana UFPR, Infect Dis Div, Virol Lab, R Padre Camargo 280, Curitiba, Parana, Brazil.
RP Malaquias, MAS (corresponding author), Pontifical Catholic Univ Parana PUCPR, Sch Med, Lab Expt Pathol, R Imaculada Conceicao 1155, Curitiba, Parana, Brazil.
EM marina.azevedo@pucpr.br; mi.mv@hotmail.com; carolbvaz@gmail.com;
   cleberius@gmail.com; victor.costa@pucpr.br; raboni.sonia@gmail.com;
   rlhalila@hotmail.com; giulianarosendo@hotmail.com;
   priscillagozzo@hotmail.com; lepanini.lp@gmail.com; pnetoc17@gmail.com;
   seigo_nagashima@hotmail.com; lnno.noronha@gmail.com
OI Cezar Neto, Plinio/0000-0002-8606-2768
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by productivity research level 2 of the National
   Council for Scientific and Technological Development (CNPq) [LN].
CR Aljurayyan A, 2018, J VIROL, V92, DOI 10.1128/JVI.00114-18
   Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021
   Barlow JL, 2011, CLIN EXP ALLERGY, V41, P1447, DOI 10.1111/j.1365-2222.2011.03806.x
   Baurakiades E, 2014, J CLIN VIROL, V61, P585, DOI 10.1016/j.jcv.2014.10.004
   Cai T., 2019, J ALLERGY CLIN IMMUN, P91
   Chen K, 2016, CELL HOST MICROBE, V20, P596, DOI 10.1016/j.chom.2016.10.003
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   Crabtree KD, 1997, WATER SCI TECHNOL, V35, P1, DOI 10.1016/S0273-1223(97)00225-4
   Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995
   Cruz AT, 2006, ANN EMERG MED, V47, P250, DOI 10.1016/j.annemergmed.2005.10.019
   De Luca A, 2017, CELL REP, V20, P1667, DOI 10.1016/j.celrep.2017.07.063
   Costa VHD, 2014, J CLIN VIROL, V61, P211, DOI 10.1016/j.jcv.2014.06.026
   Debur MD, 2010, J CLIN PATHOL, V63, P930, DOI 10.1136/jcp.2010.077867
   EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875
   Elf S., 2018, DIAGN MICROBIOL INFE
   Esposito S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152375
   Fujita J, 2012, ALLERGY, V67, P744, DOI 10.1111/j.1398-9995.2012.02825.x
   Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586
   Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11
   Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334
   Giordano Salvatore, 2018, Infez Med, V26, P81
   Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063
   Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877
   Herfst S, 2017, CURR OPIN VIROL, V22, P22, DOI 10.1016/j.coviro.2016.11.006
   Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0
   Hou W., 2014, J VIROL
   Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x
   Kennedy J, 1996, J INTERF CYTOK RES, V16, P611, DOI 10.1089/jir.1996.16.611
   Khanal S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010030
   Kneyber MCJ, 2000, EUR J PEDIATR, V159, P399, DOI 10.1007/s004310051296
   Kostareva OS, 2019, BIOCHEMISTRY-MOSCOW+, V84, P193, DOI 10.1134/S0006297919140116
   Kumar B, 2018, ARCH VIROL, V163, P831, DOI 10.1007/s00705-018-3708-y
   Lai YP, 2016, ENCYCLOPEDIA OF IMMUNOBIOLOGY, VOL 2: MOLECULAR IMMUNOLOGY, P534, DOI 10.1016/B978-0-12-374279-7.10014-1
   Lambert SB, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-11
   Lankester AC, 2002, CLIN INFECT DIS, V34, P864, DOI 10.1086/339073
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Lore NI, 2016, CYTOKINE GROWTH F R, V30, P19, DOI 10.1016/j.cytogfr.2016.03.009
   Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350
   Malaquias MAS, 2018, ALLERGOL IMMUNOPATH, V46, P136, DOI 10.1016/j.aller.2017.06.003
   Malekshahi SS, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.36953
   McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231
   McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994
   MURTAGH P, 1993, ACTA PAEDIATR, V82, P557, DOI 10.1111/j.1651-2227.1993.tb12753.x
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Ostergaard MS, 2018, NPJ PRIM CARE RESP M, V28, DOI 10.1038/s41533-018-0081-y
   Payne S, 2017, VIRUSES: FROM UNDERSTANDING TO INVESTIGATION, P197, DOI 10.1016/B978-0-12-803109-4.00023-4
   Pinter A, 2019, CLIN COSMET INV DERM, V12, P509, DOI 10.2147/CCID.S211938
   Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07
   Resa C, 2014, J CLIN VIROL, V60, P270, DOI 10.1016/j.jcv.2014.03.019
   Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
   Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401
   Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6
   Schmidt M.E., 2018, FRONT IMMUNOL, V26, P81
   SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017
   Sichelstiel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098440
   Somers J, 2015, J HEART LUNG TRANSPL, V34, P941, DOI 10.1016/j.healun.2015.03.009
   Sonego F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00155
   TAKALA AK, 1993, PEDIATR INFECT DIS J, V12, P189, DOI 10.1097/00006454-199303000-00003
   Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009
   Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397
   Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007
   Willis CR, 2015, AM J RESP CELL MOL, V53, P810, DOI 10.1165/rcmb.2015-0038OC
   Wong CK, 2010, EUR RESPIR J, V35, P883, DOI 10.1183/09031936.00088309
   Wonnenberg B, 2016, INNATE IMMUN-LONDON, V22, P620, DOI 10.1177/1753425916668244
   World Health Organization, 2014, INFL FACT SHEET
   Yanagisawa H, 2017, AM J PHYSIOL-LUNG C, V312, pL122, DOI 10.1152/ajplung.00301.2016
   Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5
   Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519
   Yoshizumi M, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00124
   Zhang J, 2019, AM J PHYSIOL-LUNG C, V316, pL487, DOI 10.1152/ajplung.00301.2018
   Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967
NR 71
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD JUL
PY 2020
VL 225
IS 4
AR 151981
DI 10.1016/j.imbio.2020.151981
PG 8
WC Immunology
SC Immunology
GA MW0LF
UT WOS:000556738300009
PM 32747026
DA 2020-12-08
ER

PT J
AU Witkowski, SM
   de Castro, EM
   Nagashima, S
   Martins, APC
   Okamoto, CT
   Nakata, GTM
   Collete, M
   Machado-Souza, C
   de Noronha, L
AF Witkowski, Sandra Mara
   de Castro, Eduardo Morais
   Nagashima, Seigo
   Camargo Martins, Ana Paula
   Okamoto, Cristina Terumy
   Moreno Nakata, Gustavo Takao
   Collete, Mariana
   Machado-Souza, Cleber
   de Noronha, Lucia
TI Analysis of interleukins 6, 8, 10 and 17 in the lungs of premature
   neonates with bronchopulmonary dysplasia
SO CYTOKINE
LA English
DT Article
DE Bronchopulmonary dysplasia; Interleukin; Neonate; Lung; Biomarkers
ID PRETERM INFANTS; INFLAMMATORY RESPONSE; GENE-EXPRESSION; CELLS; DISEASE;
   BIRTH; CYTOKINES; OUTCOMES; PERIOD; ROLES
AB Bronchopulmonary dysplasia (BPD) is an abnormality that occurs in premature neonate lung development. The pathophysiology is uncertain, but the inflammatory response to lung injury may be the responsible pathway. The objective of this study is to evaluate the role of interleukins 6, 8, 10, and 17 through the anatomopathological and immunohistochemical study of the lungs of premature neonates with BPD. Thirty-two cases of neonatal autopsies from the Pathology Department of the Clinics Hospital of the Universidade Federal do Parana, who presented between 1991 and 2005 were selected. The sample included neonates less than 34 weeks of gestational age who underwent oxygen therapy and had pulmonary formalin-fixed paraffin-embedded (FFPE) samples. Pulmonary specimens were later classified into three groups according to histopathological and morphometric changes (classic BPD, new BPD, and without BPD) and subjected to immunohistochemical analysis. The antibodies selected for the study were anti-IL-6, anti-IL-8, anti-IL-10, and anti-IL-17A monoclonal antibodies. IL-6, IL-8, and IL-10 showed no significant differences in tissue expression among the groups. IL-17A had higher tissue immunoreactivity in the group without BPD compared with the classic BPD group (1686 vs. 866 mu m(2), p = 0.029). This study showed that the involvement of interleukins 6, 8, and 10 might not be significantly different between the two types of BPD. We speculated that IL-17A could be a protective factor in this disease.
C1 [Witkowski, Sandra Mara; Nagashima, Seigo; Camargo Martins, Ana Paula; Okamoto, Cristina Terumy; Moreno Nakata, Gustavo Takao; Collete, Mariana; de Noronha, Lucia] Pontificia Univ Catolica Parana, Sch Med, Lab Expt Pathol, Curitiba, Parana, Brazil.
   [de Castro, Eduardo Morais; Machado-Souza, Cleber] Pele Pequeno Principe Inst, Postgrad Program Biotechnol Appl Hlth Children &, Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Pontificia Univ Catolica Parana, Lab Patol Expt, Rua Imaculada Conceicao,1155 Prado Velho, Curitiba, Parana, Brazil.
EM sandrawtk@gmail.com.br; lnno.noronha@gmail.com
CR Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526
   Baier RJ, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-10
   Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279
   Bhandari A, 2006, SEMIN PERINATOL, V30, P219, DOI 10.1053/j.semperi.2006.05.009
   BONIKOS DS, 1976, HUM PATHOL, V7, P643, DOI 10.1016/S0046-8177(76)80077-9
   Caron JE, 2014, PEDIATR RES, V76, P522, DOI 10.1038/pr.2014.133
   Cerny L, 2008, LUNG, V186, P75, DOI 10.1007/s00408-007-9069-z
   Chakraborty M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114524
   Choi CW, 2008, J KOREAN MED SCI, V23, P609, DOI 10.3346/jkms.2008.23.4.609
   Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8
   COALSON JJ, 1995, AM J RESP CRIT CARE, V152, P640, DOI 10.1164/ajrccm.152.2.7633720
   Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   Davidson D, 2013, AM J TRANSL RES, V5, P103
   Fogli I.K., 2013, J IMMUNOL, V191, P6
   Forghani B., 1989, PROCEDURES RICKETTSI, P135
   Gleditsch DD, 2014, PEDIATR RES, V76, P33, DOI 10.1038/pr.2014.57
   Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8
   Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432
   Hawwa RL, 2011, LUNG, V189, P341, DOI 10.1007/s00408-011-9310-7
   Hawwa RL, 2011, PEDIATR PULM, V46, P640, DOI 10.1002/ppul.21433
   Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407
   Hikino S, 2012, PEDIATR INT, V54, P208, DOI 10.1111/j.1442-200X.2011.03510.x
   Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010
   Hsiao CC, 2017, PEDIATR NEONATOL, V58, P63, DOI 10.1016/j.pedneo.2016.01.004
   Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329
   Ikegami T, 2000, EUR J OBSTET GYN R B, V93, P97, DOI 10.1016/S0301-2115(00)00247-5
   Jensen EA, 2014, BIRTH DEFECTS RES A, V100, P145, DOI 10.1002/bdra.23235
   Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723
   Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027
   Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9
   Koksal N, 2012, EUR CYTOKINE NETW, V23, P29, DOI 10.1684/ecn.2012.0304
   Kumar B, 2004, PATHOLOGY, V36, P295, DOI 10.1080/00313020410001721555
   Kunzmann S., 2013, AM J OBSTET GYNECOL, V1
   Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656
   Laughon MM, 2009, SEMIN FETAL NEONAT M, V14, P374, DOI 10.1016/j.siny.2009.08.002
   Lawrence SM, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12800
   Lee HS, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-68
   Li TJ, 2017, MOL MED REP, V16, P2225, DOI 10.3892/mmr.2017.6837
   Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904
   Liu Dong-Yun, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P444
   Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL715, DOI 10.1152/ajplung.00166.2004
   McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005
   MCFARLANE MJ, 1987, JAMA-J AM MED ASSOC, V258, P331, DOI 10.1001/jama.258.3.331
   McGowan EC, 2009, PEDIATR RES, V66, P455, DOI 10.1203/PDR.0b013e3181b3b0fa
   Metcalfe A, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0878-9
   Mikacenic C, 2016, CRIT CARE MED, V44, P496, DOI 10.1097/CCM.0000000000001409
   Monte Luciana F. Velloso, 2005, J. Pediatr. (Rio J.), V81, P99, DOI 10.1590/S0021-75572005000300004
   Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002
   NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701
   O'Reilly M, 2013, CLIN EXP PHARMACOL P, V40, P765, DOI 10.1111/1440-1681.12068
   Okamoto Cristina T., 2016, J. Bras. Patol. Med. Lab., V52, P253, DOI 10.5935/1676-2444.20160042
   Ozalkaya E, 2016, PEDIATR INT, V58, P850, DOI 10.1111/ped.12895
   Paananen R, 2009, J PEDIATR-US, V154, P39, DOI 10.1016/j.jpeds.2008.07.012
   Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x
   Parera MC, 2005, AM J PHYSIOL-LUNG C, V288, pL141, DOI 10.1152/ajplung.00148.2004
   Pomar EG, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00397
   Righetti RF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01021
   Rito DC, 2017, PEDIATR RES, V81, P639, DOI 10.1038/pr.2016.254
   Ryan RM, 2008, CLIN REV ALLERG IMMU, V34, P174, DOI 10.1007/s12016-007-8031-4
   Sakaguchi R, 2016, INT IMMUNOL, V28, P233, DOI 10.1093/intimm/dxv070
   Schelonka RL, 2011, CYTOKINE, V53, P249, DOI 10.1016/j.cyto.2010.11.003
   Shimoya K, 2000, HUM REPROD, V15, P2234, DOI 10.1093/humrep/15.10.2234
   Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01
   Sood BG, 2012, PEDIATR RES, V72, P212, DOI 10.1038/pr.2012.56
   Speer C.P., 2004, PEDIATRRESP REV, V5, P241
   Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2
   Su BH, 2005, J FORMOS MED ASSOC, V104, P244
   Tang XQ, 2018, MED SCI MONITOR, V24, P6717, DOI 10.12659/MSM.910851
   Tannuri U., 2004, VENTILACAO PULMONAR, P559
   Thekkeveedu RK, 2017, RESP MED, V132, P170, DOI 10.1016/j.rmed.2017.10.014
   Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971
   von Bismarck P, 2008, EXP LUNG RES, V34, P694, DOI 10.1080/01902140802389693
   Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808
   Witkowski Sandra Mara, 2016, J. Bras. Patol. Med. Lab., V52, P407, DOI 10.5935/1676-2444.20160064
   Woods SJ, 2015, AM J PHYSIOL-LUNG C, V308, pL912, DOI 10.1152/ajplung.00048.2015
   You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019
   Zhang ZQ, 2014, EUR J PEDIATR, V173, P15, DOI 10.1007/s00431-013-2148-7
NR 78
TC 0
Z9 0
U1 1
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JUL
PY 2020
VL 131
AR 155118
DI 10.1016/j.cyto.2020.155118
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA MA4JJ
UT WOS:000541881200020
PM 32403004
DA 2020-12-08
ER

PT J
AU Malinowski, EA
   Matias, JEF
   Percicote, AP
   Nakadomari, T
   Robes, R
   Petterle, RR
   De Noronha, L
   De Godoy, JL
AF Malinowski, Eduardo Augustus
   Fouto Matias, Jorge Eduardo
   Percicote, Ana Paula
   Nakadomari, Thaisa
   Robes, Rogerio
   Petterle, Ricardo Rasmussen
   De Noronha, Lucia
   De Godoy, Jose Luiz
TI Conservation of both hematocrit and liver regeneration in hepatectomies:
   a vascular occlusion approach in rats
SO ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF
   DIGESTIVE SURGERY
LA English
DT Article
DE Hepatectomy; Hematoait; Liver; Bloodless medical and surgical procedures
ID BLOOD-TRANSFUSION; RISK SCORE; RESECTION; COSTS
AB Background: Hepatectomies promote considerable amount of blood loss and the need to administrate blood products, which are directly linked to higher morbimortality rates. The blood-conserving hepatectomy (BCH) is a modification of the selective vascular occlusion technique. It could be a surgical maneuver in order to avoid or to reduce the blood products utilization in the perioperative period. Aim: To evaluate in rats the BCH effects on the hematocrit (HT) variation, hemoglobin serum concentration (HB), and on liver regeneration. Methods: Twelve Wistar rats were divided into two groups: control (n=6) and intervention (n=6). The ones in the control group had their livers partially removed according to the Higgins and Anderson technique, while the rats in the treatment group were submitted to BCH technique. HT and HB levels were measured at day D0, D1 and D7. The rate between the liver and rat weights was calculated in D0 and D7. Liver regeneration was quantitatively and qualitatively evaluated. Results: The HT and HB levels were lower in the control group as of D1 onwards, reaching an 18% gap at D7 (p=0.01 and p=0.008, respectively); BCH resulted in the preservation of HT and HB levels to the intervention group rats. BCH did not alter liver regeneration in rats. Conclusion: The BCH led to beneficial effects over the postoperative HT and serum HB levels with no setbacks to liver regeneration. These data are the necessary proof of evidence for translational research into the surgical practice.
C1 [Malinowski, Eduardo Augustus] Univ Fed Parana, Hlth Sci Sect, Curitiba, Parana, Brazil.
   [Fouto Matias, Jorge Eduardo; Nakadomari, Thaisa; De Godoy, Jose Luiz] Univ Fed Parana, Dept Surg, Hlth Sci Sect, Curitiba, Parana, Brazil.
   [Percicote, Ana Paula; De Noronha, Lucia] Univ Fed Parana, Pathol Dept, Hlth Sci Sect, Curitiba, Parana, Brazil.
   [Robes, Rogerio] Univ Fed Parana, Vet Med, Agr Sci Sect, Curitiba, Parana, Brazil.
   [Petterle, Ricardo Rasmussen] Univ Fed Parana, Stat, Hlth Sci Sect, Curitiba, Parana, Brazil.
RP De Godoy, JL (corresponding author), Univ Fed Parana, Dept Surg, Hlth Sci Sect, Curitiba, Parana, Brazil.
EM de_godoy@yahoo.com
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; Rasmussen Petterle,
   Ricardo/0000-0001-7735-1077; Malinowski, Eduardo
   Augustus/0000-0002-3648-8605; Percicote, Ana/0000-0001-6325-0195; Fouto
   Matias, Jorge Eduardo/0000-0001-6377-8870
CR Bennett S, 2018, ANN SURG, V267, P766, DOI 10.1097/SLA.0000000000002205
   BISMUTH H, 1989, ANN SURG, V210, P13, DOI 10.1097/00000658-198907000-00002
   Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185
   Chiappa A, 2001, HEPATO-GASTROENTEROL, V48, P1416
   Cockbain AJ, 2010, HPB, V12, P50, DOI 10.1111/j.1477-2574.2009.00126.x
   Columbano A, 1996, FASEB J, V10, P1118
   De Godoy JL, 1998, HEPATOLOGY, V27, P697, DOI 10.1002/hep.510270310
   Evans PM, 1998, SURGERY, V124, P807, DOI 10.1067/msy.1998.91225
   Figueras J, 2005, ANN SURG, V241, P582, DOI 10.1097/01.sla.0000157168.26021.b8
   FONSECA Gilton Marques, 2018, ABCD, arq. bras. cir. dig., V31, pe1355, DOI 10.1590/0102-672020180001e1355
   Gimenez ME, 2018, ABCD-ARQ BRAS CIR DI, V31, DOI 10.1590/0102-672020180001e1346
   Goodnough LT, 2013, LANCET, V381, P1791, DOI 10.1016/S0140-6736(13)60673-X
   GRISHAM JW, 1962, CANCER RES, V22, P842
   Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007632
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hoekstra LT, 2012, DIGEST SURG, V29, P35, DOI 10.1159/000335724
   Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3
   Lemke M, 2017, BRIT J SURG, V104, P434, DOI 10.1002/bjs.10416
   Paolo F, 2013, WORLD J HEPATOL, V5, P1, DOI 10.4254/wjh.v5.i1.1
   Pulitano C, 2007, BRIT J SURG, V94, P860, DOI 10.1002/bjs.5731
   Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x
   Sima CS, 2009, ANN SURG, V250, P914, DOI 10.1097/SLA.0b013e3181b7fad3
   Sun HY, 2015, EJSO-EUR J SURG ONC, V41, P243, DOI 10.1016/j.ejso.2014.10.057
   Trentino KM, 2015, TRANSFUSION, V55, P1082, DOI 10.1111/trf.12958
NR 24
TC 0
Z9 0
U1 0
U2 0
PU COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD
PI SAO PAULO SP
PA AV BRIGADEIRO LUIZ ANTONIO, 278-6-SALAS 10 E 11, SAO PAULO SP,
   01318-901, BRAZIL
SN 0102-6720
EI 2317-6326
J9 ABCD-ARQ BRAS CIR DI
JI ABCD-Arq. Bras. Cir. Dig.-Braz. Arch. Dig. Surg.
PY 2020
VL 33
IS 1
AR e1484
DI 10.1590/0102-672020190001e1484
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA ME0HW
UT WOS:000544346100001
PM 32236290
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Sebastiao, APM
   Xu, B
   Lozada, JR
   Pareja, F
   Geyer, FC
   Paula, AD
   da Silva, EM
   Ghossein, RA
   Weinreb, I
   de Noronha, L
   Weigelt, B
   Reis, JS
   Katabi, N
AF Sebastiao, Ana Paula Martins
   Xu, Bin
   Lozada, John R.
   Pareja, Fresia
   Geyer, Felipe C.
   Paula, Arnaud Da Cruz
   da Silva, Edaise M.
   Ghossein, Ronald A.
   Weinreb, Ilan
   de Noronha, Lucia
   Weigelt, Britta
   Reis-Filho, Jorge S.
   Katabi, Nora
TI Histologic spectrum of polymorphous adenocarcinoma of the salivary gland
   harbor genetic alterations affecting PRKD genes
SO MODERN PATHOLOGY
LA English
DT Article
ID LOW-GRADE ADENOCARCINOMA; CRIBRIFORM ADENOCARCINOMA; SOMATIC MUTATIONS;
   TONGUE; VARIANT
AB Polymorphous adenocarcinoma (PAC) and cribriform adenocarcinoma of (minor) salivary gland (CASG) are salivary gland tumors with overlapping spectrum of morphology. Whether these represent distinct entities or a histologic spectrum of the same tumor remains contentious. PACs harbor recurrent PRKD1 E710D hotspot mutations in >70% of cases, whereas 80% of CASGs display rearrangements involving PRKD1, PRKD2, or PRKD3 (PRKD1/2/3). We studied the molecular and morphologic features of 37 PACs/CASGs, seeking to identify the associations among genotype, histologic phenotype, and classification. DNA was subjected to Sanger sequencing analysis of the PRKD1 hotspot locus. Fluorescence in situ hybridization (FISH) analysis for PRKD1/2/3 was performed using dual-color break-apart probes. Tumors were classified into four categories as described previously: PAC, CASG, tumor with indeterminate features (TIF), and tumor with a predominant papillary pattern (TPPP). PRKD1 E710D hotspot mutations were identified in 56%, 20%, 43% and 0% of PACs, CASGs, TIFs, and TPPPs, respectively. FISH demonstrated PRKD1/2/3 rearrangements in 13%, 78%, 36%, and 75% of PACs, CASGs, TIFs, and TPPPs, respectively. Histologically, fusion-positive tumors were associated with a high percentage of papillary growth, low percentage of single filing arrangement, a propensity of base of tongue location, and frequent (50%) lymph node metastasis, compared with the mutation-related tumors which had negligible nodal metastasis risk. Our results demonstrated that (1) PACs/CASGs are underpinned by genetic alterations affecting PRKD genes; (2) despite the associations between PAC and PRKD1 hotspot mutations and CASG and PRKD1/2/3 fusion, such distinction is not absolute; and (3) there is of a novel genotypic-phenotypic association whereby fusion-positive tumors are usually located in the base of the tongue, show papillary architecture and have a high risk of nodal metastasis. Genetic analysis of PRKD genes appears to be useful characterizing this spectrum of tumors, not only histologically but also clinically identifying those tumors with high risk of nodal metastasis.
C1 [Sebastiao, Ana Paula Martins; Xu, Bin; Lozada, John R.; Pareja, Fresia; Geyer, Felipe C.; Paula, Arnaud Da Cruz; da Silva, Edaise M.; Ghossein, Ronald A.; Weigelt, Britta; Reis-Filho, Jorge S.; Katabi, Nora] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.
   [Sebastiao, Ana Paula Martins; de Noronha, Lucia] Pontificia Univ Catolica Parana, Postgrad Program Hlth Sci, Curitiba, Parana, Brazil.
   [Sebastiao, Ana Paula Martins] Univ Fed Parana, Dept Med Pathol, Curitiba, Parana, Brazil.
   [Weinreb, Ilan] Univ Toronto, Univ Hlth Network, Dept Pathol, Toronto, ON, Canada.
RP Reis, JS; Katabi, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.
EM reisfilj@mskcc.org; katabin@mskcc.org
RI Sebastiao, Ana Paula Martins/AAG-6227-2020
OI Lozada, John/0000-0001-8953-4110; Xu, Bin/0000-0003-4638-9835
FU Cancer Center Support Grant of the National Institutes of
   Health/National Cancer Institute [P30CA008748]; Breast Cancer Research
   Foundation; Cycle for Survival
FX Research reported in this publication was partly funded by a Cancer
   Center Support Grant of the National Institutes of Health/National
   Cancer Institute (grant no. P30CA008748). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. JSR-F is partly
   funded by the Breast Cancer Research Foundation and BW by Cycle for
   Survival.
CR Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020
   Castle JT, 1999, CANCER, V86, P207, DOI 10.1002/(SICI)1097-0142(19990715)86:2<207::AID-CNCR4>3.3.CO;2-H
   Cocek A, 2011, ONCOL LETT, V2, P135, DOI 10.3892/ol.2010.213
   Evans HL, 2000, AM J SURG PATHOL, V24, P1319, DOI 10.1097/00000478-200010000-00001
   Fonseca I, 2017, WHO CLASSIFICATION H
   Geyer FC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04128-5
   Gnepp DR, 2014, HEAD NECK PATHOL, V8, P42, DOI 10.1007/s12105-014-0532-x
   Kimple AJ, 2014, LARYNGOSCOPE, V124, P2714, DOI 10.1002/lary.24788
   Laco J, 2012, VIRCHOWS ARCH, V461, P531, DOI 10.1007/s00428-012-1320-1
   Majewska H, 2016, POL J PATHOL, V67, P84, DOI 10.5114/PJP.2016.59223
   Michal M, 1999, HISTOPATHOLOGY, V35, P495
   Michal M, 2013, HEAD NECK PATHOL, V7, pS3, DOI 10.1007/s12105-013-0457-9
   MILLS SE, 1984, AM J SURG PATHOL, V8, P367, DOI 10.1097/00000478-198405000-00005
   Piscuoglio S, 2016, HISTOPATHOLOGY, V68, P1055, DOI 10.1111/his.12883
   Piscuoglio S, 2016, J PATHOL, V238, P381, DOI 10.1002/path.4675
   Skalova A, 2011, AM J SURG PATHOL, V35, P1168, DOI 10.1097/PAS.0b013e31821e1f54
   WALDRON CA, 1988, ORAL SURG ORAL MED O, V66, P323, DOI 10.1016/0030-4220(88)90240-X
   Weinreb I, 2014, NAT GENET, V46, P1166, DOI 10.1038/ng.3096
   Weinreb I, 2014, GENE CHROMOSOME CANC, V53, P845, DOI 10.1002/gcc.22195
   Wilkerson PM, 2017, ONCOTARGET, V8, P6057, DOI 10.18632/oncotarget.14011
   Xu B, 2016, AM J SURG PATHOL, V40, P1526, DOI 10.1097/PAS.0000000000000705
NR 21
TC 2
Z9 2
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0893-3952
EI 1530-0285
J9 MODERN PATHOL
JI Mod. Pathol.
PD JAN
PY 2020
VL 33
IS 1
DI 10.1038/s41379-019-0351-4
PG 9
WC Pathology
SC Pathology
GA JY9IC
UT WOS:000504718800007
PM 31492931
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Collatusso, C
   Roderjan, JG
   de Noronha, L
   Klosowski, A
   Suss, PH
   Guarita-Souza, LC
   da Costa, FDA
AF Collatusso, Claudinei
   Roderjan, Joao Gabriel
   de Noronha, Lucia
   Klosowski, Allyson
   Suss, Paula Hansen
   Guarita-Souza, Luiz Cesar
   Affonso da Costa, Francisco Diniz
TI Decellularization as a method to reduce calcification in bovine
   pericardium bioprosthetic valves
SO INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
LA English
DT Article
DE Bioprosthesis; Calcification; Decellularization; Bovine pericardium
ID LONG-TERM OUTCOMES; IMMUNE-RESPONSE; ALPHA-GAL; AORTIC-VALVE;
   RECONSTRUCTION; ALLOGRAFTS
AB OBJECTIVES: Decellularization is an alternative method for processing biological tissues with decreased antigenicity and resistance to calcification. The aim of this study was to characterize the properties of decellularized (dCell) bovine pericardium fixed with 0.1% glutaraldehyde (GA) and to evaluate outcomes of bioprosthetic valves constructed with this tissue when implanted in the mitral position of juvenile sheep.
   METHODS: Bioprosthetic mitral valves were constructed with fresh bovine pericardium fixed in 0.5% GA (control group) or dCell bovine pericardium fixed in 0.1% GA (study group). Before implantation, samples were submitted to histological (haematoxylin-eosin, Movat and 4',6-diamidino-2-phenylindole), biochemical (residual deoxyribonucleic acid and alpha-gal epitopes) and biomechanical characterization. Valves were implanted (n = 8 in each group) as a mitral valve replacement for 180 days in sheep and explants were re-evaluated histologically and for calcification with radiological studies and calcium content determination.
   RESULTS: Unimplanted dCell pericardia exhibited a well-preserved extracellular matrix with absence of cells, a 77% reduction in deoxyribonucleic acid levels and with no detectable alpha-gal epitopes. When compared to controls, they had lower ultimate tensile strength (7.3 +/- 5.4 vs 10.2 +/- 3.0 mPa, P = 0.04) and greater percentage elongation in the longitudinal direction (29 +/- 6.5% vs 23.8 +/- 5.1%, P = 0.02). After 180 days in mitral position, dCell valves showed pliable leaflets without macroscopic signs of calcification. Histologically, dCell leaflets had intact collagen fibres, better tissue remodelling and a significant 89% reduction in calcium content.
   CONCLUSIONS: This study demonstrates that bioprosthetic valves constructed with dCell bovine pericardium fixed in low GA concentration were resistant to calcification and may thereby improve long-term durability of the of the tissue.
C1 [Collatusso, Claudinei; Klosowski, Allyson; Guarita-Souza, Luiz Cesar; Affonso da Costa, Francisco Diniz] Pontificia Univ Catolica Parana PUCPR, Dept Cardiac Surg, Rua Major Franca Gomes,1170 Santa Quiteria, BR-80310000 Curitiba, Parana, Brazil.
   [Roderjan, Joao Gabriel] PUCPR, Dept Biochem, Curitiba, Parana, Brazil.
   [de Noronha, Lucia; Suss, Paula Hansen] PUCPR, Dept Pathol, Curitiba, Parana, Brazil.
RP Collatusso, C (corresponding author), Pontificia Univ Catolica Parana PUCPR, Dept Cardiac Surg, Rua Major Franca Gomes,1170 Santa Quiteria, BR-80310000 Curitiba, Parana, Brazil.
EM claudineicl@yahoo.com.br
RI Suss, Paula Hansen/J-4709-2015
OI Hansen Suss, Paula/0000-0002-8525-3853
CR da Costa FDA, 2017, WORLD J PEDIATR CONG, V8, P605, DOI 10.1177/2150135117723916
   Bourguignon T, 2016, EUR J CARDIO-THORAC, V49, P1462, DOI 10.1093/ejcts/ezv384
   Bourguignon T, 2015, ANN THORAC SURG, V99, P831, DOI 10.1016/j.athoracsur.2014.09.030
   Brizard CP, 2014, J THORAC CARDIOV SUR, V148, P3194, DOI 10.1016/j.jtcvs.2014.08.002
   Colatusso C, 2012, BRAZ J CARDIOV SURG, V27, P88
   Colatusso C, 2011, BRAZ J CARDIOV SURG, V26, P419
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   da Costa FDA, 2018, ANN THORAC SURG, V105, P1205, DOI 10.1016/j.athoracsur.2017.09.057
   Etnel JRG, 2018, EUR J CARDIO-THORAC, V54, P434, DOI 10.1093/ejcts/ezy079
   Ferreira Andrea Dumsch de Aragon, 2007, Braz. J. Cardiovasc. Surg., V22, P303, DOI 10.1590/S0102-76382007000300006
   Flameng W, 2015, J THORAC CARDIOV SUR, V149, P340, DOI 10.1016/j.jtcvs.2014.09.062
   Gutierrez JRP, 2015, TISSUE ENG PT A, V21, P332, DOI [10.1089/ten.tea.2014.0003, 10.1089/ten.TEA.2014.0003]
   Heuschkel MA, 2019, XENOTRANSPLANTATION, V26, DOI 10.1111/xen.12464
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17
   Meuris B, 2018, J THORAC CARDIOV SUR, V156, P197, DOI 10.1016/j.jtcvs.2018.01.099
   Meuris B, 2016, J THORAC CARDIOV SUR, V152, P1167, DOI 10.1016/j.jtcvs.2016.05.024
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   Naso F, 2017, TISSUE ENG PT A, V23, P1181, DOI 10.1089/ten.tea.2016.0474
   Navarro FB, 2010, REV BRAS CIR CARDIOV, V25, P377, DOI 10.1590/S0102-76382010000300015
   Park CS, 2010, J HEART VALVE DIS, V19, P124
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Umashankar PR, 2013, J BIOMED MATER RES A, V101, P2202, DOI 10.1002/jbm.a.34535
   Une D, 2014, EUR J CARDIO-THORAC, V46, P825, DOI 10.1093/ejcts/ezu014
NR 24
TC 5
Z9 5
U1 2
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1569-9293
EI 1569-9285
J9 INTERACT CARDIOV TH
JI Interact Cardiovasc. Thorac. Surg.
PD AUG
PY 2019
VL 29
IS 2
BP 302
EP 311
DI 10.1093/icvts/ivz041
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA JI2IW
UT WOS:000493288300022
PM 30848795
OA Bronze
DA 2020-12-08
ER

PT J
AU Fedato, RA
   Francisco, JC
   Sliva, G
   de Noronha, L
   Olandoski, M
   Neto, JRF
   Ferreira, PE
   Simeoni, RB
   Abdelwahid, E
   de Carvalho, KAT
   Guarita-Souza, LC
AF Fedato, Rosangela Alquieri
   Francisco, Julio Cesar
   Sliva, Gabriel
   de Noronha, Lucia
   Olandoski, Marcia
   Faria Neto, Jose Rocha
   Ferreira, Priscila Elias
   Simeoni, Rossana Baggio
   Abdelwahid, Eltyeb
   Teixeira de Carvalho, Katherine Athayde
   Guarita-Souza, Luiz Cesar
TI Stem Cells and Platelet-Rich Plasma Enhance the Healing Process of
   Tendinitis in Mice
SO STEM CELLS INTERNATIONAL
LA English
DT Article
ID GROWTH-FACTORS; TENDON REPAIR; HORSES; MATRIX; BLOOD
AB Objective. Achilles tendon pathologies occur frequently and have a significant socioeconomic impact. Currently, there is no evidence on the best treatment for these pathologies. Cell therapy has been studied in several animal models, and encouraging results have been observed with respect to tissue regeneration. This study is aimed at evaluating the functional and histological effects of bone marrow stem cell or platelet-rich plasma implantation compared to eccentric training in the treatment of Achilles tendinopathy in rats. Methods. Fourty-one male Wistar rats received collagenase injections into their bilateral Achilles tendons (collagenase-induced tendinopathy model). The rats were randomly divided into four groups: stem cells (SC), platelet-rich plasma (PRP), stem cells+platelet-rich plasma (SC+PRP), and control (eccentric training (ET)). After 4 weeks, the Achilles tendons were excised and subjected to biomechanical and histological analyses (Sirius red and hematoxylin-eosin staining). Results. Biomechanical assessments revealed no differences among the groups in ultimate tensile strength or yield strength of the tendons (p=0.157), but there were significant differences in the elastic modulus (MPa; p=0.044) and maximum tensile deformation (p=0.005). The PRP group showed the greatest maximum deformation, and the SC group showed the highest Young's modulus (elasticity) measurement. In histological analysis (hematoxylin-eosin and Sirius red staining), there were no differences among the groups. Conclusion. PRP and SC+PRP yielded better biomechanical results than eccentric training, showing that these treatments offer better tend function outcomes. This theoretical rationale for the belief that cell therapies can serve as viable alternatives to current treatments chronic fibrotic opens the door for opportunities to continue this research.
C1 [Fedato, Rosangela Alquieri; Sliva, Gabriel; de Noronha, Lucia; Olandoski, Marcia; Faria Neto, Jose Rocha; Simeoni, Rossana Baggio; Guarita-Souza, Luiz Cesar] Pontifical Catholic Univ Parana PUCPR, Inst Biol & Hlth Sci, Expt Lab, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, PR, Brazil.
   [Francisco, Julio Cesar] Posit Univ UP, Rua Prof Pedro Viriato Parigot de Souza 5300, BR-80710570 Curitiba, PR, Brazil.
   [Ferreira, Priscila Elias; Teixeira de Carvalho, Katherine Athayde] Pele Pequeno Principe Inst, Cell Therapy & Biotechnol Regenerat Med Res Grp, Ave Silva Jardim 1632, BR-80250200 Curitiba, PR, Brazil.
   [Abdelwahid, Eltyeb] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.
RP Fedato, RA (corresponding author), Pontifical Catholic Univ Parana PUCPR, Inst Biol & Hlth Sci, Expt Lab, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, PR, Brazil.
EM rosangela.fedato@pucpr.edu.br
RI Carvalho, Katherine/ABF-4961-2020; Francisco, Julio Cesar/AAD-5243-2020
OI Carvalho, Katherine/0000-0003-4860-2855; Francisco, Julio
   Cesar/0000-0003-1970-6399
FU Pontificia Universidade Catolica do Parana (PUCPR), Rua Imaculada
   Conceicao, Curitiba, PR, Brazil
FX This project was funded by the researcher's private funds and
   institutional funds from the Pontificia Universidade Catolica do Parana
   (PUCPR), Rua Imaculada Conceicao 1155, 80215-901 Curitiba, PR, Brazil.
   No external funding support was received.
CR Ahmad Z, 2012, ARTHROSCOPY, V28, P1018, DOI 10.1016/j.arthro.2011.12.009
   Ahmed IM, 1998, J ORTHOPAED RES, V16, P591, DOI 10.1002/jor.1100160511
   Allen Kelli D, 2017, N C Med J, V78, P306, DOI 10.18043/ncm.78.5.306
   Anitua E, 1999, INT J ORAL MAX IMPL, V14, P529
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Bissell L, 2015, CURR STEM CELL RES T, V10, P19
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Crovace A, 2008, VET COMP ORTHOPAED, V21, P329, DOI 10.3415/VCOT-07-05-0050
   Dallaudiere Benjamin, 2014, Muscles Ligaments Tendons J, V4, P351
   Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422
   Ferrero G, 2012, J Ultrasound, V15, P260, DOI 10.1016/j.jus.2012.09.006
   Filardo G, 2014, BLOOD TRANSFUS-ITALY, V12, P533, DOI 10.2450/2014.0289-13
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kaux JF, 2013, J ORTHOP RES, V31, P119, DOI 10.1002/jor.22202
   LEADBETTER WB, 1992, CLIN SPORT MED, V11, P533
   Li HY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6492597
   Lovati AB, 2012, INT J ARTIF ORGANS, V35, P996, DOI 10.5301/ijao.5000129
   Mastrogiacomo M, 2001, OSTEOARTHR CARTILAGE, V9, pS36, DOI 10.1053/joca.2001.0442
   Nixon AJ, 2008, AM J VET RES, V69, P928, DOI 10.2460/ajvr.69.7.928
   Parafioriti A, 2011, MLTJ-MUSCLE LIGAMENT, V1, P41
   Sanchez M, 2007, AM J SPORT MED, V35, P245, DOI 10.1177/0363546506294078
   Shah V, 2013, J ORTHOP RES, V31, P413, DOI 10.1002/jor.22222
   Sobhani S, 2013, SCAND J MED SCI SPOR, V23, P669, DOI 10.1111/j.1600-0838.2012.01509.x
   Urdzikova LM, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-42
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
NR 25
TC 1
Z9 2
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PD JUN 2
PY 2019
VL 2019
AR 1497898
DI 10.1155/2019/1497898
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA JG3HF
UT WOS:000491964500001
PM 31662764
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Roderjan, JG
   de Noronha, L
   Stimamiglio, MA
   Correa, A
   Leitolis, A
   Bueno, RRL
   da Costa, FDA
AF Roderjan, Joao Gabriel
   de Noronha, Lucia
   Stimamiglio, Marco Augusto
   Correa, Alejandro
   Leitolis, Amanda
   Loures Bueno, Ronaldo Rocha
   Affonso da Costa, Francisco Diniz
TI Structural assessments in decellularized extracellular matrix of porcine
   semilunar heart valves: Evaluation of cell niches
SO XENOTRANSPLANTATION
LA English
DT Article
DE basement membrane; decellularization; extracellular matrix; heart
   valves; regenerative medicine; tissue engineering
ID HISTOLOGICAL CHARACTERIZATION; RAMAN-SPECTROSCOPY; XENOGENEIC TISSUE;
   IMMUNE-RESPONSE; URINARY-BLADDER; PULMONARY VALVE; ALLOGRAFTS; IMPACT;
   DETERGENTS; SCAFFOLDS
AB Tissue-engineered heart valves aim to reproduce the biological properties of natural valves with anatomically correct structure and physiological performance. The closest alternative to creating an ideal heart valve substitute is to use decellularized porcine heart valves, due to their anatomy and availability. However, the immunological barrier and the structural maintenance limit the long-term physiological performance of decellularized porcine heart valves. This study investigated the extracellular matrix (ECM) structure of aortic and pulmonary porcine valves decellularized by a low concentration sodium dodecyl sulfate (SDS)-based method in order to determine the ECM scaffold (ECMS) conditions related to remodeling potential. To assess the structures of the leaflets and conduits of the heart valves, ECM components and their organization were evaluated by histology, biochemical analysis (BC), scanning electron microscopy, multiphoton microscopy, tensile test, immunofluorescence labeling (IF), and Raman microspectroscopy used to draw a profile of the cell niches. Histology and multiphoton imaging of decellularized aortic and pulmonary leaflets and conduits revealed a collagen and elastin histoarchitecture with rearrangement, loosening fibers, and glycosaminoglycan depletion confirmed by biochemistry quantification. The potential cytotoxicity of SDS residues was eliminated after 10 wash cycles. The mechanical properties of the structure of the valve indicated a functional resistance of decellularized ECM. The IF demonstrated the presence of basement membrane, suggesting a potential structure for host cell attachment. The RM analysis showed evidence of molecular interactions, suggesting conservation of the chemical composition, particularly among the protein molecular structures. The structural analyses performed in the semilunar porcine heart valves demonstrate that decellularized ECMS has structural properties that support physiological performance and potential host tissue integration. In fact, decellularized leaflet scaffolds were prone to cell interaction after human adipose-derived stromal cell seeding and culturing. Further analysis of biocompatibility, particularly the ECM-cell interaction, can elucidate the remodeling process, in preserved decellularized heart valve scaffold.
C1 [Roderjan, Joao Gabriel] Univ Tecnol Fed Parana, Programa Posgrad Engn Biomed, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.
   [Stimamiglio, Marco Augusto; Correa, Alejandro; Leitolis, Amanda] FIOCRUZ PR, Inst Carlos Chagas, Curitiba, Parana, Brazil.
   [Loures Bueno, Ronaldo Rocha] Univ Fed Parana, Setor Med Interna, Curitiba, Parana, Brazil.
   [Affonso da Costa, Francisco Diniz] Pontificia Univ Catolica Parana, Escola Med, Curitiba, Parana, Brazil.
RP Roderjan, JG (corresponding author), Univ Tecnol Fed Parana, Programa Posgrad Engn Biomed, Curitiba, Parana, Brazil.
EM gabriel.roderjan@pucpr.br
RI Leitolis, Amanda/AAE-6472-2019; Stimamiglio, Marco
   Augusto/AAA-8129-2019; noronha, lucia/F-6339-2015
OI Stimamiglio, Marco Augusto/0000-0001-8537-2812; Roderjan, Joao
   Gabriel/0000-0003-4705-5837; noronha, lucia/0000-0003-0310-7164
FU Programa de Pos-graduacao em Medicina Interna of Universidade Federal do
   Parana
FX We would like to acknowledge the Programa de Pos-graduacao em Medicina
   Interna of Universidade Federal do Parana for the support of this
   research. We also acknowledge technical support from Dr. Celia Regina
   Cavichiolo Franco and her staff for the SEM analysis at Centro de
   Microscopia Eletronica da UFPR; the Microscopy Facility RPT07C PDTIS
   from Carlos Chagas Institute, FIOCRUZ-PR; and Dr. Carmen Rebelatto of
   PUCPR for the assistance of immunofluorescence assays.
CR Andree B, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0441-x
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Bro R, 2014, ANAL METHODS-UK, V6, P2812, DOI 10.1039/c3ay41907j
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Chapters General, 2013, 36NF31 USP
   Cicha I, 2011, CARDIOVASC PATHOL, V20, P222, DOI 10.1016/j.carpath.2010.04.006
   Collatusso C, 2012, REV BRAS CIR CARDIOV, V27, P88, DOI 10.5935/1678-9741.20120013
   Collatusso C, 2011, REV BRAS CIR CARDIOV, V26, P419, DOI 10.5935/1678-9741.20110017
   da Costa FDA, 2005, EUR J CARDIO-THORAC, V27, P572, DOI 10.1016/j.ejcts.2004.12.057
   da Costa FDA, 2018, ANN THORAC SURG, V105, P1205, DOI 10.1016/j.athoracsur.2017.09.057
   Dallan LA, 2005, J THORAC CARDIOV SUR, V129, P225, DOI 10.1016/j.jtcvs.2004.05.015
   Dohmen PM, 2012, HEART LUNG VESSEL, V4, P89
   Dohmen PM, 2008, ANN THORAC SURG, V85, P2163, DOI 10.1016/j.athoracsur.2007.12.021
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V881, P46, DOI 10.1016/0304-4165(86)90095-4
   Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Grauss RW, 2003, J THORAC CARDIOV SUR, V126, P2003, DOI 10.1016/S0022-5223(03)00956-5
   Gutierrez JRP, 2015, TISSUE ENG PT A, V21, P332, DOI [10.1089/ten.tea.2014.0003, 10.1089/ten.TEA.2014.0003]
   Haykal S, 2012, TISSUE ENG PART C-ME, V18, P614, DOI [10.1089/ten.tec.2011.0579, 10.1089/ten.TEC.2011.0579]
   Heuschkel MA, 2019, XENOTRANSPLANTATION, V26, DOI 10.1111/xen.12464
   Hilfiker A, 2014, XENOTRANSPLANTATION, V21, P190, DOI 10.1111/xen.12083_14
   Hinderer S, 2014, BIOMATERIALS, V35, P2130, DOI 10.1016/j.biomaterials.2013.10.080
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   HUIZINGA A, 1989, EXP EYE RES, V48, P487, DOI 10.1016/0014-4835(89)90032-8
   Iop L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099593
   Jana S, 2014, ACTA BIOMATER, V10, P2877, DOI 10.1016/j.actbio.2014.03.014
   Kaiitani M, 2001, ASAIO J, V47, P342, DOI 10.1097/00002480-200107000-00009
   Kneib C, 2012, TISSUE ANTIGENS, V80, P165, DOI 10.1111/j.1399-0039.2012.01885.x
   Knight RL, 2008, P I MECH ENG H, V222, P129, DOI 10.1243/09544119JEIM230
   Korossis SA, 2005, J HEART VALVE DIS, V14, P408
   Korossis S, 2009, BIOMATERIALS, V30, P266, DOI 10.1016/j.biomaterials.2008.09.034
   Korossis S, 2006, TISSUE ENG, V12, P635, DOI 10.1089/ten.2006.12.635
   Ksiazek Agnieszka A, 2016, J Heart Valve Dis, V25, P380
   Lee PF, 2017, ACTA BIOMATER, V49, P181, DOI 10.1016/j.actbio.2016.11.047
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Meyer SR, 2005, J THORAC CARDIOV SUR, V130, P469, DOI 10.1016/j.jtcvs.2005.03.021
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Motta SE, 2018, EXPERT REV MED DEVIC, V15, P35, DOI 10.1080/17434440.2018.1419865
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Namiri M, 2017, J TISSUE ENG REGEN M, V11, P1675, DOI 10.1002/term.2127
   Naso F, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12354
   Roosens A, 2016, ANN BIOMED ENG, V44, P2827, DOI 10.1007/s10439-016-1555-0
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Saldin LT, 2017, ACTA BIOMATER, V49, P1, DOI 10.1016/j.actbio.2016.11.068
   Santoro R, 2016, J BIOMED MATER RES B, V104, P345, DOI 10.1002/jbm.b.33404
   Sarikouch S, 2016, EUR J CARDIO-THORAC, V50, P281, DOI 10.1093/ejcts/ezw050
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2016, CARDIOVASC PATHOL, V25, P341, DOI 10.1016/j.carpath.2016.05.002
   Sierad LN, 2015, TISSUE ENG PART C-ME, V21, P1284, DOI [10.1089/ten.tec.2015.0170, 10.1089/ten.TEC.2015.0170]
   Smit FE, 2015, MED SCI MONIT BASIC, V21, P1, DOI 10.12659/MSMBR.893546
   Somers P, 2012, ARTIF CELL BLOOD SUB, V40, P151, DOI 10.3109/10731199.2011.637925
   Spector M, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/2/020201
   Theodoridis K, 2016, ACTA BIOMATER, V43, P71, DOI 10.1016/j.actbio.2016.07.013
   Theodoridis K, 2015, BIOMATERIALS, V52, P221, DOI 10.1016/j.biomaterials.2015.02.023
   Timchenko EV, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.9.091511
   Vafaee T, 2018, J TISSUE ENG REGEN M, V12, pE841, DOI [10.1002/term.2507, 10.1002/term.2391]
   van Steenberghe M, 2017, CELL TISSUE BANK, V18, P249, DOI 10.1007/s10561-017-9610-0
   Voges I, 2013, EUR J CARDIO-THORAC, V44, pE272, DOI 10.1093/ejcts/ezt328
   Votteler M, 2012, J BIOPHOTONICS, V5, P47, DOI 10.1002/jbio.201100068
   White LJ, 2017, ACTA BIOMATER, V50, P207, DOI 10.1016/j.actbio.2016.12.033
   Wilczek P, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/5/055006
   Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028
   Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088
NR 69
TC 3
Z9 3
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0908-665X
EI 1399-3089
J9 XENOTRANSPLANTATION
JI Xenotransplantation
PD MAY
PY 2019
VL 26
IS 3
AR e12503
DI 10.1111/xen.12503
PG 15
WC Medicine, Research & Experimental; Transplantation
SC Research & Experimental Medicine; Transplantation
GA IE8XY
UT WOS:000472658100001
PM 30770594
DA 2020-12-08
ER

PT J
AU Fogaca, RL
   Alvarenga, LM
   Woiski, TD
   Becker-Finco, A
   Teixeira, KN
   Silva, SK
   de Moraes, RN
   de Noronha, L
   Noiray, M
   de Figueiredo, BC
   Billiald, P
   de Moura, J
AF Fogaca, Rafaela L.
   Alvarenga, Larissa M.
   Woiski, Thiago D.
   Becker-Finco, Alessandra
   Teixeira, Kadima N.
   Silva, Sabrina K.
   de Moraes, Rosana N.
   de Noronha, Lucia
   Noiray, Magali
   de Figueiredo, Bonald C.
   Billiald, Philippe
   de Moura, Juliana
TI Biomolecular engineering of antidehydroepiandrosterone antibodies: a new
   perspective in cancer diagnosis and treatment using single-chain
   antibody variable fragment
SO NANOMEDICINE
LA English
DT Article
DE adrenal cortex; adrenocortical carcinoma; dehydroepiandrosterone; DHEA;
   monoclonal antibody; scFv; tumor marker; zona reticularis
ID ADRENOCORTICAL TUMORS; FUSION PROTEINS; NANOPARTICLES; SPECIFICITY;
   HYBRIDOMAS; AFFINITY; BIOLOGY; CELLS
AB Aim: To develop a monoclonal antibody against dehydroepiandrosterone (DHEA) and miniaturize it, generating a single-chain antibody variable fragment (scFv) against DHEA as an adrenocortical carcinoma (ACC) marker. Material & methods: DHEA conjugated to keyhole limpet hemocyanin was used as an immunogen to obtain anti-DHEA hybridomas. Variable fragments were cloned from hybridoma 5B7 total RNA, and used to detect DHEA in normal adrenal tissue and ACC cells. Results: IgM monoclonal antibody was highly specific, and the recombinant scFv preserved parental antibody characteristics, allowing tissue localization of DHEA. Conclusion: Undefined small lesions are challenges for clinicians and impact clinical adrenocortical tumor management. Generating an anti-DHEA scFv facilitates development of imaging tests for early diagnosis of pediatric ACC.
C1 [Fogaca, Rafaela L.; Alvarenga, Larissa M.; de Moura, Juliana] Posgrad Engn Bioproc & Biotecnol, Curitiba, Parana, Brazil.
   [Alvarenga, Larissa M.; Silva, Sabrina K.; de Noronha, Lucia; de Moura, Juliana] Pos Grad Microbiol Parasitol & Patol, Curitiba, Parana, Brazil.
   [Fogaca, Rafaela L.; Alvarenga, Larissa M.; Becker-Finco, Alessandra; Silva, Sabrina K.; de Moura, Juliana] UFPR, Dept Patol Basica, Curitiba, Parana, Brazil.
   [Woiski, Thiago D.; de Figueiredo, Bonald C.] Fac Pequeno Principe, Inst Pele Pequeno Principe, Curitiba, Parana, Brazil.
   [Teixeira, Kadima N.] UFPR, Fac Med, Toledo, Brazil.
   [de Moraes, Rosana N.] UFPR, Dept Fisiol, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] PUCPR, Dept Med, Curitiba, Parana, Brazil.
   [Noiray, Magali; Billiald, Philippe] Univ Paris Sud, Fac Pharm, INSERM, UMR S1193, Chatenay Malabry, France.
   [Noiray, Magali; Billiald, Philippe] UMS IPSIT, Chatenay Malabry, France.
   [Billiald, Philippe] Museum Natl Hist Nat, CNRS, UMR 7245, Paris, France.
RP de Moura, J (corresponding author), Posgrad Engn Bioproc & Biotecnol, Curitiba, Parana, Brazil.; de Moura, J (corresponding author), Pos Grad Microbiol Parasitol & Patol, Curitiba, Parana, Brazil.; de Moura, J (corresponding author), UFPR, Dept Patol Basica, Curitiba, Parana, Brazil.; Billiald, P (corresponding author), Univ Paris Sud, Fac Pharm, INSERM, UMR S1193, Chatenay Malabry, France.; Billiald, P (corresponding author), UMS IPSIT, Chatenay Malabry, France.; Billiald, P (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7245, Paris, France.
EM philippe.billiald@u-psud.fr; julianademoura@ufpr.br
RI de Moura, Juliana F/C-8143-2013; Morais, Rosana/R-4928-2016; Alvarenga,
   L M/J-2628-2015; noronha, lucia/F-6339-2015
OI de Moura, Juliana F/0000-0003-1532-2304; Morais,
   Rosana/0000-0002-0816-4371; noronha, lucia/0000-0003-0310-7164;
   BILLIALD, Philippe/0000-0001-8148-5297; Alvarenga,
   Larissa/0000-0002-1756-8183
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq,
   Brazil (Ciencia sem Fronteiras - PVE) [401355/2014-4]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, CAPESCAPES; CNPqNational
   Council for Scientific and Technological Development (CNPq)
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, CNPq, Brazil (Ciencia sem Fronteiras - PVE,
   grant No.401355/2014-4). The authors are grateful to the following
   institutions for their support to the respective authors: Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, CAPES (RL Fogaca, TD
   Woiski and SK Silva) and CNPq (A Becker-Finco, BC de Figueiredo, P
   Billiald and J de Moura). The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Alvarenga LM, 2017, CURRENT DEVELOPMENTS IN BIOTECHNOLOGY AND BIOENGINEERING: HUMAN AND ANIMAL HEALTH APPLICATIONS, P97, DOI 10.1016/B978-0-444-63660-7.00005-X
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a
   Bradbury ARM, 2018, MABS-AUSTIN, V10, P539, DOI 10.1080/19420862.2018.1445456
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Dolatabadi JEN, 2016, BIOIMPACTS, V6, P117, DOI 10.15171/bi.2016.17
   Dubreuil O, 2005, J BIOL CHEM, V280, P24880, DOI 10.1074/jbc.M500048200
   Ehrenmann Francois, 2011, Cold Spring Harb Protoc, V2011, P726, DOI 10.1101/pdb.prot5635
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Fields C, 2013, NAT PROTOC, V8, P1125, DOI 10.1038/nprot.2013.057
   Frigerio B, 2017, ONCOTARGET, V8, P10919, DOI 10.18632/oncotarget.14229
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Havelock JC, 2004, SEMIN REPROD MED, V22, P337, DOI 10.1055/s-2004-861550
   Jiacomini I, 2016, IMMUNOL LETT, V173, P1, DOI 10.1016/j.imlet.2016.03.001
   Juste M, 2006, ANAL BIOCHEM, V349, P159, DOI 10.1016/j.ab.2005.10.046
   Keegan CE, 2002, TRENDS ENDOCRIN MET, V13, P200, DOI 10.1016/S1043-2760(02)00602-1
   Lippert J, 2018, J CLIN ENDOCR METAB, V103, P1
   Mazzocco C, 2016, SCI REP, V6, P1
   Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378
   Michalkiewicz E, 2004, J CLIN ONCOL, V22, P838, DOI 10.1200/JCO.2004.08.085
   Mitchell JS, 2010, BIOSENSORS, P151
   Mousli M, 1998, BBA-GEN SUBJECTS, V1425, P348, DOI 10.1016/S0304-4165(98)00090-7
   NEAL CE, 1993, SEMIN NUCL MED, V23, P114, DOI 10.1016/S0001-2998(05)80092-3
   Oyama H, 2013, ANAL CHEM, V85, P11553, DOI 10.1021/ac402868f
   Pietersz GA, 2017, NANOMEDICINE-UK, V12, P1873, DOI 10.2217/nnm-2017-0043
   Pinto EM, 2013, CLIN CANCER RES, V19, P1740, DOI 10.1158/1078-0432.CCR-12-3354
   PORATH J, 1992, PROTEIN EXPRES PURIF, V3, P263, DOI 10.1016/1046-5928(92)90001-D
   Prough RA, 2016, J MOL ENDOCRINOL, V56, pR139, DOI 10.1530/JME-16-0013
   Rezaei G, 2017, NANOMEDICINE-UK, V12, P597, DOI 10.2217/nnm-2016-0302
   Ribeiro RC, 2000, BRAZ J MED BIOL RES, V33, P1225, DOI 10.1590/S0100-879X2000001000013
   Ribeiro RC, 2017, TXB UNCOMMON CANC, P1126
   Rodriguez-Galindo C, 2005, PEDIATR BLOOD CANCER, V45, P265, DOI 10.1002/pbc.20318
   Rodriguez-Galindo C, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.10515
   Safdari Y, 2013, BIOTECHNOL GENET ENG, V29, P175, DOI 10.1080/02648725.2013.801235
   Shrivastav TG, 2011, J IMMUNOASS IMMUNOCH, V32, P269, DOI 10.1080/15321819.2011.560325
   Sun N, 2018, ENDOCRINOLOGY, V159, P1511, DOI 10.1210/en.2018-00064
   Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0
   Woiski TD, 2017, J BIOMED NANOTECHNOL, V13, P68, DOI 10.1166/jbn.2017.2331
   Woitok M, 2016, CANCER LETT, V381, P323, DOI 10.1016/j.canlet.2016.08.003
   2013, J CLIN ONCOL, V31, P2619, DOI DOI 10.1200/JCO.2012.46.3711
   2012, MOL CELL ENDOCRINOL, V351, P44, DOI DOI 10.1016/J.MCE.2011.10.019
NR 47
TC 3
Z9 3
U1 2
U2 9
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD MAR
PY 2019
VL 14
IS 6
BP 689
EP 705
DI 10.2217/nnm-2018-0230
PG 17
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA HU9JW
UT WOS:000465611700004
PM 30691340
DA 2020-12-08
ER

PT J
AU Silva, EN
   Ribas, JM
   Tabushi, FI
   Silva, MAP
   Siqueira, EBD
   de Noronha, L
   da Silva, ABD
   Lipinski, LC
   Guth, I
   Vosgerau, LM
AF Silva, Eduardo Nascimento
   Ribas-Filho, Jurandir Marcondes
   Tabushi, Fernando Issamu
   Pachnicki Silva, Majenna Andrade
   Dalledone Siqueira, Elisa Beatriz
   de Noronha, Lucia
   Duarte da Silva, Alfredo Benjamim
   Lipinski, Leandro Cavalcante
   Guth, Isabelle
   Vosgerau, Larissa Maria
TI Smooth Muscle Alpha Actin Immunoexpression (-Sma) and CD-117 Antibody
   (C-Kit) in Capsules Formed by Polyurethane Foam-Coated Silicone Implants
   and with Textured Surface: A Study on Rats
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE Implant capsular contracture; Breast implants; Mammaplasty;
   Immunohistochemistry
ID BREAST IMPLANTS; MAST-CELLS; FIBROBLAST PROLIFERATION;
   BACTERIAL-CONTAMINATION; STAPHYLOCOCCUS-AUREUS; COLLAGEN LATTICE;
   CONTRACTURE; BIOFILM; EXPRESSION; EXPERIENCE
AB BackgroundOne of the undesirable complications that might occur after breast augmentation with silicone implants is capsular contracture. In its etiology, the relations between mast cells and myofibroblasts play an important role in collagen synthesis. Mast cells are able to activate fibroblasts into myofibroblasts, through paracrine secretions, inducing collagen production. The objectives of this study were to analyze the myofibroblast concentration through the -SMA immunomarker and evaluate the intensity of mast cell expression against the C-Kit immunomarker.Material and MethodSixty-four Wistar rats were used, divided into two groups (polyurethane foam and textured surface) with 32 animals in each. The animals received silicone implants on the back, below the panniculus carnosus, and after the determined period, they were killed and the capsules formed around the implants were studied. The capsules were analyzed employing the immunohistochemical technique, with the -SMA and C-Kit immunomarkers in subgroups of 30, 50, 70 and 90days.ResultsThe myofibroblast concentration was higher in the polyurethane group when compared to the textured group (30days p=0.105; 50days p=0.247; 70days p=0.014 and 90days p=0.536). The intensity of mast cell expression was more pronounced in the polyurethane group when compared to the textured group (30days p=0.798; 50days p=0.537; 70days p=0.094 and 90days p=0.536).ConclusionsPolyurethane-coated implants induced higher concentrations of myofibroblasts and higher expression of mast cells, when compared to the textured surface implants.No Level AssignedThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
C1 [Silva, Eduardo Nascimento; Ribas-Filho, Jurandir Marcondes; Tabushi, Fernando Issamu; Dalledone Siqueira, Elisa Beatriz; Guth, Isabelle; Vosgerau, Larissa Maria] Evangel Univ Hosp Curitiba HUEC, Evangel Fac Med Parana FEPAR, Curitiba, PR, Brazil.
   [Silva, Eduardo Nascimento; Ribas-Filho, Jurandir Marcondes; Tabushi, Fernando Issamu; Dalledone Siqueira, Elisa Beatriz; Guth, Isabelle; Vosgerau, Larissa Maria] Inst Med Res IPEM, Curitiba, PR, Brazil.
   [Silva, Eduardo Nascimento; Duarte da Silva, Alfredo Benjamim] State Univ Ponta Grossa UEPG, Plast Surg & Anat, Ave Doutor Francisco Burzio 991, BR-84010200 Ponta Grossa, PR, Brazil.
   [de Noronha, Lucia] Pontifical Catholic Univ Parana PUC PR, Anat Pathol, Curitiba, PR, Brazil.
   [Duarte da Silva, Alfredo Benjamim] Fed Univ Parana UFPR, Operat Tech, Curitiba, PR, Brazil.
   [Lipinski, Leandro Cavalcante] State Univ Ponta Grossa UEPG, Operat Tech, Ponta Grossa, PR, Brazil.
RP Silva, EN (corresponding author), Evangel Univ Hosp Curitiba HUEC, Evangel Fac Med Parana FEPAR, Curitiba, PR, Brazil.; Silva, EN (corresponding author), Inst Med Res IPEM, Curitiba, PR, Brazil.; Silva, EN (corresponding author), State Univ Ponta Grossa UEPG, Plast Surg & Anat, Ave Doutor Francisco Burzio 991, BR-84010200 Ponta Grossa, PR, Brazil.
EM dr_eduardosilva@yahoo.com.br
RI ; noronha, lucia/F-6339-2015
OI Lipinski, Leandro/0000-0001-5662-622X; noronha,
   lucia/0000-0003-0310-7164
CR Abramo AC, 2010, AESTHET PLAST SURG, V34, P555, DOI 10.1007/s00266-010-9495-9
   Adams WP, 2017, PLAST RECONSTR SURG, V140, P427, DOI 10.1097/PRS.0000000000003575
   Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26
   Arad E, 2013, PLAST RECONSTR SURG, V131, P205, DOI 10.1097/PRS.0b013e3182778590
   Avninder S, 2008, J POSTGRAD MED, V54, P158, DOI 10.4103/0022-3859.40790
   Barr S, 2017, J MECH BEHAV BIOMED, V75, P75, DOI 10.1016/j.jmbbm.2017.06.030
   Bastos EM, 2007, AESTHET PLAST SURG, V31, P559, DOI 10.1007/s00266-006-0257-7
   Bergmann PA, 2014, J PLAST RECONSTR AES, V67, P1364, DOI 10.1016/j.bjps.2014.05.040
   Boyko TV, 2017, PLAST RECONSTR SURG, V139, P654, DOI 10.1097/PRS.0000000000003077
   Brazin J, 2014, AESTHET PLAST SURG, V38, P592, DOI 10.1007/s00266-014-0318-2
   Bresnick SD, 2017, PLAST RECONSTR SURG, V139, p379E, DOI 10.1097/PRS.0000000000003006
   Bui JM, 2015, AESTHET PLAST SURG, V39, P306, DOI 10.1007/s00266-014-0439-7
   Calobrace MB, 2014, PLAST RECONSTR SURG, V134, p6S, DOI 10.1097/PRS.0000000000000347
   Ceua-Fiocruz, 2008, MAN UT AN FIOCRUZ
   Chen HM, 2017, EXP THER MED, V14, P4438, DOI 10.3892/etm.2017.5082
   da Silva PR, 2008, ACTA CIR BRAS, V23, P93, DOI 10.1590/S0102-86502008000100015
   Danino MA, 2017, PLAST RECONSTR SURG, V140, P878, DOI 10.1097/PRS.0000000000003767
   Duxbury PJ, 2016, J PLAST RECONSTR AES, V69, P452, DOI 10.1016/j.bjps.2016.01.013
   Foley TT, 2014, PLAST RECONSTR SURG, V133, p638E, DOI 10.1097/PRS.0000000000000103
   Foley TT, 2013, PLAST RECONSTR SURG, V131, P1036, DOI 10.1097/PRS.0b013e3182865c3f
   Foley TT, 2011, PLAST RECONSTR SURG, V127, P1478, DOI 10.1097/PRS.0b013e318208d0bb
   Frame J, 2015, AESTHET PLAST SURG, V39, P713, DOI 10.1007/s00266-015-0550-4
   Gancedo M, 2008, AESTHET PLAST SURG, V32, P32, DOI 10.1007/s00266-007-9051-4
   Graf R, 2015, PLAST RECONSTR SURG, V136, p592E, DOI 10.1097/PRS.0000000000001683
   Haddad D, 2007, ACTA CIR BRAS, V22, P187, DOI 10.1590/S0102-86502007000300006
   Hwang K, 2010, AESTHET PLAST SURG, V34, P716, DOI 10.1007/s00266-010-9532-8
   Isenberg JS, 2014, AESTHET PLAST SURG, V38, P815, DOI 10.1007/s00266-014-0327-1
   Jacombs A, 2014, PLAST RECONSTR SURG, V133, p471E, DOI 10.1097/PRS.0000000000000020
   Kyle DJT, 2015, PLAST RECONSTR SURG, V135, P1413, DOI 10.1097/PRS.0000000000001177
   Lee SG, 2015, AESTHET PLAST SURG, V39, P162, DOI 10.1007/s00266-014-0436-x
   Loch-Wilkinson A, 2017, PLAST RECONSTR SURG, V140, P645, DOI 10.1097/PRS.0000000000003654
   Lu F, 2007, PLAST RECONSTR SURG, V119, P844, DOI 10.1097/01.prs.0000255539.99698.f4
   Major MR, 2015, PLAST RECONSTR SURG, V135, P1489, DOI 10.1097/PRS.0000000000001193
   Maxwell GP, 2014, PLAST RECONSTR SURG, V134, p12S, DOI 10.1097/PRS.0000000000000348
   Minami E, 2006, PLAST RECONSTR SURG, V118, P874, DOI 10.1097/01.prs.0000240878.24213.b7
   Moreira M, 2009, AESTHET PLAST SURG, V33, P90, DOI 10.1007/s00266-008-9245-4
   Moyer KE, 2013, PLAST RECONSTR SURG, V131, P680, DOI 10.1097/PRS.0b013e31828189d0
   Pistorio AL, 2011, J CELL BIOCHEM, V112, P1441, DOI 10.1002/jcb.23061
   Poeppl N, 2007, AESTHET PLAST SURG, V31, P133, DOI 10.1007/s00266-006-0091-y
   Prantl L, 2007, PLAST RECONSTR SURG, V120, P275, DOI 10.1097/01.prs.0000264398.85652.9a
   Rocha-De-Souza CM, 2008, INFECT IMMUN, V76, P4489, DOI 10.1128/IAI.00270-08
   Balderrama CMSR, 2009, ACTA CIR BRAS, V24, P367, DOI 10.1590/S0102-86502009000500006
   Segreto F, 2016, PLAST RECONSTR SURG, V137, P792, DOI 10.1097/01.prs.0000479941.42174.f1
   Silva EN, 2016, ACTA CIR BRAS, V31, P774, DOI [10.1590/S0102-865020160120000001, 10.1590/s0102-865020160120000001]
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Unlu RE, 2007, AESTHET PLAST SURG, V31, P358, DOI 10.1007/s00266-006-0248-8
   van Zwieten A, 2013, PATHOLOGY, V45, P71, DOI 10.1097/PAT.0b013e32835b7b99
   Vieira VJ, 2016, AN ACAD BRAS CIENC, V88, P1459, DOI 10.1590/0001-3765201620150874
   Vieira VJ, 2010, PLAST RECONSTR SURG, V126, P1899, DOI 10.1097/PRS.0b013e3181f446d5
   Wagenfuhr J, 2012, ACTA CIR BRAS, V27, P866, DOI 10.1590/S0102-86502012001200007
   Wagenfuhr Junior J, 2007, REV SOC BRAS CIR PLA, V22, P19
   Wiener TC, 2008, AESTHET PLAST SURG, V32, P303, DOI 10.1007/s00266-007-9061-2
   Younan GJ, 2011, PLAST RECONSTR SURG, V128, p649E, DOI 10.1097/PRS.0b013e318230c55d
NR 53
TC 1
Z9 1
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-216X
EI 1432-5241
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD FEB
PY 2019
VL 43
IS 1
BP 233
EP 242
DI 10.1007/s00266-018-1238-3
PG 10
WC Surgery
SC Surgery
GA HJ7TG
UT WOS:000457399600033
PM 30276460
DA 2020-12-08
ER

PT J
AU Tagliari, E
   Campos, LF
   Campos, AC
   Costa-Casagrande, TA
   de Noronha, L
AF Tagliari, Eliane
   Campos, Leticia Fuganti
   Campos, Antonio Carlos
   Costa-Casagrande, Thais Andrade
   de Noronha, Lucia
TI EFFECT OF PROBIOTIC ORAL ADMINISTRATION ON SKIN WOUND HEALING IN RATS
SO ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF
   DIGESTIVE SURGERY
LA English
DT Article
DE Probiotics; Wound healing; Rats; Administration, oral
ID TOLL-LIKE RECEPTORS; BACTERIA; ACID
AB Background: Manipulating intestinal microbiota with probiotics might stimulate skin response. Understanding all stages of the healing process, as well as the gut-skin-healing response can improve the skin healing process. Aim: To evaluate the effect of perioperative oral administration of probiotics on the healing of skin wounds in rats. Methods: Seventy-two Wistar male adult rats were weighed and divided into two groups with 36 each, one control group (supplemented with oral maltodextrin 250 mg/day) and one probiotic group (supplemented with Lactobacillus paracasei LPC-37, Bifidobacterium lactis HN0019, Lactobacillus rhamnosus HN001, Lactobacillus acidophilus NCFM (R) at a dose of 250 mg/day), both given orally daily for 15 days. The two groups were subsequently divided into three subgroups according to the moment of euthanasia: in the 3rd, 7th and 10th postoperative days. Results: There were no significant changes in weight in both groups. Wound contraction was faster in probiotic group when compared to the controls, resulting in smaller wound area in the 7th postoperative day. As for histological aspects, the overall H&E score was lower in the probiotic group. The probiotic group showed increased fibrosis from 3rd to the 7th postoperative day. The type I collagen production was higher in the probiotic group at the 10th postoperative day, and the type III collagen increased in the 7th. Conclusion: The perioperative use of orally administrated probiotic was associated with a faster reduction of the wound area in rats probably by reducing the inflammatory phase, accelerating the fibrosis process and the deposition of collagen.
C1 [Tagliari, Eliane; Campos, Leticia Fuganti] Univ Fed Parana, Hlth Sci Sect, Postgrad Program Clin Surg, Curitiba, PR, Brazil.
   [Campos, Antonio Carlos] Univ Fed Parana, Hlth Sci Sect, Dept Surg, Curitiba, PR, Brazil.
   [Costa-Casagrande, Thais Andrade] Positivo Univ, Profess Master Program Ind Biotechnol, Curitiba, PR, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Pathol Lab, Curitiba, PR, Brazil.
RP Tagliari, E (corresponding author), Univ Fed Parana, Hlth Sci Sect, Postgrad Program Clin Surg, Curitiba, PR, Brazil.
EM elianetagliari@yahoo.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; TAGLIARI, ELIANE/0000-0002-0263-6147
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil
   (CAPES)CAPES [001]; FQM-FARMA
FX This study was financed in part by FQM-FARMA, and in part by Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES) -
   Finance Code 001
CR Belkaid Y, 2016, NAT REV IMMUNOL, V16, P353, DOI 10.1038/nri.2016.48
   Borkowski AW, 2014, J INVEST DERMATOL, V134, P2315, DOI 10.1038/jid.2014.167
   Campos ACL, 2008, CURR OPIN CLIN NUTR, V11, P281, DOI 10.1097/MCO.0b013e3282fbd35a
   Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267
   CHEN Y, 2011, AFRICAN J PHARM PHAR, V5
   de Castilho TJC, 2015, ABCD-ARQ BRAS CIR DI, V28, P258, DOI 10.1590/S0102-6720201500040010
   Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
   Wagner NRF, 2018, ABCD-ARQ BRAS CIR DI, V31, DOI 10.1590/0102-672020180001e1400
   Flesch AGT, 2014, ABCD-ARQ BRAS CIR DI, V27, P206, DOI 10.1590/S0102-67202014000300012
   Houdek MT, 2016, PLAST RECONSTR SURG, V137, P1498, DOI 10.1097/PRS.0000000000002094
   Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x
   Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062
   Lai Yuping, 2008, Infectious Disorders - Drug Targets, V8, P144
   Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867
   Campos ACL, 2007, ABCD-ARQ BRAS CIR DI, V20, P51, DOI 10.1590/S0102-67202007000100010
   Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120
   Lukic J, 2017, WOUND REPAIR REGEN, V25, P912, DOI 10.1111/wrr.12607
   Nery RA, 2015, ABCD-ARQ BRAS CIR DI, V28, P290, DOI 10.1590/S0102-6720201500040018
   Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018
   Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898
   Radek KA, 2010, ADV WOUND CARE-SER, V1, P223, DOI 10.1089/awc.2009.0129
   Salgado FLL, 2016, ABCD-ARQ BRAS CIR DI, V29, P223, DOI 10.1590/0102-6720201600040003
   Sato T, 2010, WOUND REPAIR REGEN, V18, P586, DOI 10.1111/j.1524-475X.2010.00632.x
   Scotti E, 2017, TOXICOLOGY RES APPL, V1
   Tagliari E, 2017, ABCD-ARQ BRAS CIR DI, V30, P211, DOI 10.1590/0102-6720201700030011
   Vizzotto Junior Alvo Orlando, 2003, J. Bras. Patol. Med. Lab., V39, P143, DOI 10.1590/S1676-24442003000200009
   Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454
   Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009
   World Gastroenterology Organization(WGO), 2017, PROBIOTICS PREBIOTIC
NR 29
TC 0
Z9 0
U1 0
U2 2
PU COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD
PI SAO PAULO SP
PA AV BRIGADEIRO LUIZ ANTONIO, 278-6-SALAS 10 E 11, SAO PAULO SP,
   01318-901, BRAZIL
SN 0102-6720
EI 2317-6326
J9 ABCD-ARQ BRAS CIR DI
JI ABCD-Arq. Bras. Cir. Dig.-Braz. Arch. Dig. Surg.
PY 2019
VL 32
IS 3
AR e1457
DI 10.1590/0102-672020190001e1457
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA JX6VZ
UT WOS:000503871300011
PM 31826084
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Sturzeneker, MCS
   de Noronha, L
   Olandoski, M
   Wendling, LU
   Precoma, DB
AF Soares Sturzeneker, Mario Claudio
   de Noronha, Lucia
   Olandoski, Marcia
   Wendling, Larissa Uhlmann
   Precoma, Dalton Bertolim
TI Ramipril significantly attenuates the development of non-alcoholic
   steatohepatitis in hyperlipidaemic rabbits
SO AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE
LA English
DT Article
DE Non-alcoholic fatty liver disease; non-alcoholic steatohepatitis;
   renin-angiotensin system; hypertension; atherosclerosis; insulin
   resistance
ID FATTY LIVER-DISEASE; CONVERTING ENZYME-INHIBITORS; HEPATIC
   INSULIN-RESISTANCE; ANGIOTENSIN-II; AMERICAN ASSOCIATION; METABOLIC
   SYNDROME; RECEPTOR BLOCKERS; RISK; HYPERGLYCEMIA; METAANALYSIS
AB Background: Non-alcoholic fatty liver disease (NAFLD) is considered as the most frequent cause of chronic hepatic disease in adults. It is strictly correlated with insulin resistance, frequently associated with components of metabolic syndrome, and, similarly to the latter, it has been correlated with high risk of developing type 2 diabetes and cardiovascular diseases. Systemic arterial hypertension has been suggested to be associated with NAFLD in approximately 40% of the cases, and NAFLD has been independently associated with an increased risk of arterial hypertension in observational studies. Therefore, we can infer that treating arterial hypertension in NAFLD carriers will be often necessary and that the potential beneficial effects of the antihypertensive might, in this context, influence the choice of the respective drug. The renin-angiotensin system has been correlated to the whole basic phys-iopathogenic mechanism of NAFLD in experimental models. Based on these findings, we conducted this study to evaluate the effects of the ACE-inhibitor ramipril, used preventively, in NAFLD induced in rabbits fed hyperlipidaemic diet. Methods: Twenty-nine rabbits were divided into three groups (normal, placebo, and ramipril). The placebo and ramipril groups were fed a ration containing 0.925% cholesterol. The groups were orally administered 0.35 mg/kg/day of ramipril, and an equivalent volume of vehicle was administered to the placebo group. At the end of the 8th week, all rabbits underwent segmental hepatic resection and were euthanized. Blood samples were collected to determine glucose, insulin, creatinine, total cholesterol, triglycerides, HDL-C, and aminotransferase levels at baseline and euthanasia. Haematoxylin and eosin and Gomori trichrome-stained slides were analysed based on the histological scoring system for NAFLD. Sudan III-stained slides were analysed by morphometry and immunostained based on the Allred scoring system. Results: When compared with placebo, ramipril significantly diminished the development of steatosis (P=0.032), lobular inflammation (P=0.006), hepatocellular ballooning (P=0.023), and fibrosis (P=0.02). Based on the NAFLD activity score (NAS), ramipril significantly reduced the development of non-alcoholic steatohepatitis (NASH) (P=0.003). Conclusions: The preventive use of ramipril in rabbits fed hyperlipidaemic diet, attenuates the development of the whole NAFLD histopathological spectrum and based on NAS, ramipril significantly reduced the development of NASH.
C1 [Soares Sturzeneker, Mario Claudio; de Noronha, Lucia; Olandoski, Marcia; Wendling, Larissa Uhlmann; Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Dept Med, Curitiba, Parana, Brazil.
   [Soares Sturzeneker, Mario Claudio] Univ Estadual Ponta Grossa, Dept Med, Ponta Grossa, Brazil.
RP Sturzeneker, MCS (corresponding author), Pontificia Univ Catolica Parana, Dept Med, Curitiba, Parana, Brazil.
EM mcssturzeneker@gmail.com
OI Sturzeneker, Mario/0000-0001-5629-697X
CR Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051
   Bataller R, 2003, AM J PHYSIOL-GASTR L, V285, pG642, DOI 10.1152/ajpgi.00037.2003
   Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212
   Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Charbonneau A, 2010, DIABETES, V59, P861, DOI 10.2337/db09-1238
   Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327
   Filozof C, 2015, DRUGS, V75, P1373, DOI 10.1007/s40265-015-0437-3
   Francque SM, 2016, J HEPATOL, V65, P425, DOI 10.1016/j.jhep.2016.04.005
   Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340
   Fujita K, 2007, DIGEST DIS SCI, V52, P3455, DOI 10.1007/s10620-007-9741-4
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579
   Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140
   Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623
   Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474
   Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638
   Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kudo H, 2009, LIVER INT, V29, P988, DOI 10.1111/j.1478-3231.2009.02006.x
   Lopez-Suarez A, 2011, EUR J GASTROEN HEPAT, V23, P1011, DOI 10.1097/MEG.0b013e32834b8d52
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004
   Ogihara T, 2002, HYPERTENSION, V40, P872, DOI 10.1161/01.HYP.0000040262.48405.A8
   PACHALY J.R., 2006, TRATADO ANIMAIS SELV, P1215
   Ryoo JH, 2014, J GASTROEN HEPATOL, V29, P1926, DOI 10.1111/jgh.12643
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678
   Shinozaki S, 2011, J BIOL CHEM, V286, P34959, DOI 10.1074/jbc.M110.187666
   Sturzeneker MCS, 2011, ATHEROSCLEROSIS, V216, P97, DOI 10.1016/j.atherosclerosis.2011.01.047
   Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314
   Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135
   Toblli JE, 2008, OBESITY, V16, P770, DOI 10.1038/oby.2007.114
   Tocci G, 2011, AM J HYPERTENS, V24, P582, DOI 10.1038/ajh.2011.8
   Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781
   Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018
   Yamamoto E, 2008, HYPERTENSION, V52, P573, DOI 10.1161/HYPERTENSIONAHA.108.112292
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
   2011, CLIN GASTROENTEROL H, V9, P524, DOI DOI 10.1016/J.CGH.2011.03.020
NR 40
TC 0
Z9 0
U1 0
U2 0
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 2160-200X
J9 AM J CARDIOVASC DIS
JI Am. J. Cardiovasc. Dis.
PY 2019
VL 9
IS 2
BP 8
EP 17
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HX3KV
UT WOS:000467291700001
PM 31131153
DA 2020-12-08
ER

PT J
AU Claro, LM
   Moreno-Amaral, AN
   Gadotti, AC
   Dolenga, CJ
   Nakao, LS
   Azevedo, MLV
   de Noronha, L
   Olandoski, M
   de Moraes, TP
   Stinghen, AEM
   Pecoits, R
AF Claro, Ligia Maria
   Moreno-Amaral, Andrea N.
   Gadotti, Ana Carolina
   Dolenga, Carla J.
   Nakao, Lia S.
   Azevedo, Marina L. V.
   de Noronha, Lucia
   Olandoski, Marcia
   de Moraes, Thyago P.
   Stinghen, Andrea E. M.
   Pecoits-Filho, Roberto
TI The Impact of Uremic Toxicity Induced Inflammatory Response on the
   Cardiovascular Burden in Chronic Kidney Disease
SO TOXINS
LA English
DT Article
DE uremic toxins; inflammatory biomarkers; sCD36; sRAGE; fractalkine
   (CX3CL1); fractalkine receptor (CX3CR1)
ID RENAL-FUNCTION; CARDIORENAL SYNDROME; FRACTALKINE CX3CL1; DIALYSIS
   PATIENTS; INDOXYL SULFATE; SOLUBLE FAS; TOXINS; ATHEROSCLEROSIS; CELLS;
   RISK
AB Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to identify the associations between UT, inflammatory biomarkers and biomarkers of the uremic cardiovascular response (BUCVR) and their impact on cardiovascular status as well as their roles as predictors of outcome in CKD patients. CKD patients stages 3, 4 and 5 (n = 67) were recruited and UT (indoxyl sulfate/IS, p-cresil sulfate/pCS and indole-3-acetic acid/IAA); inflammatory biomarkers [Interleukin-6 (IL-6), high sensitivity C reactive protein (hsCRP), monocyte chemoattractant protein-1 (MCP-1), soluble vascular adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble Fas (sFas)] and BUCVRs [soluble CD36 (sCD36), soluble receptor for advanced glycation end products (sRAGE), fractalkine] was measured. Patients were followed for 5.2 years and all causes of death was used as the primary outcome. Artery segments collected at the moment of transplantation were used for the immunohistochemistry analysis in a separate cohort. Estimated glomerular filtration rate (eGFR), circulating UT, plasma biomarkers of systemic and vascular inflammation and BUCVR were strongly interrelated. Patients with plaque presented higher signs of UT-induced inflammation and arteries from CKD patients presented higher fractalkine receptor (CX3CR1) tissue expression. Circulating IS (p = 0.03), pCS (p = 0.007), IL-6 (p = 0.026), sFas (p = 0.001), sCD36 (p = 0.01) and fractalkine (p = 0.02) were independent predictors of total mortality risk in CKD patients. Our results reinforce the important role of uremic toxicity in the pathogenesis of cardiovascular disease (CVD) in CKD patients through an inflammatory pathway.
C1 [Claro, Ligia Maria; Moreno-Amaral, Andrea N.; Gadotti, Ana Carolina; Azevedo, Marina L. V.; de Noronha, Lucia; Olandoski, Marcia; de Moraes, Thyago P.; Pecoits-Filho, Roberto] Pontificia Univ Catolica Parana, Sch Med, Grad Program Hlth Sci, BR-80215901 Curitiba, PR, Brazil.
   [Dolenga, Carla J.; Nakao, Lia S.; Stinghen, Andrea E. M.] Univ Fed Parana, Basic Pathol Dept, BR-80050540 Curitiba, PR, Brazil.
RP Pecoits, R (corresponding author), Pontificia Univ Catolica Parana, Sch Med, Grad Program Hlth Sci, BR-80215901 Curitiba, PR, Brazil.
EM lmclaro@gmail.com; deamoreno@gmail.com; ana_raixu3@hotmail.com;
   carla.vet10@gmail.com; lia.nakao@ufpr.br; malu_tu@yahoo.com.br;
   lnno.noronha@gmail.com; bio.estatistica@pucpr.br;
   thyago.moraes@pucpr.br; andreastinghen@ufpr.br; r.pecoits@pucpr.br
RI Nakao, Lia S/M-1507-2018; Stinghen, Andrea E M/A-4947-2010; de Moraes,
   Thyago Proenca/AAH-7000-2020; de Moraes, Thyago Proenca/M-9400-2014;
   noronha, lucia/F-6339-2015
OI Nakao, Lia S/0000-0001-9647-6350; Stinghen, Andrea E
   M/0000-0001-8595-5321; de Moraes, Thyago Proenca/0000-0002-2983-3968;
   Moreno-Amaral, Andrea N/0000-0002-2730-2952; noronha,
   lucia/0000-0003-0310-7164
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [483632/2011-12]; Fundacao AraucariaFundacao Araucaria
   [202/2012-23715]
FX This research was funded by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), grant number 483632/2011-12 and
   Fundacao Araucaria, grant number 202/2012-23715.
CR Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609
   Borges NA, 2016, J RENAL NUTR, V26, P396, DOI 10.1053/j.jrn.2016.07.005
   Chmielewski M, 2010, CLIN CHIM ACTA, V411, P2079, DOI 10.1016/j.cca.2010.09.009
   Dalboni MA, 2003, ARTIF ORGANS, V27, P687, DOI 10.1046/j.1525-1594.2003.07274.x
   Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283
   El-Agroudy AE, 2010, CLIN EXP NEPHROL, V14, P152, DOI 10.1007/s10157-009-0261-8
   Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
   Goncalves S, 2006, NEPHROL DIAL TRANSPL, V21, P2788, DOI 10.1093/ndt/gfl273
   Guilgen G, 2011, BLOOD PURIFICAT, V32, P296, DOI 10.1159/000330327
   HUH HY, 1995, J BIOL CHEM, V270, P6267, DOI 10.1074/jbc.270.11.6267
   Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665
   Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926
   Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x
   Kaminski TW, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0457-1
   Kashiyama K, 2015, INT J CARDIOVAS IMAG, V31, P935, DOI 10.1007/s10554-015-0633-y
   Kim HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03130-z
   Lekawanvijit S, 2016, AM J PHYSIOL-RENAL, V311, pF52, DOI 10.1152/ajprenal.00348.2015
   Lekawanvijit S, 2014, J PHYSIOL-LONDON, V592, P3969, DOI 10.1113/jphysiol.2014.273078
   Leurs P, 2013, ARCH MED RES, V44, P601, DOI 10.1016/j.arcmed.2013.11.002
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77
   Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592
   Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589
   Lin CJ, 2012, ARCH MED RES, V43, P451, DOI 10.1016/j.arcmed.2012.08.002
   Liu H, 2011, CLIN CHIM ACTA, V412, P1180, DOI 10.1016/j.cca.2011.03.036
   Loomis SJ, 2017, CLIN CHEM, V63, P980, DOI 10.1373/clinchem.2016.264135
   Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF
   Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184
   Moradi H, 2013, AM J NEPHROL, V38, P136, DOI 10.1159/000351758
   Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6
   Rebholz CM, 2015, NEPHROL DIAL TRANSPL, V30, P77, DOI 10.1093/ndt/gfu282
   Richter B, 2012, THROMB HAEMOSTASIS, V108, P1220, DOI 10.1160/TH12-03-0195
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rossi M, 2014, ARCH MED RES, V45, P309, DOI 10.1016/j.arcmed.2014.04.002
   Selvin E, 2013, DIABETES, V62, P2116, DOI 10.2337/db12-1528
   Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x
   Stinghen AEM, 2009, NEPHRON CLIN PRACT, V111, pC117, DOI 10.1159/000191205
   Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815
   Yadav AK, 2011, J ATHEROSCLER THROMB, V18, P958
NR 39
TC 12
Z9 12
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6651
J9 TOXINS
JI Toxins
PD OCT
PY 2018
VL 10
IS 10
AR 384
DI 10.3390/toxins10100384
PG 17
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA GY7UG
UT WOS:000448820400005
PM 30249039
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Noronha, L
   Zanluca, C
   Burger, M
   Suzukawa, AA
   Azevedo, M
   Rebutini, PZ
   Novadzki, IM
   Tanabe, LS
   Presibella, MM
   dos Santos, CND
AF de Noronha, Lucia
   Zanluca, Camila
   Burger, Marion
   Suzukawa, Andreia Akemi
   Azevedo, Marina
   Rebutini, Patricia Z.
   Novadzki, Iolanda Maria
   Tanabe, Laurina Setsuko
   Presibella, Mayra Marinho
   Duarte dos Santos, Claudia Nunes
TI Zika Virus Infection at Different Pregnancy Stages: Anatomopathological
   Findings, Target Cells and Viral Persistence in Placental Tissues
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; vertical transmission; placenta; anatomopathological
   analysis; Hofbauer cells; morphometric analysis
ID HOFBAUER CELLS; PATHOLOGY; BRAZIL; REPLICATION; MICRONESIA; ASSAY
AB Zika virus (ZIKV) infection in humans has been associated with congenital malformations and other neurological disorders, such as Guillain-Barre syndrome. The mechanism(s) of ZIKV intrauterine transmission, the cell types involved, the most vulnerable period of pregnancy for severe outcomes from infection and other physiopathological aspects are not completely elucidated. In this study, we analyzed placental samples obtained at the time of delivery from a group of 24 women diagnosed with ZIKV infection during the first, second or third trimesters of pregnancy. Villous immaturity was the main histological finding in the placental tissues, although placentas without alterations were also frequently observed. Significant enhancement of the number of syncytial sprouts was observed in the placentas of women infected during the third trimester, indicating the development of placental abnormalities after ZIKV infection. Hyperplasia of Hofbauer cells (HCs) was also observed in these third-trimester placental tissues, and remarkably, HCs were the only ZIKV-positive fetal cells found in the placentas studied that persisted until birth, as revealed by immunohistochemical (IHC) analysis. Thirty-three percent of women infected during pregnancy delivered infants with congenital abnormalities, although no pattern correlating the gestational stage at infection, the IHC positivity of HCs in placental tissues and the presence of congenital malformations at birth was observed. Placental tissue analysis enabled us to confirm maternal ZIKV infection in cases where serum from the acute infection phase was not available, which reinforces the importance of this technique in identifying possible causal factors of birth defects. The results we observed in the samples from naturally infected pregnant women may contribute to the understanding of some aspects of the pathophysiology of ZIKV.
C1 [de Noronha, Lucia; Azevedo, Marina; Rebutini, Patricia Z.] Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.
   [Zanluca, Camila; Suzukawa, Andreia Akemi; Duarte dos Santos, Claudia Nunes] Fundacao Oswald Cruz, Lab Virol Mol, Inst Carlos Chagas, Curitiba, Parana, Brazil.
   [Burger, Marion; Novadzki, Iolanda Maria; Tanabe, Laurina Setsuko] Secretaria Saude Estado Parana, Curitiba, Parana, Brazil.
   [Presibella, Mayra Marinho] Lab Cent Estado Parana, Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.; dos Santos, CND (corresponding author), Fundacao Oswald Cruz, Lab Virol Mol, Inst Carlos Chagas, Curitiba, Parana, Brazil.
EM lnno.noronha@gmail.com; claudia.dossantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; Rebutini, Patricia
   Z/I-5283-2017; noronha, lucia/F-6339-2015
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; Rebutini, Patricia
   Z/0000-0002-7364-6844; noronha, lucia/0000-0003-0310-7164; Zanluca,
   Camila/0000-0001-7350-9105
FU Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq) [439968/2016-0]; CapesCAPES [481-2016
   (88887.116626/2016-01)]; Fundacao AraucariaFundacao Araucaria [CP
   04/2016]; CNPq fellowshipNational Council for Scientific and
   Technological Development (CNPq)
FX Fiocruz, CNPq (439968/2016-0), Capes Zika Fast Track 481-2016
   (88887.116626/2016-01), and Fundacao Araucaria (CP 04/2016). CD and LN
   have a CNPq fellowship.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CDC-Centers for Disease Control and Prevention, 2017, ZIK MAC ELISA
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   International Comittee on Taxonomy of Viruses (ICTV), 2017, VIR TAX 2016 REL
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Khan S, 2000, BIOL REPROD, V62, P1075, DOI 10.1095/biolreprod62.4.1075
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Loukeris K, 2010, PEDIATR DEVEL PATHOL, V13, P305, DOI 10.2350/09-08-0692-OA.1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore K., 2014, DEV HUMAN CLIN ORIEN, P48
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Tang ZH, 2011, AM J REPROD IMMUNOL, V66, P336, DOI 10.1111/j.1600-0897.2011.01006.x
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   World Health Organization (WHO), 2017, ZIK SIT REP 2017
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 15
Z9 15
U1 0
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 25
PY 2018
VL 9
AR 2266
DI 10.3389/fmicb.2018.02266
PG 11
WC Microbiology
SC Microbiology
GA GU8JT
UT WOS:000445586100001
PM 30337910
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Faria, AR
   Jung, JE
   de Catro, CCS
   de Noronha, L
AF Faria, Adriane Reichert
   Jung, Juliana Elizabeth
   Silva de Catro, Caio Cesar
   de Noronha, Lucia
TI Reduced immunohistochemical expression of CCN3 in vitiligo
SO INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY
LA English
DT Article
DE Adhesion; CCN3; immunohistochemistry; vitiligo
ID GENERALIZED VITILIGO; DDR1; SKIN; MELANOCYTES; HYPOTHESIS; EPIDERMIS
AB Background: Defective adhesion seems to be involved in the chronic loss of melanocytes observed in vitiligo. Recent findings showed an association of genetic variants of an adhesion gene with vitiligo and reduced immunohistochemical expression of some adhesion molecules in vitiligo skin.
   Aims: To compare CCN3 immunohistochemical expression in lesional and non-lesional epidermis of individuals with vitiligo.
   Methods: A total of 66 skin specimens from 33 volunteers with vitiligo were analyzed by immunohistochemistry using anti-CCN3 antibodies. Absence of topical or systemic treatment for vitiligo over the previous 30 days and availability of an area of non-lesional skin for biopsy at least 15 cm away from any vitiliginous macules were the main inclusion criteria.
   Limitations: Paraffin embedded skin samples do not allow investigation by molecular biology methods. Not all samples allowed analysis due to the lamina preparation technique. Complete clinical data was not available for all patients.
   Conclusion: Our results support the hypothesis of impaired cell adhesion in vitiligo suggested by genetic studies. The pattern of immunohistochemical expression suggests that vitiligo might be an epithelial disease and not just a melanocyte disorder.
C1 [Faria, Adriane Reichert; Silva de Catro, Caio Cesar] Pontificia Univ Catolica Parana, Santa Casa De Misericordia Hosp, Sch Med, Dept Dermatol, Curitiba, Parana, Brazil.
   [Jung, Juliana Elizabeth] Pontificia Univ Catolica Parana, Hosp ErastoGaertner, Dept Pathol, Curitiba, Parana, Brazil.
   [Faria, Adriane Reichert; de Noronha, Lucia] Pontificia Univ Catolica Parana, Sch Med, Grad Program Hlth Sci, Dept Pathol, Curitiba, Parana, Brazil.
RP Faria, AR (corresponding author), Rua Padre Anchieta 1846,Sala 1003, BR-80730000 Curitiba, Parana, Brazil.
EM adri_reichert@yahoo.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
FU Laboratory of Experimental Pathology of School of Medicine, Pontifical
   Catholic University of Parana, Curitiba, Parana, Brazil
FX Laboratory of Experimental Pathology of School of Medicine, Pontifical
   Catholic University of Parana, Curitiba, Parana, Brazil.
CR Alikhan A, 2011, J AM ACAD DERMATOL, V65, P473, DOI 10.1016/j.jaad.2010.11.061
   Cario-Andre M, 2007, PIGM CELL RES, V20, P385, DOI 10.1111/j.1600-0749.2007.00396.x
   Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025
   Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x
   Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132
   Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x
   Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x
   Halder RM, 2009, SEMIN CUTAN MED SURG, V28, P86, DOI 10.1016/j.sder.2009.04.008
   Kumar R, 2011, BRIT J DERMATOL, V164, P187, DOI 10.1111/j.1365-2133.2010.10039.x
   Liang YH, 2007, J INVEST DERMATOL, V127, P2552, DOI 10.1038/sj.jid.5700904
   MOELLMANN G, 1982, J INVEST DERMATOL, V79, P321, DOI 10.1111/1523-1747.ep12500086
   Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0
   Reichert-Faria A, 2013, J EUR ACAD DERMATOL, V27, P1057, DOI 10.1111/jdv.12013
   Ricard AS, 2012, EXP DERMATOL, V21, P411, DOI 10.1111/j.1600-0625.2012.01473.x
   Rittie L, 2011, J CELL COMMUN SIGNAL, V5, P69, DOI 10.1007/s12079-010-0114-y
   de Castro CCS, 2010, J INVEST DERMATOL, V130, P1813, DOI 10.1038/jid.2010.34
   Taieb A, 2007, PIGM CELL RES, V20, P27, DOI 10.1111/j.1600-0749.2006.00355.x
NR 17
TC 0
Z9 0
U1 0
U2 3
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0378-6323
EI 0973-3922
J9 INDIAN J DERMATOL VE
JI Indian J. Dermatol. Venereol. Leprol.
PD SEP-OCT
PY 2018
VL 84
IS 5
BP 558
EP 562
DI 10.4103/ijdvl.IJDVL_954_16
PG 5
WC Dermatology
SC Dermatology
GA GR8FU
UT WOS:000442951700006
PM 29998862
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Almeida, SM
   Salvador, GLO
   Roza, TH
   Izycki, LF
   dos Santos, I
   Aragao, A
   Kulik, A
   Muro, M
   Torres, LFB
   de Noronha, L
AF de Almeida, Sergio Monteiro
   Salvador, Gabriel L. O.
   Roza, Thiago Henrique
   Izycki, Luis Felipe
   dos Santos, Isaias
   Aragao, Afonso
   Kulik, Amanda
   Muro, Marisol
   Bleggi Torres, Luis Fernando
   de Noronha, Lucia
TI Geographical evaluation of Neuroparacoccidioidomycosis and
   Paracoccidioidomycosis in Southern Brazil
SO MYCOSES
LA English
DT Article
DE autopsy; biopsy; central nervous system; environmental factors;
   Neuroparacoccidioidomycosis; Paracoccidioides spp
ID CENTRAL-NERVOUS-SYSTEM; BRASILIENSIS; RESISTANCE
AB Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis among immunocompetent patients in Latin America. This study aimed to describe the expansion over time and the geographical distribution of confirmed Neuroparacoccidioidomycosis (NPCM) and PCM cases, and relate it to environmental characteristics such as climate, soil types and coffee crops. This was a retrospective study of autopsy and biopsy reports between 1951 and 2014 from the Medical Pathology Section of the Hospital de Clinicas, Universidade Federal do Parana (UFPR), Curitiba, Southern Brazil. PCM was predominant in male agricultural workers. PCM cases predominated in areas with subtropical climate with hot summers in North West Parana state. NPCM cases were distributed statewide more frequent in rural than metropolitan area. There was no association with climate, soil type, or coffee crop culture. Most of the PCM cases were in the metropolitan area of the capital, chiefly due to migration fluxes. Even though the history is predominantly agricultural, PCM cases were distributed mainly in the metropolitan area of the state capital, there was no association with climate and soil. NPCM cases were numerically more frequent in rural than metropolitan area.
C1 [de Almeida, Sergio Monteiro; Salvador, Gabriel L. O.; Roza, Thiago Henrique; Izycki, Luis Felipe; dos Santos, Isaias; Aragao, Afonso; Bleggi Torres, Luis Fernando; de Noronha, Lucia] Univ Fed Parana, Med Pathol Dept, Sch Med, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro] Univ Fed Parana, Virol Lab, Hosp Clin, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro; Kulik, Amanda; Bleggi Torres, Luis Fernando] Fac Pequeno Principe, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro; Kulik, Amanda; Bleggi Torres, Luis Fernando] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.
   [Muro, Marisol] Univ Fed Parana, Hosp Clin, Mycol Lab, Curitiba, Parana, Brazil.
RP de Almeida, SM (corresponding author), Hosp Clin UFPR, Setor Anal Clin, Secao Virol, Curitiba, Parana, Brazil.
EM sergio.ma@ufpr.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Arantes TD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004606
   Bellissimo-Rodrigues F, 2013, MED MYCOL, V51, P313, DOI 10.3109/13693786.2012.714529
   Bellissimo-Rodrigues F, 2011, AM J TROP MED HYG, V85, P546, DOI 10.4269/ajtmh.2011.11-0084
   Benard G, 2000, CLIN INFECT DIS, V31, P1032, DOI 10.1086/318146
   Buitrago MJ, 2011, J TRAVEL MED, V18, P26, DOI 10.1111/j.1708-8305.2010.00477.x
   Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037
   de Almeida SM, 2004, J INFECTION, V48, P193, DOI 10.1016/j.jinf.2003.08.012
   desAlmeida SM, 2017, MYCOSES, V61, P237
   Gasparetto EL, 2003, J COMPUT ASSIST TOMO, V27, P12, DOI 10.1097/00004728-200301000-00003
   Koppen W, 1936, HDB KLIMATOLOGIE, P44
   Marques S A, 1983, Rev Inst Med Trop Sao Paulo, V25, P87
   Munoz JF, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00213-16
   Nobre Vandack, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P69, DOI 10.1590/S0036-46652003000200003
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Pedroso VSP, 2009, REV SOC BRAS MED TRO, V42, P691, DOI 10.1590/S0037-86822009000600016
   Queiroz-Telles F, 2017, LANCET INFECT DIS, V17, pE367, DOI 10.1016/S1473-3099(17)30306-7
   RESTREPO A, 1984, INFECT IMMUN, V46, P346, DOI 10.1128/IAI.46.2.346-353.1984
   Shankar J, 2011, CLIN MICROBIOL REV, V24, P296, DOI 10.1128/CMR.00062-10
   Shikanai-Yasuda MA, 2017, REV SOC BRAS MED TRO, V50, P715, DOI 10.1590/0037-8682-0230-2017
   Campos MVS, 2008, REV SOC BRAS MED TRO, V41, P169, DOI 10.1590/S0037-86822008000200007
   Theodoro RC, 2008, FUNGAL GENET BIOL, V45, P1284, DOI 10.1016/j.fgb.2008.07.003
   Wagner G, 2016, MED MYCOL CASE REP, V14, P12, DOI 10.1016/j.mmcr.2016.12.002
   WHO/Department of Control of Neglected Tropical Diseases, 2013, SUST DRIV OV GLOB IM
NR 23
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0933-7407
EI 1439-0507
J9 MYCOSES
JI Mycoses
PD AUG
PY 2018
VL 61
IS 8
BP 587
EP 593
DI 10.1111/myc.12782
PG 7
WC Dermatology; Mycology
SC Dermatology; Mycology
GA GO2UD
UT WOS:000439832600008
PM 29663530
DA 2020-12-08
ER

PT J
AU de Almeida, SM
   Roza, TH
   Salvador, GLO
   Izycki, LF
   Locatelli, G
   dos Santos, I
   Aragao, A
   Torres, LFB
   de Noronha, LH
AF de Almeida, Sergio Monteiro
   Roza, Thiago Henrique
   Salvador, Gabriel L. O.
   Izycki, Luis Felipe
   Locatelli, Giuliana
   dos Santos, Isaias
   Aragao, Afonso
   Bleggi Torres, Luis Fernando
   de Noronha, Lucia Helena
TI Autopsy and biopsy study of paracoccidioidomycosis and
   neuroparacoccidioidomycosis with and without HIV co-infection
SO MYCOSES
LA English
DT Article
DE autopsy; central nervous system; HIV; necropsy; Paracoccidioides
   brasiliensis; paracoccidioidomycosis
ID CENTRAL-NERVOUS-SYSTEM; IMMUNODEFICIENCY-VIRUS-INFECTION; BRASILIENSIS;
   INVOLVEMENT; RESISTANCE; DIAGNOSIS; BRAZIL; AREA; AIDS
AB Paracoccidioidomycosis (PCM) is a systemic mycosis prevalent among immunocompetent patients in Latin America. This study aimed to describe the frequency, demographics and clinical characteristics of central nervous system PCM (NPCM) and PCM in an endemic region, and the impact of human immunosuppression virus (HIV) co-infection. This was a retrospective study of autopsy and biopsy reports from the Medical Pathology Section of the Hospital de Clinicas, UFPR, Curitiba, Southern Brazil, between 1951 and 2014. PCM was present in 0.1% of 378,323 cases examined, with 5.7% being NPCM. Infection was prevalent in working-age men, agricultural workers and rural residents. Numbers of HIV autopsy cases increased over time, while those of PCM cases decreased. Prevalence of co-infection of HIV/PCM and HIV/NPCM was 1.6%, and 0.4%, respectively. Adrenals were affected more frequently in the NPCM group compared with the PCM group. Mortality was higher on NPCM group. The clinical course of PCM in HIV patients resembles an acute/sub-acute infection. Association of NPCM and HIV is rare, while diagnosis of NPCM is difficult, it should be considered a differential diagnosis in HIV patients who live in, or have visited, endemic areas and present with neurological symptoms.
C1 [de Almeida, Sergio Monteiro; Roza, Thiago Henrique; Salvador, Gabriel L. O.; Izycki, Luis Felipe; Locatelli, Giuliana; dos Santos, Isaias; Aragao, Afonso; Bleggi Torres, Luis Fernando; de Noronha, Lucia Helena] Univ Fed Parana, Med Patol Dept, Sch Med, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro] Univ Fed Parana, Virol Lab, Hosp Clin, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro; Bleggi Torres, Luis Fernando] Fac Pequeno Principe, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro; Bleggi Torres, Luis Fernando] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil.
   [de Noronha, Lucia Helena] Pontificia Univ Catolica Parana, Escola Med, Lab Patol Expt, Curitiba, Parana, Brazil.
RP de Almeida, SM (corresponding author), Hosp Clinicas UFPR, Secao Virol, Setor Analises Clin, Curitiba, Parana, Brazil.
EM sergio.ma@ufpr.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR ARAUJO JC, 1978, J NEUROSURG, V49, P425, DOI 10.3171/jns.1978.49.3.0425
   Azevedo AP, 1949, HOSPITAL, V36, P21
   Bellissimo-Rodrigues F, 2013, MED MYCOL, V51, P313, DOI 10.3109/13693786.2012.714529
   Bellissimo-Rodrigues F, 2011, AM J TROP MED HYG, V85, P546, DOI 10.4269/ajtmh.2011.11-0084
   Benard G, 2000, CLIN INFECT DIS, V31, P1032, DOI 10.1086/318146
   Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390
   Brasil Ministerio da Saude, 2016, PROGR NAC DST AIDS
   BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993
   Buitrago MJ, 2011, J TRAVEL MED, V18, P26, DOI 10.1111/j.1708-8305.2010.00477.x
   Colombo AL, 1989, 26 C SOC BRAS MED TR
   Almeida Sérgio Monteiro de, 2005, Braz J Infect Dis, V9, P126, DOI 10.1590/S1413-86702005000200002
   de Almeida SM, 2017, MYCOPATHOLOGIA, V182, P393, DOI 10.1007/s11046-016-0076-6
   de Almeida SM, 2004, J INFECTION, V48, P193, DOI 10.1016/j.jinf.2003.08.012
   De Almeida SM, 2017, J NEUROVIROL, P1
   Elias J, 2005, SURG NEUROL, V63, P13, DOI 10.1016/j.surneu.2004.09.019
   Fagundes-Pereyra WJ, 2006, ARQ NEURO-PSIQUIAT, V64, P269, DOI 10.1590/S0004-282X2006000200018
   Finamor LP, 2002, AM J OPHTHALMOL, V134, P456, DOI 10.1016/S0002-9394(02)01574-X
   Franco M, 1987, Rev Soc Bras Med Trop, V20, P129, DOI 10.1590/S0037-86821987000200012
   FRANCO M, 1989, BAILLIERE CLIN TROP, V4, P185
   Gasparetto EL, 2003, J COMPUT ASSIST TOMO, V27, P12, DOI 10.1097/00004728-200301000-00003
   GOLDANI LZ, 1995, CLIN INFECT DIS, V21, P1275, DOI 10.1093/clinids/21.5.1275
   Guimaraes JCA, 1991, REV SOC BRAS MED S2, V24, P30
   Mendes RP, 2005, TRATADO INFECTOLOGIA, P1381
   Paniago AMM, 2007, T ROY SOC TROP MED H, V101, P414, DOI 10.1016/j.trstmh.2006.07.006
   Nobre Vandack, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P69, DOI 10.1590/S0036-46652003000200003
   Pereira W C, 1965, Arq Neuropsiquiatr, V23, P95
   Pedroso VSP, 2012, REV SOC BRAS MED TRO, V45, P586, DOI 10.1590/S0037-86822012000500009
   Pedroso VSP, 2009, REV SOC BRAS MED TRO, V42, P691, DOI 10.1590/S0037-86822009000600016
   Queiroz-Telles F, 2017, LANCET INFECT DIS
   Reis F, 2013, MYCOPATHOLOGIA, V175, P181, DOI 10.1007/s11046-012-9607-y
   RESTREPO A, 1984, INFECT IMMUN, V46, P346, DOI 10.1128/IAI.46.2.346-353.1984
   de Souza PVS, 2014, ARQ NEURO-PSIQUIAT, V72, P904, DOI 10.1590/0004-282X20140162
   Shankar J, 2011, CLIN MICROBIOL REV, V24, P296, DOI 10.1128/CMR.00062-10
   Shikanai-Yasuda M.A., 2017, REV SOC BRAS MED TRO
   Campos MVS, 2008, REV SOC BRAS MED TRO, V41, P169, DOI 10.1590/S0037-86822008000200007
   Silva-Vergara ML, 2014, MYCOPATHOLOGIA, V177, P137, DOI 10.1007/s11046-014-9729-5
   Silva-Vergara ML, 2003, MED MYCOL, V41, P259, DOI 10.1080/369378031000137215
   Theodoro RC, 2008, FUNGAL GENET BIOL, V45, P1284, DOI 10.1016/j.fgb.2008.07.003
   Tichellio AG, 2008, REV ARGENT MICROBIOL, V40, P24
   Wagner G, 2016, MED MYCOL CASE REP, V14, P12, DOI 10.1016/j.mmcr.2016.12.002
   WHO/Department of Control of Neglected Tropical Diseases, 2013, SUST DRIV OV GLOB IM
   Wittig E, 1968, ARQ NEURO-PSIQUIAT, V26, P73
   WITZIG RS, 1994, SOUTHERN MED J, V87, P715, DOI 10.1097/00007611-199407000-00008
NR 43
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0933-7407
EI 1439-0507
J9 MYCOSES
JI Mycoses
PD APR
PY 2018
VL 61
IS 4
BP 237
EP 244
DI 10.1111/myc.12737
PG 8
WC Dermatology; Mycology
SC Dermatology; Mycology
GA FZ3JQ
UT WOS:000427484300003
PM 29274088
DA 2020-12-08
ER

PT J
AU Malaquias, MAS
   Oyama, LA
   Jerico, PC
   Costa, I
   Padilha, G
   Nagashima, S
   Lopes-Pacheco, M
   Rebelatto, CLK
   Michelotto, PV
   Xisto, DG
   Brofman, PRS
   Rocco, PRM
   de Noronha, L
AF Malaquias, M. A. S.
   Oyama, L. A.
   Jerico, P. C.
   Costa, I.
   Padilha, G.
   Nagashima, S.
   Lopes-Pacheco, M.
   Rebelatto, C. L. K.
   Michelotto, P. V.
   Xisto, D. G.
   Brofman, P. R. S.
   Rocco, P. R. M.
   de Noronha, L.
TI Effects of mesenchymal stromal cells play a role the oxidant/antioxidant
   balance in a murine model of asthma
SO ALLERGOLOGIA ET IMMUNOPATHOLOGIA
LA English
DT Article
DE Asthma; Oxidative stress; Nitrotyrosine; Peroxynitrite; Mesenchymal
   cells
ID BONE-MARROW; STEM-CELLS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS;
   ALLERGIC-ASTHMA; AIRWAY; LUNG; PEROXYNITRITE; MANAGEMENT; THERAPIES
AB Asthma is a heterogeneous disease characterised by chronic airway inflammation. One of the most devastating consequences of this inflammatory process is the generation of reactive oxygen and nitrogen species responsible for oxidative stress. The aim of this study is to analyse the efficiency of treatment with human bone marrow-derived mesenchymal stromal cells (hMSC) in maintaining the oxidative balance in a murine model of allergic asthma by quantifying nitrotyrosine in lung tissues. After confirmation of asthma in the experimental model, samples of lung parenchyma were submitted to immunohistochemical assessment. Intravenous administration of hMSC reduced the levels of nitrotyrosine in the ASTHMA-hMSC group compared to those in the ASTHMA-SAL group. In conclusion, therapeutic administration of hMSC had a beneficial effect on oxidative stress, reducing the levels of nitrotyrosine in lung tissues in a model of allergic asthma. (C) 2017 SEICAP. Published by Elsevier Espana, S.L.U. All rights reserved.
C1 [Malaquias, M. A. S.; Oyama, L. A.; Jerico, P. C.; Nagashima, S.; de Noronha, L.] Pontificia Univ Catolica Parana, Sch Med, Pathol Expt Lab, Curitiba, Parana, Brazil.
   [Costa, I.; Padilha, G.; Lopes-Pacheco, M.; Xisto, D. G.; Rocco, P. R. M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Pulm Invest, Rio De Janeiro, Brazil.
   [Rebelatto, C. L. K.; Michelotto, P. V.; Brofman, P. R. S.] Pontificia Univ Catolica Parana, Sch Med, Expt Lab Cell Culture, Curitiba, Parana, Brazil.
RP Malaquias, MAS (corresponding author), Pontificia Univ Catolica Parana, Sch Med, Pathol Expt Lab, Curitiba, Parana, Brazil.
EM mi.mv@hotmail.com
RI Lopes-Pacheco, Miqueias/I-1290-2017; Lopes-Pacheco,
   Miqueias/AAM-7432-2020; Rebelatto, Carmen/P-7252-2019; PV,
   Michelotto/J-2180-2012; noronha, lucia/F-6339-2015
OI Lopes-Pacheco, Miqueias/0000-0002-7444-9359; Lopes-Pacheco,
   Miqueias/0000-0002-7444-9359; PV, Michelotto/0000-0003-0893-1654;
   noronha, lucia/0000-0003-0310-7164
CR Agbetile J, 2011, J ASTHMA ALLERGY, V4, P1, DOI 10.2147/JAA.S8671
   Ankan-Ayyildiz Z, 2013, ALLERGOL IMMUNOPATH, P1
   [Anonymous], 2012, POCKET GUIDE ASTHMA
   Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807
   BARNES PJ, 1990, FREE RADICAL BIO MED, V9, P235, DOI 10.1016/0891-5849(90)90034-G
   Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707
   BATES JHT, 1988, J APPL PHYSIOL, V65, P408
   Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033
   Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]
   Dusse Luci Maria Sant'Ana, 2003, J. Bras. Patol. Med. Lab., V39, P343, DOI 10.1590/S1676-24442003000400012
   Dworski R, 2001, CLIN EXP ALLERGY, V31, P387, DOI 10.1046/j.1365-2222.2001.01055.x
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   GINA, 2014, MANAGEMENT, P148
   Hackett TL, 2012, CURR OPIN ALLERGY CL, V12, P53, DOI 10.1097/ACI.0b013e32834ec6eb
   HADDAD IY, 1993, AM J PHYSIOL, V265, pL555
   Kim Byoung-Ju, 2012, Korean J Pediatr, V55, P185, DOI 10.3345/kjp.2012.55.6.185
   Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047
   Mabalirajan U, 2010, J ALLERGY CLIN IMMUN, V125, P626, DOI 10.1016/j.jaci.2009.10.065
   Nadeem A, 2014, PULM PHARMACOL THER, V29, P31, DOI 10.1016/j.pupt.2014.06.001
   Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107
   Ogulur I, 2014, INT IMMUNOPHARMACOL, V20, P101, DOI 10.1016/j.intimp.2014.02.028
   Okamoto C, 2009, J BRAS PATOL MED LAB, P155
   Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356
   Sahiner UM, 2011, WORLD ALLERGY ORGAN, V4, P151, DOI 10.1097/WOX.0b013e318232389e
   SAKAE RS, 1994, AM J PHYSIOL, V266, pL23
   Saleh D, 1998, FASEB J, V12, P929
   Sun T, 2015, AM J TRANSL RES, V7, P891
   Trzil JE, 2014, CLIN EXP ALLERGY, V44, P1546, DOI 10.1111/cea.12411
   Voraphani N, 2014, MUCOSAL IMMUNOL, V7, P1175, DOI 10.1038/mi.2014.6
   Voraphani N, 2013, NITRIC OXIDE-BIOL CH, V31, pS15, DOI 10.1016/j.niox.2013.02.008
   WEIBEL ER, 1972, RESP PHYSIOL, V14, P26
   Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW
   Zhao F, 2008, TRANSPL P, V40, P1700, DOI 10.1016/j.transproceed.2008.01.080
   Zhao YJ, 2013, INT IMMUNOPHARMACOL, V15, P246, DOI 10.1016/j.intimp.2012.12.008
NR 34
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0301-0546
EI 1578-1267
J9 ALLERGOL IMMUNOPATH
JI Allergol. Immunopath.
PD MAR-APR
PY 2018
VL 46
IS 2
BP 136
EP 143
DI 10.1016/j.aller.2017.06.003
PG 8
WC Allergy; Immunology
SC Allergy; Immunology
GA FY4MS
UT WOS:000426799400006
PM 29174587
DA 2020-12-08
ER

PT J
AU da Silva-Camargo, CCV
   Baldin, RKS
   Polli, NLC
   Agostinho, AP
   Olandosk, M
   de Noronha, L
   Sotomaior, VS
AF Veloso da Silva-Camargo, Claudia Caroline
   Svoboda Baldin, Rosimeri Kuhl
   Costacurta Polli, Nayanne Louise
   Agostinho, Amanda Pereira
   Olandosk, Marcia
   de Noronha, Lucia
   Sotomaior, Vanessa Santos
TI Parkin protein expression and its impact on survival of patients with
   advanced colorectal cancer
SO CANCER BIOLOGY & MEDICINE
LA English
DT Article
DE Parkin; PARK2; advanced colorectal cancer; survival
ID RECESSIVE JUVENILE PARKINSONISM; MITOPHAGY; MITOCHONDRIA; GENE;
   CARCINOMA; LIGASE; PROLIFERATION; ACTIVATION; PROGNOSIS; AUTOPHAGY
AB Objective: Features of colorectal cancer such as natural history, molecular, chromosomal, and epigenetic alterations have been well described. However, there is still a lack of accurate prognostic markers, which is evident by the lower overall survival rates of patients with advanced cancer. Although alterations in parkin protein expression have been described in colorectal cancer, the functional significance of this protein remains unknown. The present study aimed to investigate the involvement of parkin expression in colorectal adenocarcinoma development and progression by evaluating the association between its expression, clinicopathological parameters, and expression of known proteins involved in colorectal cancer.
   Methods: Tissue microarrays consisting of 73 tumor and 64 normal tissue samples were generated to examine parkin expression and localization by immunohistochemistry.
   Results: A positive correlation of parkin and APC expression was observed in the superficial, intermediate, and profound regions of all cases (rho = 0.37; P = 0.001). Parkin expression was also significantly associated with tumors in men (P = 0.049), those of the mucinous subtype (P = 0.028), and of advanced stage (III + IV, P = 0.041). In addition, increased parkin expression was observed in the invasive front tumor region (P = 0.013). More importantly, a positive correlation was found between parkin expression and the overall survival of patients with advanced colorectal cancer (P = 0.019). Multivariate analysis showed that parkin expression was independent of any of the clinicopathological parameters evaluated in relation to patient survival.
   Conclusions: These results suggest that parkin expression status can be used as a potential independent prognostic marker of survival in advanced colorectal cancer.
C1 [Veloso da Silva-Camargo, Claudia Caroline; Costacurta Polli, Nayanne Louise; Agostinho, Amanda Pereira; Olandosk, Marcia; de Noronha, Lucia; Sotomaior, Vanessa Santos] Pontificia Univ Catolica Parana PUCPR, Sch Hlth & Biosci, Grp Adv Mol Invest NIMA, BR-80215901 Curitiba, Parana, Brazil.
   [Svoboda Baldin, Rosimeri Kuhl; de Noronha, Lucia] Univ Fed Parana UFPR, Hosp Clin, BR-80215901 Curitiba, Parana, Brazil.
RP da Silva-Camargo, CCV (corresponding author), Pontificia Univ Catolica Parana PUCPR, Sch Hlth & Biosci, Grp Adv Mol Invest NIMA, BR-80215901 Curitiba, Parana, Brazil.
EM claudia.veloso@pucpr.edu.br
RI Sotomaior, Vanessa/AAX-4818-2020; Veloso, Claudia/AAJ-6694-2020;
   noronha, lucia/F-6339-2015
OI Sotomaior, Vanessa/0000-0001-5388-6384; noronha,
   lucia/0000-0003-0310-7164
CR ABBAS AK, 2000, CELLULAR MOL IMMUNOL
   BLENKINSOPP WK, 1981, J CLIN PATHOL, V34, P509, DOI 10.1136/jcp.34.5.509
   Bonhin RG, 2014, BRAZ J OTORHINOLAR, V80, P290, DOI 10.1016/j.bjorl.2014.05.016
   Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen JX, 2012, ASIAN PAC J CANCER P, V13, P3427, DOI 10.7314/APJCP.2012.13.7.3427
   Chen JS, 2010, FEBS J, V277, P3028, DOI 10.1111/j.1742-4658.2010.07712.x
   Chew MH, 2010, INT J COLORECTAL DIS, V25, P1221, DOI 10.1007/s00384-010-1033-3
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200
   Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gong YX, 2017, NEOPLASIA, V19, P75, DOI 10.1016/j.neo.2016.12.006
   Gong YX, 2014, NAT GENET, V46, P588, DOI 10.1038/ng.2981
   Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485
   Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131
   Hugen N, 2016, NAT REV CLIN ONCOL, V13, P361, DOI 10.1038/nrclinonc.2015.140
   Hyngstrom JR, 2012, ANN SURG ONCOL, V19, P2814, DOI 10.1245/s10434-012-2321-7
   Ikeuchi K, 2009, INT J CANCER, V125, P2029, DOI 10.1002/ijc.24565
   International Agency for Research on Cancer, EST INC MORT PREV WO
   Kitada T, 1998, NATURE, V392, P605
   Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048
   Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304
   Lee S, 2016, ONCOTARGET, V7, P44211, DOI 10.18632/oncotarget.9954
   Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005
   Love RR, 2016, BREAST, V29, P188, DOI 10.1016/j.breast.2016.06.003
   Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nitsche U, 2013, ANN SURG, V258, P775, DOI 10.1097/SLA.0b013e3182a69f7e
   Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107
   Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9
   Sun XD, 2013, CELL CYCLE, V12, P1133, DOI 10.4161/cc.24215
   Tay SP, 2010, J BIOL CHEM, V285, P29231, DOI 10.1074/jbc.M110.108241
   Tran TNH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025969
   Ussakli CH, 2013, JNCI-J NATL CANCER I, V105, P1239, DOI 10.1093/jnci/djt167
   Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491
   Verhulst J, 2012, J CLIN PATHOL, V65, P381, DOI 10.1136/jclinpath-2011-200340
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wang F, 2004, GENE CHROMOSOME CANC, V40, P85, DOI 10.1002/gcc.20020
   Yang MP, 2015, ONCOTARGET, V6, P7084, DOI 10.18632/oncotarget.3054
   Yeo CWS, 2012, CANCER RES, V72, P2543, DOI 10.1158/0008-5472.CAN-11-3060
   Zitvogel L, 2004, ADV IMMUNOL, V84, P131, DOI 10.1016/S0065-2776(04)84004-5
NR 47
TC 6
Z9 6
U1 0
U2 2
PU CHINESE ANTI-CANCER ASSOC
PI TIANJIN
PA TI-YUAN-BEI, HUANHU XI LU, HEXIQU, TIANJIN, 300060, PEOPLES R CHINA
SN 2095-3941
J9 CANCER BIOL MED
JI Cancer Biol. Med.
PD FEB
PY 2018
VL 15
IS 1
BP 61
EP 69
DI 10.20892/j.issn.2095-3941.2017.0136
PG 9
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FX1WD
UT WOS:000425841700007
PM 29545969
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Percicote, AP
   Mardegan, GL
   Gugelmim, ES
   Ioshii, SO
   Kuczynski, AP
   Nagashima, S
   de Noronha, L
AF Percicote, Ana Paula
   Mardegan, Gabriel Lazaretti
   Gugelmim, Elizabeth Schneider
   Ioshii, Sergio Ossamu
   Kuczynski, Ana Paula
   Nagashima, Seigo
   de Noronha, Lucia
TI Tissue expression of retinoic acid receptor alpha and CRABP2 in
   metastatic nephroblastomas
SO DIAGNOSTIC PATHOLOGY
LA English
DT Article
DE Nephroblastoma; Retinoic acid; CRABP2
ID WILMS-TUMORS REVEALS; CANCER; CELL; METABOLISM; TRANSPORT; RELAPSE;
   PROTEIN; GENES
AB Background: Nephroblastoma or Wilms tumor is the most frequent kidney cancer in children and accounts for 98% of kidney tumors in this age group. Despite favorable prognosis, a subgroup of these patients progresses to recurrence and death. The retinoic acid (RA) pathway plays a role in the chemoprevention and treatment of tumors due to its effects on cell differentiation and its antiproliferative, anti-oxidant, and pro-apoptotic activities. Reports describe abnormal cellular retinoic acid-binding protein 2 (CRABP2) expression in neoplasms and its correlation with prognostic factors and clinical and pathological characteristics. The aim of this study was to evaluate the immunohistochemical expression of retinoic acid receptor alpha (RARA) and CRABP2 in paraffin-embedded samples of nephroblastomas via semiquantitative and quantitative analyses and to correlate this expression with prognostic factors.
   Methods: Seventy-seven cases of nephroblastomas were selected from pediatric oncology services. The respective medical records and surgical specimens were reviewed. Three representative tumor samples and one non-tumor renal tissue sample were selected for the preparation of tissue microarrays (TMA). The Allred scoring system was used for semiquantitative immunohistochemical analyses, whereas a morphometric analysis of the stained area was employed for quantitative evaluation. The nonparametric Mann-Whitney test was used for comparisons between two groups, while the nonparametric Kruskal-Wallis test was used to compare three or more groups.
   Results: Immunopositivity for RARA and CRABP2 was observed in both the nucleus and cytoplasm. All histological components of the nephroblastoma (blastema, epithelium, and stroma) were positive for both markers. RARA, based on semiquantitative analyses, and CRABP2, bases on quantitative analyses, exhibited increased immunohistochemical expression in patients with metastasis, with p values of 0.0247 and 0.0128, respectively. These findings were similar to the results of the quantitative analysis of RARA expression, showing greater immunopositivity in tumor samples of patients subjected to pre-surgical chemotherapy. No significant correlation was found with the other variables studied, such as disease stage, anaplasia, risk group, histological type, nodal involvement, and clinical evolution.
   Conclusions: Semiquantitative and quantitative analyses of the markers RARA and CRABP2 indicate their potential as biomarkers for tumor progression and their participation in nephroblastoma tumorigenesis.
C1 [Percicote, Ana Paula; Mardegan, Gabriel Lazaretti] Univ Fed Parana, Curitiba, Parana, Brazil.
   [Gugelmim, Elizabeth Schneider] Pequeno Principe Hosp, Anat Pathol Serv, Curitiba, Parana, Brazil.
   [Ioshii, Sergio Ossamu; de Noronha, Lucia] Univ Fed Parana, Dept Med Pathol, Curitiba, Parana, Brazil.
   [Ioshii, Sergio Ossamu; Nagashima, Seigo; de Noronha, Lucia] Pontificia Univ Catolica Parana, Sch Hlth, Curitiba, Parana, Brazil.
   [Kuczynski, Ana Paula] Pequeno Principe Hosp, Oncol Serv, Curitiba, Parana, Brazil.
RP Percicote, AP (corresponding author), Univ Fed Parana, Curitiba, Parana, Brazil.
EM appercicote@gmail.com
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR BLOMHOFF R, 1994, NUTR REV, V52, P13
   Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   Dome JS, 2015, J CLIN ONCOL, V33, P2999, DOI 10.1200/JCO.2015.62.1888
   Favorskaya I, 2014, TUMOR BIOL, V35, P10295, DOI 10.1007/s13277-014-2348-4
   Goto E, 2011, BLOOD, V118, P1600, DOI 10.1182/blood-2011-01-329433
   Gupta A, 2008, EXP CELL RES, V314, P3663, DOI 10.1016/j.yexcr.2008.09.029
   Gupta S, 2012, CLIN CANCER RES, V18, P280, DOI 10.1158/1078-0432.CCR-11-2165
   Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474
   Honeyman JN, 2012, J PEDIATR SURG, V47, P1228, DOI 10.1016/j.jpedsurg.2012.03.030
   Li WL, 2005, ONCOGENE, V24, P457, DOI 10.1038/sj.onc.1208228
   Liebler S, 2004, AM J PHYSIOL-RENAL, V286, pF458, DOI 10.1152/ajprenal.00173.2003
   Maschietto M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.105
   Napoli JL, 1996, CLIN IMMUNOL IMMUNOP, V80, pS52, DOI 10.1006/clin.1996.0142
   Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481
   Passeri D, 2016, J INVEST DERMATOL, V136, P1255, DOI 10.1016/j.jid.2016.01.039
   Pritchard-Jones K, 2012, ANN ONCOL, V23, P2457, DOI 10.1093/annonc/mds025
   Simoes MA, 2017, PATHOL RES PRACT, V213, P222, DOI 10.1016/j.prp.2016.12.011
   Stiller CA, 1996, BRIT MED BULL, V52, P682
   Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z
   Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14
   Wang H, 2017, ONCOL LETT, V13, P2045, DOI 10.3892/ol.2017.5706
   Wegert J, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-136
   Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564
   Zirn B, 2005, ONCOGENE, V24, P5246, DOI 10.1038/sj.onc.1208725
NR 25
TC 3
Z9 4
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-1596
J9 DIAGN PATHOL
JI Diagn. Pathol.
PD JAN 22
PY 2018
VL 13
AR 9
DI 10.1186/s13000-018-0686-z
PG 7
WC Pathology
SC Pathology
GA FX1MN
UT WOS:000425815700003
PM 29378601
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Rabinovich, I
   Sebastiao, APM
   Lima, RS
   Urban, CD
   Schunemann, E
   Anselmi, KF
   Elifio-Esposito, S
   de Noronha, L
   Moreno-Amaral, AN
AF Rabinovich, Iris
   Martins Sebastiao, Ana Paula
   Lima, Rubens Silveira
   Urban, Cicero de Andrade
   Schunemann Jr, Eduardo
   Anselmi, Karina Furlan
   Elifio-Esposito, Selene
   de Noronha, Lucia
   Moreno-Amaral, Andrea Novais
TI Cancer stem cell markers ALDH1 and CD44(+)/CD24(-) phenotype and their
   prognosis impact in invasive ductal carcinoma
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE Breast cancer; CD44+/CD24-phenotype; ALDH1; molecular subtypes; cancer
   stem cells
ID ALDEHYDE DEHYDROGENASE 1; BREAST-CANCER; CD44; EXPRESSION; BIOMARKER;
   RECEPTOR; SUBTYPES; CD24
AB Breast cancer is a very heterogeneous disease. The intrinsic molecular subtypes can explain the intertumoral heterogeneity and the cancer stem cell (CSC) hypothesis can explain the intratumoral heterogeneity of this kind of Minor. CD44(+)/CD24(-) phenotype and ALDH1 expression are the major CSC markers described in invasive breast cancer. In the present study, 144 samples of invasive breast carcinoma, no special type were distributed in 15 tissue microarrays (TMA) and then evaluated for expression of the CD44(+)/CD24(-) phenotype and ALDH1 to understand the importance of these CSC markers and the clinical aspects of breast cancer. The samples were classified into four molecular subtypes according to clinicopathological criteria: Luminal A, Luminal B, HER2, and Basal-like. A statistical association was found between the molecular subtypes and the CSC markers, with HER2 the most frequent subtype for both markers. ALDH1 was also associated with other poor prognostic variables, such as a high histological grade and larger tumors, but it was not associated with the patients' prognosis in this sample nor was the CD44(+)/CD24(-) phenotype in a multivariate analysis. There are still many controversies about the role of these markers in breast cancer molecular subtypes. The identification of these populations of cells, through immunohistochemical markers. can help to better understand the CSC theory in clinical practice and, in the near future. contribute to developing new target therapies.
C1 [Rabinovich, Iris; Elifio-Esposito, Selene; de Noronha, Lucia; Moreno-Amaral, Andrea Novais] Pontificia Univ Catolica Parana, Med Sch, Dept Hlth Sci, Av Vereador Toaldo Tulio 895 Casa 9, BR-82320010 Curitiba, Parana, Brazil.
   [Rabinovich, Iris; Lima, Rubens Silveira; Schunemann Jr, Eduardo] Univ Fed Parana, Dept Tocogynecoliw, Curitiba, Parana, Brazil.
   [Martins Sebastiao, Ana Paula] Univ Fed Parana, Dept Pathol, Curitiba, Parana, Brazil.
   [Lima, Rubens Silveira] Nossa Senhora das Gracas Hosp, Dept Breast Surg, Curitiba, Parana, Brazil.
   [Urban, Cicero de Andrade; Anselmi, Karina Furlan] Positivo Univ, Dept Sci Methodol, Curitiba, Parana, Brazil.
RP Rabinovich, I (corresponding author), Pontificia Univ Catolica Parana, Med Sch, Dept Hlth Sci, Av Vereador Toaldo Tulio 895 Casa 9, BR-82320010 Curitiba, Parana, Brazil.
EM iris_rbv@yahoo.com.br
RI Sebastiao, Ana Paula Martins/AAG-6227-2020; Urban, Cicero A/D-1578-2011;
   noronha, lucia/F-6339-2015
OI Urban, Cicero A/0000-0001-8964-9487; Elifio-Esposito,
   Selene/0000-0002-8676-134X; noronha, lucia/0000-0003-0310-7164;
   Moreno-Amaral, Andrea N/0000-0002-2730-2952
CR Adamczyk A, 2014, J MOL HISTOL, V45, P35, DOI 10.1007/s10735-013-9523-6
   Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8
   Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100
   Allegra A, 2014, CANCER INVEST, V32, P470, DOI 10.3109/07357907.2014.958231
   Brierley JD, 2017, TNM CLASSIFICATION M
   Camerlingo R, 2014, ONCOL REP, V31, P1127, DOI 10.3892/or.2013.2943
   Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082
   Chekhun S. V., 2015, Experimental Oncology, V37, P58
   Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004
   Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x
   Elston C W, 2005, Verh Dtsch Ges Pathol, V89, P35
   Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014
   Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304
   GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L
   Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003
   Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108
   Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005
   Kim YS, 2014, J BREAST CANCER, V17, P121, DOI 10.4048/jbc.2014.17.2.121
   LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0
   Li WZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14364-2
   Lin CY, 2016, HISTOPATHOLOGY, V68, P119, DOI 10.1111/his.12868
   Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994
   Moon YW, 2018, ONCOTARGET, V9, P2622, DOI 10.18632/oncotarget.23519
   Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076
   Moreira MP, 2018, EXP CELL RES, V363, P283, DOI 10.1016/j.yexcr.2018.01.018
   Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003
   Nakshatri H, 2009, CURR STEM CELL RES T, V4, P50, DOI 10.2174/157488809787169110
   Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418
   Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Qiu H, 2015, CELL MOL LIFE SCI, V72, P3411, DOI 10.1007/s00018-015-1920-4
   Riaz N, 2018, TRANSL ONCOL, V11, P920, DOI 10.1016/j.tranon.2018.05.002
   Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456
   Sebastiao A., 2010, ESTUDO EXPRESSAO FEN
   Sneath RJS, 1998, J CLIN PATHOL-MOL PA, V51, P191, DOI 10.1136/mp.51.4.191
   Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1
   Tan B, 2000, CURR OPIN ONCOL, V12, P450, DOI 10.1097/00001622-200009000-00011
   Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954
   Tsang JYS, 2012, BREAST CANCER RES TR, V136, P407, DOI 10.1007/s10549-012-2271-6
   Wang KH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-288
   Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984
   Zhong Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0864-0
NR 42
TC 14
Z9 14
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1121-760X
EI 2038-8306
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 2018
VL 62
IS 3
BP 231
EP 237
AR 2943
DI 10.4081/ejh.2018.2943
PG 7
WC Cell Biology
SC Cell Biology
GA HG0FW
UT WOS:000454619200007
PM 30362671
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Zanluca, C
   de Noronha, L
   dos Santos, CND
AF Zanluca, Camila
   de Noronha, Lucia
   Duarte dos Santos, Claudia Nunes
TI Maternal-fetal transmission of the zika virus: An intriguing interplay
SO TISSUE BARRIERS
LA English
DT Review
DE ex vivo models; Hofbauer cells; maternal-fetal transmission; natural
   infections; placental barriers; Zika virus
ID HUMAN PLACENTAL TROPHOBLASTS; SEXUAL TRANSMISSION; VIRAL-INFECTION;
   MOUSE MODEL; PATHOLOGY; BRAZIL; STATES; BRAIN; PROLIFERATION;
   COMPLICATIONS
AB In this review, we give an overview of aspects related to the congenital transmission of the Zika virus (ZIKV). Although we acknowledge that important advances in research on ZIKV pathogenesis have come from studies using animal models, particularly non-human primates, this review emphasizes studies using ex-vivo human cells and tissues as well as natural infections in pregnant women. The possible routes used by ZIKV to cross or breach the placental barrier and infect the fetal central nervous system are presented. Understanding the viral infection biology and ZIKV pathogenesis during pregnancy may guide the design of affordable antiviral strategies to benefit pregnant women in areas at risk.
C1 [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas Fiocruz PR, Lab Virol Mol, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), ICC Fiocruz, Rua Prof Algacyr Munhoz Mader,3775 Cidade Ind Cur, BR-81350070 Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; noronha, lucia/F-6339-2015
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; Zanluca,
   Camila/0000-0001-7350-9105; noronha, lucia/0000-0003-0310-7164
FU CNDS; CNPqNational Council for Scientific and Technological Development
   (CNPq)
FX CNDS and LN have a CNPq fellowship.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   [Anonymous], 2017, B EPIDEMIOLOGICO MON
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Benirschke K, 2012, PATHOLOGY HUMAN PLAC, P41
   Bernischkee K, 2012, PATHOLOGY HUMAN PLAC, P55
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P7
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO, 2017, REG ZIK EP UPD AM
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   WEISBLUM Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 76
TC 10
Z9 10
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2168-8370
J9 TISSUE BARRIERS
JI Tissue Barriers
PY 2018
VL 6
IS 1
AR e1402143
DI 10.1080/21688370.2017.1402143
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GL6DL
UT WOS:000437269200005
PM 29370577
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Donaduzzi, LC
   Reinheimer, A
   da Silva, MAR
   de Noronha, L
   Johann, ACBR
   Franco, A
   Couto, SDB
   Souza, PHC
AF Donaduzzi, Liziane Cattelan
   Reinheimer, Angelica
   Ramires da Silva, Maria Augusta
   de Noronha, Lucia
   Batista Rodrigues Johann, Aline Cristina
   Franco, Ademir
   Berti Couto, Soraya de Azambuja
   Couto Souza, Paulo Henrique
TI Primary Diffuse Large B Cell Lymphoma Mimicking Hyperplastic Reactive
   Lesion (Lymphoma of the Oral Cavity)
SO CASE REPORTS IN PATHOLOGY
LA English
DT Article
ID NON-HODGKINS-LYMPHOMA; MALIGNANT-LYMPHOMA; CLASSIFICATION
AB Objective. To report a case of a challenging oral diagnosis involving a primary diffuse large B cell lymphoma of the oral cavity mimicking a hyperplastic reactive lesion. Case Report. A 72-year-old male patient was referred to the Department of Stomatology presenting a proliferative nodular lesion in the anterior region of the mandible involving the anterior teeth. The clinical examination revealed anterior teeth affected by periodontal disease, suggesting the nodular cession hyperplastic reaction. Incisional biopsy was performed under local anesthesia. The histopathological examination revealed a diffuse proliferation of atypical large lymphoid cells. The tumor cells showed immunopositivity for CD20 and Ki67 (100%) and negativity for CD3, CD30, and CD15. The diagnosis of diffuse large B cell lymphoma was established. The patient underwent chemotherapy and progressed to death after nine months. Conclusion. Lymphomas of the oral cavity are rare and may have nonspecific clinical features, mimicking inflammatory and reactive lesions. Therefore, a detailed clinical evaluation associated with histopathological and immunohistochemical analysis should be performed to enable early and accurate diagnoses in suspected oral lesions.
C1 [Donaduzzi, Liziane Cattelan; Reinheimer, Angelica; Ramires da Silva, Maria Augusta; Batista Rodrigues Johann, Aline Cristina; Franco, Ademir; Berti Couto, Soraya de Azambuja; Couto Souza, Paulo Henrique] Pontificia Univ Catolica Parana, Dept Dent, Sch Life Sci, Curitiba, PR, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Sch Med, Curitiba, PR, Brazil.
RP Johann, ACBR (corresponding author), Pontificia Univ Catolica Parana, Dept Dent, Sch Life Sci, Curitiba, PR, Brazil.
EM aline.johann@pucpr.br
RI Johann, Aline C B R/G-7190-2012; Franco, Ademir/D-6665-2017
OI Johann, Aline C B R/0000-0002-1678-9363; Franco,
   Ademir/0000-0002-1417-2781
CR Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719
   Basavaraj K F, 2012, J Nat Sci Biol Med, V3, P189, DOI 10.4103/0976-9668.101913
   Bhattacharyya I, 2010, HEAD NECK PATHOL, V4, P181, DOI 10.1007/s12105-010-0184-4
   Castellarin P, 2010, J ONCOL, V2010, DOI 10.1155/2010/202305
   Chan WC, 1997, BLOOD, V89, P3909
   Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015
   Epstein JB, 2001, ORAL SURG ORAL MED O, V92, P519, DOI 10.1067/moe.2001.116062
   Inchingolo F, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-1
   Jayakrishnan R., 2008, Journal of Oral and Maxillofacial Pathology, V12, P85
   Manjunatha B S, 2011, J Indian Soc Periodontol, V15, P418, DOI 10.4103/0972-124X.92584
   Marrelli M, 2012, INT J MED SCI, V9, P47, DOI 10.7150/ijms.9.47
   Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252
   Rozza-de-Menezes R. E., 2013, CASE REPORTS DENT, V2013, P1
   Shah GH, 2011, INDIAN J MED PAEDIAT, V32, P76, DOI 10.4103/0971-5851.89776
   Souto GR, 2013, J CLIN EXPT DENT, V5, P287
   Swerdlow SH, 2008, WHO CLASSIFICATION T
   Tatullo M, 2015, J CANCER, V6, P976, DOI 10.7150/jca.11936
   Yin HF, 1999, VIRCHOWS ARCH, V435, P400, DOI 10.1007/s004280050417
   Zapater E, 2010, ORAL DIS, V16, P119, DOI 10.1111/j.1601-0825.2009.01586.x
NR 19
TC 1
Z9 1
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-6781
EI 2090-679X
J9 CASE REP PATHOL
JI Case Rep. Pathol.
PY 2018
AR 2981689
DI 10.1155/2018/2981689
PG 4
WC Pathology
SC Pathology
GA FW6UX
UT WOS:000425455400001
PM 29552368
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Almeida, SM
   Roza, TH
   Salvador, GLO
   Franca, JCB
   Vidal, LRR
   Nogueira, MB
   Oliva, LV
   Torres, LFB
   de Noronha, LH
AF de Almeida, Sergio Monteiro
   Roza, Thiago H.
   Salvador, Gabriel L. O.
   Franca, Joao C. B.
   Renaud Vidal, Luine Rosele
   Nogueira, Meri Bordignon
   Oliva, Lubomira Veronica
   Bleggi Torres, Luis Fernando
   de Noronha, Lucia Helena
TI Neurological and multiple organ involvement due to Paracoccidioides
   brasiliensis and HIV co-infection diagnosed at autopsy
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Central nervous system; Co-infection; HIV; Neuro-paracoccidioidomycosis;
   Paracoccidioides brasiliensis; Paracoccidioidomycosis
ID CENTRAL-NERVOUS-SYSTEM; HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION; AIDS
AB Paracoccidioidomycosis (PCM), caused by Paracoccidioides brasiliensis, is the most prevalent systemic mycosis among immunocompetent patients in Latin America; it is rare in immunocompromised patients. The estimated frequency of central nervous system (CNS) involvement in the HIV/PCM population was 2.5%. We report a case of HIV/P. brasiliensis co-infection, with neurological (NPCM) and multiple organ involvement, indicating a diagnosis of AIDS. PCM diagnosis was established during the autopsy. This is the first described case of HIV/P. brasiliensis co-infection with CNS involvement diagnosed at autopsy. In conclusion, the diagnosis of NPCM is challenging, and it must be considered in the differential diagnosis in HIV-positive patients who reside in or have visited areas in which the condition is endemic and who present with neurological symptoms.
C1 [de Almeida, Sergio Monteiro; Roza, Thiago H.; Salvador, Gabriel L. O.; Oliva, Lubomira Veronica; Bleggi Torres, Luis Fernando; de Noronha, Lucia Helena] Univ Fed Parana, Sch Med, Dept Med Pathol, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro; Renaud Vidal, Luine Rosele; Nogueira, Meri Bordignon] Univ Fed Parana, Hosp Clin, Virol Lab, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro] Fac Pequeno Principe, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil.
   [de Almeida, Sergio Monteiro] Hosp Clin UFPR, Secao Virol, Setor Anal Clin, Rua Padre Camargo 280, Curitiba, PR, Brazil.
   [Franca, Joao C. B.] Univ Fed Parana, Hosp Clin, Infect Dis Unit, Curitiba, Parana, Brazil.
   [de Noronha, Lucia Helena] Pontificia Univ Catolica Parana, Escola Med, Lab Patol Expt, Curitiba, Parana, Brazil.
RP de Almeida, SM (corresponding author), Univ Fed Parana, Sch Med, Dept Med Pathol, Curitiba, Parana, Brazil.; de Almeida, SM (corresponding author), Univ Fed Parana, Hosp Clin, Virol Lab, Curitiba, Parana, Brazil.; de Almeida, SM (corresponding author), Fac Pequeno Principe, Curitiba, Parana, Brazil.; de Almeida, SM (corresponding author), Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil.; de Almeida, SM (corresponding author), Hosp Clin UFPR, Secao Virol, Setor Anal Clin, Rua Padre Camargo 280, Curitiba, PR, Brazil.
EM sergio.ma@ufpr.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Bellissimo-Rodrigues F, 2010, MEM I OSWALDO CRUZ, V105, P904, DOI 10.1590/S0074-02762010000700011
   Benard G, 2000, CLIN INFECT DIS, V31, P1032, DOI 10.1086/318146
   Buitrago MJ, 2009, MED MYCOL, V47, P879, DOI 10.3109/13693780802713208
   Colombo AL, 1989, PROGR 26 C SOC BRAS
   de Almeida JN, 2015, J CLIN MICROBIOL, V53, P1383, DOI 10.1128/JCM.02847-14
   Almeida Sérgio Monteiro de, 2005, Braz J Infect Dis, V9, P126, DOI 10.1590/S1413-86702005000200002
   de Almeida SM, 2017, MYCOPATHOLOGIA, V182, P393, DOI 10.1007/s11046-016-0076-6
   de Almeida SM, 2002, AM J CLIN PATHOL, V118, P864, DOI 10.1092/UB6VWQKDFJKQKW14
   de Almeida SM, 2004, J INFECTION, V48, P193, DOI 10.1016/j.jinf.2003.08.012
   Finamor LP, 2002, AM J OPHTHALMOL, V134, P456, DOI 10.1016/S0002-9394(02)01574-X
   GOLDANI LZ, 1995, CLIN INFECT DIS, V21, P1275, DOI 10.1093/clinids/21.5.1275
   Guimaraes JCA, 1991, REV SOC BRAS MED S2, V24, P30
   Lorenzoni PJ, 2002, ARQ NEURO-PSIQUIAT, V60, P1015, DOI 10.1590/S0004-282X2002000600025
   Morejon KML, 2009, AM J TROP MED HYG, V80, P359, DOI 10.4269/ajtmh.2009.80.359
   Pedroso VSP, 2009, REV SOC BRAS MED TRO, V42, P691, DOI 10.1590/S0037-86822009000600016
   Restrepo AM, 1978, ACT MED COLOMBIANA, V3, P33
   Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017
   Silva-Vergara ML, 2014, MYCOPATHOLOGIA, V177, P137, DOI 10.1007/s11046-014-9729-5
   Silva-Vergara ML, 2003, MED MYCOL, V41, P259, DOI 10.1080/369378031000137215
NR 19
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2017
VL 23
IS 6
BP 913
EP 918
DI 10.1007/s13365-017-0577-1
PG 6
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA FP6NF
UT WOS:000417742100012
PM 28895099
DA 2020-12-08
ER

PT J
AU de Abreu, JP
   Rebelatto, CLK
   Savari, CA
   Capriglione, LGA
   Miyague, L
   de Noronha, L
   do Amaral, VF
AF de Abreu, Jaqueline Pedroso
   Kuniyoshi Rebelatto, Carmen Lucia
   Savari, Carolina Antunes
   Achcar Capriglione, Luiz Guilherme
   Miyague, Lye
   de Noronha, Lucia
   do Amaral, Vivian Ferreira
TI The Effect of Mesenchymal Stem Cells on Fertility in Experimental
   Retrocervical Endometriosis
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE endometriosis; mesenchymal stem cell; fertility; rabbits
ID DEEP INFILTRATING ENDOMETRIOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; WOMEN
AB Purpose To evaluate the effect of mesenchymal stem cells (MSCs) on fertility in experimental retrocervical endometriosis.
   Methods A total of 27 New Zealand rabbits were divided into three groups: endometriosis, in which endometrial implants were created; mesenchymal, in which MSCs were applied in addition to the creation of endometrial implants; and control, the group without endometriosis. Fisher's exact test was performed to compare the dichotomous qualitative variables among the groups. The quantitative variables were compared by the nonparametric Mann-Whitney and Kruskal-Wallis tests. The Mann-Whitney test was used for post-hoc multiple comparison with Boniferroni correction.
   Results Regarding the beginning of the fertile period, the three groups had medians of 14 +/- 12.7, 40 +/- 5, and 33 +/- 8.9 days respectively (p +/- 0.005). With regard to fertility (number of pregnancies), the endometriosis and control groups showed a rate of 77.78%, whereas the mesenchymal group showed a rate of 11.20% (p +/- 0.015). No differences in Keenan's histological classification were observed among the groups (p +/- 0.730). With regard to the macroscopic appearance of the lesions, the mesenchymal group showed the most pelvic adhesions.
   Conclusion The use of MSCs in endometriosis negatively contributed to fertility, suggesting the role of these cells in the development of this disease.
C1 [de Abreu, Jaqueline Pedroso; Savari, Carolina Antunes; de Noronha, Lucia] Pontificia Univ Catolica Parana PUC PR, Ctr Hlth & Biol Sci, Escola Med, Curitiba, Parana, Brazil.
   [Kuniyoshi Rebelatto, Carmen Lucia] PUC PR, Expt Lab Cell Culture, Curitiba, Parana, Brazil.
   [Achcar Capriglione, Luiz Guilherme; Miyague, Lye] PUC PR, Ctr Hlth & Biol Sci, Escola Ciencias Agr & Med Vet, Curitiba, Parana, Brazil.
   [do Amaral, Vivian Ferreira] Univ Fed Parana UFPR, Dept Obstet & Gynecol, Curitiba, Parana, Brazil.
RP de Abreu, JP (corresponding author), Dept Tocoginecol HCUFPR, Gen Carneiro 181, BR-80060900 Curitiba, Parana, Brazil.
EM jaquelinepabreu@gmail.com
RI Rebelatto, Carmen/P-7252-2019; noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029
   Canis M, 1997, FERTIL STERIL, V67, P817
   Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109
   Porto BTD, 2015, REV BRAS GINECOL OBS, V37, P87, DOI [10.1590/S0100-720320140004650, 10.1590/SO100-720320140004650]
   De Miguel MP, 2012, CURR MOL MED, V12, P574
   de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4
   Deane JA, 2013, CURR OPIN OBSTET GYN, V25, P193, DOI 10.1097/GCO.0b013e32836024e7
   Dhesi AS, 2015, WOMENS HEALTH, V11, P35, DOI [10.2217/whe.14.57, 10.2217/WHE.14.57]
   do Amaral VF, 2016, INT J CLIN EXP PATHO, V9, P1116
   Amaral Vivian Ferreira do, 2009, Rev. Col. Bras. Cir., V36, P250, DOI 10.1590/S0100-69912009000300012
   Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]
   Du H, 2009, REPROD SCI, V16, P126, DOI 10.1177/1933719108329956
   Du X, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3573846
   Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8
   Gargett CE, 2004, AUST NZ J OBSTET GYN, V44, P380, DOI 10.1111/j.1479-828X.2004.00290.x
   HOWARDJONES N, 1985, WHO CHRON, V39, P51
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Keenan JA, 1999, FERTIL STERIL, V72, P135, DOI 10.1016/S0015-0282(99)00157-0
   Li T, 2014, EUR J OBSTET GYN R B, V178, P89, DOI 10.1016/j.ejogrb.2014.04.001
   Figueira PGM, 2011, ANN NY ACAD SCI, V1221, P10, DOI 10.1111/j.1749-6632.2011.05969.x
   Matsuzaki S, 2012, HUM REPROD, V27, P712, DOI 10.1093/humrep/der442
   Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148
   Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X
   Oliveira R, 2015, REPROD CLIM, V30, P5
   Pillet MCL, 2014, HUM REPROD, V29, P1666, DOI 10.1093/humrep/deu128
   Risi E, 2014, REPROD DOMEST ANIM, V49, P81, DOI 10.1111/rda.12300
   SCHOR E, 1999, RBGO, V21, P281, DOI DOI 10.1590/S0100-72031999000500006
   Stratton P, 2014, HUM REPROD, V29, P1627, DOI 10.1093/humrep/deu131
   Vidane AS, 2013, REPROD SCI, V20, P1137, DOI 10.1177/1933719113477484
   Zhao J, 2014, FERTIL STERIL, V101, P587, DOI 10.1016/j.fertnstert.2013.10.053
NR 31
TC 3
Z9 3
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAY
PY 2017
VL 39
IS 5
BP 217
EP 223
DI 10.1055/s-0037-1601484
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4RC
UT WOS:000410252100004
PM 28399593
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Manica, GCM
   Ribeiro, CF
   de Oliveira, MAS
   Pereira, IT
   Chequin, A
   Ramos, EAS
   Klassen, LMB
   Sebastiao, APM
   Alvarenga, LM
   Zanata, SM
   De Noronha, L
   Rabinovich, I
   Costa, FF
   Souza, EM
   Klassen, G
AF Manica, Graciele C. M.
   Ribeiro, Caroline F.
   de Oliveira, Marco A. S.
   Pereira, Isabela T.
   Chequin, Andressa
   Ramos, Edneia A. S.
   Klassen, Liliane M. B.
   Sebastiao, Ana Paula M.
   Alvarenga, Larissa M.
   Zanata, Silvio M.
   De Noronha, Lucia
   Rabinovich, Iris
   Costa, Fabricio F.
   Souza, Emanuel M.
   Klassen, Giseli
TI Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast
   Cancer
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ESTROGEN-RECEPTOR; EXPRESSION; CELL; PROTEIN; GENE; PROGRESSION;
   SUBTYPES; IMMUNOHISTOCHEMISTRY; CLASSIFICATION; DISINTEGRIN
AB Breast cancer is a heterogeneous disease with differences in its clinical, molecular and biological features. Traditionally, immunohistochemical markers together with clinicopathologic parameters are used to classify breast cancer and to predict disease outcome. Triple-negative breast cancer (TNBC) is a particular type of breast cancer that is defined by a lack of expression of hormonal receptors and the HER2 gene. Most cases of TNBC also have a basal-like phenotype (BLBC) with expression of cytokeratin 5/6 and/or EGFR. A basal marker alone is insufficient for a better understanding of the tumor biology of TNBC. In that regard, the ADAM33 gene is silenced by DNA hypermethylation in breast cancer, which suggests that ADAM33 might be useful as a molecular marker. In the present study, we have produced monoclonal antibodies against the ADAM33 protein and have investigated the role of ADAM33 protein in breast cancer. We used 212 breast tumor samples and lower levels of ADAM33 were correlated with TNBC and basal-like markers. A lower level of ADAM33 was also correlated with shorter overall survival and metastasis-free survival and was considered an independent prognostic factor suggesting that ADAM33 is a novel molecular biomarker of TNBC and BLBC that might be useful as a prognostic factor.
C1 [Manica, Graciele C. M.; Ribeiro, Caroline F.; Pereira, Isabela T.; Chequin, Andressa; Ramos, Edneia A. S.; Klassen, Liliane M. B.; Alvarenga, Larissa M.; Zanata, Silvio M.; Klassen, Giseli] Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil.
   [de Oliveira, Marco A. S.] Univ Estadual Maringa, Dept Biochem, Maringa, Parana, Brazil.
   [Sebastiao, Ana Paula M.] Univ Fed Parana, Dept Med Pathol, Curitiba, Parana, Brazil.
   [De Noronha, Lucia] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil.
   [Rabinovich, Iris] Univ Fed Parana, Dept Tocogynecol, Curitiba, Parana, Brazil.
   [Costa, Fabricio F.] Univ Catolica Brasilia, Genom Sci & Biotechnol Program, Brasilia, DF, Brazil.
   [Souza, Emanuel M.] Univ Fed Parana, Dept Biochem & Mol Biol, Curitiba, Parana, Brazil.
RP Klassen, G (corresponding author), Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil.
EM giseli@ufpr.br
RI Cavalieri, Edneia ASR/Q-9636-2019; Oliveira, Marco A.S./F-4664-2017;
   Klassen, Giseli/F-8753-2012; Alvarenga, L M/J-2628-2015; Klassen,
   Giseli/AAF-3962-2019; Sebastiao, Ana Paula Martins/AAG-6227-2020;
   noronha, lucia/F-6339-2015
OI Cavalieri, Edneia ASR/0000-0002-8855-5988; Oliveira, Marco
   A.S./0000-0002-1993-7771; Klassen, Giseli/0000-0001-5336-6178; Klassen,
   Giseli/0000-0001-5336-6178; Alvarenga, Larissa/0000-0002-1756-8183;
   noronha, lucia/0000-0003-0310-7164; Pereira,
   Isabela/0000-0001-8951-9965; Zanata, Silvio/0000-0003-2818-6954
FU Funcacao Araucaria, Projeto PPSUS [3242]
FX This work was supported by grant from the Funcacao Araucaria, Projeto
   PPSUS 2012 (number3242).
CR Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6
   Baurakiades E, 2014, J CLIN VIROL, V61, P585, DOI 10.1016/j.jcv.2014.10.004
   Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66
   Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279
   Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658
   Costa FF, 2004, ONCOGENE, V23, P1481, DOI 10.1038/sj.onc.1207263
   Dai XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14499
   DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535
   Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4
   Feldinger K, 2014, ONCOTARGET, V5, P6633, DOI 10.18632/oncotarget.1955
   Fields C, 2013, NAT PROTOC, V8, P1125, DOI 10.1038/nprot.2013.057
   Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665
   Garlisi CG, 2003, BIOCHEM BIOPH RES CO, V301, P35, DOI 10.1016/S0006-291X(02)02976-5
   Gloyeske NC, 2015, APPL IMMUNOHISTO M M, V23, P202, DOI 10.1097/PAI.0000000000000076
   Haitchi HM, 2005, AM J RESP CRIT CARE, V171, P958, DOI 10.1164/rccm.200409-1251OC
   Harlow E. D, 1988, TRENDS BIOCHEM SCI, V14, P429
   Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474
   Holloway JW, 2010, ATHEROSCLEROSIS, V211, P224, DOI 10.1016/j.atherosclerosis.2010.02.023
   Huang J, 2005, MOL BIOL CELL, V16, P4982, DOI 10.1091/mbc.E05-03-0258
   Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X
   Kim KE, 2009, J IMMUNOL, V182, P3548, DOI 10.4049/jimmunol.0801695
   Lee JY, 2006, AM J RESP CRIT CARE, V173, P729, DOI 10.1164/rccm.200409-1175OC
   McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092
   Micocci KC, 2013, BIOCHIMIE, V95, P1371, DOI 10.1016/j.biochi.2013.03.001
   Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985
   Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x
   Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220
   O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161
   Orth P, 2004, J MOL BIOL, V335, P129, DOI 10.1016/j.jmb.2003.10.037
   Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171
   Ruff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139179
   Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33
   Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703
   Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006
   Seniski GG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-80
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293
   Toquet C, 2012, INT J CANCER, V130, P278, DOI 10.1002/ijc.25891
   Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038
   Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878
   Viale G, 2014, ANN ONCOL, V25, P816, DOI 10.1093/annonc/mdu026
   White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001
   WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275
   Yang YW, 2008, J ALLERGY CLIN IMMUN, V121, P1393, DOI 10.1016/j.jaci.2008.02.031
   Zou J, 2004, J BIOL CHEM, V279, P9818, DOI 10.1074/jbc.M309696200
NR 49
TC 8
Z9 9
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 15
PY 2017
VL 7
AR 44414
DI 10.1038/srep44414
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN9PV
UT WOS:000396333000001
PM 28294120
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Carvalho, NS
   de Carvalho, BF
   Doris, B
   Biscaia, ES
   Fugaca, CA
   de Noronha, L
AF de Carvalho, Newton Sergio
   de Carvalho, Beatriz Freitas
   Doris, Bruna
   Biscaia, Evellyn Silverio
   Fugaca, Cyllian Arias
   de Noronha, Lucia
TI Zika virus and pregnancy: An overview
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Review
DE congenital malformations; microcephaly; obstetrician; pregnancy; Zika
   virus
ID SEXUAL TRANSMISSION; INFECTION; BRAZIL; NEWBORNS; BARRIER; CONDOMS
AB In May 2015, the first episodes of Zika virus infection of the Latin America were confirmed in Brazil, where currently 196 976 cases were reported. The main route of transmission occurs by Aedes mosquitoes, and the most common symptoms are maculopapular rash, fever, conjunctivitis, polyarthralgia, and periarticular edema. However, the infection is asymptomatic in 80% of the cases. The congenital infection is characterized when the transmission to the fetus occurs during pregnancy, but the mechanisms of how the virus infects the placenta remain unclear. Anatomopathological findings were described in first-and third-trimester human placentas; however, the major affected tissue of the baby is the neural. Several clinical situations were listed in these fetuses, such as neurological, ophthalmological, auditory, and articular alterations. The World Health Organization proposed a new congenital syndrome caused by Zika virus. The virus has an important neurotropism and the main manifestation observed in the syndrome is microcephaly, which is usually severe and associated with other neurological injuries. The appearance of sudden rash in pregnant women determines immediate investigation through RT-PCR and serological analysis. Moreover, the prevention consists in using repellents and avoiding endemic areas, considering that the vaccine is still under development.
C1 [de Carvalho, Newton Sergio] Univ Fed Parana, Infect Dis Gynecol & Obstet Sector, Dept Gynecol & Obstet, Clin Hosp, Curitiba, PR, Brazil.
   [de Carvalho, Beatriz Freitas; Doris, Bruna; Biscaia, Evellyn Silverio; Fugaca, Cyllian Arias; de Noronha, Lucia] Pontif Cathol Univ Parana, Curitiba, PR, Brazil.
RP de Carvalho, NS (corresponding author), Univ Fed Parana, Infect Dis Gynecol & Obstet Sector, Dept Gynecol & Obstet, Clin Hosp, Curitiba, PR, Brazil.
EM newtosdc@gmail.com
RI noronha, lucia/F-6339-2015; de carvalho, newton/B-8175-2015
OI noronha, lucia/0000-0003-0310-7164; de carvalho,
   newton/0000-0001-7561-4566
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   [Anonymous], 2005, WHO STAT 1 M INT HLT
   [Anonymous], 2016, POSSIBLE ASS ZIKA VI
   [Anonymous], 2016, ZIKA VIRUS VACCINE P
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benirschke K, 2006, PATHOLOGY HUMAN PLAC, P700
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   CAREY RF, 1992, SEX TRANSM DIS, V19, P230, DOI 10.1097/00007435-199207000-00009
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcante AL, 2016, B EPIDEMIOLOGICO, V47, P47
   Chibueze EC, 2016, B WORLD HEALTH ORGAN, V6, P1
   COES - Microcefalias, 2016, MON CAS MICR BRAS, V2016
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V59, P23
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   GREENOUGH A, 1994, ARCH DIS CHILD-FETAL, V70, pF163, DOI 10.1136/fn.70.3.F163
   Hayden EC, 2016, NATURE, V532, P16
   He Q, 2013, AM J OBSTET GYNECOL, V33, P395, DOI DOI 10.1186/S12348-014-0026-8
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Leal MDC, 2020, BRAZ J OTORHINOLAR, V86, P513, DOI 10.1016/j.bjorl.2016.06.001
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Manhart LE, 2002, SEX TRANSM DIS, V29, P725, DOI 10.1097/00007435-200211000-00018
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J., 2016, NEW ENGL J MED, P1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Ommeren MV, 2016, GUIA PRELIMINAR PROV, P18
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, P1
   Rosenberg AZ, 2016, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2016-0401-OA, DOI 10.5858/ARPA.2016--0401-OA]
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2016, ARCH PATHOL LAB MED, DOI [10.5858/arpa.2016-0343-OA, DOI 10.5858/ARPA.2016--0343--OA]
   Secretaria da Saude do Estado da Bahia, 2016, PROT AT GEST SUSP ZI
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 69
TC 9
Z9 9
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD FEB
PY 2017
VL 77
IS 2
AR e12616
DI 10.1111/aji.12616
PG 8
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EP3DZ
UT WOS:000397264200009
PM 28045216
OA Bronze
DA 2020-12-08
ER

PT J
AU Jorge, TR
   Mosimann, ALP
   de Noronha, L
   Maron, A
   dos Santos, CND
AF Jorge, Taissa Ricciardi
   Pamplona Mosimann, Ana Luiza
   de Noronha, Lucia
   Maron, Angela
   Duarte dos Santos, Claudia Nunes
TI Isolation and characterization of a Brazilian strain of yellow fever
   virus from an epizootic outbreak in 2009
SO ACTA TROPICA
LA English
DT Article
DE Yellow fever virus; Wild-type strain; Brazil; Epizootic
ID NONHUMAN-PRIMATES; DENGUE VIRUS; INTERFERON; INFECTION; DISPERSAL;
   PROTEIN; STATE
AB During a series of epizootics caused by Yellow fever virus in Brazil between 2007 and 2009, a monkey was found dead (May 2009) in a sylvatic area in the State of Parana. Brain samples from this animal were used for immunohistochemical analysis and isolation of a wild-type strain of YFV. This viral strain was characterized, and sequence analyzes demonstrated that it is closely related with YFV strains of the recently identified subclade 1E of the South American genotype I. Further characterization included indirect-immunofluorescence of different infected cell lines and analysis of the kinetics of virus replication and infectivity inhibition by type I IFN. The generated data contributes to the knowledge of YFV evolution and phylogeny. Additionally, the reagents generated and characterized during this study, such as a panel of monoclonal antibodies, are useful tools for further studies on YFV. Lastly, this case stresses the importance of yellow fever surveillance through sentinel monkeys. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Jorge, Taissa Ricciardi; Pamplona Mosimann, Ana Luiza; Duarte dos Santos, Claudia Nunes] Fiocruz MS, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
   [Maron, Angela] Secretaria Saude Estado Parana, Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), Prof Algacyr Munhoz Mader St 3775, Curitiba, Parana, Brazil.
EM taissarj@gmail.com; anamosimann@fiocruz.br; lnno@terra.com.br;
   angela.maron@gmail.com; clsantos@fiocruz.br
RI Santos, Claudia Duarte dos/P-4868-2019; noronha, lucia/F-6339-2015;
   Mosimann, Ana Luiza Pamplona/AAB-4714-2019; Duarte dos Santos,
   Claudia/E-1857-2018
OI Santos, Claudia Duarte dos/0000-0001-8707-6638; noronha,
   lucia/0000-0003-0310-7164; Mosimann, Ana Luiza
   Pamplona/0000-0002-3504-5562; Duarte dos Santos,
   Claudia/0000-0001-8707-6638; Ricciardi-Jorge, Taissa/0000-0003-1110-2128
FU CNPq fellowshipNational Council for Scientific and Technological
   Development (CNPq)
FX CNDS and LN are recipients of a CNPq fellowship
CR Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Araujo FAA, 2011, EPIDEMIOL SERV SAUDE, V20, P527, DOI 10.5123/S1679-49742011000400012
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P99, DOI 10.3201/eid2101.140814
   Auguste AJ, 2010, J VIROL, V84, P9967, DOI 10.1128/JVI.00588-10
   Bryant JE, 2005, J VIROL, V79, P3807, DOI 10.1128/JVI.79.6.3807-3821.2005
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   de Filippis AMB, 2002, J MED VIROL, V68, P620, DOI 10.1002/jmv.10226
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Fialho Marcos de Souza, 2012, Biotemas, V25, P217
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Julander JG, 2007, ANTIVIR RES, V73, P140, DOI 10.1016/j.antiviral.2006.08.008
   Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10
   Kuno G, 2006, AM J TROP MED HYG, V75, P1165, DOI 10.4269/ajtmh.2006.75.1165
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Mazzarotto GCA, 2009, J VIROL METHODS, V162, P96, DOI 10.1016/j.jviromet.2009.07.022
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tranquilin MV, 2013, REV SOC BRAS MED TRO, V46, P522, DOI 10.1590/0037-8682-0106-2013
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197
   Vasconcelos PFC, 2003, T ROY SOC TROP MED H, V97, P60, DOI 10.1016/S0035-9203(03)90023-X
NR 31
TC 5
Z9 5
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2017
VL 166
BP 114
EP 120
DI 10.1016/j.actatropica.2016.09.030
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EI8PN
UT WOS:000392769900016
PM 27818122
DA 2020-12-08
ER

PT J
AU Faria, AR
   Jung, JE
   de Castro, CCS
   de Noronha, L
AF Faria, Adriane Reichert
   Jung, Juliana Elizabeth
   Silva de Castro, Caio Cesar
   de Noronha, Lucia
TI Reduced immunohistochemical expression of adhesion molecules in vitiligo
   skin biopsies
SO PATHOLOGY RESEARCH AND PRACTICE
LA English
DT Article
DE Vitiligo; Immunohistochemistry; Adhesion; Skin biopsy; Paraffin-
   embedded
ID LESIONAL SKIN; CLASS-II; MELANOCYTES; INTEGRINS; DDR1
AB Because defects in adhesion impairment seem to be involved in the etiopathogenesis of vitiligo, this study aimed to compare the immunohistochemical expression of several adhesion molecules in the epidermis of vitiligo and non lesional vitiligo skin.
   Sixty-six specimens of lesional and non lesional skin from 33 volunteers with vitiligo were evaluated by immunohistochemistry using anti-beta-catenin, anti-E-cadherin, anti-laminin, anti-betal integrin, anti collagen IV, anti-ICAM-1 and anti-VCAM-1 antibodies. Biopsies of vitiligo skin demonstrated a significant reduction in the expression of laminin and integrin. The average value of the immunohistochemically positive reaction area of the vitiligo specimens was 3053.2 m(2), compared with the observed value of 3431.8 pATI2 in non vitiligo skin (p = 0.003) for laminin. The immuno-positive area was 7174.6 mu m(2) (vitiligo) and 8966.7 p..mu m(2) (non lesional skin) for integrin (p = 0.042). A reduction in ICAM-1 and VCAM1 expression in the basal layer of the epidermis in vitiligo samples was also observed (p = 0.001 and p < 0.001, respectively). However, no significant differences were observed with respect to the expression of beta-catenin, E-cadherin, and collagen IV between vitiligo and non lesional skin.
   Our results suggest that an impairment in adhesion exists in vitiligo skin, which is supported by the diminished immunohistochemical expression of laminin, betal integrin, ICAM-1 and VCAM-1. (C) 2017 Elsevier GmbH. All rights reserved.
C1 [Faria, Adriane Reichert; Silva de Castro, Caio Cesar] Santa Casa de Misericordia Curitiba Hosp, Praca Rui Barbosa,694 Ctr, BR-80010030 Curitiba, Parana, Brazil.
   [Faria, Adriane Reichert; de Noronha, Lucia] Pontifial Catholic Univ Parana, Sch Med, Expt Pathol Lab, Rua Imaculada Conceicao,1155 Prado Velho, BR-80215901 Curitiba, Parana, Brazil.
   [Jung, Juliana Elizabeth] Erasto Gaertner Hosp, Curitiba, Parana, Brazil.
RP Faria, AR (corresponding author), Santa Casa de Misericordia Curitiba Hosp, Dept Dermatol, Ctr Med, Praca Rui Barbosa,694 Ctr, BR-80010030 Curitiba, Parana, Brazil.
EM adri_reichert@yahoo.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Abdallah M, 2003, EUR J DERMATOL, V13, P548
   Ahn Sung Ku, 1994, Yonsei Medical Journal, V35, P404
   ALBADRI AMT, 1993, J PATHOL, V169, P203, DOI 10.1002/path.1711690205
   Aplin AE, 1998, PHARMACOL REV, V50, P197
   Cabrijan L, 2011, CLIN DERMATOL, V29, P427, DOI 10.1016/j.clindermatol.2011.01.012
   Cario-Andre M, 2007, PIGM CELL RES, V20, P385, DOI 10.1111/j.1600-0749.2007.00396.x
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   Dell'Anna ML, 2006, PIGM CELL RES, V19, P406, DOI 10.1111/j.1600-0749.2006.00333.x
   Gauthier Y, 2003, PIGM CELL RES, V16, P322, DOI 10.1034/j.1600-0749.2003.00070.x
   Gauthier Y, 2003, BRIT J DERMATOL, V148, P95, DOI 10.1046/j.1365-2133.2003.05024.x
   GROVES RW, 1993, J AM ACAD DERMATOL, V29, P67, DOI 10.1016/0190-9622(93)70154-L
   Hashmi S, 2011, CLIN DERMATOL, V29, P398, DOI 10.1016/j.clindermatol.2011.01.009
   Hedley SJ, 1998, BRIT J DERMATOL, V139, P965
   Kim HJ, 2010, EUR J DERMATOL, V20, P231, DOI 10.1684/ejd.2010.0853
   Kumar R, 2011, BRIT J DERMATOL, V164, P187, DOI 10.1111/j.1365-2133.2010.10039.x
   LePoole IC, 1997, BRIT J DERMATOL, V137, P171, DOI 10.1046/j.1365-2133.1997.18011894.x
   Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22
   Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449
   Reichert-Faria A, 2013, J EUR ACAD DERMATOL, V27, P1057, DOI 10.1111/jdv.12013
   de Castro CCS, 2010, J INVEST DERMATOL, V130, P1813, DOI 10.1038/jid.2010.34
   Tarle RG, 2015, EXP DERMATOL, V24, P300, DOI 10.1111/exd.12641
   van den Wijngaard R, 2000, LAB INVEST, V80, P1299, DOI 10.1038/labinvest.3780138
   Wagner RY, 2015, J INVEST DERMATOL, V135, P1810, DOI 10.1038/jid.2015.25
   Wang C., 2009, AM J PHYSIOL-CELL PH, pC419
   Zhang SJ, 2011, ARCH DERMATOL RES, V303, P771, DOI 10.1007/s00403-011-1170-8
NR 25
TC 8
Z9 8
U1 0
U2 3
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0344-0338
J9 PATHOL RES PRACT
JI Pathol. Res. Pract.
PY 2017
VL 213
IS 3
BP 199
EP 204
DI 10.1016/j.prp.2016.12.019
PG 6
WC Pathology
SC Pathology
GA EP4TB
UT WOS:000397371700005
PM 28214208
DA 2020-12-08
ER

PT J
AU Simoes, MA
   Pabis, FC
   de Freitas, AKE
   de Azevedo, MLV
   Ronchi, DCM
   de Noronha, L
AF Simoes, Mona Adalgisa
   Pabis, Francisco Cesar
   Ehrenfried de Freitas, Ana Karyn
   Viola de Azevedo, Marina Luise
   Martins Ronchi, Daiane Cristine
   de Noronha, Lucia
TI Immunoexpression of GADD45 beta in the myocardium of newborns
   experiencing perinatal hypoxia
SO PATHOLOGY RESEARCH AND PRACTICE
LA English
DT Article
DE Apoptosis; Newborn; Immunohistochemistry; Hypoxia
ID INDUCTION
AB Aim: Among the several organs affected by perinatal hypoxia, the heart plays a central role, with cell death caused mainly by apoptosis. One of the biomarkers most often linked to hypoxia-derived apoptosis of cardiomyocytes in animals is Gadd45P. From the published literature, Gadd45P is proposed as a biomarker of hypoxia-induced lesion in cardiomyocytes, both in vitro, as well as in animal models. Our study suggests that this protein can be used as an early biomarker of cell damage in neonate's cardiomyocytes (humans specimens), a process that can ultimately lead to apoptosis. The aim is to determine levels of tissue immunoexpression of the Gadd45 P biomarker in myocardium samples of newborns affected by hypoxia, and to correlate these results with clinical and anatomopathologic data.
   Methods: Myocardium samples from the left ventricle of newborns were used. The samples were collected from 78 autopsies performed in neonates of both genders, with hypoxia (Apgar score at five minutes below 6 and/or pH below 7.2 and/or autopsy with anatomopathological signs of hypoxia), who had died within the first day of life. All samples were organized in Tissue Microarray. Immunohistochemistry analysis, using anti-Gadd450 as the primary antibody, was performed on 3 multi-sample histological slides. There was no correlation between Gadd45p tissue immunoexpression and neonatal weight (p = 0.93), gestational age (p = 0.16), Apgar score at first minute (p = 0.914), Apgar score at five minutes (p = 0.988) and arterial blood pH (p = 0.542). There was a relation between Gadd45p tissue immunoexpression and survival (p = 0.02). The maximum peak of Gadd45p tissue immunoexpression was 8.43% HPF (high power field) and was observed around of six hours of life.
   Conclusion: Gadd45 P could be a suitable biomarker of cardiomyocytes apoptosis in newborns experiencing hypoxia in the first day of life, as its highest tissue immunoexpression around at the first six hours after birth. (C) 2017 Elsevier GmbH. All rights reserved.
C1 [Simoes, Mona Adalgisa; Pabis, Francisco Cesar; Viola de Azevedo, Marina Luise; de Noronha, Lucia] Univ Parana, Div Expt Pathol, Lab Pontifical Catholic, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
   [Ehrenfried de Freitas, Ana Karyn] Univ Fed Parana, Rua Imaculada Conceicao, BR-80215901 Curitiba, Parana, Brazil.
   [Martins Ronchi, Daiane Cristine] Pontificia Univ Catolica Parana, Expt Pathol, Sch Med, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Univ Parana, Div Expt Pathol, Lab Pontifical Catholic, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
EM monasimoes@uol.com.br; franciscocpabis@uol.com.br; a.ehrenfried@ufpr.br;
   malu_tu@yahoo.com.br; dai_cmartins@hotmail.com; lnno@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
FU Pontifical Catholic University of Parana
FX This work was supported by the Pontifical Catholic University of Parana.
CR Souto ACA, 2008, REV BRAS CIR CARDIOV, V23, P378, DOI 10.1590/S0102-76382008000300015
   Awada H, 2007, NEONATOLOGY, V92, P105, DOI 10.1159/000100964
   Bortoff KD, 2010, HEPATIC MED-EVID RES, V2, P79
   Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084
   Cretu Alexandra, 2009, Cancer Ther, V7, P268
   Cruz A.C.S., 2010, REV BRAS CRESCIMENTO, V20, P302, DOI DOI 10.7322/JHGD.19968
   Debur MD, 2010, J CLIN PATHOL, V63, P930, DOI 10.1136/jcp.2010.077867
   Kim MY, 2010, CARDIOVASC RES, V87, P119, DOI 10.1093/cvr/cvq048
   Kim Y.A., 2013, J MOL MED BERL, V91, P103
   Leach PT, 2012, LEARN MEMORY, V19, P319, DOI 10.1101/lm.024984.111
   Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15
   Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861
   Michaelis KA, 2011, ENDOCRINOLOGY, V152, P3603, DOI 10.1210/en.2011-0109
   Procianoy R S, 2001, J Pediatr (Rio J), V77 Suppl 1, pS63
   Reynolds E.O.R., J CLIN PATHOL S, V11, P134
   Rohan AJ, 2009, MCN-AM J MATERN-CHIL, V34, P113
   Rohan AJ, 2009, MCN-AM J MATERN-CHIL, V34, P106, DOI 10.1097/01.NMC.0000347304.70208.eb
   Sidhu PS, 2014, CANCER CHEMOTH PHARM, V74, P787, DOI 10.1007/s00280-014-2549-y
   Takekawa M, 2011, NAGOYA J MED SCI, V73, P1
   Trevisanuto D, 2006, BIOL NEONATE, V89, P190, DOI 10.1159/000089795
   Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239
NR 21
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0344-0338
J9 PATHOL RES PRACT
JI Pathol. Res. Pract.
PY 2017
VL 213
IS 3
BP 222
EP 226
DI 10.1016/j.prp.2016.12.011
PG 5
WC Pathology
SC Pathology
GA EP4TB
UT WOS:000397371700009
PM 28214215
DA 2020-12-08
ER

PT J
AU Silva, EN
   Ribas, JM
   Czeczko, NG
   Pachnicki, JPA
   Netto, MRM
   Lipinski, LC
   de Noronha, L
   Colman, J
   Zeni, JO
   de Carvalho, CA
AF Silva, Eduardo Nascimento
   Ribas-Filho, Jurandir Marcondes
   Czeczko, Nicolau Gregori
   Andrade Pachnicki, Jan Pawel
   Montemor Netto, Mario Rodrigues
   Lipinski, Leandro Cavalcante
   de Noronha, Lucia
   Colman, Joelmir
   Zeni, Joao Otavio
   de Carvalho, Caroline Aragao
TI Histological evaluation of capsules formed by silicon implants coated
   with polyurethane foam and with a textured surface in rats
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Implant Capsular Contracture; Breast Implants; Mammaplasty; Rats
ID BREAST IMPLANTS; CONTRACTURE; SMOOTH; AUGMENTATION
AB PURPOSE: To assess the capsules formed by silicone implants coated with polyurethane foam and with a textured surface.
   METHODS: Sixty-four Wistar albinus rats were divided into two groups of 32 each using polyurethane foam and textured surface. The capsules around the implants were analyzed for 30, 50, 70 and 90 days. Were analyzed the following parameters: foreign body reaction, granulation tissue, presence of myofibroblasts, neoangiogenesis, presence of synovial metaplasia, capsular thickness, total area and collagen percentage of type I and III, in capsules formed around silicone implants in both groups.
   RESULTS: The foreign body reaction was only present in the four polyurethane subgroups. The formation of granulation tissue and the presence of myofibroblasts were higher in the four polyurethane subgroups. Regarding to neoangiogenesis and synovial metaplasia, there was no statistical difference between the groups. Polyurethane group presented (all subgroups) a greater capsule thickness, a smaller total area and collagen percentage of type I and a higher percentage area of type III, with statistical difference.
   CONCLUSION: The use of polyurethane-coated implants should be stimulated by the long-term results in a more stable capsule and a lower incidence of capsular contracture, despite developing a more intense and delayed inflammatory reaction in relation to implants with textured surface.
C1 [Silva, Eduardo Nascimento] Evangel Univ Hosp HUEC, Fac Evangel Parana FEPAR, Postgrad Program Principles Surg, Curitiba, Parana, Brazil.
   [Silva, Eduardo Nascimento; Ribas-Filho, Jurandir Marcondes; Czeczko, Nicolau Gregori; Andrade Pachnicki, Jan Pawel; Zeni, Joao Otavio; de Carvalho, Caroline Aragao] Inst Med Res IPEM, Curitiba, Parana, Brazil.
   [Silva, Eduardo Nascimento] Univ Estadual Ponta Grossa, Gen Surg, Ponta Grossa, PR, Brazil.
   [Ribas-Filho, Jurandir Marcondes; Czeczko, Nicolau Gregori; Andrade Pachnicki, Jan Pawel] Evangel Univ Hosp HUEC, FEPAR, Postgrad Program Principles Surg, Curitiba, Parana, Brazil.
   [Montemor Netto, Mario Rodrigues] Univ Fed Parana UFPR, Surg Clin, Curitiba, Parana, Brazil.
   [Montemor Netto, Mario Rodrigues] Univ Estadual Ponta Grossa, Anat Pathol, Ponta Grossa, PR, Brazil.
   [Montemor Netto, Mario Rodrigues] Santa Casa de Misericordia, Dept Anat Pathol, Ponta Grossa, PR, Brazil.
   [Lipinski, Leandro Cavalcante; Colman, Joelmir] Univ Estadual Ponta Grossa, Fac Med, Ponta Grossa, PR, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana PUCPR, Sch Med, Curitiba, Parana, Brazil.
   [Zeni, Joao Otavio; de Carvalho, Caroline Aragao] Evangel Univ Hosp HUEC, FEPAR, Curitiba, Parana, Brazil.
RP Silva, EN (corresponding author), Ave Doutor Francisco Burzio 991, BR-84010200 Ponta Grossa, PR, Brazil.
EM dr_eduardosilva@yahoo.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; Lipinski,
   Leandro/0000-0001-5662-622X
CR Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26
   Barnsley GP, 2006, PLAST RECONSTR SURG, V117, P2182, DOI 10.1097/01.prs.0000218184.47372.d5
   Bassetto F, 2010, AESTHET PLAST SURG, V34, P481, DOI 10.1007/s00266-010-9483-0
   Bui JM, 2015, AESTHET PLAST SURG, V39, P306, DOI 10.1007/s00266-014-0439-7
   da Silva PR, 2008, ACTA CIR BRAS, V23, P93, DOI 10.1590/S0102-86502008000100015
   Haddad D, 2007, ACTA CIR BRAS, V22, P187, DOI 10.1590/S0102-86502007000300006
   Hwang K, 2010, AESTHET PLAST SURG, V34, P716, DOI 10.1007/s00266-010-9532-8
   Mello Daniel Francisco, 2013, Rev. Col. Bras. Cir., V40, P37, DOI 10.1590/S0100-69912013000100007
   Mendes FH, 2008, AESTHET PLAST SURG, V32, P442, DOI 10.1007/s00266-007-9063-0
   Milcheski Dimas André, 2013, Rev. Col. Bras. Cir., V40, P392, DOI 10.1590/S0100-69912013000500008
   Minami E, 2006, PLAST RECONSTR SURG, V118, P874, DOI 10.1097/01.prs.0000240878.24213.b7
   Montes GS, 1996, CELL BIOL INT, V20, P15, DOI 10.1006/cbir.1996.0004
   MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1
   Prantl L, 2005, AESTHET PLAST SURG, V29, P510, DOI 10.1007/s00266-005-5049-y
   Prantl L, 2007, PLAST RECONSTR SURG, V120, P275, DOI 10.1097/01.prs.0000264398.85652.9a
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Balderrama CMSR, 2009, ACTA CIR BRAS, V24, P367, DOI 10.1590/S0102-86502009000500006
   Silva MM, 2011, AESTHET PLAST SURG, V35, P789, DOI 10.1007/s00266-011-9688-x
   SUVIK A., 2012, MAL J VET RES, V3, P39
   Vieira VJ, 2010, PLAST RECONSTR SURG, V126, P1899, DOI 10.1097/PRS.0b013e3181f446d5
   Wagenfuhr J, 2012, ACTA CIR BRAS, V27, P866, DOI 10.1590/S0102-86502012001200007
   Wong CH, CAPSULAR CONTRACTURE, DOI [10.1097/01.prs.0000237013.50283.d2, DOI 10.1097/01.PRS.0000237013.50283.D2]
NR 22
TC 5
Z9 5
U1 0
U2 4
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD DEC
PY 2016
VL 31
IS 12
BP 774
EP 782
DI 10.1590/S0102-865020160120000001
PG 9
WC Surgery
SC Surgery
GA EK2XO
UT WOS:000393790500001
PM 28076500
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Ramos, EAS
   da Silva, CT
   Manica, GCM
   Pereira, IT
   Klassen, LMB
   Ribeiro, EMSF
   Cavalli, IJ
   Braun-Prado, K
   Lima, RS
   Urban, CA
   Costa, FF
   de Noronha, L
   Klassen, G
AF Ramos, Edneia A. S.
   da Silva, Camila T.
   Manica, Graciele C. M.
   Pereira, Isabela T.
   Klassen, Liliane M. B.
   Ribeiro, Enilze M. S. F.
   Cavalli, Iglenir J.
   Braun-Prado, Karin
   Lima, Rubens S.
   Urban, Cicero A.
   Costa, Fabricio F.
   de Noronha, Lucia
   Klassen, Giseli
TI Worse prognosis in breast cancer patients can be predicted by
   immunohistochemical analysis of positive MMP-2 and negative estrogen and
   progesterone receptors
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE breast neoplasms; MMP-2; immunohistochemical; molecular marker
ID MATRIX METALLOPROTEINASE-2 MMP-2; INHIBITORS
AB Introduction: Breast cancer is the most cause of death, and approximately 90% of these deaths are due to metastases. Matrix metalloproteinase-2 (MMP-2) gelatinase activity is able to degrade a major constituent of the tumor microenvironment, type IV collagen. Two well-established proteins used as markers in clinical practice for breast cancer are the receptors for estrogen (ER) and progesterone (PR). Although the presence of these receptors has been associated with a better prognosis, loss of these proteins can occur during tumor progression, with subsequent resistance to hormone therapy.
   Objective: To study the correlation among MMP-2, ER, and PR, as well as the establishment of the metastatic process in primary breast tumors.
   Method: Breast cancer samples (n=44) were analyzed by immunohistochemistry for MMP-2, ER, and PR.
   Results: We observed that 90% of patients who had metastases and died showed positive staining for MMP-2 (p=0.0082 for both). Using Kaplan-Meier analysis, we found that negative ER patients who were also positive for MMP-2 had even worse disease-free survival (DFS) and overall survival (OS) (p=0.012 and p=0.005, respectively). Similar results were found in PR-negative patients for DFS (a trend p=0.077) and OS (p=0.038).
   Conclusion: Regardless of our small sample size (n=44), the data obtained strongly suggest that MMP-2 in combination with already well-established markers could help to predict the emergence of metastases and death in patients with breast cancer.
C1 [Ramos, Edneia A. S.; da Silva, Camila T.; Manica, Graciele C. M.; Pereira, Isabela T.; Klassen, Liliane M. B.; Braun-Prado, Karin; Klassen, Giseli] Univ Fed Parana, Dept Basic Pathol, Curitiba, Parana, Brazil.
   [Ribeiro, Enilze M. S. F.; Cavalli, Iglenir J.] UFPR, Dept Genet, Curitiba, PR, Brazil.
   [Lima, Rubens S.; Urban, Cicero A.] Hosp Nossa Senhora Gracas, Curitiba, PR, Brazil.
   [Costa, Fabricio F.] Northwestern Univ Feinberg, Ann & Robert Lurie Childrens Hosp Chicago Res Ctr, Sch Med, Canc Biol & Epigen Program, Chicago, IL 60614 USA.
   [Costa, Fabricio F.] Northwestern Univ Feinberg, Sch Med, Dept Pediat, Chicago, IL 60614 USA.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Dept Expt Pathol, Curitiba, Parana, Brazil.
RP Klassen, G (corresponding author), Dept Patol Basica, Ctr Politecn S-N, BR-81530900 Curitiba, Parana, Brazil.
EM giseli@ufpr.br
RI noronha, lucia/F-6339-2015; Urban, Cicero A/D-1578-2011; Klassen,
   Giseli/F-8753-2012; Ribeiro, Enilze MSF/K-7319-2012; Cavalieri, Edneia
   ASR/Q-9636-2019; Klassen, Giseli/AAF-3962-2019; Costa,
   Fabricio/M-5309-2017
OI noronha, lucia/0000-0003-0310-7164; Urban, Cicero A/0000-0001-8964-9487;
   Klassen, Giseli/0000-0001-5336-6178; Cavalieri, Edneia
   ASR/0000-0002-8855-5988; Klassen, Giseli/0000-0001-5336-6178; Pereira,
   Isabela/0000-0001-8951-9965; braun prado, Karin/0000-0002-9652-0566
FU Brazilian agency CAPESCAPES; Brazilian agency CNPqNational Council for
   Scientific and Technological Development (CNPq) [480738/2010-6,
   479211/2012-4]
FX We thank the financial support from Brazilian agencies CAPES and CNPq
   (Process 480738/2010-6 and 479211/2012-4). Particularly, we thank the
   researchers Emanuel Maltempi de Souza and Fabio de Oliveira Pedrosa for
   their financial support for the purchase of reagents and other
   laboratory material during this project.
CR Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006
   Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70
   Gonzalez-Avila G, 1998, PATHOBIOLOGY, V66, P5, DOI 10.1159/000027989
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790
   Instituto Nacional do Cancer (INCA), 2014, EST 2014
   Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x
   Kamel H, 2010, J OBSTET GYNAECOL CA, V32, P580, DOI 10.1016/S1701-2163(16)34527-3
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Min KW, 2014, APMIS, V122, P1196, DOI 10.1111/apm.12285
   Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101
   Ramos EAS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029461
   Ranogajec I, 2012, MED ONCOL, V29, P561, DOI 10.1007/s12032-011-9984-y
   Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200
   Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125
   Slattery ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063165
   Smigielski J, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-137
   Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379
   Struse Kerstin, 2000, Breast J, V6, P115, DOI 10.1046/j.1524-4741.2000.99060.x
   Talvensaari-Mattila A, 2003, BRIT J CANCER, V89, P1270, DOI 10.1038/sj.bjc.6601238
   Vaisanen A, 2011, HUM PATHOL, V42, P1103, DOI 10.1016/j.humpath.2010.11.013
   Zlotnik A, 2003, E SCHERING RES FDN W, V45, P53
NR 24
TC 6
Z9 7
U1 0
U2 2
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD NOV
PY 2016
VL 62
IS 8
BP 774
EP 781
DI 10.1590/1806-9282.62.08.774
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA EH3NI
UT WOS:000391678200013
PM 27992019
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Mattioli, TMF
   Alanis, LRA
   Sapelli, SD
   de Lima, AAS
   de Noronha, L
   Rosa, EAR
   Althobaiti, YS
   Almalki, AH
   Sari, Y
   Ignacio, SA
   Johann, ACBR
   Gregio, AMT
AF Mattioli, Tatiana M. F.
   Alanis, Luciana R. A.
   Sapelli, Silvana da Silva
   de Lima, Antonio A. S.
   de Noronha, Lucia
   Rosa, Edvaldo A. R.
   Althobaiti, Yusuf S.
   Almalki, Atiah H.
   Sari, Youssef
   Ignacio, Sergio A.
   Johann, Aline C. B. R.
   Gregio, Ana M. T.
TI Effects of Benzodiazepines on Acinar and Myoepithelial Cells
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE benzodiazepines; immunohistochemistry; salivary glands; dry mouth;
   GABA(A) receptor
ID RAT PAROTID-GLANDS; MUSCARINIC RECEPTOR; PILOCARPINE; DIAZEPAM
AB Background: Benzodiazepines (BZDs), the most commonly prescribed psychotropic drugs with anxiolytic action, may cause hyposalivation. It has been previously shown that BZDs can cause hypertrophy and decrease the acini cell number. In this study, we investigated the effects of BZDs and pilocarpine on rat parotid glands, specifically on acinar, ductal, and myoepithelial cells.
   Methods: Ninety male Wistar rats were divided into nine groups. Control groups received a saline solution for 30 days (C30) and 60 days (C60), and pilocarpine (PILO) for 60 days. Experimental groups received lorazepam (L30) and midazolam (M30) for 30 days. Another group (LS60 or MS60) received lorazepam or midazolam for 30 days, respectively, and saline for additional 30 days. Finally, other groups (LP60 or MP60) received either lorazepam or midazolam for 30 days, respectively, and pilocarpine for additional 30 days. The expression of calponin in myoepithelial cells and the proliferating cell nuclear antigen (PCNA) in acinar and ductal cells were evaluated.
   Results: Animals treated with lorazepam showed an increase in the number of positive staining cells for calponin as compared to control animals (p < 0.05). Midazolam administered with pilocarpine (MP60) induced an increase in the proliferation of acinar and ductal cells and a decrease in the positive staining cells for calponin as compared to midazolam administered with saline (MS60).
   Conclusion: We found that myoepithelial cells might be more sensitive to the effects of BZD than acinar and ductal cells in rat parotid glands.
C1 [Mattioli, Tatiana M. F.; Sapelli, Silvana da Silva] Pontificia Univ Catolica Parana, Sch Dent, Pharmacol & Expt Pathol, Curitiba, Parana, Brazil.
   [Alanis, Luciana R. A.; Rosa, Edvaldo A. R.; Ignacio, Sergio A.; Johann, Aline C. B. R.] Pontificia Univ Catolica Parana, Sch Dent, Program Postgrad, Hlth & Biosci Sch, Curitiba, Parana, Brazil.
   [de Lima, Antonio A. S.] Univ Fed Parana, Sch Dent, Dept Pathol, BR-80060000 Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Dept Pathol, Sch Med, Program Postgrad, Curitiba, Parana, Brazil.
   [Althobaiti, Yusuf S.; Almalki, Atiah H.; Sari, Youssef; Gregio, Ana M. T.] Univ Toledo, Coll Pharm & Pharmaceut, Dept Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.
   [Gregio, Ana M. T.] Pontificia Univ Catolica Parana, Program Postgrad, Dept Pharmacol, Sch Dent,Hlth & Biosci Sch, Curitiba, Parana, Brazil.
RP Gregio, AMT (corresponding author), Univ Toledo, Coll Pharm & Pharmaceut, Dept Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.; Gregio, AMT (corresponding author), Pontificia Univ Catolica Parana, Program Postgrad, Dept Pharmacol, Sch Dent,Hlth & Biosci Sch, Curitiba, Parana, Brazil.
EM ana.gregio@pucpr.br
RI Johann, Aline C B R/G-7190-2012; Azevedo-Alanis, Luciana R/G-9150-2012;
   noronha, lucia/F-6339-2015; Althobaiti, Yusuf S./ABF-5954-2020; Lima,
   Antonio Adilson A/D-1081-2015; Rosa, Edvaldo/B-1228-2008
OI Johann, Aline C B R/0000-0002-1678-9363; Azevedo-Alanis, Luciana
   R/0000-0001-8809-3579; noronha, lucia/0000-0003-0310-7164; Althobaiti,
   Yusuf S./0000-0003-3128-2824; Lima, Antonio Adilson
   A/0000-0002-9522-6832; Rosa, Edvaldo/0000-0001-6087-4365; GregioHardy,
   Ana Maria/0000-0003-0445-8206
FU Experimental Pathology Laboratory of Center for Biological Sciences and
   Health from Pontific Catholic University of Parana; CNPqNational Council
   for Scientific and Technological Development (CNPq) [474790/2004-5]
FX The authors wish to thank the support provided by Experimental Pathology
   Laboratory of the Center for Biological Sciences and Health from the
   Pontific Catholic University of Parana. This work received funding from
   CNPq (protocol number 474790/2004-5).
CR Balachander N, 2015, J PHARM BIOALLIED SC, V7, pS190, DOI 10.4103/0975-7406.155898
   Burgess KL, 1996, ORAL SURG ORAL MED O, V82, P674, DOI 10.1016/S1079-2104(96)80443-4
   da Silva S, 2009, MED CHEM, V5, P483, DOI 10.2174/157340609789117868
   De Almeida P. D. V., 2012, ORAL HLTH CARE PEDIA, P113, DOI DOI 10.5772/37693
   de Almeida PD, 2008, ORAL SURG ORAL MED O, V106, P58, DOI 10.1016/j.tripleo.2007.11.008
   Femiano F, 2008, J EUR ACAD DERMATOL, V22, P681, DOI 10.1111/j.1468-3083.2008.02637.x
   Mattioli TMF, 2011, CLINICS, V66, P1605, DOI 10.1590/S1807-59322011000900017
   Goldim J. R, 1985, PESQUISA SAUDE LEIS
   Howard P, 2014, J PAIN SYMPTOM MANAG, V47, P955, DOI 10.1016/j.jpainsymman.2014.03.001
   KLEIN RM, 2002, ORAL DEV HISTOLOGY, P292
   Kosuge Y, 2009, EUR J PHARMACOL, V610, P18, DOI 10.1016/j.ejphar.2009.02.043
   Kujirai M, 2002, BRIT J PHARMACOL, V137, P945, DOI 10.1038/sj.bjp.0704968
   Lader M, 2009, CNS DRUGS, V23, P19, DOI 10.2165/0023210-200923010-00002
   Okubo M, 1998, EUR J PHARMACOL, V359, P243, DOI 10.1016/S0014-2999(98)00628-1
   Okubo M, 2013, J PHARMACOL SCI, V122, P42, DOI 10.1254/jphs.12241FP
   Ouchi K, 2011, EUR J PHARMACOL, V657, P20, DOI 10.1016/j.ejphar.2011.01.029
   Rao Roopa S, 2014, J Contemp Dent Pract, V15, P523
   Rinaldi M, 2015, CURR PHARM BIOTECHNO, V16, P573, DOI 10.2174/138920101606150407115258
   Rocha Rafael Malagoli, 2006, J. Bras. Patol. Med. Lab., V42, P477, DOI 10.1590/S1676-24442006000600012
   SAWAKI K, 1995, JPN J PHARMACOL, V67, P359, DOI 10.1254/jjp.67.359
   Schuler SL, 2008, JPEN-PARENTER ENTER, V32, P184, DOI 10.1177/0148607108314387
   Wang SC, 2014, TRENDS PHARMACOL SCI, V35, P178, DOI 10.1016/j.tips.2014.02.004
   Zaclikevis MV, 2009, MED CHEM, V5, P74, DOI 10.2174/157340609787049262
NR 23
TC 5
Z9 5
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUN 24
PY 2016
VL 7
AR 173
DI 10.3389/fphar.2016.00173
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DP3DZ
UT WOS:000378373900001
PM 27445812
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU de Noronha, L
   Zanluca, C
   Azevedo, MLV
   Luz, KG
   dos Santos, CND
AF de Noronha, Lucia
   Zanluca, Camila
   Viola Azevedo, Marina Luize
   Luz, Kleber Giovanni
   Duarte dos Santos, Claudia Nunes
TI Zika virus damages the human placental barrier and presents marked fetal
   neurotropism
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; transplacental transmission; Hofbauer cells; neurotropism
ID WEST-NILE VIRUS; INFECTIONS; TRANSMISSION; PATHOGENESIS; EMERGENCE
AB An unusually high incidence of microcephaly in newborns has recently been observed in Brazil. There is a temporal association between the increase in cases of microcephaly and the Zika virus (ZIKV) epidemic. Viral RNA has been detected in amniotic fluid samples, placental tissues and newborn and fetal brain tissues. However, much remains to be determined concerning the association between ZIKV infection and fetal malformations. In this study, we provide evidence of the transplacental transmission of ZIKV through the detection of viral proteins and viral RNA in placental tissue samples from expectant mothers infected at different stages of gestation. We observed chronic placentitis (TORCH type) with viral protein detection by immunohistochemistry in Hofbauer cells and some histiocytes in the intervillous spaces. We also demonstrated the neurotropism of the virus via the detection of viral proteins in glial cells and in some endothelial cells and the observation of scattered foci of microcalcifications in the brain tissues. Lesions were mainly located in the white matter. ZIKV RNA was also detected in these tissues by real-time-polymerase chain reaction. We believe that these findings will contribute to the body of knowledge of the mechanisms of ZIKV transmission, interactions between the virus and host cells and viral tropism.
C1 [de Noronha, Lucia; Viola Azevedo, Marina Luize] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
   [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Inst Med Trop, BR-59072970 Natal, RN, Brazil.
RP dos Santos, CND (corresponding author), Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
RI Duarte dos Santos, Claudia/E-1857-2018; noronha, lucia/F-6339-2015;
   Santos, Claudia Duarte dos/P-4868-2019
OI Duarte dos Santos, Claudia/0000-0001-8707-6638; noronha,
   lucia/0000-0003-0310-7164; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Zanluca, Camila/0000-0001-7350-9105
FU FIOCRUZ; CNPqNational Council for Scientific and Technological
   Development (CNPq); CAPESCAPES; Fundacao AraucariaFundacao Araucaria
FX FIOCRUZ, CNPq, CAPES, Fundacao Araucaria. LN and CZ contributed equally
   to this work.
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Benirchke K, 2006, PATHOLOGY HUMAN PLAC, P502
   Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530
   Brasil P., 2016, N ENGL J ME IN PRESS
   Calvet G, 2016, LANCET INFECT DIS
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   EBC - Empresa Brasil de Comunicacao, 2016, CAS CONF MICR SOB PA
   GREENOUGH A, 1994, ARCH DIS CHILD-FETAL, V70, pF163, DOI 10.1136/fn.70.3.F163
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laszczyk Magdalena, 2007, Ginekol Pol, V78, P560
   Love S, 2002, GREENFIELDS NEUROPAT, P45
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Pan American Health Organization (PAHO), 2016, ZIK VIR INF
   Piersen TC, 2013, FIELDS VIROLOGY, P747
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 127
Z9 132
U1 0
U2 41
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2016
VL 111
IS 5
BP 287
EP +
DI 10.1590/0074-02760160085
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DN2EI
UT WOS:000376876500002
PM 27143490
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Sobral, ACL
   Neto, VM
   Traiano, G
   Percicote, AP
   Gugelmin, ES
   de Souza, CM
   Nakao, L
   Torres, LFB
   de Noronha, L
AF Lira Sobral, Ana Cristina
   Neto, Victor Moreschi
   Traiano, Gabriela
   Percicote, Ana Paula
   Gugelmin, Elizabeth Schneider
   de Souza, Cleber Machado
   Nakao, Lia
   Bleggi Torres, Luiz Fernando
   de Noronha, Lucia
TI Immunohistochemical expression of sulfhydryl oxidase (QSOX1) in
   pediatric medulloblastomas
SO DIAGNOSTIC PATHOLOGY
LA English
DT Article
DE Immunohistochemical expression; Sulfhydryl oxidase; QSOX1; Pediatric
   medulloblastomas
ID DISULFIDE BOND FORMATION; QUIESCIN Q6
AB Background: Medulloblastoma is a malignant, invasive embryonal tumor of the cerebellum and accounts for 20% of intracranial tumors in children. QSOX1, whose functions include formation of disulphide bridges, which are needed for correct protein folding and stability, formation of the extracellular matrix, regulation of the redox status and cell cycle control, appears to be involved in apoptosis in pathological states such as cancer. Thus, the aim of this study was to investigate the immunohistochemical expression of QSOX1 in medulloblastomas and nonneoplastic cerebellum.
   Methods: Histology blocks of pediatric medulloblastomas were separated and two representative areas of the tumors and non-neoplastic cerebellum samples were used to construct tissue microarrays (TMAs) that were stained with an anti-QSOX1 antibody, and the slides were read using image analysis software.
   Results: QSOX1 immunoexpression was observed in the non-neoplastic cerebellum samples and the medulloblastoma samples. There was no statistically significant relationship between QSOX1 immunopositivity in the medulloblastoma samples and the clinical and pathological variables.
   Conclusions: Although QSOX1 did not prove useful for stratifying patients into risk groups, tumor cells and the fibrillar extracellular matrix were positive for this marker, indicating that this enzyme may be involved in the pathogenesis of medulloblastoma.
C1 [Lira Sobral, Ana Cristina; Neto, Victor Moreschi; Traiano, Gabriela; de Noronha, Lucia] Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil.
   [Percicote, Ana Paula; Nakao, Lia; Bleggi Torres, Luiz Fernando] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil.
   [Percicote, Ana Paula; Nakao, Lia; Bleggi Torres, Luiz Fernando] Univ Fed Parana, Dept Med Pathol, BR-80060000 Curitiba, Parana, Brazil.
   [Gugelmin, Elizabeth Schneider] Pequeno Principe Hosp, Serv Anat Pathol, Curitiba, Parana, Brazil.
   [de Souza, Cleber Machado] Pontificia Univ Catolica Parana, Sch Hlth & Biosci, Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil.
EM lnno@terra.com.br
RI noronha, lucia/F-6339-2015; Nakao, Lia S/M-1507-2018
OI noronha, lucia/0000-0003-0310-7164; Nakao, Lia S/0000-0001-9647-6350
CR Amiot C, 2004, MOL BRAIN RES, V125, P13, DOI 10.1016/j.molbrainres.2004.02.024
   Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510
   Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324
   COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483
   Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605
   Debur MD, 2010, J CLIN PATHOL, V63, P930, DOI 10.1136/jcp.2010.077867
   Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759
   Mairet-Coello G, 2005, J COMP NEUROL, V484, P403, DOI 10.1002/cne.20411
   Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126
   Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003
   Portes KF, 2008, J MOL HISTOL, V39, P217, DOI 10.1007/s10735-007-9156-8
   Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072
   Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5
   Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200
   Tury A, 2006, CELL TISSUE RES, V323, P91, DOI 10.1007/s00441-005-0043-x
   Zanata SM, 2005, REDOX REP, V10, P319, DOI 10.1179/135100005X83699
NR 16
TC 2
Z9 2
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1746-1596
J9 DIAGN PATHOL
JI Diagn. Pathol.
PD APR 24
PY 2015
VL 10
AR 37
DI 10.1186/s13000-015-0268-2
PG 5
WC Pathology
SC Pathology
GA CG9FI
UT WOS:000353619800001
PM 25908093
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Baurakiades, E
   Costa, VH
   Raboni, SM
   de Almeida, VRT
   Larsen, KSK
   Kohler, JN
   Gozzo, PD
   Klassen, G
   Manica, GCM
   de Noronha, L
AF Baurakiades, Emanuele
   Costa, Victor Horacio, Jr.
   Raboni, Sonia Mara
   Telli de Almeida, Vivian Rafaela
   Kunze Larsen, Kelly Susana
   Kohler, Juliana Nemetz
   Gozzo, Priscilla do Carmo
   Klassen, Giseli
   Manica, Graciele C. M.
   de Noronha, Lucia
TI The roles of ADAM33, ADAM28, IL-13 and IL-4 in the development of lung
   injuries in children with lethal non-pandemic acute infectious pneumonia
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE ADAM33; ADAM28; Virus; Pneumonia; IL-4; IL-13
ID COMMUNITY-ACQUIRED PNEUMONIA; EPSTEIN-BARR-VIRUS; RESPIRATORY VIRUSES;
   CELL-PROLIFERATION; CATALYTIC-ACTIVITY; VIRAL-INFECTION; DISINTEGRIN;
   IMMUNITY; DISEASE; DOMAIN
AB Background: ADAM28, ADAM33, IL-13, IL-4 and other cytokines (IL-6 and IL-10) seem to play important roles in the persistence and maintenance of acute inflammatory processes that ultimately lead to lung remodeling and pulmonary fibrosis, which may be responsible for the high morbidity and mortality rates associated with non-pandemic acute viral pneumonias in childhood.
   Objectives: The aim of this study was to evaluate the roles of ADAM33, ADAM28, IL4, IL6, IL10 and IL13 in the development of inflammation and alveolar fibrosis due to lethal acute respiratory infections of the lower airway in a pediatric population, especially in those with viral etiology.
   Study design: For this study, 193 cases were selected, and samples from the cases were processed for viral antigen detection by immunohistochemistry and then separated into two groups: virus-positive (n = 68) and virus-negative (n = 125). Immunohistochemistry was performed to assess the presence of metalloproteinases (ADAM33 and ADAM28) and inflammatory cytokines (IL-4, IL-13, IL-6, IL-10) in the alveolar septa.
   Results: The virus-positive group showed stronger immunolabeling for ADAM33, ADAM28, IL-4 and IL-13 (p < 0.0001 for all variables). The staining intensities for ADAM33 and ADAM28 were directly proportional to the intensities for IL-4 and IL-13 (p < 0.0001).
   Conclusions: The results of this study suggest that these proteins play important roles in pulmonary inflammatory reactions elicited against etiological viral agents. In addition, these mediators may affect the process of lung remodeling and the development of pulmonary fibrosis. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Baurakiades, Emanuele; Costa, Victor Horacio, Jr.; Telli de Almeida, Vivian Rafaela; Kunze Larsen, Kelly Susana; Kohler, Juliana Nemetz; Gozzo, Priscilla do Carmo; de Noronha, Lucia] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
   [Raboni, Sonia Mara] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil.
   [Klassen, Giseli; Manica, Graciele C. M.] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
RP Baurakiades, E (corresponding author), Pontificia Univ Catolica Parana, Rua Imaculada Conceicao 1155, Curitiba, Parana, Brazil.
EM lnno@terra.com.br; victor.costajr@gmail.com; sraboni@ufpr.br;
   vivi.telli@hotmail.com; kskl@onda.com.br; jnk@gmail.com;
   priscillagozzo@hotmail.com; giseli@ufpr.br; gracimanica@hotmail.com;
   lnno@terra.com.br
RI Raboni, Sonia M/AAF-7142-2020; Klassen, Giseli/AAF-3962-2019; Klassen,
   Giseli/F-8753-2012; noronha, lucia/F-6339-2015
OI Raboni, Sonia M/0000-0001-7907-7585; Klassen,
   Giseli/0000-0001-5336-6178; Klassen, Giseli/0000-0001-5336-6178;
   noronha, lucia/0000-0003-0310-7164
CR Bridges LC, 2005, BIOCHEM J, V387, P101, DOI 10.1042/BJ20041444
   Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045
   Choi EH, 2002, J INFECT DIS, V186, P1207, DOI 10.1086/344310
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   Cruz AT, 2006, ANN EMERG MED, V47, P250, DOI 10.1016/j.annemergmed.2005.10.019
   Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943
   Daknama A, 2009, J ALLERGY CLIN IMMUN, V123, P138
   Debur MD, 2010, J CLIN PATHOL, V63, P930, DOI 10.1136/jcp.2010.077867
   Glynn P, 1999, THORAX, V54, P51, DOI 10.1136/thx.54.1.51
   Howard L, 2001, FEBS LETT, V498, P82, DOI 10.1016/S0014-5793(01)02506-6
   Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021
   Kurzius-Spencer M, 2012, PEDIAT ALLERG IMM-UK, V23, P21, DOI 10.1111/j.1399-3038.2011.01220.x
   Lambert SB, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-11
   LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030
   Lee HH, 2008, J EXP MED, V205, P2269, DOI 10.1084/jem.20071371
   Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Manica GCM, 2013, J CANC SCI THER, V5, P14
   McClellan MJ, 2012, J VIROL, V86, P5165, DOI 10.1128/JVI.07161-11
   McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994
   Mitsui Y, 2006, CANCER RES, V66, P9913, DOI 10.1158/0008-5472.CAN-06-0377
   Nakayama T, 2004, J VIROL, V78, P1665, DOI 10.1128/JVI.78.4.1665-1674.2004
   Newcomb DC, 2012, J IMMUNOL, V188, P1027, DOI 10.4049/jimmunol.1102216
   Ohtsuka T, 2006, INT J CANCER, V118, P263, DOI 10.1002/ijc.21324
   Ou R, 2008, J VIROL, V82, P2952, DOI 10.1128/JVI.02191-07
   Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07
   Ramaswamy M, 2006, VIROLOGY, V344, P328, DOI 10.1016/j.virol.2005.09.009
   Ripple MJ, 2010, J IMMUNOL, V185, P4804, DOI 10.4049/jimmunol.1000484
   Roberts CM, 1999, J BIOL CHEM, V274, P29251, DOI 10.1074/jbc.274.41.29251
   Rudan I, 2013, J GLOBAL HLTH, V3, P11
   Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769
   Sharma N, 2011, ALLERGY RHINOL, V2, pE63, DOI 10.2500/ar.2011.2.0018
   Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4
   Tachdjian R, 2009, J EXP MED, V206, P2191, DOI 10.1084/jem.20091480
   WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275
   Yoshinaka T, 2002, GENE, V282, P227, DOI 10.1016/S0378-1119(01)00818-6
   Zou J, 2004, J BIOL CHEM, V279, P9818, DOI 10.1074/jbc.M309696200
NR 37
TC 9
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 2014
VL 61
IS 4
BP 585
EP 589
DI 10.1016/j.jcv.2014.10.004
PG 5
WC Virology
SC Virology
GA AU4KO
UT WOS:000345579900018
PM 25453333
DA 2020-12-08
ER

PT J
AU Damasio, DD
   Nolte, S
   Polak, LP
   Brandt, AP
   Bonan, NB
   Zischler, L
   Stuelp-Campelo, PM
   Cadena, SMSC
   de Noronha, L
   Elifio-Esposito, SL
   Moreno-Amaral, AN
AF Damasio, Danusa de Castro
   Nolte, Stefanie
   Polak, Leonardo Puchetti
   Brandt, Anna Paula
   Bonan, Natalia Borges
   Zischler, Luciana
   Stuelp-Campelo, Patricia M.
   Cadena, Silvia Maria S. C.
   de Noronha, Lucia
   Elifio-Esposito, Selene L.
   Moreno-Amaral, Andrea Novais
TI The lectin BJcuL induces apoptosis through TRAIL expression, caspase
   cascade activation and mitochondrial membrane permeability in a human
   colon adenocarcinoma cell line
SO TOXICON
LA English
DT Article
DE Lectin BJcuL; TRAIL expression; Colon adenocarcinoma; Apoptosis;
   Mitochondria activity; Caspase cascade
ID BOTHROPS-JARARACUSSU VENOM; CYTOCHROME-C RELEASE; RECOGNITION MOLECULES;
   DEATH RECEPTORS; CONCANAVALIN-A; BINDING LECTIN; CANCER-CELLS;
   TUMOR-CELLS; PROLIFERATION; PROTEINS
AB It has been demonstrated that the cytotoxic effect of BJcuL, the lectin isolated from Bothrops jararacussu venom, on human gastric carcinoma is accompanied by the inhibition of extracellular matrix adhesion, cytoskeleton disassembly and apoptosis induction. The present study aimed to evaluate the apoptosis mechanisms triggered by the BJcuL interaction with specific glycans on the surface of HT29 human colon adenocarcinoma cells. The results demonstrated that BJcuL interacts with glycoligands targets on the cell, which were inhibited in the presence of D-galactose. It shows a dose-dependently cytotoxic effect that is inhibited in the presence of D-galactose. A dose-dependent cell aggregation decrease was also observed for the HT29 cells. Analysis of cell proliferation inhibition was assessed by anti-PCNA and demonstrated that lectin diminishes PCNA expression when compared with untreated cells. Differences in apoptotic marker expression estimated by immunohistochemistry revealed that the lectin promotes an increase in TRAIL expression, leading to an increase in the expression of FADD, caspase-8 and Bax. Besides the increased expression of apoptosis-related proteins, our results revealed that the lectin promotes a mitochondrial respiration decrease and a 75% increase in the amount of cytochrome c released. Together these results suggest that the cytotoxicity of BJcuL can sensitize prD-apoptotic proteins in the cytoplasm and mitochondria, leading to the apoptotic cascade. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Damasio, Danusa de Castro; Nolte, Stefanie; Polak, Leonardo Puchetti; Bonan, Natalia Borges; Zischler, Luciana; Stuelp-Campelo, Patricia M.; de Noronha, Lucia; Elifio-Esposito, Selene L.; Moreno-Amaral, Andrea Novais] Pontificia Univ Catolica Parana, Escola Med, Posgrad Ciencias Saude, BR-80215901 Curitiba, Parana, Brazil.
   [Brandt, Anna Paula; Cadena, Silvia Maria S. C.] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil.
RP Moreno-Amaral, AN (corresponding author), Pontificia Univ Catolica Parana, Escola Med, Posgrad Ciencias Saude, BR-80215901 Curitiba, Parana, Brazil.
EM andrea.moreno@pucpr.br
RI Cadena, Silvia MSC/C-2702-2013; noronha, lucia/F-6339-2015
OI Cadena, Silvia MSC/0000-0003-4661-8458; noronha,
   lucia/0000-0003-0310-7164; Zischler, Luciana/0000-0001-8169-7601;
   Moreno-Amaral, Andrea N/0000-0002-2730-2952; Elifio-Esposito,
   Selene/0000-0002-8676-134X
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [80964/2007-6]
FX The authors thank Ms Ana Paula Camargo Martins and Marina Azevedo for
   skillful technical assistance and the Butantan Institute/Brazil for
   providing B. jararacussu venom. We also thank BD Bioscience for
   supplying the matrigel. This research was supported by grants from CNPq
   (80964/2007-6).
CR Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220
   Appaix F, 2000, BBA-BIOENERGETICS, V1457, P175, DOI 10.1016/S0005-2728(00)00098-0
   Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001
   BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039
   Bernardi S, 2012, RECENT PAT ANTI-CANC, V7, P207, DOI 10.2174/157489212799972927
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen J, 2009, PHYTOMEDICINE, V16, P352, DOI 10.1016/j.phymed.2008.07.003
   Chong H, 2009, J IMMUNOASS IMMUNOCH, V30, P166, DOI 10.1080/15321810902782863
   de Carvalho D. D., 1998, BIOCH BIOL MOL INT, V44, P933
   de Carvalho DD, 2001, TOXICON, V39, P1471, DOI 10.1016/S0041-0101(01)00106-4
   Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8
   Elifio-Esposito SL, 2007, J VENOM ANIM TOXINS, V13, P782, DOI 10.1590/S1678-91992007000400009
   Elifio-Esposito S, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-10
   Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608
   Fulda S, 2004, CURR CANCER DRUG TAR, V4, P569, DOI 10.2174/1568009043332763
   Gastman B, 2004, BIOCHEM BIOPH RES CO, V316, P263, DOI 10.1016/j.bbrc.2004.02.043
   Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8
   Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39
   Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013
   Haas H, 1999, EUR J IMMUNOL, V29, P918, DOI 10.1002/(SICI)1521-4141(199903)29:03&lt;918::AID-IMMU918&gt;3.0.CO;2-T
   KENNEDY JF, 1995, CARBOHYD POLYM, V26, P219, DOI 10.1016/0144-8617(94)00091-7
   Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5
   Kiss R, 1997, GUT, V40, P253, DOI 10.1136/gut.40.2.253
   KNIBBS RN, 1994, GLYCOBIOLOGY, V4, P419, DOI 10.1093/glycob/4.4.419
   Lacour S, 2001, CANCER RES, V61, P1645
   LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274
   Liu B, 2009, AUTOPHAGY, V5, P432, DOI 10.4161/auto.5.3.7924
   Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527
   Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9
   Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5
   MASTRO AM, 1986, CELL TISSUE KINET, V19, P557, DOI 10.1111/j.1365-2184.1986.tb00756.x
   Nolte S, 2012, TOXICON, V59, P81, DOI 10.1016/j.toxicon.2011.10.012
   OZEKI Y, 1994, ARCH BIOCHEM BIOPHYS, V308, P306, DOI 10.1006/abbi.1994.1043
   Pereira-Bittencourt M, 1999, ANTICANCER RES, V19, P4023
   Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232
   POWELL LD, 1995, J BIOL CHEM, V270, P14243, DOI 10.1074/jbc.270.24.14243
   Pryme I F, 1996, J Exp Ther Oncol, V1, P171
   Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3
   Sarray S, 2009, CANCER LETT, V285, P174, DOI 10.1016/j.canlet.2009.05.012
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581
   Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307
   Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792
   Zhu SQ, 2012, CANCER BIOTHER RADIO, V27, P577, DOI 10.1089/cbr.2012.1256
NR 44
TC 13
Z9 13
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD NOV
PY 2014
VL 90
BP 299
EP 307
DI 10.1016/j.toxicon.2014.08.062
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA AU7ZR
UT WOS:000345817200032
PM 25194746
DA 2020-12-08
ER

PT J
AU Costa, VHD
   Baurakiades, E
   Azevedo, MLV
   Traiano, G
   Rosales, JK
   Larsen, KSK
   Raboni, SM
   de Noronha, L
AF de Souza Costa, Victor Horacio, Jr.
   Baurakiades, Emanuele
   Viola Azevedo, Marina Louise
   Traiano, Gabriela
   Rosales, Jeana Kowal
   Kunze Larsen, Kelly Susana
   Raboni, Sonia Maria
   de Noronha, Lucia
TI Immunohistochemistry analysis of pulmonary infiltrates in necropsy
   samples of children with non-pandemic lethal respiratory infections
   (RSV; ADV; PIV1; PIV2; PIV3; FLU A; FLU B)
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Virus; Pneumonia; Childhood; Immunohistochemistry; Autopsy
ID SYNCYTIAL VIRUS-INFECTION; EFFECTOR ACTIVITY; DISEASE; EXPRESSION;
   MEMORY
AB Background: Acute viral respiratory infections represent a globally important cause of morbidity and mortality in childhood. An individual's cellular response appears to play a critical role in recovery from infections, given that individuals with impaired cellular immunity, congenital or acquired, have more severe diseases and secrete the virus for longer periods.
   Objectives: The aim of this study was to immunohistochemically evaluate the expression of the cell surface antigens CD4, CD8, CD25, CD14 and CD74, in pneumonic infiltrates in the alveolar septa using paraffin-embedded lung samples from autopsies of immunocompetent children who died of lethal, non-pandemic, severe acute respiratory infections.
   Study design: From 794 cases of pediatric autopsies of patients with severe respiratory disease (between 1960 and 2004), 193 cases were selected for this study. To identify subpopulations of inflammatory cells in the alveolar septa, cell surface antigen expression was assessed by immunohistochemistry using the following primary antibodies: anti-CD4, anti-CD8, anti-CD14, anti-CD25 and anti-CD74.
   Results: The TCD8+ lymphocyte count was higher in the virus-positive group (p = 0.04) and was also much higher among cases that were positive for more than three viral types (p = 0.016). There were fewer CD14+ cells in cases of AdV (adenovirus) infection (p = 0.002), and there was a predominance of CD74+ cells in the histopathological pattern defined as interstitial pneumonitis (p = 0.037).
   Conclusions: The results of this study demonstrate that TCD8+ lymphocytes present in the alveolar septa participate to a greater extent in the response toward viral pneumonia, while CD 14+ cell numbers are often reduced in cases of AdV. (C) 2014 Elsevier B.V. All rights reserved.
C1 [de Souza Costa, Victor Horacio, Jr.; Baurakiades, Emanuele; Viola Azevedo, Marina Louise; Traiano, Gabriela; Rosales, Jeana Kowal; Kunze Larsen, Kelly Susana; de Noronha, Lucia] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
   [Raboni, Sonia Maria] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Pontificia Univ Catolica Parana, Rua Imaculada Conceicao,1155 Prado Velho, Curitiba, Parana, Brazil.
EM victor.costajr@gmail.com; manubaurakiades@gmail.com;
   malu_tu@yahoo.com.br; gabrielatraiano@hotmail.com;
   jeana-jkr@hotmail.com; kskl@onda.com.br; sraboni@ufpr.br;
   lnno@terra.com.br
RI Raboni, Sonia M/AAF-7142-2020; noronha, lucia/F-6339-2015
OI Raboni, Sonia M/0000-0001-7907-7585; noronha, lucia/0000-0003-0310-7164
CR Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x
   Bruder D, 2006, VIRAL IMMUNOL, V19, P147, DOI 10.1089/vim.2006.19.147
   Chang J, 2004, J IMMUNOL, V172, P503, DOI 10.4049/jimmunol.172.1.503
   Chang J, 2002, NAT MED, V8, P54, DOI 10.1038/nm0102-54
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   Costa LF, 2006, MEM I OSWALDO CRUZ, V101, P301, DOI 10.1590/S0074-02762006000300014
   Debur MD, 2010, J CLIN PATHOL, V63, P930, DOI 10.1136/jcp.2010.077867
   Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408
   Farha Talal, 2005, Paediatr Respir Rev, V6, P76, DOI 10.1016/j.prrv.2005.03.001
   Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2
   Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002
   KNOTT AM, 1994, PEDIATR INFECT DIS J, V13, P269, DOI 10.1097/00006454-199404000-00005
   Lambert SB, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-11
   Lanari M, 2002, PEDIATR PULM, V33, P458, DOI 10.1002/ppul.10047
   Lanari M, 2012, PEDIAT PULMONOL, V33, P458
   MCCONNOCHIE KM, 1988, AM J PUBLIC HEALTH, V78, P34, DOI 10.2105/AJPH.78.1.34
   Michelow IC, 2010, PEDIAT INFECT DIS, V113, P701
   Ministerio da Saude do Brasil, 2012, SIST INF MORT PER 20
   Miyao C R, 1999, J Pediatr (Rio J), V75, P334
   Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415
   Peiris JS, 2012, NEW ENGL J MED, V349, P2431
   Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07
   Ray CG, 2003, PEDIATR INFECT DIS J, V12, P10
   Rodrigues Joaquim Carlos, 2002, J. Pediatr. (Rio J.), V78, P129, DOI 10.1590/S0021-75572002000800004
   Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421
   Straliotto SM, 2010, REV SOC BRAS MED TRO, V35, P283
   Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4
   Tsuchiya LRRV, 2005, J INFECTION, V51, P401, DOI 10.1016/j.jinf.2004.12.002
   Van Gucht S, 2005, VIRAL IMMUNOL, V18, P116
   Varga SM, 2001, IMMUNITY, V15, P637, DOI 10.1016/S1074-7613(01)00209-6
NR 30
TC 5
Z9 6
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD OCT
PY 2014
VL 61
IS 2
BP 211
EP 215
DI 10.1016/j.jcv.2014.06.026
PG 5
WC Virology
SC Virology
GA AP4MY
UT WOS:000342052300006
PM 25052332
OA Green Published
DA 2020-12-08
ER

PT J
AU Torres, RJD
   Luchini, A
   Barberini, LY
   Precoma, L
   Torres, CLD
   Torres, RAD
   De Noronha, L
   Erbano, BO
   Casella, AMB
   Precoma, DB
AF De Almeida Torres, Rogil Jose
   Luchini, Andrea
   Barberini, Lucas Younes
   Precoma, Leonardo
   De Almeida Torres, Caroline Luzia
   De Almeida Torres, Robson Antonio
   De Noronha, Lucia
   Erbano, Bruna Olandoski
   Barbante Casella, Antonio Marcelo
   Precoma, Dalton Bertolim
TI Expression of TNF-alpha and IL-6 cytokines in the choroid and sclera of
   hypercholesterolemic rabbits
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Cholesterol; Macrophages; Cytokines; Tumor necrosis factor;
   Interleukin-6; Choroid; Sclera; Macular degeneration
ID TUMOR-NECROSIS-FACTOR; ENDOTHELIAL GROWTH-FACTOR; PIGMENT
   EPITHELIAL-CELLS; MACULAR DEGENERATION; NEOVASCULARIZATION;
   INTERLEUKIN-6; ANGIOGENESIS; MACROPHAGE; MODEL; RECRUITMENT
AB Purpose: This study aimed to evaluate the expression of the inflammatory cytokines TNF-alpha and IL-6 in the sclera and choroid of hypercholesterolemic rabbits.
   Method: Twenty-one New Zealand male albino rabbits were divided into two groups: NG and HG. The NG group was fed a standard rabbit diet and the HG group was fed a cholesterol-enriched diet (1%). The serum total cholesterol, triglyceride, HDL cholesterol, and fasting blood glucose levels were determined at the beginning of the experiment and on the day of euthanasia. Euthanasia of animals in the NG and HG groups was performed at the end of the 4th and 8th week, respectively. The eyes were analyzed immunohistochemically using TNF-alpha and IL-6 antibodies.
   Results: At the time of euthanasia, the HG group showed a significant increase in total cholesterol and triglyceride when compared with the NG group (p<0.001). When compared with the NG group, there was a significant increase in the expression of TNF-alpha (p<0.001) and IL-6 (p=0.002) in the choroid and sclera of animals in the HG group.
   Conclusion: This study demonstrates that the hypercholesterolemic diet induces expression of TNF-alpha and IL-6 in the choroid and sclera of rabbits.
C1 [De Almeida Torres, Rogil Jose; Luchini, Andrea; Barberini, Lucas Younes; Precoma, Leonardo; De Almeida Torres, Caroline Luzia; De Almeida Torres, Robson Antonio; De Noronha, Lucia; Erbano, Bruna Olandoski; Barbante Casella, Antonio Marcelo; Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
RP Torres, RJD (corresponding author), Rua Emiliano Perneta,390 Conj 1-407, BR-80420080 Curitiba, Parana, Brazil.
EM rjat@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
FU CEUA - Pontificia Universidade Catolica do Parana [240/080]
FX Project Number 240/080. CEUA - Pontificia Universidade Catolica do
   Parana.
CR Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4
   Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0
   Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736
   Torres RJD, 2013, J OCUL PHARMACOL TH, V29, P709, DOI 10.1089/jop.2012.0142
   Torres RJD, 2013, ARQ BRAS OFTALMOL, V76, P1, DOI 10.1590/S0004-27492013000100002
   Torres RJD, 2010, OPHTHAL SURG LAS IM, V41, P562, DOI 10.3928/15428877-20100726-05
   ELNER VM, 1992, EXP EYE RES, V54, P361, DOI 10.1016/0014-4835(92)90048-W
   Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038
   FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277
   Grossniklaus HE, 2002, MOL VIS, V8, P119
   Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8
   Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018
   Kantor B, 1999, Cardiovasc Radiat Med, V1, P48, DOI 10.1016/S1522-1865(98)00005-5
   KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   Majka S, 2002, INVEST OPHTH VIS SCI, V43, P260
   Naldini A, 1997, J CELL PHYSIOL, V173, P335, DOI 10.1002/(SICI)1097-4652(199712)173:3<335::AID-JCP5>3.3.CO;2-T
   Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891
   Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002
   Patterson C, 1996, J CLIN INVEST, V98, P490, DOI 10.1172/JCI118816
   Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2
   PLANCK SR, 1992, INVEST OPHTH VIS SCI, V33, P78
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220
   Salazar JJ, 2007, EXP EYE RES, V84, P412, DOI 10.1016/j.exer.2006.10.012
   Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774
   Semkova I, 2011, INVEST OPHTH VIS SCI, V52, P6101, DOI 10.1167/iovs.10-5996
   Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007
   Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x
   Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004
   Trivino A, 2006, EXP EYE RES, V83, P357, DOI 10.1016/j.exer.2005.12.020
   Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436
   VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253
   Wallach D, 2002, ARTHRITIS RES THER, V4, pS189, DOI 10.1186/ar585
   Wu L, 2013, J OCUL PHARMACOL TH, V29, P366, DOI 10.1089/jop.2012.0203
NR 35
TC 1
Z9 1
U1 0
U2 5
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD MAY-JUN
PY 2014
VL 77
IS 3
BP 168
EP 172
DI 10.5935/0004-2749.20140043
PG 5
WC Ophthalmology
SC Ophthalmology
GA AR5PR
UT WOS:000343636700009
PM 25295904
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Teixeira, BCD
   Mahfouz, K
   Escuissato, DL
   Costa, AFCB
   de Noronha, L
AF de Almeida Teixeira, Bernardo Correa
   Mahfouz, Kssia
   Escuissato, Dante Luiz
   Cardoso Buarque Costa, Ana Flvia
   de Noronha, Lucia
TI Solitary benign metastasizing leiomyoma: imaging features and
   pathological findings
SO JORNAL BRASILEIRO DE PNEUMOLOGIA
LA English
DT Letter
ID UTERUS; LUNG
C1 [de Almeida Teixeira, Bernardo Correa; Cardoso Buarque Costa, Ana Flvia] Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil.
   [Mahfouz, Kssia; Escuissato, Dante Luiz; de Noronha, Lucia] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
RP Teixeira, BCD (corresponding author), Univ Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Abramson S, 2001, AM J ROENTGENOL, V176, P1409, DOI 10.2214/ajr.176.6.1761409
   Fasih N, 2008, RADIOGRAPHICS, V28, P1931, DOI 10.1148/rg.287085095
   Jautzke G, 1996, PATHOL RES PRACT, V192, P215, DOI 10.1016/S0344-0338(96)80224-X
   Lin XP, 2010, INT J GYNECOL OBSTET, V110, P154, DOI 10.1016/j.ijgo.2010.03.017
   Maredia R, 1998, RADIOGRAPHICS, V18, P779, DOI 10.1148/radiographics.18.3.9599398
   Steiner PE, 1939, AM J PATHOL, V15, P89
NR 6
TC 1
Z9 2
U1 0
U2 1
PU SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA
PI BRASILIA DF
PA SEPS 714-719, BLOCO E ASA SUL, SALAS 220-223, BRASILIA DF, CEP70390-145,
   BRAZIL
SN 1806-3713
EI 1806-3756
J9 J BRAS PNEUMOL
JI J. Bras. Pneumol.
PD MAR-APR
PY 2014
VL 40
IS 2
BP 193
EP 195
PG 3
WC Respiratory System
SC Respiratory System
GA AF2UX
UT WOS:000334569100015
PM 24831406
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Torres, RJD
   Luchini, A
   Torres, RDD
   de Oliveira, LRS
   Torres, CLD
   Torres, RAD
   Olandoski, M
   Nagashima, S
   de Noronha, L
   Precoma, DB
AF de Almeida Torres, Rogil Jose
   Luchini, Andrea
   de Almeida Torres, Regiane do Rocio
   Silva de Oliveira, Luciano Rodrigo
   de Almeida Torres, Caroline Luzia
   de Almeida Torres, Robson Antonio
   Olandoski, Marcia
   Nagashima, Seigo
   de Noronha, Lucia
   Precoma, Dalton Bertolim
TI Effect of candesartan on the expression of sclera-choroidal
   intercellular adhesion molecule-1 in hypercholesterolemic models
SO CLINICS
LA English
DT Article
DE Renin-Angiotensin System; Cholesterol; Cell Adhesion Molecules;
   Macrophages; Choroid; Sclera; Macular Degeneration
ID RENIN-ANGIOTENSIN SYSTEM; ENDOTHELIAL GROWTH-FACTOR; MACULAR
   DEGENERATION; BRUCHS MEMBRANE; VASCULAR INFLAMMATION;
   NEOVASCULARIZATION; ATHEROSCLEROSIS; PATHOGENESIS; MACROPHAGES;
   OLMESARTAN
AB OBJECTIVE: To evaluate the effect of blocking the angiotensin II AT-1 receptor by the systemic administration of candesartan on the expression of intercellular adhesion molecule-1 in the sclera and choroid of hypercholesterolemic rabbits.
   METHODS: New Zealand rabbits were divided into 3 groups, as follows: GI, which was fed a rabbit standard diet; GII, which was fed a hypercholesterolemic diet; and GIII, which received hypercholesterolemic diet plus candesartan. Samples of the rabbits' sclera and choroid were then studied by hematoxylin-eosin staining and histomorphometric and immunohistochemical analyses for intercellular adhesion molecule-1 expression.
   RESULTS: Histological analysis of hematoxylin-and eosin-stained sclera and choroid revealed that macrophages were rarely present in GI, and GII had significantly increased macrophage numbers compared to GIII. Moreover, in GII, the sclera and choroid morphometry showed a significant increase in thickness in comparison to GI and GIII. GIII presented a significant increase in thickness in relation to GI. Sclera and choroid immunohistochemical analysis for intercellular adhesion molecule-1 expression revealed a significant increase in immunoreactivity in GII in relation to GI and GIII. GIII showed a significant increase in immunoreactivity in relation to GI.
   CONCLUSION: Candesartan reduced the expression of intercellular adhesion molecule-1 and consequently macrophage accumulation in the sclera and choroid of hypercholesterolemic rabbits.
C1 [de Almeida Torres, Rogil Jose; de Almeida Torres, Regiane do Rocio; Olandoski, Marcia; Nagashima, Seigo; de Noronha, Lucia; Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Curitiba, PR, Brazil.
   [de Almeida Torres, Rogil Jose] Hosp Angelina Caron, Campina Grande Do Sul, PR, Brazil.
   [Luchini, Andrea] Ctr Oftalmol Curitiba, Curitiba, PR, Brazil.
   [Silva de Oliveira, Luciano Rodrigo] Univille, Sao Bento Do Sul, SC, Brazil.
   [de Almeida Torres, Caroline Luzia; de Almeida Torres, Robson Antonio] Univ Posit, Curitiba, PR, Brazil.
RP Torres, RJD (corresponding author), Pontificia Univ Catolica Parana, Curitiba, PR, Brazil.
EM rjat@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2
   Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736
   Torres RJD, 2013, J OCUL PHARMACOL TH, V29, P709, DOI 10.1089/jop.2012.0142
   Torres RJD, 2010, OPHTHAL SURG LAS IM, V41, P562, DOI 10.3928/15428877-20100726-05
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P68, DOI 10.1590/S0004-27492009000100014
   DUGUID IGM, 1992, CURR EYE RES, V11, P153, DOI 10.3109/02713689208999526
   ELNER SG, 1992, LAB INVEST, V66, P200
   Friedman E, 1997, AM J OPHTHALMOL, V124, P677, DOI 10.1016/S0002-9394(14)70906-7
   Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7
   Grossniklaus HE, 2002, MOL VIS, V8, P119
   Hikichi T, 2001, AM J OPHTHALMOL, V132, P587, DOI 10.1016/S0002-9394(01)01139-4
   KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003
   Markomichelakis NN, 2005, AM J OPHTHALMOL, V139, P537, DOI 10.1016/j.ajo.2004.09.058
   Marshall TG, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-1
   McLeod S, 1995, AM J PATHOL, V147, P642
   Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406
   Mullins RF, 2006, MOL VIS, V12, P224
   Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe
   PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Ruberti JW, 2003, INVEST OPHTH VIS SCI, V44, P1753, DOI 10.1167/iovs.02-0496
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097
   Satofuka S, 2008, AM J PATHOL, V173, P1911, DOI 10.2353/ajpath.2008.080457
   Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063
   Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007
   Smalley DM, 1996, ARTERIOSCL THROM VAS, V16, P585, DOI 10.1161/01.ATV.16.4.585
   Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x
   Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436
   van de Stolpe Avan der Saag PT, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069
   van der Hoorn JWA, 2007, J HYPERTENS, V25, P2454, DOI 10.1097/HJH.0b013e3282ef79f7
   Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P1208, DOI 10.1161/01.ATV.0000022847.38083.B6
   Zhou Xin-fu, 2010, Chinese Journal of Pathology, V39, P106, DOI 10.3760/cma.j.issn.0529-5807.2010.02.008
NR 35
TC 2
Z9 3
U1 0
U2 1
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2014
VL 69
IS 2
BP 145
EP 149
DI 10.6061/clinics/2014(02)11
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA AB6XC
UT WOS:000331931800011
PM 24519206
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Araujo, DGB
   Nakao, L
   Gozzo, P
   Souza, CDA
   Balderrama, V
   Gugelmin, ES
   Kuczynski, AP
   Olandoski, M
   de Noronha, L
AF Araujo, D. G. B.
   Nakao, L.
   Gozzo, P.
   Souza, C. D. A.
   Balderrama, V.
   Gugelmin, E. S.
   Kuczynski, A. P.
   Olandoski, M.
   de Noronha, L.
TI Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in
   neuroblastomas
SO EUROPEAN JOURNAL OF HISTOCHEMISTRY
LA English
DT Article
DE neuroblastoma; QSOX1; proliferation; apoptosis; prognostic factors
ID DISULFIDE BOND FORMATION
AB Neuroblastoma is the most common extracranial solid malignant tumor observed during childhood. Although these tumors can sometimes regress spontaneously or respond well to treatment in infants, genetic alterations that influence apoptosis can, in some cases, confer resistance to chemotherapy or result in relapses and adversely affect prognosis for these patients. The aim of this study was to correlate immunohistochemical expression of the protein quiescin sulfhydryl oxidase 1 (QSOX1) in samples obtained from untreated neuroblastomas with the patients' clinical and pathological prognostic factors and clinical course. Neuroblastoma samples (n=23) obtained from histology blocks were arrayed into tissue microarrays and analysed by immunohistochemistry. The cases were classified according to the following clinical and pathological prognostic factors: age at diagnosis greater or less than/equal to 18 months; location of the lesion at diagnosis (abdominal or extra-abdominal); presence or absence of bone-marrow infiltration; tumor differentiation (well or poorly differentiated); Shimada histopathologic classification (favourable or unfavourable); state of the tumor extracellular matrix (Schwannian-stroma rich or poor); amplification of the MYCN oncogene; and clinical course (dead or alive with or without relapses/residual lesions). Twelve of the cases were female, 9 children were over 18 months old, 9 cases presented with extra-abdominal tumors and 9 cases exhibited tumors with unfavourable histologies. Fifteen patients underwent bone-marrow biopsy, and 4 of these were positive for metastasis. Nine patients died. The higher immunohistochemical expression of QSOX1 was more common in well-differentiated samples (P=0.029), in stroma-rich samples (P=0.029) and in samples from patients with a high prevalence of relapses/residual disease. The functions of QSOX1 include extracellular matrix maturation and the induction of apoptosis. Therefore, QSOX1 may be involved in neuroblastoma differentiation and regression and may thus function as a biomarker for identifying risk groups for this neoplasm.
C1 [Araujo, D. G. B.; Gozzo, P.; Souza, C. D. A.; Balderrama, V.; Olandoski, M.; de Noronha, L.] Pontificia Univ Catolica Parana, Sch Med, BR-80215901 Curitiba, Parana, Brazil.
   [Nakao, L.] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil.
   [Gugelmin, E. S.] Pequeno Principe Childrens Hosp, Dept Pediat Pathol, Curitiba, Parana, Brazil.
   [Kuczynski, A. P.] Pequeno Principe Childrens Hosp, Dept Pediat Oncol, Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Pontificia Univ Catolica Parana, Sch Med, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
EM lnno@terra.com.br
RI noronha, lucia/F-6339-2015; Nakao, Lia S/M-1507-2018
OI noronha, lucia/0000-0003-0310-7164; Nakao, Lia S/0000-0001-9647-6350
CR Amiot C, 2004, MOL BRAIN RES, V125, P13, DOI 10.1016/j.molbrainres.2004.02.024
   Benayoun B, 2001, J BIOL CHEM, V276, P13830, DOI 10.1074/jbc.M010933200
   Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993
   Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510
   Coppock D, 1991, CELL GROWTH DIFFER, V4, P483
   COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483
   Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605
   Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002
   Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q
   Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759
   HOOBER KL, 1996, BIOL CHEM, V271, P30510
   Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279
   Inaba K, 2010, GENES CELLS, V15, P935, DOI 10.1111/j.1365-2443.2010.01434.x
   Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358
   Katchman BA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3407
   Kushner BH, 2005, NEW ENGL J MED, V353, P2215, DOI 10.1056/NEJMp058251
   Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564
   Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x
   Morel C, 2007, EXP CELL RES, V313, P3971, DOI 10.1016/j.yexcr.2007.09.003
   Noronha Lúcia de, 2013, J. Bras. Patol. Med. Lab., V49, P57, DOI 10.1590/S1676-24442013000100009
   Portes KF, 2008, J MOL HISTOL, V39, P217, DOI 10.1007/s10735-007-9156-8
   Soloviev M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057327
   Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5
   Wittke I, 2003, CANCER RES, V63, P7742
   Zanata SM, 2005, REDOX REPORT EDINBUR, V10, P6
NR 25
TC 10
Z9 10
U1 0
U2 0
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 1121-760X
EI 2038-8306
J9 EUR J HISTOCHEM
JI Eur. J. Histochem.
PY 2014
VL 58
IS 1
BP 52
EP 56
DI 10.4081/ejh.2014.2228
PG 5
WC Cell Biology
SC Cell Biology
GA V41RI
UT WOS:000209562900001
PM 24704990
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Schade, L
   Fritsch, S
   Gentili, AC
   de Noronha, L
   Azevedo, VF
   Paiva, ED
AF Schade, Lilian
   Fritsch, Scheila
   Gentili, Arthur Conelian
   de Noronha, Lucia
   Azevedo, Valderilio Feijo
   Paiva, Eduardo dos Santos
TI Adult Still's disease associated with ovarian cancer - case report
SO REVISTA BRASILEIRA DE REUMATOLOGIA
LA English
DT Article
DE Late-onset Still's disease; Ovarian neoplasms; Paraneoplastic syndromes
ID BREAST-CANCER; LYMPHOMA
AB We report a case of adult-onset Still's disease in a female patient with fever, myalgia, vanishing rash and bilateral inguinal lymphadenopathy, diagnosed after extensive workup to exclude other rheumatic, infectious and neoplastic diseases. The patient initially responded to corticosteroid therapy, but progressed to increased lymph nodes size that when biopsied, revealed serous ovarian adenocarcinoma. To our knowledge, this is the first report of ovarian neoplasm associated with adult-onset Still's disease. (C) 2013 Elsevier Editora Ltda. All rights reserved.
C1 [Schade, Lilian; Fritsch, Scheila; Azevedo, Valderilio Feijo; Paiva, Eduardo dos Santos] Univ Fed Parana, Hosp Clin, Serv Rheumatol, BR-80060000 Curitiba, Parana, Brazil.
   [Gentili, Arthur Conelian; de Noronha, Lucia] Univ Fed Parana, Hosp Clin, Serv Anat Pathol, BR-80060000 Curitiba, Parana, Brazil.
RP Schade, L (corresponding author), Univ Fed Parana, Hosp Clin, Serv Rheumatol, BR-80060000 Curitiba, Parana, Brazil.
EM lilianschade@yahoo.com.br
RI Azevedo, Valderilio Feijo/ABF-8713-2020; noronha, lucia/F-6339-2015
OI Azevedo, Valderilio Feijo/0000-0002-2346-388X; noronha,
   lucia/0000-0003-0310-7164
CR Ahn JK, 2010, CLIN RHEUMATOL, V29, P221, DOI 10.1007/s10067-009-1305-x
   Bagnari V, 2010, RHEUMATOL INT, V30, pCP9, DOI 10.1007/s00296-009-1291-y
   Colina M, 2011, SEMIN ARTHRITIS RHEU
   Jiang L, 2011, J RHEUMATOL
   Kim HA, 2011, THERAPEUTIC RESPONSE
   Komano Yukiko, 2004, Mod Rheumatol, V14, P410, DOI 10.1007/s10165-004-0333-2
   Manger B, 2010, CLIN EXP RHEUMATOL, V28, pS168
   Mekinian A, 2008, REV MED INTERNE, V29, P936, DOI 10.1016/j.revmed.2008.01.028
   Nakagawa Y, 2005, INTERNAL MED, V44, P994, DOI 10.2169/internalmedicine.44.994
   Neishi J, 2000, SCAND J RHEUMATOL, V29, P328
   ROGUES AM, 1993, J RHEUMATOL, V20, P1786
   Shanbhogue AK, CLIN SYNDROMES ASS O
   Shibuya Yuko, 2003, Ryumachi, V43, P577
   Sono H, 2000, LUPUS, V9, P468, DOI 10.1191/096120300678828514
   TROTTA F, 1993, J RHEUMATOL, V20, P1788
NR 15
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0482-5004
J9 REV BRAS REUMATOL
JI Rev. Bras. Reumatol.
PD NOV-DEC
PY 2013
VL 53
IS 6
BP 532
EP 534
DI 10.1016/j.rbre.2013.05.001
PG 3
WC Rheumatology
SC Rheumatology
GA AB1FM
UT WOS:000331536900012
PM 24477732
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Torres, RJD
   de Noronha, L
   Casella, AMB
   Grobe, SF
   Martins, ID
   Torres, RDD
   Luchini, A
   Sturzeneker, MCS
   Torres, CLD
   Precoma, DB
AF de Almeida Torres, Rogil Jose
   de Noronha, Lucia
   Barbante Casella, Antonio Marcelo
   Grobe, Sarah Fagundes
   Martins, Isabela de Carvalho
   de Almeida Torres, Regiane do Rocio
   Luchini, Andrea
   Soares Sturzeneker, Mario Claudio
   de Almeida Torres, Caroline Luzia
   Precoma, Dalton Bertolim
TI Effect of Olmesartan on Leukocyte Recruitment in Choroid-Sclera Complex
   in Hypercholesterolemia Model
SO JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACULAR DEGENERATION;
   ANGIOTENSIN-II; METABOLIC SYNDROME; INFLAMMATION; MACROPHAGE;
   EXPRESSION; PATHOGENESIS; NEOVASCULARIZATION; ATHEROSCLEROSIS
AB Purpose: Demonstrate that the blockade of angiotensin II AT-1 receptors, through the systemic administration of olmesartan, can reduce the MCP-1 expression and the resulting macrophage accumulation in the choroid and sclera of hypercholesterolemic rabbits. Methods: Thirty-two New Zealand rabbits were divided into 3 groups: group I (GI) was fed a standard rabbit diet; group II (GII) was fed a hypercholesterolemic diet; and group III (GIII) was fed a hypercholesterolemic diet plus olmesartan. Serum levels of total cholesterol, triglyceride, HDL cholesterol, and blood glucose were determined in fasting rabbits at the beginning of the experiment and on the day of euthanasia. The choroid and sclera were submitted to morphometric analysis as well as immunohistochemical analysis with MCP-1 and RAM-11 (macrophage marker) antibodies. Results: No abnormality was detected in GI. Group II and III had significant increases in choroid-sclera complex thicknesses when compared with group I (P<0.001). GII showed a significant increase in immunoreactivity for MCP-1 in relation to GI (P=0.001) and GIII (P=0.004). GII showed a significant increase in immunoreactivity for RAM-11 of the choroid-sclera complex in relation to GI (P<0.001) and GIII (P=0.034). A significant increase in immunoreactivity for RAM-11 was observed in GIII in relation to GI (P=0.008). Conclusion: Olmesartan reduced the MCP-1 expression and the resultant macrophage accumulation in the choroid-sclera complex of hypercholesterolemic rabbits.
C1 [de Almeida Torres, Rogil Jose; Grobe, Sarah Fagundes; Martins, Isabela de Carvalho; de Almeida Torres, Regiane do Rocio; Soares Sturzeneker, Mario Claudio] Pontificia Univ Catolica Parana, BR-80420080 Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Dept Pathol, BR-80420080 Curitiba, Parana, Brazil.
   [Barbante Casella, Antonio Marcelo] Univ Estadual Londrina, Dept Ophthalmol, Londrina, Brazil.
   [Luchini, Andrea] Ctr Oftalmol Curitiba, Curitiba, Parana, Brazil.
   [Soares Sturzeneker, Mario Claudio] Santa Casa de Misericordia de Ponta Grossa, Dept Cardiol, Curitiba, Parana, Brazil.
   [de Almeida Torres, Caroline Luzia] Univ Positivo, Curitiba, Parana, Brazil.
   [Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Dept Cardiol, BR-80420080 Curitiba, Parana, Brazil.
   [Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Postgrad Program Hlth Sci, BR-80420080 Curitiba, Parana, Brazil.
   [Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Postgrad Program Surg, BR-80420080 Curitiba, Parana, Brazil.
RP Torres, RJD (corresponding author), Pontificia Univ Catolica Parana, Rua Emiliano Perneta 390,Conj 1407, BR-80420080 Curitiba, Parana, Brazil.
EM rjat@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950
   Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2
   Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17
   Cousins SW, 2004, ARCH OPHTHALMOL-CHIC, V122, P1013, DOI 10.1001/archopht.122.7.1013
   Torres RJD, 2010, OPHTHAL SURG LAS IM, V41, P562, DOI 10.3928/15428877-20100726-05
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P406, DOI 10.1590/S0004-27492009000300027
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P68, DOI 10.1590/S0004-27492009000100014
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P793, DOI 10.1590/S0004-27492009000600010
   Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008
   Ferder L, 2006, CURR HYPERTENS REP, V8, P191, DOI 10.1007/s11906-006-0050-7
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Friedman E, 1997, AM J OPHTHALMOL, V124, P677, DOI 10.1016/S0002-9394(14)70906-7
   Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7
   Grossniklaus HE, 2002, MOL VIS, V8, P119
   Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742
   Hikichi T, 2001, AM J OPHTHALMOL, V132, P587, DOI 10.1016/S0002-9394(01)01139-4
   Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497
   MIZUNO M, 1995, EUR J PHARMACOL, V285, P181, DOI 10.1016/0014-2999(95)00401-6
   Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe
   NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411
   Nicoletti A, 2000, J INTERN MED, V247, P397, DOI 10.1046/j.1365-2796.2000.00660.x
   Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Ruberti JW, 2003, INVEST OPHTH VIS SCI, V44, P1753, DOI 10.1167/iovs.02-0496
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097
   Salazar JJ, 2007, EXP EYE RES, V84, P412, DOI 10.1016/j.exer.2006.10.012
   Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593
   Satofuka S, 2008, AM J PATHOL, V173, P1911, DOI 10.2353/ajpath.2008.080457
   Sola S, 2005, CIRCULATION, V111, P343, DOI 10.1161/01.CIR.0000153272.48711.B9
   Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194
   Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x
   van der Hoorn JWA, 2007, J HYPERTENS, V25, P2454, DOI 10.1097/HJH.0b013e3282ef79f7
   Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f
   YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252
NR 37
TC 4
Z9 4
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1080-7683
EI 1557-7732
J9 J OCUL PHARMACOL TH
JI J. Ocular Pharmacol. Ther.
PD OCT 1
PY 2013
VL 29
IS 8
BP 709
EP 714
DI 10.1089/jop.2012.0142
PG 6
WC Ophthalmology; Pharmacology & Pharmacy
SC Ophthalmology; Pharmacology & Pharmacy
GA 224UR
UT WOS:000324915900003
PM 23683100
DA 2020-12-08
ER

PT J
AU Greca, FH
   de Noronha, L
   Marcolini, FRN
   Verona, A
   Pereira, IA
   Bier, RS
AF Greca, Fernando Hintz
   de Noronha, Lucia
   Nastally Marcolini, Fayrus Rodrigo
   Verona, Alessandro
   Pereira, Ian Arantes
   Bier, Rodrigo Shueda
TI Small intestinal submucosa as a graft to increase rectum diameter
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE Small intestinal submucosa; Graft; Coloplasty; Collagen; Diameter
ID STRENGTH; SURGERY; REPAIR
AB Background: The purpose of our study was to assess the biocompatibility of the porcine small bowel submucosa and its ability to increase the rectal diameter compared with a formal transverse coloplasty.
   Methods: We assigned 36 New Zealand male rabbits to four experimental groups: groups C1 and C2 were treated with transverse coloplasty and groups S1 and S2 were treated with a patch of a porcine small intestine submucosa. We killed the animals in the C1 and S1 groups on the 7th postoperative day, and the animals in the C2 and S2 groups on the 30th postoperative day. We evaluated outcomes on the basis of animal survival, clinical course, anastomosis bursting pressures, morphometric examination, and histologic and immunohistochemical assessment.
   Results: Morphometric examination showed a significant increase in colonic diameter in animals in the S2 group. We found no statistical difference regarding anastomosis bursting pressure between the C1 and S1 groups, and the C2 and S2 groups. On the 30th postoperative day, histologic examination showed total epithelium coverage of the grafts, and the immunohistochemical study showed an organized smooth muscular layer covering the graft. The higher concentration of collagen ticker fiber, type I, was seen in the S2 and C2 groups, but there was no statistical difference between them.
   Conclusions: The implanted graft proved superior to transverse coloplasty regarding the increase in distal colon diameter. Remarkable regeneration, marked fibroplasia, and epithelium coverage occurred throughout the graft on the 30th postoperative day. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Greca, Fernando Hintz; Nastally Marcolini, Fayrus Rodrigo; Verona, Alessandro; Pereira, Ian Arantes; Bier, Rodrigo Shueda] Pontif Catholic Univ Parana, Dept Surg, BR-80240010 Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontif Catholic Univ Parana, Dept Pathol, BR-80240010 Curitiba, Parana, Brazil.
RP Greca, FH (corresponding author), Pontif Catholic Univ Parana, Dept Surg, Visconde de Guarapuava 5087 Ap 1401, BR-80240010 Curitiba, Parana, Brazil.
EM greca.fernando@gmail.com
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Ambe R, 2012, J GASTROINTEST SURG, V16, P209, DOI 10.1007/s11605-011-1651-2
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   CRONIN K, 1968, SURG GYNECOL OBSTETR, V126, P747
   de la Fuente SG, 2003, J GASTROINTEST SURG, V7, P96, DOI 10.1016/S1091-255X(02)00050-1
   De Ugarte DA, 2004, AM SURGEON, V70, P49
   Demirbilek S, 2003, PEDIATR SURG INT, V19, P588, DOI 10.1007/s00383-003-1025-2
   Drake David, 2011, J Clin Dent, V22, P1
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Freeman HJ, 2009, WORLD J GASTROENTERO, V15, P4883, DOI 10.3748/wjg.15.4883
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hoeppner J, 2010, WORLD J GASTROENTERO, V16, P4031, DOI 10.3748/wjg.v16.i32.4031
   Hoeppner J, 2009, J GASTROINTEST SURG, V13, P113, DOI 10.1007/s11605-008-0639-z
   Hoeppner J, 2009, INT J COLORECTAL DIS, V24, P543, DOI 10.1007/s00384-009-0637-y
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   KATARIYA RN, 1977, BRIT J SURG, V64, P496, DOI 10.1002/bjs.1800640713
   LEE ECG, 1982, ANN ROY COLL SURG, V64, P229
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   Nassif ACT, 2009, EUR SURG RES, V42, P209, DOI 10.1159/000208519
   Schlegel RD, 2001, DIS COLON RECTUM, V44, P1464, DOI 10.1007/BF02234598
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Souza Filho Zacarias Alves de, 2005, Acta Cir Bras, V20, P394
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yamamoto T, 2007, DIS COLON RECTUM, V50, P1968, DOI 10.1007/s10350-007-0279-5
NR 27
TC 5
Z9 5
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD AUG
PY 2013
VL 183
IS 2
BP 503
EP 508
DI 10.1016/j.jss.2013.01.059
PG 6
WC Surgery
SC Surgery
GA 182JH
UT WOS:000321737300005
PM 23522453
DA 2020-12-08
ER

PT J
AU Zischler, LDCD
   Damasio, DC
   Nolte, S
   Bonan, NB
   Dotti, N
   de Noronha, L
   Moreno-Amaral, AN
   Elifio-Esposito, S
AF Zischler, Luciana de F. C. de M.
   Damasio, Danusa C.
   Nolte, Stefanie
   Bonan, Nathalia Borges
   Dotti, Nayara
   de Noronha, Lucia
   Moreno-Amaral, Andrea N.
   Elifio-Esposito, Selene
TI RJcuL, a C-type lectin from Bothrops jararacussu venom, sensitizes
   colorectal adenocarcinoma cell line to TRAIL
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Meeting Abstract
C1 [Zischler, Luciana de F. C. de M.; Damasio, Danusa C.; Nolte, Stefanie; Bonan, Nathalia Borges; Dotti, Nayara; de Noronha, Lucia; Moreno-Amaral, Andrea N.; Elifio-Esposito, Selene] Pontificia Univ Catolica Parana, Escola Med, BR-80215901 Curitiba, Parana, Brazil.
RI Elifio-Esposito, Selene/N-6411-2014
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
J9 INT J MOL MED
JI Int. J. Mol. Med.
PY 2013
VL 32
SU 1
MA 254
BP S43
EP S43
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 219LC
UT WOS:000324507400155
DA 2020-12-08
ER

PT J
AU Torres, RJD
   de Noronha, L
   Casella, AMB
   Torres, RDD
   Martins, ID
   Zotz, R
   Luchini, A
   Hoffman, CR
   Precoma, DB
AF de Almeida Torres, Rogil Jose
   de Noronha, Lucia
   Barbante Casella, Antonio Marcelo
   de Almeida Torres, Regiane do Rocio
   Martins, Isabela de Carvalho
   Zotz, Rafael
   Luchini, Andrea
   Hoffman Filho, Conrado Roberto
   Precoma, Dalton Bertolim
TI Increased VEGFR-1 immunoreactivity in the choroid-scleral complex in
   hypercholesterolemia experimental model
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA Portuguese
DT Article
DE Vascular endothelial growth factor A; Macular degeneration; Macrophages;
   Cholesterol; Choroid; Sclera; Animals; Rabbits
ID ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; MACULAR
   DEGENERATION; BRUCHS MEMBRANE; ULTRASTRUCTURAL-CHANGES; INCREASED
   EXPRESSION; AGE; PATHOGENESIS; NEOVASCULARIZATION; CHORIOCAPILLARIS
AB Purpose: The aim of this study is to investigate the expression of vascular endothelial growth factor (VEGF) in the choroid and sclera using hypercholesterolemia experimental model.
   Methods: New Zealand rabbits were divided into two groups: 8 rabbits (8 eyes), in the normal diet group (NG), were fed by a standard diet for 4 weeks; and 13 rabbits (13 eyes), in the hypercholesterolemic group (HG), were fed by a 1% cholesterol-enriched diet for 8 weeks. Total serum cholesterol, triglyceride, HDL cholesterol and fasting blood glucose exams were performed at the initiation of the experiment and at the euthanasia time. After hypercholesterolemic group 8th week and NG 4th week, animals were euthanized and their eyes underwent immunohistochemical analysis with the RAM-11 and VEGFR-1).
   Results: The diet has induced a significant increase in total cholesterol and triglyceride levels in HG when compared with NG (p<0.001). There was a significant increase in the RAM-11 and VEGFR-1 expressions in hypercholesterolemic group choroid and sclera in relation to NG (p <= 0,001).
   Conclusion: This study has revealed that the hypercholesterolemic diet in rabbits induces an increase in the macrophage concentration and immunoreactivity to VEGFR-1 in the choroid and sclera, resembling human age-related macular degeneration (ARMD).
C1 [de Almeida Torres, Rogil Jose; de Noronha, Lucia; Barbante Casella, Antonio Marcelo; de Almeida Torres, Regiane do Rocio; Martins, Isabela de Carvalho; Zotz, Rafael; Luchini, Andrea; Hoffman Filho, Conrado Roberto; Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Curitiba, PR, Brazil.
RP Torres, RJD (corresponding author), Rua Emiliano Perneta 390 Conj 1407, BR-80420080 Curitiba, PR, Brazil.
EM rjat@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4
   Blann AD, 2001, AM J CARDIOL, V87, P1160, DOI 10.1016/S0002-9149(01)01486-2
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P406, DOI 10.1590/S0004-27492009000300027
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P68, DOI 10.1590/S0004-27492009000100014
   Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   FISHER RF, 1987, EYE, V1, P184, DOI 10.1038/eye.1987.35
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7
   Guidry C, 2002, INVEST OPHTH VIS SCI, V43, P267
   Kantor B, 1999, Cardiovasc Radiat Med, V1, P48, DOI 10.1016/S1522-1865(98)00005-5
   KORTE GE, 1984, INVEST OPHTH VIS SCI, V25, P1135
   Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338
   Lutty G, 1999, MOL VIS, V5
   Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X
   Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373
   Nowak JZ, 2006, PHARMACOL REP, V58, P353
   Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891
   PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171
   RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857
   Rudolf M, 2005, BRIT J OPHTHALMOL, V89, P1627, DOI 10.1136/bjo.2005.071183
   Salazar JJ, 2007, EXP EYE RES, V84, P412, DOI 10.1016/j.exer.2006.10.012
   Schmidt-Erfurth U, 2008, INVEST OPHTH VIS SCI, V49, P390, DOI [10.1167/IOVS.07-0227, 10.1167/iovs.07-0227]
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x
   Trivino A, 2006, EXP EYE RES, V83, P357, DOI 10.1016/j.exer.2005.12.020
   van Wijngaarden P, 2005, JAMA-J AM MED ASSOC, V293, P1509, DOI 10.1001/jama.293.12.1509
   Yamada H, 2000, J CELL PHYSIOL, V185, P135, DOI 10.1002/1097-4652(200010)185:1<135::AID-JCP13>3.0.CO;2-Y
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
NR 30
TC 4
Z9 4
U1 0
U2 2
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2013
VL 76
IS 1
BP 1
EP 5
PG 5
WC Ophthalmology
SC Ophthalmology
GA 177TE
UT WOS:000321397500002
PM 23812517
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Miguez, AC
   Francisco, JC
   Barberato, SH
   Simeoni, R
   Precoma, D
   do Amaral, VF
   Rodrigues, E
   Olandoski, M
   de Noronha, L
   Greca, FH
   de Carvalho, KAT
   Faria-Neto, JR
   Guarita-Souza, LC
AF Miguez, Ana C.
   Francisco, Julio C.
   Barberato, Silvio H.
   Simeoni, Rossana
   Precoma, Dalton
   do Amaral, Vivian Ferreira
   Rodrigues, Edson
   Olandoski, Marcia
   de Noronha, Lucia
   Greca, Fernando H.
   Teixeira de Carvalho, Katherine Athayde
   Faria-Neto, Jose Rocha
   Guarita-Souza, Luiz C.
TI The functional effect of soybean extract and isolated isoflavone on
   myocardial infarction and ventricular dysfunction The soybean extract on
   myocardial infarction
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Isoflavone; Soybean; Myocardial infarction; Ventricular dysfunction;
   Functional foods; Arginase
ID SOY PROTEIN; CARDIOVASCULAR-DISEASE; RATS; HEART; CASEIN; MUSCLE;
   LIPIDS; WOMEN
AB Background: Myocardial infarction is a public health problem. Functional food is an alternative treatment for cardiovascular diseases.
   Objective: The objective was to analyze the functional and anatomopathological post-myocardial-infarction effects of soybean extract (SE) and isoflavone (IF).
   Methods: Myocardial infarction was induced in adult Wistar rats. After 5 days, an echocardiogram was performed to determine heart rate (HR), ejection fraction (EF), systolic volume (LVESV) and diastolic volume (LVEDV). Animals with ventricular dysfunction (EF<45%) were selected for study. The animals were divided into three groups: control (n=14), SE (n=15) and IF (n=12). The IF group received 120 mg/kg/day isolated IF, and the SE group received 12.52 g/day. After 30 days, a new echocardiogram was performed. A histological exam was carried out to determine the collagen. Activity of biochemical markers [arginase. lactate dehydrogenase (LDH) and malate dehydrogenasel was measured.
   Results: The animals of the control, IF and SE groups showed a reduction in EF after the infarction (P=.432, P=.017 and P=.320, respectively). An increase of LVESV and LVEDV was observed in all groups (P=.009, P=.001 and P=.140; and P=.003, P=.008 and P=.205, respectively). A reduction of HR was found in the SE group (P=.020). There was a greater activity of LDH in the SE group. A smaller quantity of mature collagen was found in the region proximal to the myocardial infarction in the SE group.
   Conclusion: A protective effect in the SE group was observed 30 days after the myocardial infarction. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Miguez, Ana C.; Francisco, Julio C.; Barberato, Silvio H.; Simeoni, Rossana; Precoma, Dalton; do Amaral, Vivian Ferreira; Olandoski, Marcia; de Noronha, Lucia; Greca, Fernando H.; Faria-Neto, Jose Rocha; Guarita-Souza, Luiz C.] Pontifical Catholic Univ Parana PUCPR, Ctr Biol & Hlth Sci, Expt Lab, Curitiba, Parana, Brazil.
   [Rodrigues, Edson] Univ Taubate, Unitau, SP, Brazil.
   [Teixeira de Carvalho, Katherine Athayde] Pele Little Prince Inst Chid & Adolescent Hlth Re, Curitiba, Parana, Brazil.
RP Guarita-Souza, LC (corresponding author), Rua Rosa Kaint Nadolny 190,Ap 501, BR-81200525 Curitiba, Parana, Brazil.
EM guaritasouzalc@hotmail.com
RI Francisco, Julio Cesar/AAD-5243-2020; noronha, lucia/F-6339-2015;
   Rodrigues, Edson/C-6792-2015; Neto, Jose R Faria/G-7559-2012; BARBERATO,
   SILVIO H/K-6131-2012; Carvalho, Katherine/ABF-4961-2020
OI Francisco, Julio Cesar/0000-0003-1970-6399; noronha,
   lucia/0000-0003-0310-7164; Rodrigues, Edson/0000-0003-3968-6882; Neto,
   Jose R Faria/0000-0002-1397-0634; Carvalho,
   Katherine/0000-0003-4860-2855; Barberato, Silvio
   Henrique/0000-0002-0711-7995
FU Graduate Program in Health Sciences (PUCPR, Brazil)
FX We would like to thank the Graduate Program in Health Sciences (PUCPR,
   Brazil) for the research support and methodological expertise.
CR Alekel DL, 2010, AM J CLIN NUTR, V91, P218, DOI 10.3945/ajcn.2009.28306
   Anthony MS, 2000, J NUTR, V130, p662S
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budin P, 1891, PRATIQUE ACCOUCHEMEN
   Budin P, 1904, MANUEL PRATIQUE ACCO
   Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572
   Cadenas S, 2010, CARDIOVASC RES, V88, P219, DOI 10.1093/cvr/cvq256
   CHILDRESS JJ, 1979, MAR BIOL, V52, P273, DOI 10.1007/BF00398141
   Clarkson TB, 2001, J CLIN ENDOCR METAB, V86, P41, DOI 10.1210/jc.86.1.41
   Correa F, 2010, CURR MED CHEM, V17, P2261, DOI 10.2174/092986710791331077
   Crouse JR, 1999, ARCH INTERN MED, V159, P2070, DOI 10.1001/archinte.159.17.2070
   FDA-Food and Drug Administration, 1999, US FOOD LAB HLTH CLA
   Ganesan B, 2007, J HEALTH SCI, V53, P671, DOI 10.1248/jhs.53.671
   Goyal SN, 2010, PHYTOMEDICINE, V17, P227, DOI 10.1016/j.phymed.2009.08.009
   Greaves KA, 1999, J NUTR, V129, P1585
   Hagen MK, 2009, NUTR METAB CARDIOVAS, V19, P91, DOI 10.1016/j.numecd.2008.03.001
   Iyamu EW, 2008, ANAL BIOCHEM, V383, P332, DOI 10.1016/j.ab.2008.08.016
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Lapointe A, 2006, J NUTR BIOCH, V12, P381
   Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016
   Lorenzen JM, 2009, WORLD J UROL, V27, P805, DOI 10.1007/s00345-009-0405-1
   Ma Shan-Feng, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P278, DOI 10.3736/jcim20040414
   Martin Doug, 2008, Cardiovasc Hematol Disord Drug Targets, V8, P297
   Murray CJL, 1996, GLOBAL BURDEN DIS CO
   Nagata C, 1998, J NUTR, V128, P209
   Pagano M, 2004, PRINCIPIOS BIOESTATI
   Prunier F, 2002, AM J PHYSIOL-HEART C, V283, pH346, DOI 10.1152/ajpheart.01050.2001
   Rimbach G, 2008, FOOD CHEM TOXICOL, V46, P1308, DOI 10.1016/j.fct.2007.06.029
   Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Schmitt CA, 2009, NITRIC OXIDE-BIOL CH, V21, P77, DOI 10.1016/j.niox.2009.05.006
   Shukla A, 2007, J NUTR BIOCHEM, V18, P313, DOI 10.1016/j.jnutbio.2006.05.007
   Sliva S., 2006, THESIS PUCPR
   Taku K, 2010, ASIA PAC J CLIN NUTR, V19, P33
   Thuesen EV, 2005, J MAR BIOL ASSOC UK, V85, P603, DOI 10.1017/S0025315405011537
   Wu G, 2010, AMINO ACIDS, P1
NR 36
TC 1
Z9 2
U1 1
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD DEC
PY 2012
VL 23
IS 12
BP 1740
EP 1748
DI 10.1016/j.jnutbio.2011.05.017
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 045QA
UT WOS:000311710700024
PM 22717376
DA 2020-12-08
ER

PT J
AU da Silva, TFA
   de Souza, GK
   Simoes, MA
   Pabis, FC
   de Noronha, L
AF Alves da Silva, Tarcisio Fulgencio
   de Souza, Greyce Kelly
   Simoes, Mona Adalgisa
   Pabis, Francisco Cesar
   de Noronha, Lucia
TI Immunohistochemical Expression of Cell Differentiation and Growth in
   Neonate Cardiomyocytes
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA English
DT Article
DE Infant; newborn; myocytes; cardiac / classification;
   immunohistochemistry; phase transition; placental circulation
ID CYCLE; PROTEINS
AB Background: The cardiac alterations during the fetal heart transition to extrauterine life have been explored by several animal studies and the cell mechanisms responsible for these modifications are not well documented in humans.
   Objective: To evaluate the mechanism of cell differentiation into cardiomyocytes that occur in the first days of life, through immunohistochemical analysis of proteins involved in proliferation and muscle contraction processes, in samples of human neonate myocardium.
   Methods: Cross-sectional study of paraffin-sample sections of myocardium from an autopsy database of human neonates, divided into two sample groups: full-term neonates who died after a maximum of two days of life (NEO1) with 10 cases, and full- term infants who died between 3 and 10 days of life (NEO2) with 14 cases, in order to follow a temporal line that would contemplate the transition from fetal circulation to extrauterine life. The samples were studied in tissue microarray and the antibodies used were Ki67, PCNA, PTEN, Bcl2 (proliferation), HHF35 and sarcomeric actin (contractile proteins).
   Results: Difference was observed regarding Ki67, p = 0.02; HHF35, p < 0.01 and sarcomeric actin, p = 0.02, with Ki67 expression being higher in NEO1 group, whereas HHF35 and sarcomeric actin expression was higher in the NEO2 group.
   Conclusion: The results suggest that cardiomyocytes have a proliferation characteristic (Ki67) in NEO1 which, following a temporal line, will be replaced by a differentiation characteristic (HHF35 and sarcomeric actin) in NEO2 (Arq Bras Cardiol 2012;99(3):797-801)
RP Simoes, MA (corresponding author), Itaiopolis 254,Apto 302, BR-89204100 Joinville, SC, Brazil.
EM simoes@saude.sc.gov.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; Silva, Tarcisio Fulgencio
   Alves/0000-0001-5982-9954
CR Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD
   Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3
   Evans HJ, 2003, AM J PHYSIOL-HEART C, V285, pH570, DOI 10.1152/ajpheart.01027.2002
   Field LJ, 2004, ANN NY ACAD SCI, V1015, P160, DOI 10.1196/annals.1302.013
   Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86
   Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163
   MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289
   MCGILL CJ, 1995, CARDIOVASC RES, V30, P557, DOI 10.1016/0008-6363(95)00113-1
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708
   Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509
   Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130
   Tang MK, 2004, CELL TISSUE RES, V316, P339, DOI 10.1007/s00441-004-0881-y
NR 14
TC 1
Z9 1
U1 0
U2 0
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI RIO DE JANEIRO
PA AVENIDA MARECHAL CAMARA 160-330 CENTRO, RIO DE JANEIRO, RJ 20 020-907,
   BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD SEP
PY 2012
VL 99
IS 3
BP 797
EP 800
DI 10.1590/S0066-782X2012005000074
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 011UK
UT WOS:000309190500007
PM 22886229
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Borba, L
   Strottmann, DM
   de Noronha, L
   Mason, PW
   dos Santos, CND
AF de Borba, Luana
   Strottmann, Daisy M.
   de Noronha, Lucia
   Mason, Peter W.
   Duarte dos Santos, Claudia N.
TI Synergistic Interactions between the NS3(hel) and E Proteins Contribute
   to the Virulence of Dengue Virus Type 1
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INTERFERON-STIMULATED GENES; BORNE ENCEPHALITIS-VIRUS;
   CENTRAL-NERVOUS-SYSTEM; STEM-ANCHOR REGION; ENVELOPE PROTEIN;
   CYCLIZATION SEQUENCES; NS3 HELICASE; RNA-BINDING; AMINO-ACID; FLAVIVIRUS
AB Background: Dengue includes a broad range of symptoms, ranging from fever to hemorrhagic fever and may occasionally have alternative clinical presentations. Many possible viral genetic determinants of the intrinsic virulence of dengue virus (DENV) in the host have been identified, but no conclusive evidence of a correlation between viral genotype and virus transmissibility and pathogenicity has been obtained.
   Methodology/Principal Findings: We used reverse genetics techniques to engineer DENV-1 viruses with subsets of mutations found in two different neuroadapted derivatives. The mutations were inserted into an infectious clone of DENV-1 not adapted to mice. The replication and viral production capacity of the recombinant viruses were assessed in vitro and in vivo. The results demonstrated that paired mutations in the envelope protein (E) and in the helicase domain of the NS3 (NS3(hel)) protein had a synergistic effect enhancing viral fitness in human and mosquito derived cell lines. E mutations alone generated no detectable virulence in the mouse model; however, the combination of these mutations with NS3(hel) mutations, which were mildly virulent on their own, resulted in a highly neurovirulent phenotype.
   Conclusions/Significance: The generation of recombinant viruses carrying specific E and NS3(hel) proteins mutations increased viral fitness both in vitro and in vivo by increasing RNA synthesis and viral load (these changes being positively correlated with central nervous system damage), the strength of the immune response and animal mortality. The introduction of only pairs of amino acid substitutions into the genome of a non-mouse adapted DENV-1 strain was sufficient to alter viral fitness substantially. Given current limitations to our understanding of the molecular basis of dengue neuropathogenesis, these results could contribute to the development of attenuated strains for use in vaccinations and provide insights into virus/host interactions and new information about the mechanisms of basic dengue biology.
C1 [de Borba, Luana; Strottmann, Daisy M.; Duarte dos Santos, Claudia N.] Inst Carlos Chagas ICC FIOCRUZ PR, Lab Virol Mol, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana PUC PR, Lab Patol Expt, Curitiba, Parana, Brazil.
   [Mason, Peter W.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.
RP de Borba, L (corresponding author), Inst Carlos Chagas ICC FIOCRUZ PR, Lab Virol Mol, Curitiba, Parana, Brazil.
EM clsantos@tecpar.br
RI P, CM/B-1358-2013; noronha, lucia/F-6339-2015; Santos, Claudia Duarte
   dos/P-4868-2019; Duarte dos Santos, Claudia/E-1857-2018
OI noronha, lucia/0000-0003-0310-7164; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Duarte dos Santos, Claudia/0000-0001-8707-6638
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fundacao AraucariaFundacao Araucaria; Fiocruz; CAPESCAPES
FX The work was supported by CNPq, Fundacao Araucaria, Fiocruz. LB and DMS
   are supported by a fellowship from CAPES. CNDS is a CNPq fellowship
   recipient. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   BARNES WJS, 1974, AM J TROP MED HYG, V23, P495, DOI 10.4269/ajtmh.1974.23.495
   Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bordignon J, 2008, VIROLOGY, V377, P319, DOI 10.1016/j.virol.2008.04.033
   Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   CHEN W, 1995, J VIROL, V69, P5186, DOI 10.1128/JVI.69.8.5186-5190.1995
   Chen YP, 1996, J VIROL, V70, P8765, DOI 10.1128/JVI.70.12.8765-8772.1996
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   Davis CT, 2007, J VIROL, V81, P6111, DOI 10.1128/JVI.02387-06
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469
   Despres P, 1998, J VIROL, V72, P823
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   dos Santos CND, 2000, VIROLOGY, V274, P292, DOI 10.1006/viro.2000.0457
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713
   Gould EA, 1985, VIROLOGY PRACTICAL A, P43
   Grant D, 2011, J VIROL, V85, P7775, DOI 10.1128/JVI.00665-11
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041
   Huerta V, 2008, VIRUS RES, V137, P225, DOI 10.1016/j.virusres.2008.07.022
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Khromykh AA, 1999, J VIROL, V73, P9247, DOI 10.1128/JVI.73.11.9247-9255.1999
   Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Kurane I, 1994, Curr Top Microbiol Immunol, V189, P93
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Ling LM, 2007, J CLIN VIROL, V38, P265, DOI 10.1016/j.jcv.2006.12.011
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638
   Mangada MNM, 1998, VIROLOGY, V244, P458, DOI 10.1006/viro.1998.9093
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nogueira R. M. R., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P68
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08
   Purdy DE, 2005, VIROLOGY, V333, P239, DOI 10.1016/j.virol.2004.12.036
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rice C. M., 1996, FIELDS VIROLOGY, P931
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05
   Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07
   Silveira GF, 2011, J VIROL, V85, P5374, DOI 10.1128/JVI.01915-10
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026
   TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653
   Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06
   Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3
   WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M
   Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
NR 78
TC 16
Z9 17
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2012
VL 6
IS 4
AR e1624
DI 10.1371/journal.pntd.0001624
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 935CP
UT WOS:000303496800035
PM 22530074
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Collatusso, C
   Roderjan, JG
   Vieira, ED
   da Costa, FDA
   de Noronha, L
   Fornazari, DD
AF Collatusso, Claudinei
   Roderjan, Joao Gabriel
   Vieira, Eduardo Discher
   Affonso da Costa, Francisco Diniz
   de Noronha, Lucia
   Fornazari, Daniele de Fatima
TI Effect of SDS-based decelullarization in the prevention of calcification
   in glutaraldehyde-preserved bovine pericardium. Study in rats
SO REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR
LA English
DT Article
DE Bioprosthesis; Pericardium; Tissue engineering; Calcium
ID BIOPROSTHETIC HEART-VALVES; DECELLULARIZATION; EFFICACY
AB Objective: The aim of this study was to investigate the SDS-based decellularization process as an anticalcification method in glutaraldehyde-preserved bovine pericardium in subcutaneous rat model.
   Methods: Pericardium samples with 0.5 cm(2) area and divided into four groups: GDA group: 0.5% glutaraldehyde-preserved pericardium (GDA); GDA-GL group: GDA + 0.2% glutamic acid (GL); D-GDA group: decellularized (D) pericardium with 0.1% SDS + GDA, and D-GDA-GL group: decellularized pericardium + GDA + 0.2% glutamic acid. Afterwards these samples were implanted in 18 rats in subcutaneous position up to 90 days. Each animal received samples of the four groups. The explants were performed at 45 and 90 days. The explants were subjected to histology in glass slides stained with hematoxilin-eosin and alizarin red, morphometry evaluation and the calcium content was measured by flame atomic absorption spectrometry.
   Results: The standard of inflammatory infiltrate was the same in all groups, however more intense in GDA and GDA-GL groups in 45 days, increasing at 90 days. The calcium contents for 45 days were: 32.52 +/- 3.19 mu g/mg in GDA group; 22.12 +/- 3.87 mu g/mg in GDA-GL group; 1.06 +/- 0.38 mu g/mg in D-GDA group and 3.99 +/- 5.78 mu g/mg in D-GDA-GL (P<0.001). For 90 days were 65.91 +/- 24.67 mu g/mg in GDA group; 38.37 +/- 13.79 mu g/mg in GDA-GL group; 1.24 +/- 0.99 mu g/mg in D-GDA group and 30.54 +/- 8.21 mu g/mg in D-GDA-GL (P<0.001). Only D-GDA did not show increase rates of calcium at 45 to 90 days (P=0.314).
   Conclusion: SDS-based decellularization process reduced the inflammatory intensity and calcification in bovine pericardium in subcutaneous rat model for 90 days.
C1 [Collatusso, Claudinei; Fornazari, Daniele de Fatima] Santa Casa de Curitiba, Curitiba, Parana, Brazil.
   [Roderjan, Joao Gabriel; Vieira, Eduardo Discher] Cell Culture Cardiovasc Grafts Ctr, Curitiba, Parana, Brazil.
   [Affonso da Costa, Francisco Diniz] Cardiac Surg Serv Santa Casa de Curitiba, Curitiba, Parana, Brazil.
   [Affonso da Costa, Francisco Diniz] Hosp Ecoville, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Lab Expt Pathol CCBS PUCPR, Curitiba, Parana, Brazil.
   [Fornazari, Daniele de Fatima] Santa Casa Misericordia de Curitiba, Curitiba, Parana, Brazil.
RP Collatusso, C (corresponding author), Rua Schiller 143 Ap 1301 Cristo Rei, BR-80050260 Curitiba, PR, Brazil.
EM claudineicl@yahoo.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Bottio T, 2003, J THORAC CARDIOV SUR, V126, P99, DOI 10.1016/S0022-5223(03)00131-4
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467, DOI 10.1016/S0022-5223(19)42561-0
   Carpentier SM, 1998, ANN THORAC SURG, V66, pS264, DOI 10.1016/S0003-4975(98)01101-1
   Costa Francisco, 2007, Braz. J. Cardiovasc. Surg., V22, P454, DOI 10.1590/S0102-76382007000400012
   Costa Jean Newton Lima, 2005, Rev Bras Cir Cardiovasc, V20, P14, DOI 10.1590/S0102-76382005000100007
   da Costa FDA, 2010, ANN THORAC SURG, V90, P1854, DOI 10.1016/j.athoracsur.2010.08.022
   Ferreira Andrea Dumsch de Aragon, 2007, Braz. J. Cardiovasc. Surg., V22, P303, DOI 10.1590/S0102-76382007000300006
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gross JM, 2001, J THORAC CARDIOV SUR, V121, P428, DOI 10.1067/mtc.2001.113595
   JorgeHerrero E, 1996, BIOMATERIALS, V17, P571, DOI 10.1016/0142-9612(96)88707-2
   Maizato MJS, 2008, ARTIF ORGANS, V32, P268, DOI 10.1111/j.1525-1594.2008.00541.x
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Pettenazzo E, 2008, EUR J CARDIO-THORAC, V34, P418, DOI 10.1016/j.ejcts.2008.05.012
   Sardeto Evandro Antonio, 2006, Braz. J. Cardiovasc. Surg., V21, P409, DOI 10.1590/S0102-76382006000400011
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   Shen M, 2001, ANN THORAC SURG, V71, pS413, DOI 10.1016/S0003-4975(01)02521-8
   Wang D, 2008, CHINESE MED J-PEKING, V121, P1675, DOI 10.1097/00029330-200809010-00017
NR 20
TC 5
Z9 5
U1 0
U2 9
PU SOC BRASIL CIRURGIA CARDIOVASC
PI SAO PAULO SP
PA RUA BEIRA RIO, 45, 7 ANDAR-CJ 72 VILA OLIMPIA, SAO PAULO SP,
   CEP04548-050, BRAZIL
SN 0102-7638
J9 REV BRAS CIR CARDIOV
JI Rev. Bras. Cir. Cardiovasc.
PD JAN-MAR
PY 2012
VL 27
IS 1
BP 88
EP 96
DI 10.5935/1678-9741.20120013
PG 9
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA 995KZ
UT WOS:000308008200013
PM 22729305
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Torres, RJD
   de Noronha, L
   Casella, AMB
   Lumikoski, TI
   Precoma, LB
   Torres, CLD
   Luchini, A
   Sturzeneker, MCS
   Precoma, DB
AF de Almeida Torres, Rogil Jose
   de Noronha, Lucia
   Barbante Casella, Antonio Marcelo
   Lumikoski, Thais Isabel
   Precoma, Leonardo Brandao
   de Almeida Torres, Caroline Luzia
   Luchini, Andrea
   Soares Sturzeneker, Mario Claudio
   Precoma, Dalton Bertolim
TI Increase of choroidal and scleral MCP-1 expression in
   hypercholesterolemia experimental model
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA Portuguese
DT Article
DE Macrophage activation; Macular degeneration; Atherosclerosis;
   Cholesterol; Choroid; sclera; Monocyte chemoattractant proteins;
   Animals; Rabbits
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACULAR DEGENERATION;
   ATHEROSCLEROSIS; PATHOGENESIS; MACROPHAGE; CHEMOKINES; RABBITS; DISEASE;
   RISK
AB Purpose: The aim of this study is to experientially demonstrate that a cholesterol-enriched diet induces an increase in the MCP-1 expression in the choroid and sclera.
   Method: New Zealand rabbits were divided into two groups: GN (normal diet group) of 8 rabbits (8 eyes) was fed a standard rabbit diet for 4 weeks; GH (hypercholesterolemic group) of 13 rabbits (13 eyes) was fed a 1% cholesterol enriched diet for 8 weeks. Total serum cholesterol, triglyceride, HDL cholesterol and fasting blood glucose exams were performed at the start of the experiment and at the euthanasia time. After GH 8th week and GN 4th week animals were euthanized and their eyes underwent immunohistochemical analysis with the anti-MCP-1 antibody.
   Results: The diet has induced a significant increase in GH total cholesterol and triglyceride levels when compared with NG (p<0.001). There was a significant increase in the MCP-1 expression in GH choroid and sclera in relation to GN (p<0.001).
   Conclusion: This study has revealed that the hypercholesterolemic diet in rabbits induces an increase in the MCP-1 expression in the choroid and sclera.
C1 PUC PR, Surg Tech Lab, Curitiba, Parana, Brazil.
   Angelina Caron Hosp, Study Ctr, Campina Grande, Brazil.
RP Torres, RJD (corresponding author), Rua Emiliano Perneta 390,Conj 1407, BR-80010050 Curitiba, PR, Brazil.
EM rjat@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950
   Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17
   Cousins SW, 2004, ARCH OPHTHALMOL-CHIC, V122, P1013, DOI 10.1001/archopht.122.7.1013
   Torres RJD, 2010, OPHTHAL SURG LAS IM, V41, P562, DOI 10.3928/15428877-20100726-05
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P406, DOI 10.1590/S0004-27492009000300027
   Torres RJD, 2009, ARQ BRAS OFTALMOL, V72, P68, DOI 10.1590/S0004-27492009000100014
   Friedman E, 1997, AM J OPHTHALMOL, V124, P677, DOI 10.1016/S0002-9394(14)70906-7
   Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7
   Friedman E, 1997, AM J OPHTHALMOL, V124, P677
   Grossniklaus HE, 2002, MOL VIS, V8, P119
   Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742
   Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497
   Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309
   NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411
   Nicolai U, 1993, Ger J Ophthalmol, V2, P195
   Nicoletti A, 2000, J INTERN MED, V247, P397, DOI 10.1046/j.1365-2796.2000.00660.x
   Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891
   QUEIROZ J. M., 1958, REV ASSOC MED BRASIL, V4, P328
   Ross R, 1999, NEW ENGL J MED, V340, P1929
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Ruberti JW, 2003, INVEST OPHTH VIS SCI, V44, P1753, DOI 10.1167/iovs.02-0496
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097
   Salazar JJ, 2007, EXP EYE RES, V84, P412, DOI 10.1016/j.exer.2006.10.012
   Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593
   Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194
   Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x
   Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f
   Yang DL, 2011, INVEST OPHTH VIS SCI, V52, P6026, DOI 10.1167/iovs.10-7023
   YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252
NR 32
TC 1
Z9 2
U1 0
U2 1
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2012
VL 75
IS 1
BP 48
EP 52
PG 5
WC Ophthalmology
SC Ophthalmology
GA 934LE
UT WOS:000303444800010
PM 22552418
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Baurakiades, E
   Martins, APC
   Moreschi, NV
   Souza, CDA
   Abujamra, K
   Saito, AO
   Mecatti, MC
   Santos, MG
   Pimentel, CR
   Silva, LLG
   Cruz, CR
   de Noronha, L
AF Baurakiades, Emanuele
   Martins, Ana P. C.
   Victor Moreschi, N.
   Souza, Camila D. A.
   Abujamra, Karla
   Saito, Augusto O.
   Mecatti, Maira C.
   Santos, Monica G.
   Pimentel, Camilla R.
   Silva, Larissa L. G.
   Cruz, Cristina R.
   de Noronha, Lucia
TI Histomorphometric and immunohistochemical analysis of infectious agents,
   T-cell subpopulations and inflammatory adhesion molecules in placentas
   from HIV-seropositive pregnant women
SO DIAGNOSTIC PATHOLOGY
LA English
DT Article
DE HIV; p24; CD4; CD8; ICAM; VCAM; placenta
ID IMMUNODEFICIENCY-VIRUS TYPE-1; LOCALIZATION; EXPRESSION; RESPONSES;
   BARRIER; ANTIGEN
AB Background: The aim of this study was to compare histomorphometric changes and the results of immunohistochemical tests for VCAM, ICAM-1, CD4 and CD8 in normal placentas from HIV-seropositive pregnant women.
   Methods: Samples of normal placentas were divided into 2 groups: healthy HIV-seronegative pregnant women (control group = C = 60) and HIV-seropositive women (experimental group = E = 57). Conventional histological sections were submitted to morphometric analysis and evaluated in terms of the immunohistochemical expression of ICAM-1, VCAM, CD4 and CD8.
   Results: The villi in group E were smaller than those in group C. The median for the CD8+ T cell count was higher in group E than in group C (p = 0.03). Immunohistochemical expression of ICAM-1 was observed in 57% of the cases in group E, compared with 21% of those in group C (p = 0.001). There was no difference in VCAM expression or CD4+ cell counts between groups and no correlation between the data for antiretroviral therapy and morphometric or immunohistochemical data.
   Conclusions: The morphometric data showed that placentas of HIV-seropositive pregnant women tend to have smaller villi than those of seronegative women. In addition, immunohistochemical testing for infectious agents helped to identify cases that were positive for microorganisms (6/112) that routine pathological examination had failed to detect. The anti-p24 antibody had a limited ability to detect HIV viral protein in this study (2/57). Correlation of immunohistochemical expression of CD8+ T cells and ICAM-1 with the presence of HIV in the placenta revealed that those expressions can act as biomarkers of inflammatory changes. There was no correlation between the data for antiretroviral therapy and morphometric or immunohistochemical data.
C1 [Martins, Ana P. C.; Victor Moreschi, N.; Souza, Camila D. A.; Abujamra, Karla; Saito, Augusto O.; Mecatti, Maira C.; Santos, Monica G.; Pimentel, Camilla R.; de Noronha, Lucia] Pontificia Univ Catolica Parana, Lab Expt Pathol, Ctr Hlth & Biol Sci, BR-80215901 Curitiba, Parana, Brazil.
   [Silva, Larissa L. G.] Univ Fed Parana, Pathol Anat Dept, BR-80060900 Curitiba, Parana, Brazil.
   [Cruz, Cristina R.] Inst Univ Fed Parana, Pediat Dept, BR-80060900 Curitiba, Parana, Brazil.
RP Moreschi, NV (corresponding author), Pontificia Univ Catolica Parana, Lab Expt Pathol, Ctr Hlth & Biol Sci, BR-80215901 Curitiba, Parana, Brazil.
EM victor_moreschi@msn.com
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Anderson ME, 2003, PHARMACEUT RES, V20, P1523, DOI 10.1023/A:1026188212126
   Anderson VM, 1997, OBSTET GYN CLIN N AM, V24, P797, DOI 10.1016/S0889-8545(05)70345-4
   Bogliolo BFG, 2006, PATOLOGIA BOGLIOLO, P644
   BRUCH JF, 1992, PATHOL BIOL, V40, P679
   Farquhar C, 2003, CLIN EXP IMMUNOL, V134, P367, DOI 10.1111/j.1365-2249.2003.02292.x
   Fear WR, 1998, J VIROL, V72, P1334, DOI 10.1128/JVI.72.2.1334-1344.1998
   Haytlick SJ, 1998, IMMUNOLOGIC RES, V17, P313
   Jung-Sun K, 2008, HISTOPATHOLOGY, V52, P457
   Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997
   Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102
   Marlin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005971
   MATTERN CFT, 1992, PEDIATRICS, V89, P207
   Menu E, 1999, J INFECT DIS, V179, P44, DOI 10.1086/314542
   Ministerio da Saude, 2004, B EP AIDS 2004 AN 17
   Schwartz DA, 2000, J INFECT DIS, V182, P1652, DOI 10.1086/317634
   Schwartz RH, 1998, SCIENCE, V1349, P1480
   Sheikh AU, 2000, AM J OBSTET GYNECOL, V182, P207, DOI 10.1016/S0002-9378(00)70514-X
   TOTH FD, 1995, J VIROL, V69, P2223
   Tripathi V, 2009, J CLIN IMMUNOL, V29, P379, DOI 10.1007/s10875-008-9258-4
   Tscherning-Casper C, 1999, J VIROL, V73, P9673, DOI 10.1128/JVI.73.11.9673-9678.1999
   Villegas-Castrejon H, 1996, Ginecol Obstet Mex, V64, P167
NR 21
TC 10
Z9 12
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1746-1596
J9 DIAGN PATHOL
JI Diagn. Pathol.
PD OCT 24
PY 2011
VL 6
AR 101
DI 10.1186/1746-1596-6-101
PG 7
WC Pathology
SC Pathology
GA 846OM
UT WOS:000296913100001
PM 22024147
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Kondo, W
   dal Lago, EA
   Francisco, JC
   Simeoni, RB
   de Noronha, L
   Martins, APC
   de Azevedo, MLV
   Ferreira, CC
   Maestrelli, P
   Olandoski, M
   Guarita-Souza, LC
   do Amaral, VF
AF Kondo, William
   dal Lago, Eduardo Andreazza
   Francisco, Julio Cesar
   Simeoni, Rossana Baggio
   de Noronha, Lucia
   Camargo Martins, Ana Paula
   Viola de Azevedo, Marina Luise
   Ferreira, Carolina Chaves
   Maestrelli, Priscila
   Olandoski, Marcia
   Guarita-Souza, Luiz Cesar
   do Amaral, Vivian Ferreira
TI Effect of the bone marrow derived-mononuclear stem cells transplantation
   in the growth, VEGF-R and TNF-alpha expression of endometrial implants
   in Wistar rats
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Endometriosis; Stem cells; Vascular endothelial growth factor receptor;
   Experimental endometriosis; Tumor necrosis factor alpha
ID PERITONEAL-FLUID; PATHOGENESIS; THERAPY; REGRESSION; CYTOKINE; GENOMICS;
   EXPLANTS; TISSUE; WOMEN
AB Objective: To study the effect of bone marrow derived-mononuclear stem cells transplantation in the growth, VEGF-R and TNF-alpha expression of surgically induced endometriosis in an experimental model.
   Study design: This is an experimental study conducted in the Center for Health and Biological Sciences at the Pontifical Catholic University of Parana, Brazil. Endometriotic implants were surgically induced in 120 female Wistar rats. The animals with viable endometrial implant (larger than 25 mm(2)) were randomically divided into 3 groups to receive an intraperitoneal injection of 0.2 cc of saline solution (C group; n = 30), a subcutaneous injection of 1 mg/kg of leuprolide (L group; n = 34), or an intraperitoneal injection of 5 x 10(6) bone marrow derived-mononuclear stem cells (SC group; n = 36). They were sacrificed after 21 days to assess the implants' size and the tissue expression of vascular endothelial growth factor receptor (VEGF-R) and tumor necrosis factor-alpha (TNF-alpha).
   Results: Treatment with leuprolide decreased the surface area of the endometriotic implant compared to the SC group and the C group. The absolute reduction in the surface area of the implant was 16.5 mm, 0 mm, and 0 mm (p = 0.007), respectively, and the percent reduction was 40.2%, 0%, and 0% (p = 0.001). VEGF-R expression in the endometriotic implant decreased after treatment in the L and SC groups compared to the C group (409.6 mu m(2) vs. 465 mu m(2) vs. 920.9 mu m(2), respectively; p = 0.021). TNF-alpha expression also reduced in the L and SC groups compared to the C group (585.7 mu m(2) vs. 549.3 mu m(2) vs. 2402.1 mu m(2), respectively; p < 0.001).
   Conclusion: Bone marrow derived-mononuclear stem cells transplantation decreased the expression of VEGF-R and TNF-alpha in the endometriotic implant but did not reduce the surface area of the lesion. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Kondo, William; dal Lago, Eduardo Andreazza; Francisco, Julio Cesar; Simeoni, Rossana Baggio; de Noronha, Lucia; Camargo Martins, Ana Paula; Viola de Azevedo, Marina Luise; Ferreira, Carolina Chaves; Maestrelli, Priscila; Olandoski, Marcia; Guarita-Souza, Luiz Cesar; do Amaral, Vivian Ferreira] Pontifical Catholic Univ Parana PUC PR, Dept Ctr Hlth & Biol Sci, Sao Paulo, Brazil.
RP Kondo, W (corresponding author), Av Getulio Vargas 3163,Ap 21, BR-80240041 Curitiba, Parana, Brazil.
EM williamkondo@yahoo.com
RI Francisco, Julio Cesar/AAD-5243-2020; noronha, lucia/F-6339-2015
OI Francisco, Julio Cesar/0000-0003-1970-6399; noronha,
   lucia/0000-0003-0310-7164
CR Amsterdam LL, 2005, FERTIL STERIL, V84, P300, DOI 10.1016/j.fertnstert.2005.02.018
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   Carvalho KAT, 2008, TRANSPL P, V40, P847, DOI 10.1016/j.transproceed.2008.02.055
   Amaral Vivian Ferreira do, 2009, Rev. Col. Bras. Cir., V36, P250, DOI 10.1590/S0100-69912009000300012
   Dogan E, 2004, FERTIL STERIL, V82, P1115, DOI 10.1016/j.fertnstert.2004.06.033
   Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686
   Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828
   EISERMANN J, 1988, FERTIL STERIL, V50, P573
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fujii EY, 2008, REPROD SCI, V15, P1066, DOI 10.1177/1933719108323445
   Giudice LC, 2003, SEMIN REPROD MED, V21, P119
   Guarita-Souza LC, 2006, TRANSPL P, V38, P1953, DOI 10.1016/j.transproceed.2006.06.067
   Harada T, 2001, FERTIL STERIL, V76, P1, DOI 10.1016/S0015-0282(01)01816-7
   JONES RC, 1984, ACTA ENDOCRINOL-COP, V106, P282, DOI 10.1530/acta.0.1060282
   Keenan JA, 1999, FERTIL STERIL, V72, P135, DOI 10.1016/S0015-0282(99)00157-0
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844
   Leblond AL, 2009, STEM CELLS CLONING, V2, P11, DOI 10.2147/SCCAA.S6210
   Lebovic DI, 2002, IMMUNOL ALLERGY CLIN, V22, P585, DOI 10.1016/S0889-8561(02)00007-3
   Lee SH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-16
   Figueira PGM, 2011, ANN NY ACAD SCI, V1221, P10, DOI 10.1111/j.1749-6632.2011.05969.x
   Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57
   Moore J, 2001, BEST PRACT RES CL RH, V15, P711, DOI 10.1053/berh.2001.0189
   Richter Oliver N., 2005, Archives of Gynecology and Obstetrics, V271, P143, DOI 10.1007/s00404-003-0591-9
   Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014
   Scholl B, 2009, GYNECOL ENDOCRINOL, V25, P701, DOI 10.3109/09513590903159680
   Soares MBP, 2004, AM J PATHOL, V164, P441, DOI 10.1016/S0002-9440(10)63134-3
   Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81
   Taylor RN, 2002, FERTIL STERIL, V78, P694, DOI 10.1016/S0015-0282(02)03325-3
   Taylor RN, 2009, REPROD SCI, V16, P140, DOI 10.1177/1933719108324893
   Traynor AE, 2002, ARTHRITIS RHEUM, V46, P2917, DOI 10.1002/art.10594
   Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9
NR 32
TC 4
Z9 5
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD OCT
PY 2011
VL 158
IS 2
BP 298
EP 304
DI 10.1016/j.ejogrb.2011.05.004
PG 7
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 838OK
UT WOS:000296301900033
PM 21640466
DA 2020-12-08
ER

PT J
AU Collatusso, C
   Roderjan, JG
   Vieira, ED
   Myague, NI
   de Noronha, L
   da Costa, FDA
AF Collatusso, Claudinei
   Roderjan, Joao Gabriel
   Vieira, Eduardo Discher
   Myague, Nelson Itiro
   de Noronha, Lucia
   Affonso da Costa, Francisco Diniz
TI Decellularization as an anticalcification method in stentless bovine
   pericardium valve prosthesis: a study in sheep
SO REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR
LA Portuguese
DT Article
DE Pericardium; Bioprosthesis; Tissue engineering; Transplantation;
   heterologous
ID MITIGATED CALCIFICATION; TISSUE; XENOGRAFT; REPLACEMENT
AB Objective: The objective was to analyze the decellularization process with SOS in glutaraldehyde-preserved bovine pericardium as an anticalcification method in a circulatory sheep model.
   Methods: The valved tubs were implanted in pulmonary artery position in sheep by 180 days. The animals were divided in two groups of 8 animals: control group glutaraldehyde-preserved bovine pericardium and the study group - decellularized bovine pericardium with 0,1% SOS and glutaraldehyde-preserved. After explantation the tubs were analized by x-ray macroscopy, hematoxilin-eosin, alizarin-red and Russel-Movatz pentacromic histology. The calcium content was measured by flame atomic absorption spectrometry.
   Results: There was no early mortality, but two animals in each group died during the study. All cusps in the control group were severely calcified and in some points in the conduits, while the decellularized group did not show macroscopic calcification. Data were proved by x-ray and histologycal exams. The matrix was preserved in histologycal analysis in decellularized group, without gross calcification. The wall conduits calcium content was 35,25 42,13 mu g/mg in the control group versus 15,75 10,44 mu g/mg in the decellularized one: in the cusps was 264,4 126,16 mu g/mg in control group versus 94,29 27,05 mu g/mg in decellularized group (P=0,009).
   Conclusion: The decellularization with 0.1% SOS was effective as an anticalciflcation method in bovine pericardial grafts implanted in a sheep circulatory model for 180 days.
C1 [Collatusso, Claudinei; Roderjan, Joao Gabriel; Vieira, Eduardo Discher; Myague, Nelson Itiro; de Noronha, Lucia; Affonso da Costa, Francisco Diniz] PUCPR, Serv Cirurgia Cardiaca Santa Casa de Curitiba, Curitiba, PR, Brazil.
RP Collatusso, C (corresponding author), Rua Schiller 143-1301, BR-80050260 Curitiba, Parana, Brazil.
EM claudineicl@yahoo.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Alsoufi B, 2009, EUR J CARDIO-THORAC, V36, P84, DOI 10.1016/j.ejcts.2009.02.048
   Baucia José Augusto, 2006, Braz. J. Cardiovasc. Surg., V21, P180, DOI 10.1590/S0102-76382006000200011
   Braile Domingo M., 2003, Rev Bras Cir Cardiovasc, V18, P217, DOI 10.1590/S0102-76382003000300005
   Brandao CMA, 1999, REV BRAS CIR CARDIOV, V14, P27
   Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467, DOI 10.1016/S0022-5223(19)42561-0
   Costa Jean Newton Lima, 2005, Rev Bras Cir Cardiovasc, V20, P14, DOI 10.1590/S0102-76382005000100007
   Cunanan CM, 2001, ANN THORAC SURG, V71, pS417, DOI 10.1016/S0003-4975(01)02493-6
   da Costa FDA, 2004, ARTIF ORGANS, V28, P366, DOI 10.1111/j.1525-1594.2004.47357.x
   Ferreira Andrea Dumsch de Aragon, 2007, Braz. J. Cardiovasc. Surg., V22, P303, DOI 10.1590/S0102-76382007000300006
   Flameng W, 2008, ANN THORAC SURG, V85, P587, DOI 10.1016/j.athoracsur.2007.09.041
   GABBAY S, 1984, J THORAC CARDIOV SUR, V87, P782
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Pettenazzo E, 2008, EUR J CARDIO-THORAC, V34, P418, DOI 10.1016/j.ejcts.2008.05.012
   Pires AC, 1997, REV BRAS CIR CARDIOV, V12, P176
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Wang D, 2008, CHINESE MED J-PEKING, V121, P1675, DOI 10.1097/00029330-200809010-00017
   Weber PA, 2006, J THORAC CARDIOV SUR, V132, P1137, DOI 10.1016/j.jtcvs.2006.06.027
NR 23
TC 5
Z9 6
U1 0
U2 9
PU SOC BRASIL CIRURGIA CARDIOVASC
PI SAO PAULO SP
PA RUA AFONSO CELSO, 1178, SAO PAULO SP, 04119-061, BRAZIL
SN 0102-7638
EI 1678-9741
J9 REV BRAS CIR CARDIOV
JI Rev. Bras. Cir. Cardiovasc.
PD JUL-SEP
PY 2011
VL 26
IS 3
BP 419
EP 426
DI 10.5935/1678-9741.20110017
PG 8
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA 850XV
UT WOS:000297233800017
PM 22086579
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Guilgen, G
   Werneck, ML
   de Noronha, L
   Martins, APC
   Varela, AM
   Nakao, LS
   Pecoits, R
AF Guilgen, Gisah
   Werneck, Marilia Lacerda
   de Noronha, Lucia
   Camargo Martins, Ana Paula
   Varela, Alexandre M.
   Nakao, Lia Sumie
   Pecoits-Filho, Roberto
TI Increased Calcification and Protein Nitration in Arteries of Chronic
   Kidney Disease Patients
SO BLOOD PURIFICATION
LA English
DT Article
DE Atherosclerosis; Chronic kidney disease; Vascular calcification;
   Nitrotyrosine; Cardiovascular disease
ID CHRONIC-HEMODIALYSIS PATIENTS; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE;
   RENAL-DISEASE; ATHEROSCLEROSIS; STRESS; UREMIA
AB Background: Cardiovascular disease in chronic kidney disease (CKD) has peculiar characteristics. The aim of this study was to analyze atherosclerosis, vascular calcification and nitration in arteries from CKD patients. Methods: External iliac and renal artery segments from 27 stage 5 CKD patients and 25 donor controls, respectively, were collected during the transplantation procedure. Results: CKD patients presented a significantly higher degree of lesion. In a large proportion (72%) of CKD patients, we observed vascular calcifications. Immunohistochemistry for nitrotyrosine revealed a significant increase in nitrotyrosine production in arteries from CKD patients compared with control donors. In addition, within CKD patients, nitrotyrosine staining was significantly stronger in arteries with media calcification when compared with arteries without media calcification. Conclusion: The arteriopathy in the CKD patients appears in an early age and seems to be distinct from the arteriopathy of the general population, especially due to intense calcification and vascular oxidative stress. Copyright (C) 2011 S. Karger AG, Basel
C1 [Guilgen, Gisah; Werneck, Marilia Lacerda; de Noronha, Lucia; Camargo Martins, Ana Paula; Varela, Alexandre M.; Nakao, Lia Sumie; Pecoits-Filho, Roberto] Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, BR-80215901 Curitiba, Parana, Brazil.
RP Pecoits, R (corresponding author), Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
EM r.pecoits@pucpr.br
RI noronha, lucia/F-6339-2015; Nakao, Lia S/M-1507-2018; Pecoits-Filho,
   Roberto/K-7986-2013
OI noronha, lucia/0000-0003-0310-7164; Nakao, Lia S/0000-0001-9647-6350;
   Pecoits-Filho, Roberto/0000-0002-0255-6710
CR Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x
   Derici U, 2006, SEMIN DIALYSIS, V19, P60, DOI 10.1111/j.1525-139X.2006.00120.x
   Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470
   Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003
   Ignarro LJ, 2002, CIRC RES, V90, P21, DOI 10.1161/hh0102.102330
   Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003
   Massy ZA, 2003, NEPHROL DIAL TRANSPL, V18, P153, DOI 10.1093/ndt/18.1.153
   Moncada S, 1999, J ROY SOC MED, V92, P164, DOI 10.1177/014107689909200402
   Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28
   Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024
   Qunibi WY, 2007, SEMIN DIALYSIS, V20, P134, DOI 10.1111/j.1525-139X.2007.00260.x
   Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218
   Seron D, 2002, KIDNEY INT, V61, P727, DOI 10.1046/j.1523-1755.2002.00174.x
   Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20
   STARY HC, 1993, EVOLUTION HUMAN ATHE, P1
   Vaziri ND, 2002, HYPERTENSION, V39, P135, DOI 10.1161/hy0102.100540
   Yoshii T, 2006, HYPERTENS RES, V29, P457, DOI 10.1291/hypres.29.457
NR 20
TC 13
Z9 14
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0253-5068
J9 BLOOD PURIFICAT
JI Blood Purif.
PY 2011
VL 32
IS 4
BP 296
EP 302
DI 10.1159/000330327
PG 7
WC Hematology; Urology & Nephrology
SC Hematology; Urology & Nephrology
GA 856KK
UT WOS:000297638600009
PM 21876352
DA 2020-12-08
ER

PT J
AU Debur, MD
   Raboni, SM
   Flizikowski, FBZ
   Chong, DC
   Persicote, AP
   Nogueira, MB
   Rosele, LV
   de Almeida, SM
   de Noronha, L
AF Debur, Maria do Carmo
   Raboni, Sonia Mara
   Flizikowski, Fabiane B. Z.
   Chong, Debora C.
   Persicote, Ana Paula
   Nogueira, Meri B.
   Rosele, Luine V.
   de Almeida, Sergio Monteiro
   de Noronha, Lucia
TI Immunohistochemical assessment of respiratory viruses in necropsy
   samples from lethal non-pandemic seasonal respiratory infections
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID COMMUNITY-ACQUIRED PNEUMONIA; 5 YEARS OLD; HUMAN METAPNEUMOVIRUS;
   RISK-FACTORS; ACUTE BRONCHIOLITIS; CHILDREN YOUNGER; TRACT INFECTIONS;
   INFLUENZA-VIRUS; LUNG-BIOPSY; DISEASE
AB Background/aim Acute respiratory infections are an important cause of childhood morbidity and mortality throughout the world, and viruses have often been reported to be an aetiological agent. This study aimed to identify respiratory viruses in paraffin-embedded samples of paediatric lung necropsy specimens, using immunohistochemistry on tissue microarray slides.
   Methods Retrospective study in 200 lung tissue samples from children who had died from severe respiratory infections during 1985-2005. Immunoperoxidase assay was performed to detect the viruses that were most commonly associated with respiratory tract infections: influenza virus A (FLU A), influenza virus B (FLU B), respiratory syncytial virus (RSV), adenovirus (AdV) and parainfluenza virus (PIV) types 1, 2 and 3.
   Results Viruses were detected in 71 (35.5%) cases. Most positive cases were observed in children younger than 6 months. In 42.3% of cases, only one virus was detected: 11 (36.7%) RSV; 7 (23.3%) AdV; 4 (13.3%) PIV2; 3 (10%) FLU A; 2 (6.7%) FLU B; 2 ( 6.7%) PIV3; and 1 (3.3%) PIV1. Co-infection with more than one virus was observed in 41 (57.7%) cases. No positive correlations were observed between the presence of viral antigens and seasonality of the infection, sex, age or histopathological findings.
   Conclusions Non-pandemic seasonal respiratory viruses are involved in a significant number of deaths in paediatric patients; these findings highlight the importance of laboratory investigation of these agents in patients hospitalised with severe acute respiratory infections.
C1 [Raboni, Sonia Mara] Univ Fed Parana, Hosp Clin, Dept Infect Dis, Infect Dis Discipline,Virol Lab, BR-80060240 Curitiba, Parana, Brazil.
   [Debur, Maria do Carmo] Univ Fed Parana, Internal Med Postgrad Program, BR-80060240 Curitiba, Parana, Brazil.
   [Flizikowski, Fabiane B. Z.; Persicote, Ana Paula; de Noronha, Lucia] Univ Fed Parana, Hosp Clin, Serv Anat Pathol, BR-80060240 Curitiba, Parana, Brazil.
   [Chong, Debora C.] Univ Fed Parana, Hosp Clin, Dept Pediat, BR-80060240 Curitiba, Parana, Brazil.
RP Raboni, SM (corresponding author), Univ Fed Parana, Hosp Clin, Dept Infect Dis, Infect Dis Discipline,Virol Lab, R Padre Camargo 280,2nd Floor,Room 203, BR-80060240 Curitiba, Parana, Brazil.
EM sraboni@ufpr.br
RI Raboni, Sonia M/AAF-7142-2020; Raboni, Sonia Mara/F-7537-2012; noronha,
   lucia/F-6339-2015
OI Raboni, Sonia M/0000-0001-7907-7585; noronha, lucia/0000-0003-0310-7164
CR Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d
   Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102
   Alto WA, 2004, J AM BOARD FAM PRACT, V17, P466, DOI 10.3122/jabfm.17.6.466
   Andrade Victor Piana de, 2007, J. Bras. Patol. Med. Lab., V43, P55, DOI 10.1590/S1676-24442007000100011
   Bont L, 2000, Paediatr Respir Rev, V1, P221, DOI 10.1053/prrv.2000.0052
   Bousso A, 2001, J PEDIATR-US, V138, P786, DOI 10.1067/mpd.2001.112762
   CAMARGOS PAM, 1989, REV SAUDE PUBL, V23, P388, DOI 10.1590/S0034-89101989000500005
   CASCHATCRUZ M, 2005, SEMIN PEDIAT INFECT, V16, P84
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   CONSTANTOPOULOS A, 2001, J PERINAT MED 2 S1, V29, P391
   Costa LF, 2006, MEM I OSWALDO CRUZ, V101, P301, DOI 10.1590/S0074-02762006000300014
   Cruz AT, 2006, ANN EMERG MED, V47, P250, DOI 10.1016/j.annemergmed.2005.10.019
   Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408
   EJZENBERG B, 1986, PEDIAT S PAULO, V8, P99
   Fan J, 1998, CLIN INFECT DIS, V26, P1397, DOI 10.1086/516357
   Farha Talal, 2005, Paediatr Respir Rev, V6, P76, DOI 10.1016/j.prrv.2005.03.001
   FORGHANI B, 1989, DIAGNOSTIC PROCEDURE, P135
   GARDNER PS, 1978, B WORLD HEALTH ORGAN, V56, P105
   Hale KA, 2006, PAEDIATR RESPIR REV, V7, P145, DOI 10.1016/j.prrv.2006.03.011
   Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2
   HORTAL M, 1990, REV INFECT DIS, V12, pS966
   Howard TS, 2000, J PEDIATR-US, V137, P227, DOI 10.1067/mpd.2000.107525
   HUSAIN AN, 2008, ROBBINS CONTRANDPATH, P677
   Irmen KE, 2000, CLIN DIAGN LAB IMMUN, V7, P396, DOI 10.1128/CDLI.7.3.396-403.2000
   Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006
   Kaneko M, 2002, J INFECTION, V44, P240, DOI 10.1053/jinf.2002.0981
   Kim MR, 2000, J INFECTION, V41, P152, DOI 10.1053/jinf.2000.0715
   KNOTT AM, 1994, PEDIATR INFECT DIS J, V13, P269, DOI 10.1097/00006454-199404000-00005
   Kuypers J, 2006, J CLIN MICROBIOL, V44, P2382, DOI 10.1128/JCM.00216-06
   Lambert SB, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-11
   Lanari M, 2002, PEDIATR PULM, V33, P458, DOI 10.1002/ppul.10047
   Lee SJ, 2007, J VIROL, V81, P2349, DOI 10.1128/JVI.01910-06
   Lopez-Huertas MR, 2005, J VIROL METHODS, V129, P1, DOI 10.1016/j.jviromet.2005.05.004
   Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596
   MCCONNOCHIE KM, 1988, AM J PUBLIC HEALTH, V78, P34, DOI 10.2105/AJPH.78.1.34
   MCFARLANE MJ, 1987, JAMA-J AM MED ASSOC, V258, P331, DOI 10.1001/jama.258.3.331
   Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701
   NAKATANI J, 2001, ATUALIZACAO TERAPEUT, P1256
   Nicholls J M, 2009, Hong Kong Med J, V15, P13
   Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07
   RAY CG, 1993, PEDIATR INFECT DIS J, V12, P10, DOI 10.1097/00006454-199301000-00004
   Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935
   Rodrigues Joaquim Carlos, 2002, J Pediatr (Rio J), V78 Suppl 2, pS129
   Roe Michael, 2003, Paediatr Respir Rev, V4, P166, DOI 10.1016/S1526-0542(03)00056-3
   SILVA DC, 2001, J PARANAENSE PEDIAT, V2, P38
   Simon R, 2004, BIOTECHNIQUES, V36, P98, DOI 10.2144/04361RV01
   Sinaniotis C A, 2004, Paediatr Respir Rev, V5 Suppl A, pS197, DOI 10.1016/S1526-0542(04)90037-1
   Stefanutti D, 2000, J PEDIATR-US, V137, P165, DOI 10.1067/mpd.2000.106228
   Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084
   Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4
   Tajima Takeshi, 2006, Journal of Infection and Chemotherapy, V12, P372, DOI 10.1007/s10156-006-0476-5
   Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316
   Thomazelli LM, 2007, J PEDIAT-BRAZIL, V83, P422, DOI 10.1590/S0021-75572007000600005
   Tsuchiya LRRV, 2005, J INFECTION, V51, P401, DOI 10.1016/j.jinf.2004.12.002
   van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355
   VICTORA CG, 1989, INT J EPIDEMIOL, V18, P918, DOI 10.1093/ije/18.4.918
   Voduc D, 2008, SEMIN RADIAT ONCOL, V18, P89, DOI 10.1016/j.semradonc.2007.10.006
   VONLICHTENBERG F, 1991, PATOLOGIA FUNCIONAL, P254
   WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3
   Xepapadaki P, 2004, J CLIN VIROL, V30, P267, DOI 10.1016/j.jcv.2003.12.012
   Yang YG, 2001, PEDIATR INFECT DIS J, V20, P52, DOI 10.1097/00006454-200101000-00010
NR 63
TC 12
Z9 15
U1 0
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 1472-4146
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD OCT
PY 2010
VL 63
IS 10
BP 930
EP 934
DI 10.1136/jcp.2010.077867
PG 5
WC Pathology
SC Pathology
GA 654KY
UT WOS:000282168400014
PM 20876328
DA 2020-12-08
ER

PT J
AU Alessi, A
   Neto, ORF
   Prim, C
   da Silva, RFKC
   de Noronha, L
   Brofman, PRS
   Baroncini, LAV
   Precoma, DB
AF Alessi, Alexandre
   Franca Neto, Olimpio Ribeiro
   Prim, Camila
   Kuenzer Caetano da Silva, Ruy Fernando
   de Noronha, Lucia
   Slud Brofman, Paulo Roberto
   Villela Baroncini, Liz Andrea
   Precoma, Dalton Bertolim
TI Rosiglitazone and Vascular Injury in Hypercholesterolemic Rabbits:
   Neointimal Formation Assessment
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA Portuguese
DT Article
DE Rosiglitazone; rabbits; hypercholesterolemia; atherosclerosis/prevention
   & control
ID ACTIVATED RECEPTOR-GAMMA; SMOOTH-MUSCLE-CELLS;
   AMERICAN-HEART-ASSOCIATION; GENE-EXPRESSION; ANGIOTENSIN-II;
   ATHEROSCLEROSIS; MODEL; ARTERIOSCLEROSIS; PROLIFERATION; ATHEROGENESIS
AB Background: Rosiglitazone has been the focus of extensive discussion.
   Objective: To evaluate the effects of rosiglitazone on iliac arteries, both at the injury site and the contralateral artery, of hypercholesterolemic rabbits undergoing balloon catheter injury.
   Methods: White male rabbits were fed a hypercholesterolemic diet by oral gavage for 6 weeks and divided into two groups as follows: rosiglitazone group 14 rabbits treated with rosiglitazone during 6 weeks) and the control group 18 rabbits without rosiglitazone). Animals underwent balloon catheter injury of the right iliac artery on the 14(th) day.
   Results: In the contralateral iliac artery, there was no significant difference in the intima/media layer area ratio IMR) between the control and rosiglitazone groups. Rosiglitazone did not reduce the probability of type I, II, or III lesions 72.73% vs 92.31%; p=0.30) and type IV or V lesions 27.27% vs 7.69%; p = 0.30). As for the homolateral iliac artery, the intimal area was significantly lower in the rosiglitazone group, as compared to the control group p = 0.024). The luminal layer area was higher in the rosiglitazone group vs. the control group p < 0.0001). There was a significant reduction of 65% in the IMR in the rosiglitazone group vs the control group p = 0.021). None of the histological criteria for type I-V atherosclerotic lesions American Heart Association) were found in the homolateral iliac artery.
   Conclusion: These findings demonstrate that rosiglitazone given for 6 weeks prevents atherogenesis at the injury site, but not in a vessel distant from the injury site. Arq Bras Cardiol 2010; 9(3) : 283-288)
C1 [Alessi, Alexandre; Franca Neto, Olimpio Ribeiro; Prim, Camila; Kuenzer Caetano da Silva, Ruy Fernando; de Noronha, Lucia; Slud Brofman, Paulo Roberto; Villela Baroncini, Liz Andrea; Precoma, Dalton Bertolim] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
RP Baroncini, LAV (corresponding author), Av Iguacu 1325-101B, BR-80250190 Curitiba, Parana, Brazil.
EM lizavb@cardiol.br
RI Bofman, Paulo R S/P-2826-2015; noronha, lucia/F-6339-2015; BARONCINI,
   LIZ ANDREA VILLELA LIZ/Y-3078-2019; Baroncini, Liz Andrea V/F-1717-2010;
   Baroncini, Liz AndrA©a V./A-3492-2009
OI noronha, lucia/0000-0003-0310-7164; BARONCINI, LIZ ANDREA VILLELA
   LIZ/0000-0002-5005-5005; Baroncini, Liz Andrea V/0000-0002-5005-5005;
   Baroncini, Liz AndrA©a V./0000-0002-5005-5005
CR Accorsi-Mendonca D, 2004, BRIT J PHARMACOL, V142, P79, DOI 10.1038/sj.bjp.0705732
   Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04
   Blaschke F, 2006, VASC PHARMACOL, V45, P3, DOI 10.1016/j.vph.2005.11.009
   Calkin AC, 2005, ARTERIOSCL THROM VAS, V25, P1903, DOI 10.1161/01.ATV.0000177813.99577.6b
   Franca Neto Olimpio Ribeiro, 2008, Thromb J, V6, P4, DOI 10.1186/1477-9560-6-4
   Heckenkamp J, 2002, J CARDIOVASC SURG, V43, P349
   Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394
   Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3
   Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942
   Levi Z, 2003, DIABETES OBES METAB, V5, P45, DOI 10.1046/j.1463-1326.2003.00240.x
   Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P1189
   Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027
   Lonn EM, 2009, J AM COLL CARDIOL, V53, P2028, DOI 10.1016/j.jacc.2008.12.072
   Marx N, 2003, ARTERIOSCL THROM VAS, V23, P283, DOI 10.1161/01.ATV.0000054195.35121.5E
   Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097
   Murthy SN, 2005, METABOLISM, V54, P645, DOI 10.1016/j.metabol.2004.12.008
   Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Patel Chetan B, 2006, Diab Vasc Dis Res, V3, P65, DOI 10.3132/dvdr.2006.016
   Phillips JW, 2003, CIRCULATION, V108, P1994, DOI 10.1161/01.CIR.0000092886.52404.50
   Schomig A, 2005, CIRCULATION, V112, P2759, DOI 10.1161/CIRCULATIONAHA.105.583484
   SCHWARTZ RS, 2002, REV CARDIOVASC ME S5, V3, P54
   Seki N, 2005, ATHEROSCLEROSIS, V178, P1, DOI 10.1016/j.atherosclerosis.2004.08.015
   SINGH S, 2007, JAMA-J AM MED ASSOC, V298, P1216
   STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462
   STARY HC, 1992, CIRCULATION, V85, P391, DOI 10.1161/01.CIR.85.1.391
   STARY HC, 1995, CIRCULATION, V92, P355
   Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125
   Sun YP, 2000, P SOC EXP BIOL MED, V224, P166, DOI 10.1046/j.1525-1373.2000.22416.x
   Takagi T, 2000, J AM COLL CARDIOL, V36, P1529, DOI 10.1016/S0735-1097(00)00895-0
   Tao L, 2003, CIRCULATION, V108, P2805, DOI 10.1161/01.CIR.0000097003.49585.5E
   Taskiran D, 1999, TURK J MED SCI, P7
   Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199
   Wang Zhao-hui, 2005, Yaoxue Xuebao, V40, P1051
   Wilson AJ, 2004, BRIT J PHARMACOL, V142, P3, DOI 10.1038/sj.bjp.0705734
NR 35
TC 3
Z9 3
U1 0
U2 0
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI RIO DE JANEIRO
PA AVENIDA MARECHAL CAMARA 160-330 CENTRO, RIO DE JANEIRO, RJ 20 020-907,
   BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD SEP
PY 2010
VL 95
IS 3
BP 283
EP 288
DI 10.1590/S0066-782X2010005000101
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 663IC
UT WOS:000282875600006
PM 20676587
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Navarro, FB
   da Costa, FDA
   Mulinari, LA
   Pimentel, GK
   Roderjan, JG
   Vieira, ED
   de Noronha, L
   Miyague, NI
AF Navarro, Fabio Binhara
   Affonso da Costa, Francisco Diniz
   Mulinari, Leonardo Andrade
   Pimentel, Gustavo Klug
   Roderjan, Joao Gabriel
   Vieira, Eduardo Discher
   de Noronha, Lucia
   Miyague, Nelson Itiro
TI Evaluation of the biological behavior of decellularized pulmonary
   homografts: an experimental sheep model
SO REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR
LA Portuguese
DT Article
DE Transplantation, Homologous, Host vs Graft Reaction; Heart Valve
   Diseases
ID HEART-VALVES; IMMUNE-RESPONSE; EARLY FAILURE; AORTIC-VALVE; TISSUE;
   ALLOGRAFTS; IMMUNOGENICITY; CONDUITS
AB Introduction: The cryopreserved homograft is a good valve substitute due attributes like excellent hemodynamics, low incidence of thromboembolic events, infection resistance and good mid-term durability. However, progressive homograft degeneration and fibrocalcification may occur, particularly in the childhood and young adults. Their antigenicity triggers an immunological reaction that plays an important role in their degeneration and failure. The decellularization process was proposed to decrease this antigenicity. By the action of detergents and enzymes, this process removes all cellular components from the homograft matrix, diminishing immunogenicity and probably delaying its degeneration.
   Objective: The objective of this experimental and descriptive study is to evaluate the biological and functional behavior of decellularized pulmonary homografts (Decell-H), treated by a sodium dodecil sulfate solution (0.1%), developed in our University (Pontificia Universidade Cato Ilea do Parana). For the characterization of Decell-H performance, parameters like recellularization, calcification, and echocardiographic data will be analyzed.
   Methods: Eight juvenile sheep were submitted to the implantation of the Decell-H sutured into orthotopic position, through a left thoracotomy and with cardiopulmonary bypass support. They were followed-up clinically and by periodical echocardiograms until the explantation, which were performed in different time for every two sheep: seven, 30, 90 and 180 postoperative days. For histological analysis we used Hematoxilin-eosin, Movat and Alizarin-Red staining.
   Results: The sheep reached their follow-up period in a good clinical state. There was no valve regurgitation or stenonis by the echocardiogram. The animals submitted to the explantation in 90 and 180 days had a significant somatic growth and these Decell-H(s) had a diameter increase, without central valve insufficiency. Histologically, all homografts preserved their extra-cellular matrix organization and were progressively recellularized, without calcification.
   Conclusion: In this experimental model, the Decell-H behaved as an excellent valve substitute.
C1 [Navarro, Fabio Binhara; Affonso da Costa, Francisco Diniz; Mulinari, Leonardo Andrade; Pimentel, Gustavo Klug; Roderjan, Joao Gabriel; Vieira, Eduardo Discher; de Noronha, Lucia; Miyague, Nelson Itiro] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
RP Navarro, FB (corresponding author), Rua Padre Anchieta 2204,Apto 607, BR-80730000 Curitiba, Parana, Brazil.
EM fabiobnavarro@gmail.com
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; Roderjan, Joao
   Gabriel/0000-0003-4705-5837
CR Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Baskett RJ, 1996, J THORAC CARDIOV SUR, V112, P1170, DOI 10.1016/S0022-5223(96)70130-7
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Breinholt JP, 2000, CIRCULATION, V102, P179
   Cebotari S, 2006, CIRCULATION, V114, pI132, DOI 10.1161/CIRCULATIONAHA.105.001065
   Christenson JT, 2004, J THORAC CARDIOV SUR, V127, P242, DOI 10.1016/j.jtcvs.2003.07.047
   Costa Francisco Diniz Affonso Da, 2004, Rev Bras Cir Cardiovasc, V19, P74, DOI 10.1590/S0102-76382004000100013
   Dohmen P M, 2001, Semin Thorac Cardiovasc Surg, V13, P93
   Dohmen Pascal M, 2003, Med Sci Monit, V9, pBR97
   Dohmen Pascal M, 2002, Asian Cardiovasc Thorac Ann, V10, P25
   Dohmen PM, 2002, ANN THORAC SURG, V74, P1438, DOI 10.1016/S0003-4975(02)03881-X
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P87
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P82
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Hawkins JA, 2000, J THORAC CARDIOV SUR, V119, P324, DOI 10.1016/S0022-5223(00)70188-7
   Hawkins JA, 2003, J THORAC CARDIOV SUR, V126, P247, DOI 10.1016/S0022-5223(03)00116-8
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   Hopkins RA, 2009, J THORAC CARDIOV SUR, V137, P907, DOI 10.1016/j.jtcvs.2008.12.009
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   Kim WG, 2002, INT J ARTIF ORGANS, V25, P791
   Meuris B, 2001, Semin Thorac Cardiovasc Surg, V13, P99
   MITCHELL RN, 1995, ANN THORAC SURG, V60, pS108, DOI 10.1016/0003-4975(95)00258-M
   Neves JP, 1997, J THORAC CARDIOV SUR, V113, P1014, DOI 10.1016/S0022-5223(97)70286-1
   Numata S, 2004, J HEART VALVE DIS, V13, P984
   O'Brien M F, 1987, J Card Surg, V2, P153
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   O'Brien MF, 2001, J HEART VALVE DIS, V10, P334
   Oei FBS, 2002, J HEART VALVE DIS, V11, P315
   OZAKI S, 2001, ARTIF ORGANS, V25, P846
   PENTA A, 1984, CIRCULATION, V70, P182
   Pompilio G, 2004, ANN THORAC SURG, V78, P557, DOI 10.1016/j.athoracsur.2004.02.037
   Shaddy RE, 1996, CIRCULATION, V94, P1063, DOI 10.1161/01.CIR.94.5.1063
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   SMITH JD, 1995, ANN THORAC SURG, V60, pS127, DOI 10.1016/0003-4975(95)00275-P
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Lopes SAV, 2009, REV BRAS CIR CARDIOV, V24, P15, DOI 10.1590/S0102-76382009000100005
NR 36
TC 13
Z9 14
U1 0
U2 3
PU SOC BRASIL CIRURGIA CARDIOVASC
PI SAO PAULO SP
PA RUA AFONSO CELSO, 1178, SAO PAULO SP, 04119-061, BRAZIL
SN 0102-7638
EI 1678-9741
J9 REV BRAS CIR CARDIOV
JI Rev. Bras. Cir. Cardiovasc.
PD JUL-SEP
PY 2010
VL 25
IS 3
BP 377
EP 387
DI 10.1590/S0102-76382010000300015
PG 11
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA 673XZ
UT WOS:000283698800015
PM 21103747
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU De Noronha, L
   Cecilio, WAC
   Da Silva, TFA
   Maggio, EM
   Serapiao, MJ
AF De Noronha, Lucia
   Casteleins Cecilio, William Augusto
   Alves Da Silva, Tarcisio Fulgencio
   Maggio, Ewerton Marques
   Serapiao, Maria Jose
TI Congenital Peribronchial Myofibroblastic Tumor: A Case Report
SO PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
LA English
DT Article
DE congenital peribronchial myofibroblastic tumor; lung; hydrocephaly
AB We describe a rare occurrence of congenital peribronchial myofibroblastic tumor of the lung presenting in early fetal life. A female patient in the 24th week of gestation who presented with polyhydramnios was admitted for examination. Ultrasound examination revealed a mass compromising the lungs. Because the intrauterine fetal death was revealed by the ultrasound, delivery was induced. Necropsy revealed a pulmonary lesion compromising the left lower pulmonary lobe together with hepatomegaly. Microscopic analysis of the lung showed a lesion with a storiform arrangement of spindle cells with focal peribronchial distribution. Hepatic architecture was diffusely altered by fibrotic tissue. Immunohistochemical analysis on the pulmonary lesion showed high vimentin positivity in the fusocellular components, pointing to the mesenchymal nature of the lesion. Significant differentiation of smooth muscle tissue, as indicated by high HHF35 positivity, was also observed. Electron microscopy on the pulmonary lesion revealed elongated cells with some cytoplasmatic processes, a finding that is also compatible with mesenchymal differentiation.
C1 [De Noronha, Lucia] Catholic Univ Parana PUCPR, Lab Patol Expt, BR-80215901 Curitiba, Parana, Brazil.
   [Maggio, Ewerton Marques; Serapiao, Maria Jose] Fed Univ Parana UFPR, Hosp Dona Helena, Lab Anat Patol, BR-89204250 Joinville, SC, Brazil.
RP De Noronha, L (corresponding author), Catholic Univ Parana PUCPR, Lab Patol Expt, Rua Imaculada Conceicao,1155 Prado Velho, BR-80215901 Curitiba, Parana, Brazil.
EM lnno@terra.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; Silva, Tarcisio Fulgencio
   Alves/0000-0001-5982-9954
CR Alobeid B, 1997, AM J SURG PATHOL, V21, P610, DOI 10.1097/00000478-199705000-00016
   MCGINNIS M, 1993, MODERN PATHOL, V6, P487
   Mechoulan A, 2007, GYNECOL OBSTET FERTI, V35, P437, DOI 10.1016/j.gyobfe.2007.02.014
   Shimotake T, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.01.022
   Travis WD, 2004, WHO CLASSIFICATION T, P102
   WARREN J S, 1985, Pediatric Pathology, V3, P321
NR 6
TC 6
Z9 6
U1 0
U2 0
PU ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS
PI LAWRENCE
PA 810 EAST 10TH STREET, LAWRENCE, KS 66044 USA
SN 1093-5266
EI 1615-5742
J9 PEDIATR DEVEL PATHOL
JI Pediatr. Dev. Pathol.
PD MAY-JUN
PY 2010
VL 13
IS 3
BP 243
EP 246
DI 10.2350/07-05-0282.1
PG 4
WC Pathology; Pediatrics
SC Pathology; Pediatrics
GA 633KG
UT WOS:000280500400010
PM 20064015
DA 2020-12-08
ER

PT J
AU Biondo-Simoes, MDP
   Zammar, GR
   Fernandes, RD
   Biondo-Simoes, R
   de Mello, FSR
   de Noronha, L
AF Pessole Biondo-Simoes, Maria de Lourdes
   Zammar, Guilherme Roberto
   Fernandes, Rodrigo dos Santos
   Biondo-Simoes, Rachel
   Ritzdorf de Mello, Flavia Stica
   de Noronha, Lucia
TI Obesity and abdominal wound healing in rats
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article; Proceedings Paper
CT 11th National Congress of Experimental Surgery/24th Forum for Research
   in Surgery of the College of Brazilian Surgeons
CY 2008
CL Cirurgia, BRAZIL
DE Wound Healing; Obesity; Collagen; Rats
ID OPEN GASTRIC BYPASS; COLLAGEN MATRICES; COMPLICATIONS; FIBROBLASTS;
   CONTRACTION; SURGERY; DIET; RESISTANCE; OUTCOMES; RISK
AB Introduction: Treatment for obesity essentially has to do with weight loss, which can be achieved through surgical procedures. Despite the considerable rise in the number of such procedures, the relationship between obesity and the healing process has not been totally clarified. Purpose: To investigate abdominal wound healing in obese Wistar rats on the seventh and fourteenth days following a laparotomy. Methods: Thirty-six Wistar rats were randomly distributed into two groups, the control and experiment group. The control group were fed on either a standard diet for the species and the experiment group were put on a high calorie diet. After 116 days, all the animals were submitted to a laparotomy followed by laparorrhaphy. After euthanasia on the seventh or fourteenth day, fragments of the abdominal wound containing the scar were submitted to histopathological and tensiometric analysis. Results: The average weight of the animals from the experiment group was higher than that of the control group (p<0.001). The difference in the resistance of the cutaneous scars was not significant. The aponeurotic scars were more resistant in the control group after seven days (p=0.011) and fourteen days (p=0.040). There was no difference in terms of intensity of the inflammatory reaction and the collagen density was similar in both groups. Conclusion: In rats, obesity lowered the resistance of the aponeurotic scars but not the skin scars. It did not interfere with the delayed inflammatory response and the collagen density.
C1 [Zammar, Guilherme Roberto; Fernandes, Rodrigo dos Santos; Biondo-Simoes, Rachel; Ritzdorf de Mello, Flavia Stica] PUCPR, Sci Initiat Program, Curitiba, Parana, Brazil.
   [Pessole Biondo-Simoes, Maria de Lourdes] Univ Fed Parana, Dept Surg, BR-80060000 Curitiba, Parana, Brazil.
   [de Noronha, Lucia] PUCPR, Div Pathol, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] UFPR, Div Pathol, Curitiba, Parana, Brazil.
RP Biondo-Simoes, MDP (corresponding author), Rua Ari Jose Valle 1987, BR-82030000 Curitiba, Parana, Brazil.
EM biondo@avalon.sul.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5
   Almahmeed T, 2007, ARCH SURG-CHICAGO, V142, P954, DOI 10.1001/archsurg.142.10.954
   American Veterinary Medical Association, 2007, GUID EUTH FORM REP A
   Bellon Juan M, 2008, Cir Esp, V83, P3
   Bult MJF, 2008, EUR J ENDOCRINOL, V158, P135, DOI 10.1530/EJE-07-0145
   Byrne TK, 2001, SURG CLIN N AM, V81, P1181, DOI 10.1016/S0039-6109(05)70190-0
   Chang DW, 2000, PLAST RECONSTR SURG, V105, P1640, DOI 10.1097/00006534-200004050-00007
   Chen YY, 2001, AM J PHYSIOL-ENDOC M, V280, pE315
   CLARK RAF, 1989, J CLIN INVEST, V84, P1036, DOI 10.1172/JCI114227
   Cooney R, 1997, J TRAUMA, V42, P415, DOI 10.1097/00005373-199703000-00008
   Gardlund B, 2002, EUR J CARDIO-THORAC, V21, P825, DOI 10.1016/S1010-7940(02)00084-2
   GARNER WL, 1993, J INVEST DERMATOL, V101, P875, DOI 10.1111/1523-1747.ep12371710
   Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904
   Johnson DW, 2002, TRANSPLANTATION, V74, P675, DOI 10.1097/00007890-200209150-00015
   LEVIN BE, 1989, AM J PHYSIOL, V256, pR766
   Lima-Leopoldo AP, 2008, BRAZ J MED BIOL RES, V41, P615, DOI 10.1590/S0100-879X2008000700011
   Livingston EH, 2005, SURG CLIN N AM, V85, P853, DOI 10.1016/j.suc.2005.04.007
   LORDEN JF, 1986, NEUROBEH TOXICOL TER, V8, P509
   MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894
   Naderali EK, 2004, ATHEROSCLEROSIS, V172, P63, DOI 10.1016/j.atherosclerosis.2003.09.021
   Nascimento AP, 2006, BRIT J NUTR, V96, P1069, DOI 10.1017/BJN20061955
   Nascimento AF, 2008, ARQ BRAS ENDOCRINOL, V52, P968, DOI 10.1590/S0004-27302008000600007
   Nguyen NT, 2000, J AM COLL SURGEONS, V191, P149, DOI 10.1016/S1072-7515(00)00276-3
   Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002
   Puzziferri N, 2006, ANN SURG, V243, P181, DOI 10.1097/01.sla.0000197381.01214.76
   Sauerland S, 2004, Hernia, V8, P42, DOI 10.1007/s10029-003-0161-x
   SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z
   Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007
   Sugerman HJ, 1996, AM J SURG, V171, P80, DOI 10.1016/S0002-9610(99)80078-6
   *WHO, 2006, 311 WHO
   Wilson Joyce A, 2004, Adv Skin Wound Care, V17, P426, DOI 10.1097/00129334-200410000-00013
   WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920
   Yahchouchy-Chouillard E, 2003, DIGEST SURG, V20, P3, DOI 10.1159/000068850
NR 33
TC 5
Z9 5
U1 0
U2 0
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD JAN-FEB
PY 2010
VL 25
IS 1
BP 86
EP 92
DI 10.1590/S0102-86502010000100018
PG 7
WC Surgery
SC Surgery
GA 567DO
UT WOS:000275423000017
PM 20126894
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Mazzarotto, GCA
   Raboni, SM
   Stella, V
   Carstensen, S
   de Noronha, L
   Levis, S
   Zanluca, C
   Zanetti, CR
   Bordignon, J
   dos Santos, CND
AF Mazzarotto, GiovannyA. C. A.
   Raboni, Sonia M.
   Stella, Vanessa
   Carstensen, Suzana
   de Noronha, Lucia
   Levis, Silvana
   Zanluca, Camila
   Zanetti, Carlos R.
   Bordignon, Juliano
   Duarte dos Santos, Claudia N.
TI Production and characterization of monoclonal antibodies against the
   recombinant nucleoprotein of Araucaria hantavirus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Hantavirus; Monoclonal Antibody; Araucaria strain
ID VIRUS NUCLEOCAPSID PROTEIN; MAJOR ANTIGENIC DOMAIN; HEMORRHAGIC-FEVER;
   RENAL SYNDROME; HANTAAN VIRUS; EXPRESSION; PUUMALA; BRAZIL; INFECTION;
   DIAGNOSIS
AB Hantaviruses are rodent-borne RNA viruses that cause hemorrhagic fever with renal syndrome (HFRS) or hantavirus pulmonary syndrome (HPS). From the first detection of infection in Brazil in 1993 until 2009, 1161 cases of HIPS have been reported, with mortality rates of around similar to 40%. Currently, due to the absence of a vaccine or specific antiviral therapy, the only way to reduce mortality by hantavirus infection is a fast and precise diagnosis that allows for supportive clinical health care. To improve the detection of hantavirus infection, we developed monoclonal antibodies (Mabs) against the nucleoprotein (rN Delta(85)) of the Araucaria hantavirus strain (ARAUV). The specificity of generated Mabs for rN Delta(85) was demonstrated by western blot, indirect immunofluorescence and immunohistochemistry. These are the first monoclonal antibodies to be produced and characterized against the South American hantavirus strain, and may be of special interest in the development of diagnostic assays and epidemiological studies. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Mazzarotto, GiovannyA. C. A.; Raboni, Sonia M.; Stella, Vanessa; Carstensen, Suzana; Bordignon, Juliano; Duarte dos Santos, Claudia N.] ICC Fiocruz, Inst Carlos Chagas, Virol Lab, BR-81350010 Curitiba, Parana, Brazil.
   [Raboni, Sonia M.] UFPR, Dept Saude Comunitaria, BR-80060900 Curitiba, Parana, Brazil.
   [de Noronha, Lucia] PUC PR, Lab Patol Expt, BR-80215901 Curitiba, Parana, Brazil.
   [Levis, Silvana] Inst Nacl Enfermedades Virales Humanas Dr Julio I, RA-2700 Pergamino, Argentina.
   [Zanluca, Camila; Zanetti, Carlos R.] Univ Fed Santa Catarina, Lab Imunol Aplicada, BR-88040900 Florianopolis, SC, Brazil.
RP Bordignon, J (corresponding author), ICC Fiocruz PR, Inst Carlos Chagas, Rua Prof Algacyr Munhoz Mader 3775,CIC, BR-81350010 Curitiba, Parana, Brazil.
EM jbordig@tecpar.br; clsantos@tecpar.br
RI Duarte dos Santos, Claudia/E-1857-2018; noronha, lucia/F-6339-2015;
   Raboni, Sonia Mara/F-7537-2012; Santos, Claudia Duarte dos/P-4868-2019;
   Bordignon, Juliano/Z-6268-2019; Publica, Inct Saude/J-9544-2013; P,
   CM/B-1358-2013; Raboni, Sonia M/AAF-7142-2020
OI Duarte dos Santos, Claudia/0000-0001-8707-6638; noronha,
   lucia/0000-0003-0310-7164; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Bordignon, Juliano/0000-0002-1965-6152; Raboni,
   Sonia M/0000-0001-7907-7585; Zanluca, Camila/0000-0001-7350-9105
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CNPq/PROSULNational Council for Scientific and Technological
   Development (CNPq); CYTED/RIVE; Fiocruz; Fundacao AraucariaFundacao
   Araucaria
FX The authors thank Dr. Alexandre Dias Tavares Costa for critical reading
   of the manuscript. This work was supported by grants from CNPq,
   CNPq/PROSUL, CYTED/RIVE, Fiocruz and Fundacao Araucaria. GACAM, JB, CRZ
   and CNDS are fellowships from CNPq.
CR BEATY BJ, 1991, CURR TOP MICROBIOL, V169, P27
   *BRAZ MIN HLTH, 2009, CAS OB HANT UN FED P
   Chen ZT, 2008, HYBRIDOMA, V27, P467, DOI 10.1089/hyb.2008.0048
   CLARK MR, 1981, SOMAT CELL GENET, V7, P657, DOI 10.1007/BF01538755
   Elgh F, 1996, J VIROL METHODS, V59, P161, DOI 10.1016/0166-0934(96)02042-3
   FRANKO MC, 1983, P NATL ACAD SCI-BIOL, V80, P4149, DOI 10.1073/pnas.80.13.4149
   Gott P, 1997, VIRUS GENES, V14, P31, DOI 10.1023/A:1007983306341
   HA IS, 1995, CLIN DIAGN LAB IMMUN, V2, P439, DOI 10.1128/CDLI.2.4.439-442.1995
   Hager-Braun C, 2005, EXPERT REV PROTEOMIC, V2, P745, DOI 10.1586/14789450.2.5.745
   LUNDKVIST A, 1993, ARCH VIROL, V132, P255, DOI 10.1007/BF01309537
   Monroe MC, 1999, EMERG INFECT DIS, V5, P75, DOI 10.3201/eid0501.990109
   NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615
   Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677
   Raboni SM, 2005, J MED VIROL, V76, P553, DOI 10.1002/jmv.20398
   Raboni SM, 2005, AM J TROP MED HYG, V72, P800, DOI 10.4269/ajtmh.2005.72.800
   Raboni SM, 2007, DIAGN MICR INFEC DIS, V58, P89, DOI 10.1016/j.diagmicrobio.2006.11.012
   Raboni SM, 2009, J CLIN VIROL, V45, P153, DOI 10.1016/j.jcv.2009.03.015
   RUO SL, 1991, ARCH VIROL, V119, P1, DOI 10.1007/BF01314318
   Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202
   Schmidt J, 2005, VIRUS GENES, V30, P37, DOI 10.1007/s11262-004-4580-2
   Silva M. V. da, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P231, DOI 10.1590/S0036-46651997000400010
   Wang CY, 2007, HYBRIDOMA, V26, P42, DOI 10.1089/hyb.2006.035
   ZAKI SR, 1995, AM J PATHOL, V146, P552
   ZOLLER LG, 1993, J CLIN MICROBIOL, V31, P1194
NR 24
TC 19
Z9 19
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD DEC
PY 2009
VL 162
IS 1-2
BP 96
EP 100
DI 10.1016/j.jviromet.2009.07.022
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 517BA
UT WOS:000271586500015
PM 19654026
DA 2020-12-08
ER

PT J
AU Raboni, SM
   de Borba, L
   Hoffmann, FG
   de Noronha, L
   Azevedo, MLV
   Carstensen, S
   Mazzarotto, GACA
   Bordignon, J
   dos Santos, CND
AF Raboni, Sonia Mara
   de Borba, Luana
   Hoffmann, Federico G.
   de Noronha, Lucia
   Viola Azevedo, Marin Luize
   Carstensen, Suzana
   Mazzarotto, Giovanny A. C. A.
   Bordignon, Juliano
   Duarte dos Santos, Claudia Nunes
TI Evidence of circulation of Laguna Negra-like hantavirus in the Central
   West of Brazil: Case report
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Hantavirus pulmonary syndrome; Genetic characterization; Phylogeny;
   Laguna Negra-like virus
ID PULMONARY SYNDROME; SOUTH-AMERICA; HPS; PHYLOGENIES; RESERVOIRS;
   INFECTION; PROTEIN; BOLIVIA; VIRUS
AB Background: Hantavirus pulmonary syndrome has been reported with increasing frequency in some Brazilian regions, but information about viral genetic identification is still limited. Recently, the state of Mato Grosso, in the Legal Amazon of Brazil, experienced a growing number of hantavirus pulmonary syndrome (HPS) cases but the genetic characterization of the causative hantavirus is still missing.
   Objectives: Our goal was to identify the hantavirus strain involved in a fatal HPS case in the Central region of Brazil.
   Study design: Nested RT-PCR was conducted on blood clot samples from an HIPS patient from Mato Grosso. PCR-positive samples were sequenced, and the resulting sequences were compared with reference samples. Viral antigens were detected by immunohistological analyses in lung and liver tissues.
   Results: Analyses of the viral RNA isolated from the patient identified a Laguna Negra (LN)-like virus as the causative agent and histological analysis of lung sections were compatible with the genetic characterization.
   Conclusions: This is the first report of circulation and human infection by a Laguna Negra-like hantavirus in Brazil. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Duarte dos Santos, Claudia Nunes] CIC, ICC Fiocruz PR, Inst Carlos Chagas, BR-81350010 Curitiba, Parana, Brazil.
   [Raboni, Sonia Mara] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
   [de Noronha, Lucia; Viola Azevedo, Marin Luize] PUCPR, Ctr Ciencias Biol & Saude, Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), CIC, ICC Fiocruz PR, Inst Carlos Chagas, Rua Prof Algamunhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
EM clsantos@tecpar.br
RI Duarte dos Santos, Claudia/E-1857-2018; Publica, Inct Saude/J-9544-2013;
   Santos, Claudia Duarte dos/P-4868-2019; noronha, lucia/F-6339-2015; P,
   CM/B-1358-2013; Raboni, Sonia M/AAF-7142-2020; Bordignon,
   Juliano/Z-6268-2019; Raboni, Sonia Mara/F-7537-2012; Hoffmann,
   Federico/B-7134-2009
OI Duarte dos Santos, Claudia/0000-0001-8707-6638; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; noronha, lucia/0000-0003-0310-7164; Raboni,
   Sonia M/0000-0001-7907-7585; Bordignon, Juliano/0000-0002-1965-6152;
   Hoffmann, Federico/0000-0001-5056-4929
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CNPq/ProsulNational Council for Scientific and Technological
   Development (CNPq); Fiocruz; Fundacao AraucariaFundacao Araucaria;
   CYTED/RIVE; Fundo Parana
FX We are indebted with Giselia Rubio from Departamento de Vigilancia,
   SESA-PR and Irene Skraba from LACEN-PR. The authors thank CNPq,
   CNPq/Prosul, Fiocruz, Fundacao Araucaria, CYTED/RIVE and Fundo Parana
   for financial support. LB, FGH, SC, GACA, JB and CNDS are CNPq
   fellowship recipients.
CR BUTLER JC, 1994, CLIN INFECT DIS, V19, P387, DOI 10.1093/clinids/19.3.387
   Carroll DS, 2005, AM J TROP MED HYG, V72, P42, DOI 10.4269/ajtmh.2005.72.42
   Delfraro A, 2008, EMERG INFECT DIS, V14, P1447, DOI 10.3201/eid1409.080455
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Figueiredo LTM, 2008, BRAZ J MED BIOL RES, V41, P596, DOI 10.1590/S0100-879X2008000700008
   Figueiredo LTM, 2003, EMERG INFECT DIS, V9, P891
   Johnson AM, 1999, J MED VIROL, V59, P527, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;527::AID-JMV17&gt;3.0.CO;2-Y
   Johnson AM, 1997, VIROLOGY, V238, P115, DOI 10.1006/viro.1997.8840
   Padula P, 2002, EMERG INFECT DIS, V8, P437, DOI 10.3201/eid0804.010300
   Padula PJ, 2000, J CLIN MICROBIOL, V38, P3029, DOI 10.1128/JCM.38.8.3029-3035.2000
   Raboni SM, 2005, J MED VIROL, V76, P553, DOI 10.1002/jmv.20398
   Raboni SM, 2007, DIAGN MICR INFEC DIS, V58, P89, DOI 10.1016/j.diagmicrobio.2006.11.012
   ROSA ES, 2008, 2 WORKSH NAC PESQ AP
   Rosa EST, 2005, VECTOR-BORNE ZOONOT, V5, P11, DOI 10.1089/vbz.2005.5.11
   Suzuki A, 2004, EMERG INFECT DIS, V10, P2127, DOI 10.3201/eid1012.040295
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   ZAKI SR, 1995, AM J PATHOL, V146, P552
NR 20
TC 22
Z9 22
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUN
PY 2009
VL 45
IS 2
BP 153
EP 156
DI 10.1016/j.jcv.2009.03.015
PG 4
WC Virology
SC Virology
GA 462WM
UT WOS:000267388700016
PM 19395308
DA 2020-12-08
ER

PT J
AU Sapelli, S
   Ribas, M
   Martins, WD
   de Noronha, L
   Gomes, AP
AF Sapelli, Silvana
   Ribas, Marina
   Martins, Wilson D.
   de Noronha, Lucia
   Gomes, Ana Paula
TI MYOPERICYTOMA OF THE LIP: REPORT OF CASE
SO HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND
   NECK
LA English
DT Article
DE myopericytoma; lip neoplasm; soft tissue; oral; perivascular
ID SOLITARY FIBROUS TUMORS; ORAL-MUCOSA; HEMANGIOPERICYTOMA;
   MYOFIBROMATOSIS; SPECTRUM; DIFFERENTIATION; MUSCLE
AB Background. Myopericytoma is a recently delineated entity showing a hemangiopericytoma-like vascular pattern. This rare mesenchymal neoplasm arises within the subcutaneous tissue of the extremities. Only 3 cases of myopericytoma involving the soft tissues of the mouth have been reported, and this case is the first, to the best of our knowledge, that involves the lips.
   Methods. A 28-year-old black man had a slowly growing. painless, firm, ulcerated lower lip mass. Histopathologic examination and immunohistochemical analysis were performed, and the differential diagnosis included carcinoma and other well-circumscribed, vascular, slow-growing lesions of the mouth-like myofibroma, glomus tumor, and solitary fibrous tumor.
   Results. The results of the histology combined with the immunohistochemical analysis led to a diagnosis of myopericytoma.
   Conclusions. This case may aid others in recognizing this very rare entity As the myopericytoma shares morphologic features with other perivascular myoid neoplasms, it should be included in the differential diagnosis of well-circumscribed, vascular, slow-growing lesions of the mouth. (C) 2008 Wiley Periodicals, Inc. Head Neck 31: 561-564, 2009
C1 [Ribas, Marina; Martins, Wilson D.] Pontificial Catholic Univ Parana, Fac Dent, Dept Oral & Maxillofacial Surg, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificial Catholic Univ Parana, Fac Med, Dept Pathol, Curitiba, Parana, Brazil.
   [Gomes, Ana Paula] Univ Fed Pelotas, Fac Dent, Dept Hlth Sci, Depto Ciencias Saude, Pelotas, RS, Brazil.
RP Martins, WD (corresponding author), Pontificial Catholic Univ Parana, Fac Dent, Dept Oral & Maxillofacial Surg, Curitiba, Parana, Brazil.
EM w.denis@puepr.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Datta V, 2007, HEAD NECK-J SCI SPEC, V29, P605, DOI 10.1002/hed.20548
   DICTOR M, 1992, AM J SURG PATHOL, V16, P1239, DOI 10.1097/00000478-199212000-00011
   Dray MS, 2006, J CLIN PATHOL, V59, P67, DOI 10.1136/jcp.2005.028704
   FLETCHER CDM, 2002, WHO CLASSIFICATION T, P135
   Gengler C, 2006, HISTOPATHOLOGY, V48, P63, DOI 10.1111/j.1365-2559.2005.02290.x
   Granter SR, 1998, AM J SURG PATHOL, V22, P513, DOI 10.1097/00000478-199805000-00001
   Hasegawa T, 1999, HUM PATHOL, V30, P1464, DOI 10.1016/S0046-8177(99)90169-7
   Ide F, 2007, VIRCHOWS ARCH, V450, P475, DOI 10.1007/s00428-007-0368-9
   McMenamin ME, 2002, HISTOPATHOLOGY, V41, P450, DOI 10.1046/j.1365-2559.2002.01537.x
   MCMENAMIN ME, 2002, WHO CLASSIFICATION T, P112
   Mentzel T, 2006, AM J SURG PATHOL, V30, P104, DOI 10.1097/01.pas.0000178091.54147.b1
   Requena L, 1996, J CUTAN PATHOL, V23, P445, DOI 10.1111/j.1600-0560.1996.tb01434.x
   Stout AP, 1942, ANN SURG, V116, P26, DOI 10.1097/00000658-194207000-00004
   TILTON RG, 1979, MICROVASC RES, V18, P325, DOI 10.1016/0026-2862(79)90041-4
   Vallat-Decouvelaere AV, 1998, AM J SURG PATHOL, V22, P1501, DOI 10.1097/00000478-199812000-00007
   VARIEND S, 1995, HISTOPATHOLOGY, V26, P57, DOI 10.1111/j.1365-2559.1995.tb00621.x
   Veltrini VC, 2003, ORAL ONCOL, V39, P420, DOI 10.1016/S1368-8375(02)00148-3
   ZIMMERMANN KW, 1923, Z ANAT ENTWICKLUNGS, V68, P29, DOI DOI 10.1007/BF02593544
NR 18
TC 12
Z9 14
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1043-3074
EI 1097-0347
J9 HEAD NECK-J SCI SPEC
JI Head Neck-J. Sci. Spec. Head Neck
PD APR
PY 2009
VL 31
IS 4
BP 561
EP 564
DI 10.1002/hed.20933
PG 4
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 425PS
UT WOS:000264650200016
PM 18972424
DA 2020-12-08
ER

PT J
AU Franca Neto, OR
   Alessi, A
   Prim, CR
   Da Silva, RFKC
   De Noronha, L
   Caporal, A
   Baroncini, LAV
   Precoma, DB
AF Franca Neto, O. R.
   Alessi, A.
   Prim, C. R.
   Da Silva, R. F. K. Caetano
   De Noronha, L.
   Caporal, A.
   Baroncini, L. A. V.
   Precoma, D. B.
TI Rosiglitazone effects on counterlateral iliac artery after vascular
   injury in hypercholesterolemic rabbits
SO CIRCULATION
LA English
DT Meeting Abstract
CT World Congress of Cardiology
CY MAY 18-21, 2008
CL Buenos Aires, ARGENTINA
SP World Heart Federat, Argentine Soc Cardiol, Argentine Federat Cardiol
C1 [Franca Neto, O. R.; Alessi, A.; Prim, C. R.; De Noronha, L.; Caporal, A.; Baroncini, L. A. V.; Precoma, D. B.] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 16
PY 2008
VL 118
IS 12
BP E440
EP E440
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 348QK
UT WOS:000259224801350
DA 2020-12-08
ER

PT J
AU Bordignon, J
   Probst, CM
   Mosimann, ALP
   Pavoni, DP
   Stella, V
   Buck, GA
   Satproedprai, N
   Fawcett, P
   Zanata, SM
   de Noronha, L
   Krieger, MA
   dos Santos, CND
AF Bordignon, Juliano
   Probst, Christian M.
   Mosimann, Ana Luiza P.
   Pavoni, Daniela P.
   Stella, Vanessa
   Buck, Gregory A.
   Satproedprai, Nusara
   Fawcett, Paul
   Zanata, Silvio M.
   de Noronha, Lucia
   Krieger, Marco A.
   Duarte dos Santos, Claudia N.
TI Expression profile of interferon stimulated genes in central nervous
   system of mice infected with dengue virus Type-1
SO VIROLOGY
LA English
DT Article
DE dengue virus; interferon; microarray; mice; central nervous system
ID WEST-NILE-VIRUS; I INTERFERON; PERIVASCULAR CELLS; IMMUNE-RESPONSES;
   VASCULAR LEAKAGE; MICROGLIAL CELLS; PROTEIN; INNATE; IDENTIFICATION;
   COMPLEMENT
AB Dengue virus (DENV) infection can cause a self-limiting disease (dengue fever) or a more severe clinical presentation known as dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS). Furthermore, data from recent dengue epidemics in Brazil indicate that the neurological manifestations are becoming more prevalent. However, the neuropathogenesis of dengue are not well understood. The balance between viral replication efficiency and innate immunity - in opposition during the early stages of infection - determines the clinical outcome of DENV infection. In this study, we investigated the effects of DENV infection on the transcription profile of the central nervous system (CNS) of mice. We observed in infected mice the upregulation of 151 genes possibly involved in neuropathogenesis of dengue. Conversely, they may have a protective effect. Ingenuity Systems software analysis demonstrated, that the main pathways modulated by DENV infection in the mouse CNS are involved in interferon signaling and antigen presentation. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Bordignon, Juliano; Probst, Christian M.; Mosimann, Ana Luiza P.; Pavoni, Daniela P.; Stella, Vanessa; Krieger, Marco A.; Duarte dos Santos, Claudia N.] Inst Mol Biol, BR-81350010 Curitiba, Parana, Brazil.
   [Bordignon, Juliano; Probst, Christian M.; Mosimann, Ana Luiza P.; Pavoni, Daniela P.; Stella, Vanessa; Krieger, Marco A.; Duarte dos Santos, Claudia N.] Fiocruz MS, Inst Carlos Chagas ICC, BR-81350010 Curitiba, Parana, Brazil.
   [Buck, Gregory A.; Satproedprai, Nusara] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA.
   [Fawcett, Paul] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA.
   [Zanata, Silvio M.] Univ Fed Parana, Dept Patol Bas, BR-81531990 Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pontificia Univ Catolica Parana, Lab Patol Expt, BR-80215901 Curitiba, Parana, Brazil.
RP dos Santos, CND (corresponding author), Inst Mol Biol, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
EM clsantos@tecpar.br
RI Probst, Christian/B-8678-2009; Krieger, Marco/AAE-8611-2020; P,
   CM/B-1358-2013; noronha, lucia/F-6339-2015; Pavoni, Daniela
   P/L-3302-2014; Publica, Inct Saude/J-9544-2013; Duarte dos Santos,
   Claudia/B-4238-2009; Bordignon, Juliano/Z-6268-2019; Mosimann, Ana Luiza
   Pamplona/AAB-4714-2019; Santos, Claudia Duarte dos/P-4868-2019; Duarte
   dos Santos, Claudia/E-1857-2018
OI Probst, Christian/0000-0001-9993-6375; noronha,
   lucia/0000-0003-0310-7164; Pavoni, Daniela P/0000-0001-6776-4345;
   Bordignon, Juliano/0000-0002-1965-6152; Mosimann, Ana Luiza
   Pamplona/0000-0002-3504-5562; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Duarte dos Santos, Claudia/0000-0001-8707-6638;
   Zanata, Silvio/0000-0003-2818-6954
CR Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   BEARE R, 2004, SPOT CDNA MICROARRAY
   Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004
   Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N
   BOKISCH VA, 1973, NEW ENGL J MED, V289, P996, DOI 10.1056/NEJM197311082891902
   Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958
   Bourne N, 2007, J VIROL, V81, P9100, DOI 10.1128/JVI.00316-07
   Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113
   Cheroni C, 2005, NEUROBIOL DIS, V18, P509, DOI 10.1016/j.nbd.2004.12.007
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007
   Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103
   DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469
   Despres P, 1998, J VIROL, V72, P823
   Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653
   Fearon DT, 1999, QJM-MON J ASSOC PHYS, V92, P235, DOI 10.1093/qjmed/92.5.235
   GEHRMANN J, 1993, GLIA, V7, P50, DOI 10.1002/glia.440070110
   GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H
   GEHRMANN J, 1991, RESTOR NEUROL NEUROS, V2, P181, DOI 10.3233/RNN-1991-245605
   Gogate N, 1996, J NEUROPATH EXP NEUR, V55, P435, DOI 10.1097/00005072-199604000-00006
   Gould EA, 1985, VIROLOGY PRACTICAL A, P43
   GRAEBER MB, 1992, J NEUROPATH EXP NEUR, V51, P303, DOI 10.1097/00005072-199205000-00009
   GRAEBER MB, 1989, J NEUROSCI RES, V22, P103, DOI 10.1002/jnr.490220114
   Groettrup M, 1996, EUR J IMMUNOL, V26, P863, DOI 10.1002/eji.1830260421
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004
   HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002
   Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Johnston C, 2001, J VIROL, V75, P10431, DOI 10.1128/JVI.75.21.10431-10445.2001
   JOLY E, 1992, NEURON, V8, P1185, DOI 10.1016/0896-6273(92)90138-4
   Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200
   Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004
   Knapp S, 2003, GENES IMMUN, V4, P411, DOI 10.1038/sj.gene.6363984
   Kurane I, 1990, Southeast Asian J Trop Med Public Health, V21, P658
   LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4
   Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005
   Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814
   Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200
   Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149
   Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042
   Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388
   MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992
   Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004
   Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007
   Olson JK, 2001, J VIROL, V75, P9780, DOI 10.1128/JVI.75.20.9780-9789.2001
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Pasieka TJ, 2006, J VIROL, V80, P7600, DOI 10.1128/JVI.00333-06
   Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Redwine JM, 2001, AM J PATHOL, V159, P1219, DOI 10.1016/S0002-9440(10)62507-2
   Rempel LA, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-13
   Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Rothman AL, 2003, ADV VIRUS RES, V60, P397, DOI 10.1016/S0065-3527(03)60010-2
   Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07
   Sarkar SN, 2005, MODULATION OF HOST GENE EXPRESSION AND INNATE IMMUNITY BY VIRUSES, P35, DOI 10.1007/1-4020-3242-0_3
   Scherbik SV, 2007, VIROLOGY, V368, P232, DOI 10.1016/j.virol.2007.08.017
   Shaw ML, 2005, MODULATION OF HOST GENE EXPRESSION AND INNATE IMMUNITY BY VIRUSES, P1, DOI 10.1007/1-4020-3242-0_1
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Smith Kendall A, 2004, Med Immunol, V3, P3, DOI 10.1186/1476-9433-3-3
   STREIT WJ, 1989, EXP NEUROL, V105, P115, DOI 10.1016/0014-4886(89)90111-8
   *SVS MIN SAUD, 2007, BAL DENG
   Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Van den Eynde BJ, 2001, CURR OPIN IMMUNOL, V13, P147, DOI 10.1016/S0952-7915(00)00197-7
   VASS K, 1990, AM J PATHOL, V137, P789
   Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013
   Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06
   Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003
   *WHO, 2002, 117 WHO
   Yang JJ, 2006, J NEUROIMMUNOL, V181, P34, DOI 10.1016/j.jneuroim.2006.07.018
   Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362
NR 76
TC 22
Z9 24
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD AUG 1
PY 2008
VL 377
IS 2
BP 319
EP 329
DI 10.1016/j.virol.2008.04.033
PG 11
WC Virology
SC Virology
GA 320HE
UT WOS:000257223500012
PM 18570970
DA 2020-12-08
ER

PT J
AU Vieira-Karuta, SC
   Silva, ICB
   Almeida, NAP
   de Noronha, L
   Santos, MLSF
   Liberalesso, PBN
AF Vieira-Karuta, Simone C.
   Silva, Izabella C. Bertoldo
   Almeida, Nadia Aparecida P.
   de Noronha, Lucia
   Santos, Mara Lucia S. F.
   Liberalesso, Paulo B. N.
TI Griscelli syndrome and electroencephalography pattern
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
ID INVOLVEMENT; IMMUNODEFICIENCY; TRANSPLANTATION; DISEASE
C1 [Vieira-Karuta, Simone C.; Silva, Izabella C. Bertoldo; Santos, Mara Lucia S. F.; Liberalesso, Paulo B. N.] Pequeno Principe Hosp, Pediat Neurol Dept, Curitiba, Parana, Brazil.
   [Almeida, Nadia Aparecida P.] Pequeno Principe Hosp, Pediat Dermatol Dept, Curitiba, Parana, Brazil.
   [de Noronha, Lucia] Pequeno Principe Hosp, Dept Pathol, Curitiba, Parana, Brazil.
RP Liberalesso, PBN (corresponding author), Rua Benjamin Constant 90-73, BR-80060050 Curitiba, Parana, Brazil.
EM paulo.neuroped@uol.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Alva-Moncayo E, 2003, REV NEUROLOGIA, V36, P347, DOI 10.33588/rn.3604.2002451
   Arico M, 2002, BONE MARROW TRANSPL, V29, P995, DOI 10.1038/sj.bmt.1703567
   Ashrafi MR, 2006, EUR J PAEDIATR NEURO, V10, P207, DOI 10.1016/j.ejpn.2006.07.005
   GRISCELLI C, 1978, INT J DERMATOL, V17, P788, DOI 10.1111/j.1365-4362.1978.tb05980.x
   HARALDSSON A, 1991, EUR J PEDIATR, V150, P419, DOI 10.1007/BF02093723
   KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7
   Kumar Sanjay, 2006, Indian Journal of Agronomy, V51, P271
   Kurugol Z, 2001, PEDIATR INT, V43, P298, DOI 10.1046/j.1442-200x.2001.01383.x
   Malhotra AK, 2006, J AM ACAD DERMATOL, V55, P337, DOI 10.1016/j.jaad.2005.11.1056
   MANCIN AJ, 2009, J AM ACAD DERMATOL, V38, P295
   Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081
   Rath Sanjeev, 2004, Indian Journal of Pediatrics, V71, P173, DOI 10.1007/BF02723104
   Tezcan I, 1999, BONE MARROW TRANSPL, V24, P931, DOI 10.1038/sj.bmt.1702007
NR 13
TC 1
Z9 1
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2008
VL 66
IS 2B
BP 420
EP 422
DI 10.1590/S0004-282X2008000300030
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 327WV
UT WOS:000257760100030
PM 18641887
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Portes, KF
   Ikegami, CM
   Getz, J
   Martins, AP
   De Noronha, L
   Zischler, LF
   Klassen, G
   Camargo, AA
   Zanata, SM
   Bevilacqua, E
   Nakao, LS
AF Portes, Kelly F.
   Ikegami, Cecilia M.
   Getz, Joselito
   Martins, Ana P.
   De Noronha, Lucia
   Zischler, Luciana F.
   Klassen, Giseli
   Camargo, Anamaria A.
   Zanata, Silvio M.
   Bevilacqua, Estela
   Nakao, Lia S.
TI Tissue distribution of quiescin Q6/sulfhydryl oxidase (QSOX) in
   developing mouse
SO JOURNAL OF MOLECULAR HISTOLOGY
LA English
DT Article
DE redox state; mouse development; quiescin sulfhydryl oxidase; mesoderm
ID DISULFIDE BOND FORMATION; WHITE SULFHYDRYL OXIDASE;
   CENTRAL-NERVOUS-SYSTEM; MYELIN PROTEIN ZERO; Q6 GENE FAMILY; EGG-WHITE;
   RAT-BRAIN; INTEGRIN ACTIVATION; EXPRESSION; REDOX
AB Quiescin Q6/sulfhydryl oxidases (QSOX) are revisited thiol oxidases considered to be involved in the oxidative protein folding, cell cycle control and extracellular matrix remodeling. They contain thioredoxin domains and introduce disulfide bonds into proteins and peptides, with the concomitant hydrogen peroxide formation, likely altering the redox environment. Since it is known that several developmental processes are regulated by the redox state, here we assessed if QSOX could have a role during mouse fetal development. For this purpose, an anti-recombinant mouse QSOX antibody was produced and characterized. In E-13.5, E-16.5 fetal tissues, QSOX immunostaining was confined to mesoderm- and ectoderm-derived tissues, while in P1 neonatal tissues it was slightly extended to some endoderm-derived tissues. QSOX expression, particularly by epithelial tissues, seemed to be developmentally-regulated, increasing with tissue maturation. QSOX was observed in loose connective tissues in all stages analyzed, intra and possibly extracellularly, in agreement with its putative role in oxidative folding and extracellular matrix remodeling. In conclusion, QSOX is expressed in several tissues during mouse development, but preferentially in those derived from mesoderm and ectoderm, suggesting it could be of relevance during developmental processes.
C1 [Portes, Kelly F.; Getz, Joselito; Martins, Ana P.; De Noronha, Lucia; Zischler, Luciana F.; Nakao, Lia S.] Pontificia Univ Catolica Parana, Ctr Adv Mol Invest, BR-80215901 Curitiba, Parana, Brazil.
   [Ikegami, Cecilia M.; Klassen, Giseli; Zanata, Silvio M.] Univ Fed Parana, Dept Basic Pathol, BR-80060000 Curitiba, Parana, Brazil.
   [Camargo, Anamaria A.] Ludwig Inst Canc Res, Sao Paulo, Brazil.
   [Bevilacqua, Estela] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
RP Nakao, LS (corresponding author), Pontificia Univ Catolica Parana, Ctr Adv Mol Invest, Rua Imaculada Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
EM lia.nakao@pucpr.br
RI Nakao, Lia S/M-1507-2018; Bevilacqua, Estela/H-3354-2011; Klassen,
   Giseli/AAF-3962-2019; Klassen, Giseli/F-8753-2012; noronha,
   lucia/F-6339-2015; Camargo, Anamaria A/E-9388-2012
OI Nakao, Lia S/0000-0001-9647-6350; Bevilacqua,
   Estela/0000-0003-4178-4625; Klassen, Giseli/0000-0001-5336-6178;
   Klassen, Giseli/0000-0001-5336-6178; noronha, lucia/0000-0003-0310-7164;
   Camargo, Anamaria A/0000-0002-6076-9597; Zanata,
   Silvio/0000-0003-2818-6954; Zischler, Luciana/0000-0001-8169-7601
CR ALLEN RG, 1989, FREE RADICAL BIO MED, V6, P631, DOI 10.1016/0891-5849(89)90071-3
   Amiot C, 2004, MOL BRAIN RES, V125, P13, DOI 10.1016/j.molbrainres.2004.02.024
   Benayoun B, 2001, J BIOL CHEM, V276, P13830, DOI 10.1074/jbc.M010933200
   Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510
   CHANG TSK, 1978, BIOL REPROD, V18, P745, DOI 10.1095/biolreprod18.5.745
   Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324
   COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483
   Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605
   Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300
   Das KC, 2004, ANTIOXID REDOX SIGN, V6, P105, DOI 10.1089/152308604771978408
   Dennery PA, 2004, ANTIOXID REDOX SIGN, V6, P147, DOI 10.1089/152308604771978453
   FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808
   Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gullberg D, 1995, INT J DEV BIOL, V39, P845
   Harlow E, 1988, ANTIBODIES LAB MANUA
   Harvey AJ, 2002, REPRODUCTION, V123, P479, DOI 10.1530/rep.0.1230479
   Hellebrekers DMEI, 2007, CANCER RES, V67, P4138, DOI 10.1158/0008-5472.CAN-06-3032
   Hoober KL, 1999, BIOCHEMISTRY-US, V38, P3211, DOI 10.1021/bi9820816
   Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759
   Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147
   Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510
   Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312
   Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200
   Kobayashi M, 2000, ANTIOXID REDOX SIGN, V2, P653, DOI 10.1089/ars.2000.2.4-653
   Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6
   Mairet-Coello G, 2005, J COMP NEUROL, V484, P403, DOI 10.1002/cne.20411
   Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126
   Mairet-Coello G, 2002, NEUROREPORT, V13, P2049, DOI 10.1097/00001756-200211150-00012
   Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033
   Matsuba S, 2002, J DERMATOL SCI, V30, P50, DOI 10.1016/S0923-1811(02)00061-0
   Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208
   Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208
   Musard JF, 2001, BIOCHEM BIOPH RES CO, V287, P83, DOI 10.1006/bbrc.2001.5440
   OSTROWSKI MC, 1979, BIOCHEM BIOPH RES CO, V87, P171, DOI 10.1016/0006-291X(79)91662-0
   Pfend G, 2001, NEUROCHEM RES, V26, P503, DOI 10.1023/A:1010908828134
   Radom J, 2006, BBA-GENE STRUCT EXPR, V1759, P225, DOI 10.1016/j.bbaexp.2006.04.008
   Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797
   Spiryda LB, 1998, J NEUROSCI RES, V54, P137, DOI 10.1002/(SICI)1097-4547(19981015)54:2<137::AID-JNR2>3.0.CO;2-F
   Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5
   Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200
   Tury A, 2006, CELL TISSUE RES, V323, P91, DOI 10.1007/s00441-005-0043-x
   Tury A, 2004, J ENDOCRINOL, V183, P353, DOI 10.1677/joe.1.05842
   Wittke I, 2003, CANCER RES, V63, P7742
   Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i
   Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200
   Zanata SM, 2005, REDOX REP, V10, P319, DOI 10.1179/135100005X83699
   ZHANG KJ, 1994, J NEUROCHEM, V63, P367
NR 50
TC 19
Z9 19
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1567-2379
J9 J MOL HISTOL
JI J. Mol. Histol.
PD APR
PY 2008
VL 39
IS 2
BP 217
EP 225
DI 10.1007/s10735-007-9156-8
PG 9
WC Cell Biology
SC Cell Biology
GA 275ZI
UT WOS:000254110500010
PM 18034316
DA 2020-12-08
ER

PT J
AU Greca, FH
   Goncalves, NMFD
   de Souza, ZA
   de Noronha, L
   da Silva, RFKC
   Rubin, MR
AF Greca, Fernando Hintz
   Ferraz de Mello Goncalves, Neuza Maria
   de Souza Filho, Zacarias Alves
   de Noronha, Lucia
   Kuenzer Caetano da Silva, Ruy Fernando
   Rubin, Michel Risnic
TI The protective effect of methylene blue in lungs, small bowel and kidney
   after intestinal ischemia and reperfusion
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE methylene blue; ischemia-reperfusion injury; xanthine-oxidase
ID RENAL ISCHEMIA/REPERFUSION INJURY; XANTHINE-OXIDASE; MESENTERIC
   ISCHEMIA; FREE-RADICALS; PATHOGENESIS; ATTENUATION; INHIBITOR; SURVIVAL;
   ASSAY
AB Purpose: To study the role of methylene blue as an inhibitor of superoxide production by xanthine oxidase. Methods: Thirty-two Wistar rats were divided into 2 groups of 16 animals: the control group and the experimental group. All were submitted to a laparotomy for the occlusion of the cranial mesenteric artery during 60 minutes. The reperfusion was confirmed by the pulsation of the artery after the release of the temporary ligature and color change of the intestines. In the animals of the control group, 2 ml of saline were injected in the peritoneal cavity and in the animals of the experimental group, 2 ml of methylene blue were injected in the peritoneal cavity. After reperfusion for 4 hours, the animals were then sacrificed. The lungs were excised from all 32 rats. Simultaneously, the small intestine and kidneys were ressected in 20 animals (10 from the control group and 10 from the experimental group). Samples of the organs were taken to evaluate the action of xanthine-oxidase, for histopathology studies and for characterization of the edema. Results: In the animals of the experimental group, the inflammatory lesion as well as the edema in the lung was greater than in the control group. The intestinal and renal lesions were similar in both groups, but the lung damage was superior to that observed in the intestines and kidneys.. Conclusion: Despite similar action of the xanthine oxidase in the control and the experimental group, after intestinal ischemia and reperfusion, the protective effect of methylene blue was observed only in the lungs of the experimental group.
RP Greca, FH (corresponding author), Av Visconde de Guarapuava 5087-1401, BR-80240010 Curitiba, Parana, Brazil.
EM fernando.greca@bbs2.sul.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Arumugam TV, 2002, CLIN EXP PHARMACOL P, V29, P996, DOI 10.1046/j.1440-1681.2002.03766.x
   Atici AE, 2003, HEPATO-GASTROENTEROL, V50, P661
   BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3
   Benitez-Bribiesca L, 2000, ANN NY ACAD SCI, V926, P165
   BIONDOSIMOES MLP, 2001, ACTA CIR BRAS S2, V16, P9
   Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
   Ciz M, 2001, TRANSPLANT P, V33, P2871, DOI 10.1016/S0041-1345(01)02223-0
   Cohen SM, 1997, J TRAUMA, V43, P247, DOI 10.1097/00005373-199708000-00007
   Edwards MS, 2003, ANN VASC SURG, V17, P72, DOI 10.1007/s10016-001-0329-8
   Farmer DG, 2002, TRANSPLANT P, V34, P985, DOI 10.1016/S0041-1345(02)02730-6
   Galili Y, 1998, J TRAUMA, V45, P222, DOI 10.1097/00005373-199808000-00004
   Galili Y, 1997, EUR SURG RES, V29, P390, DOI 10.1159/000129548
   Genesca M, 2002, AM J PATHOL, V161, P1839, DOI 10.1016/S0002-9440(10)64460-4
   Gobe G, 1999, KIDNEY INT, V56, P1299, DOI 10.1046/j.1523-1755.1999.00701.x
   HAIMOVICI H, 1979, J CARDIOVASC SURG, V20, P349
   HASHIMOTO S, 1974, ANAL BIOCHEM, V62, P426, DOI 10.1016/0003-2697(74)90175-4
   Hirata Y, 1996, J PEDIATR SURG, V31, P1199, DOI 10.1016/S0022-3468(96)90231-6
   Hourmant M, 1999, NEPHROLOGIE, V20, P371
   Ishii Y, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34 Suppl, P126
   Kahraman A, 2003, J NEPHROL, V16, P219
   KEANEY JF, 1994, CIRC RES, V74, P1121, DOI 10.1161/01.RES.74.6.1121
   Lai IR, 2003, SHOCK, V19, P480, DOI 10.1097/01.shk.0000054371.57734.b8
   Lien YHH, 2003, LIFE SCI, V74, P543, DOI 10.1016/j.lfs.2003.08.001
   Lock G, 2002, ACTA GASTRO-ENT BELG, V65, P220
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   McQuaid KE, 1997, EXP PHYSIOL, V82, P369, DOI 10.1113/expphysiol.1997.sp004032
   NILSSON UA, 1994, GASTROENTEROLOGY, V106, P629, DOI 10.1016/0016-5085(94)90695-5
   PITT RM, 1991, J PEDIATR SURG, V26, P930, DOI 10.1016/0022-3468(91)90839-L
   SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R
   Sileri P, 2002, TRANSPLANT P, V34, P984, DOI 10.1016/S0041-1345(02)02729-X
   Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003
   STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364
   Yokota N, 2003, AM J NEPHROL, V23, P13, DOI 10.1159/000066301
NR 33
TC 18
Z9 20
U1 0
U2 0
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD MAR-APR
PY 2008
VL 23
IS 2
BP 149
EP 156
DI 10.1590/S0102-86502008000200007
PG 8
WC Surgery
SC Surgery
GA 340RD
UT WOS:000258661800007
PM 18372960
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Schuler, SL
   Gurmini, J
   Cecilio, WAC
   de Azevedo, MLV
   Olandoski, M
   de Noronha, L
AF Schuler, Sandra Lucia
   Gurmini, Jocemara
   Casteleins Cecilio, William Augusto
   Viola de Azevedo, Marina Luise
   Olandoski, Mdrcia
   de Noronha, Lucia
TI Hepatic and thymic alterations in newborn offspring of malnourished rat
   dams
SO JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
LA English
DT Article
DE Wistar rats; malnutrition; liver; thymus; tissue microarray
ID DIETARY RESTRICTION; PROTEIN RESTRICTION; TISSUE MICROARRAY; FOOD
   RESTRICTION; BODY-COMPOSITION; GROWTH; MALNUTRITION; FETAL; LACTATION;
   NUTRITION
AB Background: Protein-energy malnutrition encompasses a group of conditions resulting from a lack of both protein and calories. It affects immune function and the gastrointestinal tract. Animal model studies of the effect of malnutrition during pregnancy and lactation have shown changes in the body weight of dams, with consequences for the pups. Methods: Sixty healthy adult Wistar rats were mated for breeding. Pregnant dams (n = 19) were separated and randomly divided into 2 groups: normally nourished (NG; n = 10) and malnourished (MG; n = 9). The authors measured the average amount of feed eaten by the dams in the NG group in 24 hours and offered half this amount to the MG dams until delivery, after which both groups had an adequate amount of feed. Offspring were killed after birth and after lactation. Morphometric liver parameters were measured, and the tissue microarray method was performed manually to carry out histopathological and immunohistochemical analysis of thymuses from the offspring. Results: Body weight, body length, and intestine length measured after birth were statistically lower (P <.05) in the MG group offspring than in the NG group offspring but recovered after lactation. Histological comparison of pups livers revealed minimal differences. However, morphometric evaluation showed significant differences. Slides exposed to anti-vimentin and anti-CD45 RO stained positively in both groups, but the samples from the NG group were more heavily stained. Conclusions: Malnutrition in dams causes alterations in the liver, thymus, and other internal organs of newborn offspring. Significant changes in thymuses were found using human monoclonal antibodies that cross-react with rat proteins, a novel finding in the literature.
C1 [Schuler, Sandra Lucia; Gurmini, Jocemara; Casteleins Cecilio, William Augusto; Viola de Azevedo, Marina Luise; Olandoski, Mdrcia; de Noronha, Lucia] Pontificia Univ Catolica Parana, Ctr Biol & Hlth Sci, Expt Pathol Lab, Curitiba, Parana, Brazil.
RP Schuler, SL (corresponding author), Pontificia Univ Catolica Parana, Ctr Biol & Hlth Sci, Expt Pathol Lab, Curitiba, Parana, Brazil.
EM gastroped@hpp.org.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Alvarez C, 1997, ENDOCRINOLOGY, V138, P2267, DOI 10.1210/en.138.6.2267
   ASTER J, 2000, ROBBINS PATOLOGIA FU, P622
   Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019
   CARRAZA FR, 1999, PEDIAT BASICA, V1, P635
   Coelho-Lemos ICM, 2004, JPEN-PARENTER ENTER, V28, P241, DOI 10.1177/0148607104028004241
   CROSBY WM, 1991, AM J DIS CHILD, V145, P871, DOI 10.1001/archpedi.1991.02160080047019
   FIRMANSYAH A, 1989, AM J CLIN NUTR, V50, P261
   Gurmini Jocemara, 2005, J. Bras. Patol. Med. Lab., V41, P271, DOI 10.1590/S1676-24442005000400009
   Hong LA, 2004, PHYSIOL BEHAV, V82, P453, DOI 10.1016/j.physbeh.2004.04.008
   HUGHES PCR, 1970, J ANAT, V106, P349
   Ingelfinger JR, 2002, AM J HYPERTENS, V15, p46S, DOI 10.1016/S0895-7061(01)02302-0
   Jarvis S, 2005, ARCH DIS CHILD, V90, P474, DOI 10.1136/adc.2004.052670
   Jensen TA, 2003, J HISTOTECHNOL, V26, P101, DOI 10.1179/his.2003.26.2.101
   Jensen TA, 2001, J HISTOTECHNOL, V24, P283
   LEDERMAN SA, 1980, GROWTH, V44, P77
   LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288
   Nunez MC, 1996, J NUTR, V126, P933
   OLIVEIRA FLC, 1999, J PEDIATR, V5, P350
   OLUSI SO, 1976, PEDIATR RES, V10, P707, DOI 10.1203/00006450-197610080-00001
   Ortiz R, 2001, BRIT J NUTR, V86, P545, DOI 10.1079/BJN2001446
   PATRICIO FRS, 1984, REV PAULISTA PEDIAT, V8, P43
   Rasmussen KM, 1998, J NUTR, V128, p390S, DOI 10.1093/jn/128.2.390S
   Rush D, 2001, NUTR REV, V59, P315, DOI 10.1111/j.1753-4887.2001.tb06956.x
   Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485
   SLOBODIANIK NH, 1989, NUTRITION, V5, P417
   *STAND COMM NUTR U, 2004, NUTR IMPR DEV OUTC 5
   Trahair JF, 1997, J NUTR, V127, P637
   TRIAPEGUI JO, 1985, ARQ GASTROENTEROL, V22, P141
   Weaver LT, 1998, J PEDIATR GASTR NUTR, V27, P553, DOI 10.1097/00005176-199811000-00012
   World Health Organization, 1999, NUTR HLTH DEV PROGR
   YOUNG CM, 1987, AM J CLIN NUTR, V46, P36
   YOUNG CM, 1985, AM J CLIN NUTR, V41, P979
   ZEMAN FJ, 1967, J NUTR, V93, P167
NR 33
TC 8
Z9 8
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-6071
EI 1941-2444
J9 JPEN-PARENTER ENTER
JI J. Parenter. Enter. Nutr.
PD MAR-APR
PY 2008
VL 32
IS 2
BP 184
EP 189
DI 10.1177/0148607108314387
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 320JV
UT WOS:000257230400010
PM 18407912
DA 2020-12-08
ER

PT J
AU Marinho, JL
   Piovesan, EJ
   Leite, MP
   Kotze, LR
   de Noronha, L
   Twardowschy, CA
   Lange, MC
   Scola, RH
   Zetola, VHF
   Novak, EM
   Werneck, LC
AF Marinho, Jaqueline Luvisotto
   Piovesan, Elcio Juliato
   Leite Neto, Moacir Pereira
   Kotze, Luiz Roberto
   de Noronha, Lucia
   Twardowschy, Carlos Alexandre
   Lange, Marcos Christiano
   Scola, Rosana Herminia
   Flumignan Zetola, Viviane H.
   Novak, Edison Matos
   Werneck, Lineu Cesar
TI Clinical, neurovascular and neuropathological features in Sneddon's
   syndrome
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE antiphospholipid syndrome; cerebrovascular diseases; neuroimaging;
   neuropathology; Sneddon's syndrome
ID ANTIPHOSPHOLIPID ANTIBODY SYNDROME; OF-THE-LITERATURE; LIVEDO
   RETICULARIS; IMAGING FINDINGS; HEMORRHAGE; DISEASE; STROKE
AB Sneddon's syndrome (SS) is characterized by ischemic cerebrovascular episodes and livedo reticularis. it is more common in young women and can also be associated with valvulopathy, a history of spontaneous abortion, renal involvement and vascular dementia. We describe three cases of young women with this disease. The patients had repeated ischemic cerebral episodes, livedo reticularis and thrombocytopenia. CT and MRI showed strokes and cerebral atrophy. Autopsy in one of the patients revealed cerebral infarctions. Anticardiolipin antibodies were detected in two patients. Anti phospholipid antibodies may be found in some patients with ischemic cerebrovascular events and livedo reticularis. SS may thus be associated with antiphospholipid syndrome. We described three new cases of SS and discuss the pathophysiology of this disease.
C1 UFPR, Serv Neurol, Hosp Clin, Dept Pathol, BR-80060900 Curitiba, Parana, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   UFPR, Dept Clin Med, Hosp Clin, Div Neurol, BR-80060900 Curitiba, Parana, Brazil.
RP Piovesan, EJ (corresponding author), UFPR, Serv Neurol, Hosp Clin, Dept Pathol, Rua Gen Carneiro 181,12 Andar,Sala 1236, BR-80060900 Curitiba, Parana, Brazil.
EM piovesan@avalon.sul.com.br
RI Werneck, Lineu/Y-4038-2019; noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164; Lange, Marcos/0000-0002-0405-7157
CR Ayoub N, 2004, STROKE, V35, P1329, DOI 10.1161/01.STR.0000127534.54538.15
   Boesch SM, 2003, J NEUROL NEUROSUR PS, V74, P542, DOI 10.1136/jnnp.74.4.542
   Bolayir E, 2004, ACTA MED OKAYAMA, V58, P59
   Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187
   CHAMPION RH, 1960, P ROY SOC MED, V53, P961
   da Silva AM, 2005, MOVEMENT DISORD, V20, P248, DOI 10.1002/mds.20270
   de Groot PG, 2005, CURR OPIN INFECT DIS, V18, P205, DOI 10.1097/01.qco.0000168379.01272.53
   Fetoni V, 2000, NEUROL SCI, V21, P157, DOI 10.1007/s100720070091
   Floel A, 2002, EUR NEUROL, V48, P126, DOI 10.1159/000065510
   Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097/00005792-199907000-00001
   Frances C, 2000, J AUTOIMMUN, V15, P139, DOI 10.1006/jaut.2000.0418
   GESCHWIND DH, 1995, NEUROLOGY, V45, P557, DOI 10.1212/WNL.45.3.557
   Gondim FDA, 2003, NEURORADIOLOGY, V45, P368, DOI 10.1007/s00234-003-0990-4
   HACHULLA E, 1995, REV MED INTERNE, V16, P121, DOI 10.1016/0248-8663(96)80676-X
   Hawkins Carolyn, 2006, J Autoimmune Dis, V3, P3, DOI 10.1186/1740-2557-3-3
   Hilton DA, 2003, NEUROLOGY, V60, P1181, DOI 10.1212/01.WNL.0000055931.66009.D3
   KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464, DOI 10.1212/WNL.40.3_Part_1.464
   Kalashnikova LA, 1999, NEUROLOGY, V53, P223, DOI 10.1212/WNL.53.1.223
   Karagulle AT, 2002, EUR RADIOL, V12, P144
   LEVINE SR, 1988, NEUROLOGY, V38, P798, DOI 10.1212/WNL.38.5.798
   Macario F, 1997, NEPHRON, V75, P94, DOI 10.1159/000189506
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Ortel Thomas L, 2005, Hematology Am Soc Hematol Educ Program, P462
   Ruiz-Irastorza G, 2005, RHEUMATOLOGY, V44, P971, DOI 10.1093/rheumatology/keh666
   Serrano-Pozo A, 2004, REV NEUROLOGIA, V39, P731, DOI 10.33588/rn.3908.2004069
   Sinharay R, 2003, POSTGRAD MED J, V79, P550, DOI 10.1136/pmj.79.935.550
   SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111/j.1365-2133.1965.tb14628.x
   STOCKHAMMER G, 1993, STROKE, V24, P685, DOI 10.1161/01.STR.24.5.685
   Sumi Y, 1999, ANN NUCL MED, V13, P109, DOI 10.1007/BF03164886
   Szmyrka-Kaczmarek M, 2005, CLIN RHEUMATOL, V24, P79, DOI 10.1007/s10067-004-0981-9
   Tietjen GE, 2006, CEPHALALGIA, V26, P225, DOI 10.1111/j.1468-2982.2005.01032.x
   Zaccariotti V A, 1995, Arq Neuropsiquiatr, V53, P82
NR 32
TC 8
Z9 10
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2007
VL 65
IS 2B
BP 390
EP 395
DI 10.1590/S0004-282X2007000300005
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 192TD
UT WOS:000248225000005
PM 17665002
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Souza, ZA
   Greca, FH
   de Noronha, L
   Maranhao, ASD
   Calil, AP
   Hubie, DP
   Barbosa, FM
AF de Souza Filho, Zacarias Alves
   Greca, Fernando Hintz
   de Noronha, Lucia
   de Albuquerque Maranhao, Andre Souza
   Calil, Ana Paula
   Hubie, Danila Pinheiro
   Barbosa, Fabiana Matos
TI Abdominal wall healing in reoperated rats
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE reoperation; abdominal wall; cicatrix; rats
ID SUTURE TECHNIQUE; STRENGTH
AB Purpose: Experimental evaluation of the abdominal wall healing in reoperations on the same surgical site, by means of macroscopic analysis, histological and breaking strength studies of the surgical scar. Methods: Twenty-four rats were selected and divided in 3 groups (G1, G2 and G3). A medium longitudinal laparotomy was performed, followed by laparorrhaphy on two synthesis planes, using an interrupted suture technique. The reoperations were performed in the same way, on the same surgical site. On the first day of the study all the 24 rats were operated, on the 30(th) day the 16 animals belonging to G2 and G3 were reoperated, and finally, on the 60(th) day, the 8 rats from G3 were operated for the third and last time. After 30 days of the last laparotomy of each group, euthanasia was performed. Complications such as adhesions were evaluated during the resection of surgical site. The breaking strength study was performed next, followed by the microscopical collagen analysis, using for that histological cuts stained with picrosirius. Results: The adhesions were prevalent in G2 and G3 (16% each) when compared to G1. No significant difference was found in the breaking strength study. Statistically significant difference was observed in collagen concentration analysis. It was found higher mature collagen (type 1) as well as total collagen concentration in the groups operated more than once (G2 and G3). The highest concentration of mature collagen (p < 0,0001) and total collagen (p < 0,0021) were found in G3 followed by G2 and G1 (in this sequence). Conclusion: The highest mature collagen concentration on the experimental groups, points out the importance of inflammatory activity in the healing process; in the resutures of the abdominal wall the surgical scar maturity is faster acquired than in the primary sutures; in relation to the primary sutures, the resutures of the abdominal wall did not influence in the resistance of the surgical scar.
C1 [de Souza Filho, Zacarias Alves] Univ Fed Parana, Dept Surg, BR-80060000 Curitiba, Parana, Brazil.
RP Souza, ZA (corresponding author), R Padre Agostinho, BR-80710000 Curitiba, Parana, Brazil.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR ANGOOD PB, 2003, TRATADO CIRURG, P211
   ARAGHIZADEH F, 2001, COLON RECTAL SURG, V14, P57
   Biondo-Simões Maria de Lourdes Pessole, 2005, Acta Cir. Bras., V20, P124, DOI 10.1590/S0102-86502005000200005
   CARLSON MA, 1997, SURG CLIN N AM, V39, P606
   Fackeldey V, 2004, CHIRURG, V75, P477, DOI 10.1007/s00104-004-0868-y
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Parreira José Gustavo, 2002, Arq. Gastroenterol., V39, P188, DOI 10.1590/S0004-28032002000300010
   POOLE GV, 1984, AM SURGEON, V50, P569
   SEID MH, 1995, ARCH SURG-CHICAGO, V130, P394
   SPERANZINI MB, 2000, ASPECTOS TECNICOS CI, P383
NR 10
TC 7
Z9 7
U1 0
U2 0
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD MAR-APR
PY 2007
VL 22
IS 2
BP 147
EP 151
DI 10.1590/S0102-86502007000200013
PG 5
WC Surgery
SC Surgery
GA 339JD
UT WOS:000258573000013
PM 17375223
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Badin, AZED
   Gondek, LBE
   Garcia, MJ
   do Valle, LC
   Flizikowski, FBZ
   de Noronha, L
AF Badin, AZED
   Gondek, LBE
   Garcia, MJ
   do Valle, LC
   Flizikowski, FBZ
   de Noronha, L
TI Analysis of laser lipolysis effects on human tissue samples obtained
   from liposuction
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE laser lipoplasty; Nd : YAG; laser lipolysis; laser-assisted liposuction
AB Background: The use of the neodymium: yttrium-aluminum-garnet (Nd:YAG) laser as an auxiliary tool for lipoplasty has refined the traditional technique. The primary limitation of the traditional technique-large volume blood loss-is addressed by the use of the Nd:YAG laser. This report describe's the technique of laser-assisted liposuction, then reviews and compares the histologic and morphometric effects with those of the traditional method.
   Methods: The Nd:YAG laser was used to produce the desired injury to the adipose tissue after sufficient contact. Laser lipolysis was performed on the patient's right flank in two different areas, with the application of 1,000 and 3,000 J of accumulated energy (c), respectively. Subsequently, another cannula was introduced to suction the liquid content obtained by laser lipolysis. This tissue product was sent to the pathology laboratory for morphologic and morphometric analysis, and for comparison with material obtained from traditional lipoplasty performed on the left flank of the same patient.
   Results: The histopathologica examination of adipose tissue after laser lipolysis showed cell swelling and less bleeding, as compared with the traditional method. The morphometric analysis showed that the mean diameter of the major adipocye was 95.69 mu m with laser lipolysis using 1,000 J (epsilon), 82.63 mu m using 3,000 J (epsilon), and 84.54 mu m with the traditional method
   Conclusions: The traditional method produced less reversible cellular damage (swelling) than laser lipolysis using 1,000 J (epsilon). The area receiving 3,000 J (epsilon) showed major irreversible damage (cytoplasmatic retraction and disruption of membranes). For this reason, the mean diameter of the adipocyte was less.
C1 Catholic Pontificie Univ Brazil, Hlth & Sci Biol Ctr, Expt Pathol Lab, BR-80215901 Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Catholic Pontificie Univ Brazil, Hlth & Sci Biol Ctr, Expt Pathol Lab, Imaculada Conceicao St,1155 Prado Velho, BR-80215901 Curitiba, Parana, Brazil.
EM badinanaz@cmathena.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR APFELBERG DB, 1994, AESTHET PLAST SURG, V18, P259, DOI 10.1007/BF00449791
   APFELBERG DB, 1996, CLIN PLAST SURG, V23, P73
   Badin AZD, 2002, AESTHET PLAST SURG, V26, P335, DOI 10.1007/s00266-002-1510-3
   BADIN AZD, 2003, REJUVENESCIMENTO FAC, V17, P318
   BADIN AZD, 2002, REV SOC BRAS LASER M, V22, P17
   BARCELOS J, 1992, CIRURGIA PLASTICA ES, V83, P791
   Commons GW, 2001, PLAST RECONSTR SURG, V108, P1753, DOI 10.1097/00006534-200111000-00050
   DASSUMPCAO E, 1994, ATUALIZACAO CIRURGIA, V53, P501
   Dressel T., 1990, LIPOPLASTY SOC NEWSL, V7, P17
   GODDIO AS, 1991, PLAST RECONSTR SURG, V87, P66, DOI 10.1097/00006534-199101000-00012
   Grippaudo FR, 2000, PLAST RECONSTR SURG, V106, P197, DOI 10.1097/00006534-200007000-00037
   HORIBE ED, 2000, ESTETICA CLIN CIRURG, P273
   Matarasso A, 2001, JAMA-J AM MED ASSOC, V285, P266, DOI 10.1001/jama.285.3.266
   TOLEDO LS, 2000, ESTETICA CLIN CIRURG, V39, P265
   Young VL, 2001, PLAST RECONSTR SURG, V108, P1429, DOI 10.1097/00006534-200110000-00051
NR 15
TC 72
Z9 76
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-216X
EI 1432-5241
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD JUL-AUG
PY 2005
VL 29
IS 4
BP 281
EP 286
DI 10.1007/s00266-004-0102-9
PG 6
WC Surgery
SC Surgery
GA 956OT
UT WOS:000231310400014
PM 16075355
DA 2020-12-08
ER

PT J
AU Torres, LFB
   de Noronha, L
   Scheffel, DLH
   Pinheiro, DL
   Gugelmin, ES
AF Torres, LFB
   de Noronha, L
   Scheffel, DLH
   Pinheiro, DL
   Gugelmin, ES
TI Choroid plexus tumours: epidemiologic comparative study of 24 cases
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE central nervous system tumours; choroid plexus turnours; choroid plexus
   carcinoma
ID CARCINOMA
AB Tumours derived from choroid plexus are rare central nervous system neoplasms affecting mainly children. This study presents a series of 38 patients with neuroectodermal tumours. Twenty four of them had the histological and/or immunohistochemical diagnosis of choroid plexus carcinoma (CPC). Sixteen of these patients Were male. The left lateral ventricle was affected in most cases. Main clinical features were: hydrocephalus, intracranial hypertension and convulsion. All the patients were treated by surgery. There were 2 deaths due to surgical complications. Nine patients had recurrence, dying in a intermediate time of 12.3 months and 7 patients remain alive. The other cases did not present available data. CPC is very prevalent in Curitiba when compared to other choroid plexus tumours and it might be related to some pathogenic agent.
C1 PUCPR, Lab Patol Expt, BR-80215901 Curitiba, Parana, Brazil.
   PUCPR, Acad Inciacao Cientif, BR-80215901 Curitiba, Parana, Brazil.
   Hosp Infant Pequeno Principe, Curitiba, Parana, Brazil.
RP Torres, LFB (corresponding author), PUCPR, Lab Patol Expt, Rua Imaculata Conceicao 1155, BR-80215901 Curitiba, Parana, Brazil.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR Aguzzi A., 2000, PATHOLOGY GENETICS T, P84
   ANG LC, 1990, CANCER, V32, P131
   AUSMAN JI, 1984, SURG NEUROL, V22, P472, DOI 10.1016/0090-3019(84)90305-7
   Berger C, 1998, NEUROSURGERY, V42, P470, DOI 10.1097/00006123-199803000-00006
   BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504
   Bleggi-Torres LF, 2000, ARQ NEURO-PSIQUIAT, V58, P505, DOI 10.1590/S0004-282X2000000300017
   Chow E, 1999, INT J RADIAT ONCOL, V44, P249, DOI 10.1016/S0360-3016(98)00560-4
   COATES TL, 1989, RADIOLOGY, V173, P81, DOI 10.1148/radiology.173.1.2781035
   GOTTSCHALK J, 1993, CANCER, V72, P1343, DOI 10.1002/1097-0142(19930815)72:4<1343::AID-CNCR2820720432>3.0.CO;2-G
   LENA G, 1990, ACTA NEUROCHIR, V106, P68, DOI 10.1007/BF01809335
   MATSUDA M, 1991, SURG NEUROL, V36, P294, DOI 10.1016/0090-3019(91)90091-M
   PIERGA JY, 1993, MED PEDIATR ONCOL, V21, P480, DOI 10.1002/mpo.2950210705
   RUSSEL DS, 1989, PATHOLOGY TUMOURS NE
   TAGLE MP, 1994, CHIL PEDIATR, V65, P276
   Wolff JEA, 1999, LANCET, V353, P2126, DOI 10.1016/S0140-6736(99)01744-4
NR 15
TC 3
Z9 4
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2004
VL 62
IS 1
BP 127
EP 130
DI 10.1590/S0004-282X2004000100022
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 810RU
UT WOS:000220722200022
PM 15122446
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Noronha, L
   Ghanem, RC
   Medeiros, F
   Knopfholz, J
   Magalhaes, TA
   Sampaio, GA
   Serapiao, MJ
   Torres, LFB
AF de Noronha, L
   Ghanem, RC
   Medeiros, F
   Knopfholz, J
   Magalhaes, TA
   Sampaio, GA
   Serapiao, MJ
   Torres, LFB
TI Holoprosencephaly: morphological aspects of twelve cases of autopsy
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE holoprosencephaly; autopsy; nervous system malformations
AB The term holoprosencephaly (HPC) is used to indicate the group of hemispheric deformities caused by a failure in the development of the prosencephalic vesicle. The purpose of this study is to explain the morphologic specter of twelve cases of HPC, qualify them, and compare them to the literature. It was evaluated 5837 pediatrics necropsies, and there were 12 cases of HPC. Data like gender, age and the presence of another associated malformations were evaluated and compared to another malformations and to the total number of necropsies. The majority of the cases was male (66.66%), and stillborns (75%). The most frequently type of HPC found was the lobar type (58.3%), and the most frequently type of facial alteration was the ciclopy (25%). There is a statistic tendency to HPC affect the male sex, in comparison with other neurologic malformations. Besides, the stillborns are more frequently observed in HPC than in other neurologic malformations.
C1 PUCPR, Lab Patol Expt, BR-80215901 Curitiba, Parana, Brazil.
   UFPR, HC, SAP, UPPP, Curitiba, Parana, Brazil.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR BARR M, 1983, J PEDIATR-US, V102, P565, DOI 10.1016/S0022-3476(83)80185-1
   CHERVENAK FA, 1984, OBSTET GYNECOL, V63, P115
   DEMEYER W, 1963, NEUROLOGY, V13, P913
   DEMEYER W, 1971, BIRTH DEFECTS ORIG A, V7, P78
   DIAMENT A, 1989, NEUROLOGIA INFANTIL, P112
   DUCKETT S, 1995, PEDIAT NEUROPATHOLOG, P108
   ELIAS DL, 1992, PLAST RECONSTR SURG, V90, P951, DOI 10.1097/00006534-199212000-00002
   FRIEDE RL, 1989, DEV NEUROPATHOLOGY, P296
   Lamego I S, 1994, Arq Neuropsiquiatr, V52, P523
   NELSON WE, 1997, TRATADO PEDIAT, P35
   Noronha L, 2000, ARQ NEURO-PSIQUIAT, V58, P890, DOI [10.1590/S0004-282X2000000500015, DOI 10.1590/S0004-282X2000000500015]
   Parant O., 1997, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V26, P687
   Roach E, 1975, Birth Defects Orig Artic Ser, V11, P294
   SAUNDERS ES, 1984, J MED GENET, V21, P21, DOI 10.1136/jmg.21.1.21
   STEVENSON DK, 1997, FETAL NEONATAL BRAIN, P107
NR 15
TC 1
Z9 2
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2001
VL 59
IS 4
BP 913
EP 919
DI 10.1590/S0004-282X2001000600014
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 500JM
UT WOS:000172623600014
PM 11733837
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Noronha, L
   Medeiros, F
   Martins, VDM
   Nones, RB
   Sepulcri, RP
   Prevedello, LMS
   Sampaio, GA
   Serapiao, MJ
   Torres, LFB
AF de Noronha, L
   Medeiros, F
   Martins, VDM
   Nones, RB
   Sepulcri, RP
   Prevedello, LMS
   Sampaio, GA
   Serapiao, MJ
   Torres, LFB
TI The neuropathology of neonatal period: analysis of 1616 autopsies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE newborn; central nervous system; autopsy
ID CENTRAL-NERVOUS-SYSTEM; CONGENITAL TOXOPLASMOSIS; MENINGITIS; AUSTRALIA;
   DEFECTS
AB The lesions of the central nervous system represent an important cause of morbid-mortality in the neonatal period. This is due to the vulnerability of the brain to several adverse conditions during gestation and after birth. This study analyses the prevalence and pattern of central nervous system lesions in neonates autopsied at Hospital de Clinicas - Curitiba. There were 5743 pediatric autopsies performed in the Sector of Anatomic Pathology from 1960 to 1995 with 2049 cases corresponding to death during neonatal period. These later autopsies were reviewed and all cases with central nervous system lesions were selected and classified according to sex, age and pattern of central nervous system lesion. The central nervous system was affected in 1616 (78,87%) of neonatal autopsies and there was predominance of intracerebral hemorrhages (73,39%), congenital malformations (4,27%) and infections (3,59%). The hypoxic hemorrhages are the most prevalent central nervous system lesions in the neonatal period, affecting mainly premature babies. There was predominance of central nervous system malformations in the female neonates.
C1 Univ Fed Parana, Hosp Clin, Serv Anat Patol,Dept Patol Med, Unidade Patol Pediat & Perinatal, BR-80060900 Curitiba, Parana, Brazil.
EM luno@uol.com.br
RI noronha, lucia/F-6339-2015; Prevedello, Luciano/G-8650-2014; Nones,
   Rodrigo Bremer/AAV-6065-2020
OI noronha, lucia/0000-0003-0310-7164; Nones, Rodrigo
   Bremer/0000-0002-6256-2629; Prevedello, Luciano/0000-0002-6768-6452
CR Balasubramaniam V, 1994, Med J Malaysia, V49, P113
   Bale JF, 1997, CLIN PERINATOL, V24, P787
   Binitie O P, 1992, West Afr J Med, V11, P7
   FRANCIS BM, 1992, MED J AUSTRALIA, V156, P240, DOI 10.5694/j.1326-5377.1992.tb139741.x
   FRIEDE RL, 1989, DEV NEUROPATHOLOGY, P21
   GRANROTH G, 1977, BRIT J PREV SOC MED, V31, P164
   HENDERSON JL, 1995, CURR OPIN OBSTET GYN, V7, P130, DOI 10.1097/00001703-199504000-00010
   ICHORD RN, 1992, PEDIATR ANN, V21, P339, DOI 10.3928/0090-4481-19920601-05
   Lind P H, 1992, J Pediatr Health Care, V6, P12, DOI 10.1016/0891-5245(92)90060-H
   LOGAR J, 1992, SCAND J INFECT DIS, V24, P105, DOI 10.3109/00365549209048408
   MISHRA P C, 1989, Indian Pediatrics, V26, P32
   NAKAMURA Y, 1990, ARCH PATHOL LAB MED, V114, P966
   NATHOO KJ, 1991, ANN TROP PAEDIATR, V11, P11, DOI 10.1080/02724936.1991.11747472
   ODELOWO EOO, 1991, INT SURG, V76, P43
   SIMS ME, 1992, AM J PERINAT, V9, P152, DOI 10.1055/s-2007-999309
   SOBANIEC LM, 1996, POL MERKUIUSZ LEK, V1, P334
   Swisher C N, 1994, Semin Pediatr Neurol, V1, P4
   SYNNOTT MB, 1994, ARCH DIS CHILD-FETAL, V71, pF75, DOI 10.1136/fn.71.2.F75
   Taylor DL, 1999, BRAIN PATHOL, V9, P93
   TESSIN I, 1990, ACTA PAEDIATR SCAND, V79, P1023, DOI 10.1111/j.1651-2227.1990.tb11378.x
   TRIMBLE BK, 1978, TERATOLOGY, V17, P43, DOI 10.1002/tera.1420170111
   VERMA M, 1991, Indian Journal of Pediatrics, V58, P245, DOI 10.1007/BF02751129
   VINTERS HV, 1995, PEDIAT NEUROPATHOLOG, P302
   VOLPE JJ, 1989, ANN NEUROL, V25, P3, DOI 10.1002/ana.410250103
   WALPOLE IR, 1991, MED J AUSTRALIA, V154, P720, DOI 10.5694/j.1326-5377.1991.tb121307.x
   WIGGLESWORTH JS, 1996, PERINATAL PATHOLOGY, P23
   XIAO KZ, 1990, INT J EPIDEMIOL, V19, P978
NR 27
TC 3
Z9 4
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2001
VL 59
IS 2B
BP 411
EP 416
DI 10.1590/S0004-282X2001000300019
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 451AV
UT WOS:000169779700019
PM 11460189
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU De Noronha, L
   Medeiros, F
   Martins, VD
   Sampaio, GA
   Serapiao, MJ
   Kastin, G
   Torres, LFB
AF De Noronha, L
   Medeiros, F
   Martins, VD
   Sampaio, GA
   Serapiao, MJ
   Kastin, G
   Torres, LFB
TI Malformations of the central nervous system: analysis of 157 pediatric
   autopsies
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE malformation; central nervous system; autopsy
ID CONGENITAL-MALFORMATIONS; DEFECTS
AB The malformations of the central nervous system affect about 5 to 10 children per 1000 births. We studied the central nervous system malformations in 5837 pediatric autopsies performed in the Sector of Anatomic Pathology, Hospital de Clinicas-UFPR, between 1960 and 1995. There were 157 central nervous system malformations (2.69%), the commonest were neural tube defects (61%): 47 cases of anencephaly and 45 cases classified in the group of myeloencephaloceles. The anomalies of the prosencephalic evagination corresponded to 8% of all central nervous system malformations, with seven cases of holoprosencephaly. Posterior fossa malformations occurred in 3%, with three cases of Arnold-Chiari. In the present study, the mortality rate due to central nervous system malformations was higher in the neonatal period.
C1 Univ Fed Parana, Hosp Clin, Serv Anat Patol, Unidade Patol Pediat & Perinatal,Acad Med & Estag, BR-80060900 Curitiba, Parana, Brazil.
   Univ Fed Parana, Dept Patol Med, BR-80060900 Curitiba, Parana, Brazil.
EM luno@uol.com.br
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR BIEGGITORRES LF, 1998, THESIS CURITIBA
   GRANROTH G, 1977, BRIT J PREV SOC MED, V31, P164
   GUILBERTBARNESS E, 1997, POTTERS PATHOLOGY FE, P1045
   Himmetoglu O, 1996, INT J GYNECOL OBSTET, V55, P117, DOI 10.1016/S0020-7292(96)02743-9
   KALTER H, 1991, INT J EPIDEMIOL, V20, P173, DOI 10.1093/ije/20.1.173
   KOO H, 1991, Journal of Korean Medical Science, V6, P287
   LUFT AQ, 1998, PRENAT DIAGN, V18, P567
   MISHRA P C, 1989, Indian Pediatrics, V26, P32
   ODELOWO EOO, 1991, INT SURG, V76, P43
   ROESSMANN U, 1995, PEDIAT NEUROPATHOLOG, P123
   SOBANIEC LM, 1996, POL MERKUIUSZ LEK, V1, P334
   TRIMBLE BK, 1978, TERATOLOGY, V17, P43, DOI 10.1002/tera.1420170111
   VERMA M, 1991, Indian Journal of Pediatrics, V58, P245, DOI 10.1007/BF02751129
   WIGGLESWORTH JS, 1996, PERINATAL PATHOLOGY, P222
   XIAO KZ, 1990, INT J EPIDEMIOL, V19, P978
NR 15
TC 6
Z9 7
U1 0
U2 1
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2000
VL 58
IS 3B
BP 890
EP 896
DI 10.1590/S0004-282X2000000500015
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 362RD
UT WOS:000089791300015
PM 11018827
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU de Noronha, L
   Medeiros, F
   Nones, RB
   Martins, VD
   Sepulcri, RD
   Sampaio, GA
   Kasting, G
   Serapiao, MJ
   Torres, LFB
AF de Noronha, L
   Medeiros, F
   Nones, RB
   Martins, VD
   Sepulcri, RD
   Sampaio, GA
   Kasting, G
   Serapiao, MJ
   Torres, LFB
TI Brain hypoxic-ischaemic injury of haemorrhagic pattern in newborns:
   analysis of 1028 autopsies from 1960 to 1995
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE hypoxic-ischaemic injury; central nervous system; newborn infant
AB Hypoxic-ischaemic injury of the central nervous system (CNS) in newborns is a very prevalent entity affecting 1 to 6 children per 1000 births. This injury may induce severe neurological sequelae. We present the analysis of 1028 consecutive cases of hypoxic ischaemic CNS injuries of haemorrhagic pattern detected in autopsies performed at the Division of Anatomic Pathology, Hospital de Clinicas, University of Parana, Brazil, from 1960 to 1995. The prevalence of these lesions was high (49.73%) amongst all autopsied newborns. The main types of haemorrhage were microscopical intra-parenchymal haemorrhages, intraventricular and periventricular haemorrhages and subarachnoid foci of bleeding. Our results emphasize that premature children constitute a high 1 risk group for CNS haemorrhage needing special preventive therapeutic procedures to avoid neurological complications.
C1 Univ Fed Parana, Hosp Clin, Dept Patol Med,Serv Anat Patol, Unidade Patol Pediat & Perinatal, BR-80060900 Curitiba, Parana, Brazil.
   Univ Fed Parana, Hosp Clin, Med Acad, Unidade Patol Pediat & Perinatal, BR-80060900 Curitiba, Parana, Brazil.
EM luno@uol.com.br
RI Nones, Rodrigo Bremer/AAV-6065-2020; noronha, lucia/F-6339-2015
OI Nones, Rodrigo Bremer/0000-0002-6256-2629; noronha,
   lucia/0000-0003-0310-7164
CR CARSON SC, 1990, AM J ROENTGENOL, V155, P595, DOI 10.2214/ajr.155.3.2117361
   FRIEDE RL, 1989, DEV NEUROPATHOLOGY, P21
   Gherpelli J L, 1992, Arq Neuropsiquiatr, V50, P284
   ICHORD RN, 1992, PEDIATR ANN, V21, P339, DOI 10.3928/0090-4481-19920601-05
   NAKAMURA Y, 1990, ARCH PATHOL LAB MED, V114, P966
   Taylor DL, 1999, BRAIN PATHOL, V9, P93
   VINTERS HV, 1995, PEDIAT NEUROPATHOLOG, P302
   VOLPE JJ, 1989, ANN NEUROL, V25, P3, DOI 10.1002/ana.410250103
   WIGGLESWORTH JS, 1996, PERINATAL PATHOLOGY, P23
NR 9
TC 1
Z9 1
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1999
VL 57
IS 4
BP 950
EP 958
DI 10.1590/S0004-282X1999000600009
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 260XD
UT WOS:000083978000009
PM 10683685
OA Other Gold
DA 2020-12-08
ER

PT J
AU Torres, LFB
   Reis, JS
   Netto, MRM
   De Noronha, L
   Alessio, AB
   Neto, AD
AF Torres, LFB
   Reis, JS
   Netto, MRM
   De Noronha, L
   Alessio, AB
   Neto, AD
TI Infantile desmoplastic ganglioglioma: a clinical, pathological and
   epidemiological study of five cases
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE ganglioglioma; desmoplastic ganglioglioma; infant; brain tumors
ID CEREBRAL ASTROCYTOMA; INFANCY; TUMORS
AB Infantile desmoplastic gangliogliomas are rare tumors of the central nervous system, composed by a mixture of glial and neuronal cells and a fibrous stroma, which affect mainly young patients and arise from the surface of the cerebral hemispheres. We present five cases of infantile desmoplastic ganglioglioma: three were male and two were female. The ages ranged from three months and seven years (mean 2.62 years). The symptoms reflected the growth and topography of the tumors affecting the parietal (n=3), parieto-occipital (n=1), occipital (n=1) lobes. Immunohistochemistry was performed in two cases with similar results to those reported in the literature.
C1 Univ Fed Parana, Hosp Clin, Serv Anat Patol, Secao Microscopia Eletron & Neuropatol, BR-80060900 Curitiba, Parana, Brazil.
   Univ Fed Parana, Dept Clin Med, BR-80060900 Curitiba, Parana, Brazil.
   Univ Fed Parana, Hosp Clin, Serv Radiol, BR-80060900 Curitiba, Parana, Brazil.
CR DECHADAREVIAN JP, 1990, CANCER, V66, P173, DOI 10.1002/1097-0142(19900701)66:1<173::AID-CNCR2820660131>3.0.CO;2-H
   DUFFNER PK, 1994, NEUROSURGERY, V34, P583, DOI 10.1227/00006123-199404000-00003
   KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x
   KUCHELMEISTER K, 1993, ACTA NEUROPATHOL, V85, P199, DOI 10.1007/BF00227768
   MARTIN DS, 1991, AM J NEURORADIOL, V12, P1195
   NG THK, 1990, HISTOPATHOLOGY, V16, P235, DOI 10.1111/j.1365-2559.1990.tb01109.x
   Stevens A, 1982, THEORY PRACTICE HIST
   TARATUTO AL, 1984, CANCER, V54, P2505, DOI 10.1002/1097-0142(19841201)54:11<2505::AID-CNCR2820541132>3.0.CO;2-G
   TORRES LFB, 1995, J BRAS PATOL, V31, P65
   VANDENBERG SR, 1987, J NEUROSURG, V66, P58, DOI 10.3171/jns.1987.66.1.0058
   VANDENBERG SR, 1993, BRAIN PATHOL, V3, P275, DOI 10.1111/j.1750-3639.1993.tb00754.x
   VANDENBERG SR, 1991, BRAIN TUMOR PATHOL, V8, P25
NR 12
TC 7
Z9 7
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1998
VL 56
IS 3A
BP 443
EP 448
DI 10.1590/S0004-282X1998000300014
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 108KR
UT WOS:000075266000014
PM 9754426
OA Other Gold
DA 2020-12-08
ER

PT J
AU Torres, LFB
   Jacob, GVV
   DeNoronha, L
   Sampaio, GA
   Antoniuk, S
   Bruck, I
AF Torres, LFB
   Jacob, GVV
   DeNoronha, L
   Sampaio, GA
   Antoniuk, S
   Bruck, I
TI Electron microscopical study in neurodegenerative diseases in infancy
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE neurodegenerative diseases; electron microscopy; diagnosis; infancy
ID NIEMANN-PICK DISEASE; CONJUNCTIVAL
AB Neurodegenerative diseases are a group of disorders in which there is storage of abnormal material in cells throughout the body due to an enzyme defect. The authors present the experience in the diagnosis of the neurodegenerative diseases in infancy by electron microscopical study of skin, conjunctival and rectum material of 89 patients and 2 necropsy cases. The age of the patients ranged from 49 days to 13 years with a peak age of incidence in first year of life (n=28). Fifty patients were female and 39 were male. The most frequent sites of biopsy were the skin and conjunctival. Of the total 89 patients, 15 had a definitive diagnosis (16.8%) including 4 cases of gangliosidosis, 3 cases of mucopolysnccharidosis, a case of Gaucher's disease, a case of Niemann-Pick disease, 3 cases of neuronal ceroid lipofuscinosis and 3 cases of storage disease which could not be specified. The authors studied all these patients within clinic and ultrastructural aspects and concluded that electron microscopy is an important method in diagnosis of storage diseases but with a low sensivity as a single ''screening'' test for patients with progressive encephalopathy.
C1 UNIV FED PARANA,HOSP CLIN,SERV ANAT PATOL,SECAO MICROSCOPIA ELETRON & NEUROPATOL,BR-80060000 CURITIBA,PARANA,BRAZIL.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR ARSENIONUNES ML, 1981, ANN NEUROL, V9, P163, DOI 10.1002/ana.410090210
   ELLEDER M, 1989, PATHOL RES PRACT, V185, P293, DOI 10.1016/S0344-0338(89)80006-8
   HARZER K, 1981, ARCH PSYCHIAT NERVEN, V230, P71, DOI 10.1007/BF00343769
   LAKE BD, 1988, P R MICROSCOP SOC, V23, P45
   NAKANO T, 1978, ADV NEUROL SCI, V22, P1376
   ROSEMBERG S, 1987, Arquivos de Neuro-Psiquiatria, V45, P7
   ROSEMBERG S, 1995, NEUROPEDIATRIA, P237
   Torres L F, 1994, Arq Neuropsiquiatr, V52, P52
   TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269
   Torres LFB, 1997, ARQ NEURO-PSIQUIAT, V55, P114, DOI 10.1590/S0004-282X1997000100018
   TORRES LFB, 1990, ARQ NEUROPSIQUIATR S, V48, pA233
   VANIER MT, 1988, CLIN GENET, V33, P331
NR 12
TC 0
Z9 0
U1 0
U2 3
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1997
VL 55
IS 4
BP 788
EP 794
DI 10.1590/S0004-282X1997000500016
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA YJ091
UT WOS:A1997YJ09100016
PM 9629339
OA Other Gold
DA 2020-12-08
ER

PT J
AU Torres, LFB
   Jacob, GVV
   Reis, JS
   DeNoronha, L
AF Torres, LFB
   Jacob, GVV
   Reis, JS
   DeNoronha, L
TI Primary paediatric tumours of the central nervous system: pathological
   study of 623 cases
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE brain tumours; infancy; central nervous system; immunohistochemistry
ID CHILDHOOD BRAIN-TUMORS; CHILDREN; NEOPLASMS; GLIOMAS
AB Tumours of central nervous system (CNS) represent the second most frequent malignancy in children under 15 years of age but are the commonest cause of death. The authors present the epidemiologic and histopathologic analysis of 623 primary tumours of CNS occurring during the period 1990 to 1996 in paediatric patients. In this period 3318 biopsies of CNS were analyzed. In this total were included 623 paediatric tumours (18.7%). The age of patients ranged from 5 months to 15 years, 325 tumours occurred in males and 298 in females. The majority affected the posterior fossa. The majority of paediatric neoplasias were of glial origin (n=277). The most frequent tumours were: astrocytoma (27.9%), medulloblastoma (9.95%), craniopharyngioma (5.93%), ependymoma (4.97%) and glioblastoma (3.37%).
C1 UNIV FED PARANA,HOSP CLIN,SECAO MICROSCOPIA ELETRON & NEUROPATOL,SERV ANAT PATOL,BR-80060900 CURITIBA,PARANA,BRAZIL.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR HONIG PJ, 1982, AM J DIS CHILD, V136, P121, DOI 10.1001/archpedi.1982.03970380033008
   LAURESSEN TC, 1984, P AM ASS NEUROL SURG
   LESSER GJ, 1994, SEMIN ONCOL, V21, P220
   LIVESEY EA, 1990, BRIT J CANCER, V61, P622, DOI 10.1038/bjc.1990.138
   MARCHESE MJ, 1990, CANCER, V65, P2771, DOI 10.1002/1097-0142(19900615)65:12<2771::AID-CNCR2820651227>3.0.CO;2-J
   MOSTOW EN, 1991, J CLIN ONCOL, V9, P592, DOI 10.1200/JCO.1991.9.4.592
   NISHIO S, 1989, ACTA NEUROCHIR, V101, P3, DOI 10.1007/BF01410061
   PACKER RJ, 1994, SEMIN ONCOL, V21, P260
   PACKER RJ, 1989, J NEUROSURG, V70, P107
   PrestonMartin S, 1996, AM J EPIDEMIOL, V143, P105
   SCHIFF D, 1995, NEUROL CLIN, V13, P953, DOI 10.1016/S0733-8619(18)30027-6
   Schofield D E, 1992, Neurosurg Clin N Am, V3, P723
   SCHWARTZ RB, 1995, NEUROL CLIN, V13, P723, DOI 10.1016/S0733-8619(18)30015-X
   SEGALL HD, 1985, CANCER, V56, P1748, DOI 10.1002/1097-0142(19851001)56:7+<1748::AID-CNCR2820561304>3.0.CO;2-#
   Shiminski-Maher T, 1995, J Pediatr Oncol Nurs, V12, P188, DOI 10.1177/104345429501200403
   Stevens A, 1982, THEORY PRACTICE HIST
   Torres L F, 1990, Arq Neuropsiquiatr, V48, P279
   TORRES LFB, 1995, J BRAS PATOL, V31, P65
NR 18
TC 9
Z9 9
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1997
VL 55
IS 4
BP 795
EP 800
DI 10.1590/S0004-282X1997000500017
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA YJ091
UT WOS:A1997YJ09100017
PM 9629340
OA Other Gold
DA 2020-12-08
ER

PT J
AU Torres, LFB
   DeNoronha, L
   Jacob, GVV
   Antoniuk, S
AF Torres, LFB
   DeNoronha, L
   Jacob, GVV
   Antoniuk, S
TI Anatomo-pathological and ultrastructural features in
   mucopolysaccharidosis: Case report
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE mucopolysaccharidoses; storage diseases; neurodegenerative diseases
ID HUNTER-SYNDROME; PATIENT; DISEASE
AB The mucopolysaccharidoses (MPS) are lysosomal storage diseases in which a specific enzyme defect causes glycosaminoglicans storage in tissues. The authors present a necropsy case of a 10 years old boy with clinical and laboratorial diagnosis of MPS. The necropsy revealed thickening of meninges, cardiac valves and hepatomegaly. The microscopical examination of the brain showed finely vacuolated histiocytes around blood vessels and meninges. Systemic deposits of vacuolated histiocytes in cardiac valves and liver were also detected. The ultrastructural examination of the brain, liver and spleen showed filamentous material accumulated in vacuolated histiocytes and hepatocytes and features neuronal storage disease.
C1 UNIV FED PARANA,HOSP CLIN,SERV ANAT PATOL,SECAO MICROSCOPIA ELETR & NEUROPATOL,BR-80060000 CURITIBA,PARANA,BRAZIL.
   UNIV FED PARANA,HOSP CLIN,SERV NEUROPEDIAT,BR-80060000 CURITIBA,PARANA,BRAZIL.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR ADAMS JH, 1992, GREENFIELDS NEUROPAT, P753
   BAX MCO, 1995, ARCH DIS CHILD, V73, P77, DOI 10.1136/adc.73.1.77
   BERGSTROM SK, 1994, BONE MARROW TRANSPL, V14, P653
   CLEARY MA, 1995, ACTA PAEDIATR, V84, P337, DOI 10.1111/j.1651-2227.1995.tb13640.x
   DUCKET S, 1995, PEDIAT NEUROPATHOLOG, P525
   FANGKIRCHER SG, 1995, J INHERIT METAB DIS, V18, P94, DOI 10.1007/BF00711389
   FIELD RE, 1994, J BONE JOINT SURG BR, V76B, P975
   HOOD AF, 1995, ARCH DERMATOL, V131, P81
   KREIDSTEIN A, 1994, CAN J ANAESTH, V41, P423, DOI 10.1007/BF03009866
   PETRUSCHKA L, 1994, J INHERIT METAB DIS, V17, P89, DOI 10.1007/BF00735402
   POORTHUIS BJHM, 1994, PEDIATR RES, V36, P187, DOI 10.1203/00006450-199408000-00009
   RESNICK JM, 1994, HUM PATHOL, V25, P276, DOI 10.1016/0046-8177(94)90200-3
   Stevens A, 1982, THEORY PRACTICE HIST
   Torres L F, 1994, Arq Neuropsiquiatr, V52, P52
   TORRES LFB, 1990, ARQ NEUROPSIQUIATR S, V48, pA233
   TORRES LFB, 1991, 13 C SOC BRAS MICR E, V2, P465
NR 16
TC 1
Z9 1
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 1997
VL 55
IS 1
BP 114
EP 121
DI 10.1590/S0004-282X1997000100018
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA WP869
UT WOS:A1997WP86900018
PM 9332570
OA Other Gold
DA 2020-12-08
ER

PT J
AU Torres, LFB
   Madalozzo, LE
   Werner, B
   DeNoronha, L
   Jacob, GVV
   Medeiros, BC
   Vialle, EN
AF Torres, LFB
   Madalozzo, LE
   Werner, B
   DeNoronha, L
   Jacob, GVV
   Medeiros, BC
   Vialle, EN
TI Meningiomas: Epidemiological and pathological studies of 304 cases
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE brain tumor; meningioma; epidemiology; histopathology
ID INTRACRANIAL MENINGIOMAS; RECURRENCE; TUMORS; IRRADIATION; RECEPTOR;
   SURGERY; SERIES
AB The authors have retrospectively reviewed all tumors of central nervous system (CNS) operated at the most important neurosurgery hospitals of Curitiba in a 5-year period (1990-1994) and found 304 (22.4%) cases of meningioma. Age mean of the patients was 48.5 years, with a range of 3 to 90 years. A marked female preponderance (68.7%) was noted. The most common tumor location was brain (n=280) and the remaining cases occurred in spinal cord (n=10), cerebellum (n=9) and cranial nerves (n=5). Histologically, there were 294 (96.7%) meningiomas of the classical type, six malignant or anaplastic, three atypical and one papillary. Two hundred and sixty seven classical meningiomas were from the meningotelial subtype, ten psamomatousos, five fibroblastic, five microcystic, five transicional and two angiomatous. The authors conclude that meningiomas are one of the most common group of primary neoplasias of CNS and the definition of malignancy in those tumors is beset by frequent discordance between histologic and biologic features.
C1 UNIV FED PARANA,HOSP CLIN,SERV ANAT PATOL,SECAO NEUROPATOL & MICROSCOPIA ELET,BR-80060900 CURITIBA,PARANA,BRAZIL.
   UNIV FED PARANA,HOSP CLIN,SERV NEUROCIRURG,BR-80060900 CURITIBA,PARANA,BRAZIL.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR ADEGBITE AB, 1983, J NEUROSURG, V58, P51, DOI 10.3171/jns.1983.58.1.0051
   BERHO M, 1994, AM J SURG PATHOL, V18, P100, DOI 10.1097/00000478-199401000-00010
   BURGER PC, 1993, ATLAS TUMOR PATHOL, P259
   CARROLL RS, 1995, J NEUROSURG, V82, P453, DOI 10.3171/jns.1995.82.3.0453
   CHAN RC, 1984, J NEUROSURG, V60, P52, DOI 10.3171/jns.1984.60.1.0052
   DIETEMANN JL, 1982, NEURORADIOLOGY, V23, P207, DOI 10.1007/BF00342542
   JAASKELAINEN J, 1986, SURG NEUROL, V25, P233, DOI 10.1016/0090-3019(86)90233-8
   JESUS O, 1995, NEUROSURGERY, V36, P489
   KEPES JJ, 1984, SURG NEUROL, V22, P149, DOI 10.1016/0090-3019(84)90043-0
   KINJO T, 1995, NEUROSURGERY, V36, P1082, DOI 10.1227/00006123-199506000-00003
   KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x
   KURATSU J, 1994, ACTA NEUROCHIR WIEN, V31, P289
   MACK EE, 1993, J NEUROSURG, V79, P28, DOI 10.3171/jns.1993.79.1.0028
   MAIER H, 1992, J NEUROSURG, V77, P616, DOI 10.3171/jns.1992.77.4.0616
   MARKS SM, 1986, SURG NEUROL, V25, P436, DOI 10.1016/0090-3019(86)90081-9
   MIRIMANOFF RO, 1985, J NEUROSURG, V62, P18, DOI 10.3171/jns.1985.62.1.0018
   MOTTA LAC, 1995, ARQ NEURO-PSIQUIAT, V53, P324
   NAKASU S, 1987, SURG NEUROL, V27, P319, DOI 10.1016/0090-3019(87)90005-X
   NEW PFJ, 1980, RADIOLOGY, V136, P665, DOI 10.1148/radiology.136.3.7403545
   OLIVERO WC, 1995, J NEUROSURG, V83, P222, DOI 10.3171/jns.1995.83.2.0222
   PASQUIER B, 1986, CANCER, V58, P299, DOI 10.1002/1097-0142(19860715)58:2<299::AID-CNCR2820580215>3.0.CO;2-W
   PERROTAPPLANAT M, 1992, ACTA NEUROCHIR, V115, P20, DOI 10.1007/BF01400586
   RHEE BA, 1995, NEUROSURGERY, V36, P393, DOI 10.1227/00006123-199502000-00021
   RUSSELL EJ, 1980, RADIOLOGY, V135, P673, DOI 10.1148/radiology.135.3.7384454
   SCHWECHHEIMER K, 1984, LAB INVEST, V51, P584
   SHEEHY JP, 1983, J NEUROSURG, V59, P1, DOI 10.3171/jns.1983.59.1.0001
   SHUANGSHOTI S, 1992, SURG NEUROL, V38, P129, DOI 10.1016/0090-3019(92)90090-A
   SOFFER D, 1983, J NEUROSURG, V59, P1048, DOI 10.3171/jns.1983.59.6.1048
   Stevens A, 1982, THEORY PRACTICE HIST
   Torres L F, 1990, Arq Neuropsiquiatr, V48, P279
   TORRES LFB, 1995, J BRAS PATOL, V31, P65
   YOUNIS GA, 1995, J NEUROSURG, V82, P17, DOI 10.3171/jns.1995.82.1.0017
   ZEE CS, 1995, NEUROSURGERY, V36, P482, DOI 10.1227/00006123-199503000-00006
NR 33
TC 2
Z9 3
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1996
VL 54
IS 4
BP 549
EP 556
DI 10.1590/S0004-282X1996000400001
PG 8
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA VV486
UT WOS:A1996VV48600001
PM 9201333
OA Other Gold
DA 2020-12-08
ER

PT J
AU Torres, LFB
   DeMedeiros, BC
   DeNoronha, L
   Pedroso, A
   Ramina, R
AF Torres, LFB
   DeMedeiros, BC
   DeNoronha, L
   Pedroso, A
   Ramina, R
TI Optic nerve gliomas: A study of 11 cases
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE optic nerve; astrocytoma; optic chiasm; glioma
ID NEUROFIBROMATOSIS
AB Optic nerve gliomas may occur alone or as components of neurofibromatosis. They are rare tumors accounting for 2 to 5% of all intracranial tumors and 6% of the intra-orbitary neoplasms. The authors present II cases of optic nerve glioma diagnosed in Curitiba in the last 25 years. Out of these 11 patients there were 10 women and only 1 man. The ages ranged from 3 to 25 years old, and 6 patients were under 15 years. In this series, 27,3% (n = 3) of the cases were associated with neurofibromatosis. Five patients had their tumors restricted to the optic nerve while the others had either extension to the optic chiasm, supra-selar region, frontal or temporal lobe. All the patients had pilocytic astrocytomas.
C1 FED UNIV PARANA,HOSP CLIN,SERV ANAT PATOL,SECAO MICROSCOPIA ELETRON & NEUROPATOL,CURITIBA,PARANA,BRAZIL.
   FED UNIV PARANA,HOSP CLIN,DISCIPLINA ANAT PATOL,CURITIBA,PARANA,BRAZIL.
   FED UNIV PARANA,CURITIBA,PARANA,BRAZIL.
RI ; noronha, lucia/F-6339-2015
OI Ramina, Ricardo/0000-0002-4967-9603; noronha, lucia/0000-0003-0310-7164
CR BRUGGERS CS, 1991, AM J OPHTHALMOL, V111, P719, DOI 10.1016/S0002-9394(14)76778-9
   DEKEIZER RJW, 1989, AM J OPHTHALMOL, V108, P717, DOI 10.1016/0002-9394(89)90868-4
   EGGERS H, 1985, CLIN OPHTHALMOL, P1
   FLICKINGER JC, 1988, CANCER, V61, P635, DOI 10.1002/1097-0142(19880215)61:4<635::AID-CNCR2820610403>3.0.CO;2-2
   LISTERNICK R, 1994, J PEDIATR-US, V125, P63, DOI 10.1016/S0022-3476(94)70122-9
   LISTERNICK R, 1989, Journal of Pediatrics, V114, P788, DOI 10.1016/S0022-3476(89)80137-4
   LISTERNICK R, 1990, J PEDIATR-US, V116, P845, DOI 10.1016/S0022-3476(05)80639-0
   RUSSELL DS, 1989, PATHOLOGY TUMOURS NE, P370
   SEIFF SR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1689, DOI 10.1001/archopht.1987.01060120087032
   Torres L F, 1990, Arq Neuropsiquiatr, V48, P279
   TORRES LFB, 1995, J BRAS PATOL, V31, P65
   Wishart J H, 1822, Edinb Med Surg J, V18, P393
   WONG JYC, 1987, CANCER, V60, P1847, DOI 10.1002/1097-0142(19871015)60:8<1847::AID-CNCR2820600829>3.0.CO;2-E
NR 13
TC 0
Z9 0
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 1996
VL 54
IS 2
BP 280
EP 283
DI 10.1590/S0004-282X1996000200015
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA UM754
UT WOS:A1996UM75400015
PM 8984986
OA Other Gold
DA 2020-12-08
ER

PT J
AU DENORONHA, L
   WERNER, B
   MENDONCA, CMC
   NOMURA, L
   BLEGGITORRES, LF
AF DENORONHA, L
   WERNER, B
   MENDONCA, CMC
   NOMURA, L
   BLEGGITORRES, LF
TI SACROCOCCYGEAL CHORDOMA IN A 9-YEAR-OLD BOY
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE CHORDOMA; IMMUNOHISTOCHEMISTRY; NOTOCHORD; BONE TUMORS
ID CLINICOPATHOLOGICAL ANALYSIS; CHILDHOOD; DIAGNOSIS
AB A case of sacrococcygeal chordoma in a 9-year-old boy is presented. The symptoms al presentation were pain in both legs and sacrococcygeal region for the last two years that increased in the last foul weeks irradiating mainly to the left leg. X-my and CT scan examinations of the lumbar region revealed an expansive process in the coccygeal region with multiple calcifications and a partially eroded coccyx, There was no invasion of the retroperitoneum and regional lymph nodes. A biopsy was performed and showed cords and nests of cells with large cytoplasm, sometimes vacuolated, nuclei with moderate pleomorphism and clumped chromatin. Immunohistochemistry with avidin-biotin peroxidase technique showed positivity for CK, S-100 protein, CEA, vimentin and to EMA. Chordomas are a distinctly uncommon neoplasm in the first two decades of life, specially in the sacrococcygeal region. They have an aggressive behavior. Treatment of choice is complete resection.
C1 FED UNIV PARANA,HOSP CLIN,DEPT PEDIAT,BR-80060900 CURITIBA,PARANA,BRAZIL.
   HOSP NOSSA SENHORA DAS GRACAS,CURITIBA,PARANA,BRAZIL.
   FED UNIV PARANA,HOSP CLIN,NEUROPATHOL & ELECTRON MICROSCOPY SECT,BR-80060900 CURITIBA,PARANA,BRAZIL.
RI noronha, lucia/F-6339-2015
OI noronha, lucia/0000-0003-0310-7164
CR ABENOZA P, 1986, HUM PATHOL, V17, P744, DOI 10.1016/S0046-8177(86)80185-X
   BJORNSSON J, 1993, CANCER-AM CANCER SOC, V71, P735, DOI 10.1002/1097-0142(19930201)71:3<735::AID-CNCR2820710314>3.0.CO;2-8
   COFFIN CM, 1993, ARCH PATHOL LAB MED, V117, P927
   HRUBAN RH, 1990, AM J PATHOL, V137, P435
   KAISER TE, 1984, CANCER, V54, P2574
   KANEKO Y, 1991, NEUROSURGERY, V29, P442, DOI 10.1227/00006123-199109000-00019
   KEISCH ME, 1991, J NEUROSURG, V75, P374, DOI 10.3171/jns.1991.75.3.0374
   MIETTINEN M, 1984, ARCH PATHOL LAB MED, V108, P891
   RICH TA, 1985, CANCER, V56, P182, DOI 10.1002/1097-0142(19850701)56:1<182::AID-CNCR2820560131>3.0.CO;2-J
   SALISBURY JR, 1993, J PATHOL, V171, P59, DOI 10.1002/path.1711710112
   SALISBURY JR, 1993, J PATHOL, V171, P253, DOI 10.1002/path.1711710404
   WALAAS L, 1991, HUM PATHOL, V22, P22, DOI 10.1016/0046-8177(91)90056-U
   WOLD LE, 1983, J NEUROSURG, V59, P1043, DOI 10.3171/jns.1983.59.6.1043
NR 13
TC 3
Z9 3
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1995
VL 53
IS 3B
BP 654
EP 658
DI 10.1590/S0004-282X1995000400018
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA TB699
UT WOS:A1995TB69900018
PM 8585826
OA Other Gold
DA 2020-12-08
ER

EF